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**1**   **Characteristics of Pediatric Asthma Patients with Bronchodilator Irreversible Airflow Obstruction (AO)**

**G. Chiang**, R. C. Strunk, L. B. Bacharier; Pediatrics, Washington University/St. Louis Children\'s Hospital, St. Louis, MO.

**2**   **Epidemiological Study on Allergy and Asthma Phenotypes: Sub-clinical and Severe Asthma**

**C. D\'Ambrosio** ^1^, P. Pierimarchi^2^, M. Bresciani^1^, C. Parisi^1^, D. Spina^1^, A. Torre^2^, M. Turbati^3^, G. Rasi^2^, S. Bonini^1,2^; ^1^IRCCS San Raffaele, Roma, ITALY, ^2^INMM-CNR, Roma, ITALY, ^3^ASSILT, Roma, ITALY.

**3**   **Declines in Daily Digital Measures of FEV1 and Peak Flow Correspond with Albuterol Usage in Adults, but not in Children**

**K. D. Carel** ^1,2^, N. Rabinovitch^1,2^, M. Strand^3^, M. Gleason^1^, J. R. Mault^4^, A. H. Liu^1,2^; ^1^Pediatrics, National Jewish Medical and Research Center, Denver, CO, ^2^Pediatrics, University of Colorado School of Medicine, Denver, CO, ^3^Biostatistics, National Jewish Medical and Research Center, Denver, CO, ^4^MicroLife USA, Dunedin, FL.

**4**   **The Effect of Vascular Endothelial Growth Factor on the Bronchial Hyper-Responsiveness in Children Asthma Patients**

**H. Kim** ^1^, J. Choung^2^; ^1^Pediatrics, Korea University Hospital, Ansan, REPUBLIC OF KOREA, ^2^Pediatrics, Korea University Hospital, Seoul, REPUBLIC OF KOREA.

**5**   **Relationship between Physician Diagnosed Asthma, eNO, and Measures of Airway Hyperresponsivenes**

**F. A. Romero**, D. L. Waggoner, D. T. Chiang, J. Clark, R. J. Hopp, R. G. Townley, T. B. Casale; Department of Medicine: Division of Allergy and Immunology, Creighton University, Omaha, NE.

**6**   **Bronchodilatory Response Achieved With Foradil Compared To Regularly Dosed Albuterol In Older Asthmatics**

U. Yegen^1^, D. Till^2^, **G. P. Geba** ^1^; ^1^USCDMA, Novartis Pharmaceuticals Corp., E Hanover, NJ, ^2^Novartis Horsham Research Centre, Novartis Pharmaceuticals Corp., Horsham, UNITED KINGDOM.

**7**   **Is Wheezing the Best Endpoint for Bronchial Challenges in Young Children?**

**L. Stewart**, C. Mjaanes, M. Gleason, R. Covar, J. Spahn; Pediatrics, National Jewish Medical and Research Center, Denver, CO.

**8**   **Percentage Fall in FVC at the Methacholine PC~20~ (DFVC) in Cough-Variant Asthma and Classic Asthma**

**Y. Yoo** ^1^, J. Yu^2^, D. K. Kim^2^, S. H. Choi^2^, Y. Y. Koh^2^; ^1^Department of Pediatrics, Korea University Anam Hospital, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Seoul National University Hospital, Seoul, REPUBLIC OF KOREA.

**9**   **Misdiagnosis of Exercise Induced Asthma in Two Patients Years After Surgical Repair of Congenital Anomalies**

**Y. K. Persaud** ^1^, C. Lamm^2^, B. Silverman^1^, A. T. Schneider^1^; ^1^Allergy and Immunology, Long Island College Hospital, Brooklyn, NY, ^2^Allergy and Immunology, Mount Sinai Hospital, New York, NY.

**10**   **ROC Curve Analysis of Skin Testing and Specific IgE Antibodies Values to Predict Clinical Allergy to Alternaria in Asthmatic Subjects**

**E. Bevilacqua**, N. Fernández, C. Fernández, M. Garcimartin, S. Romero, A. Gomez, R. Vives; Servicio de alergia, HOSPITAL 12 DE OCTUBRE, MADRID, SPAIN.

**11**   **Versican is Required for Hyaluronan (HA) Dependant Poly I:C Stimulated Leukocyte Binding to Human Lung Fibroblasts (HLF)**

**L. C. Altman** ^1,2^, S. Perigo^2^, T. Wilkinson^2^, P. Johnson^2^, T. N. Wight^3,2^; ^1^Allergy, University of Washington School of Medicine, Seattle, WA, ^2^Benaroya Research Institute, Seattle, WA, ^3^University of Washington, Seattle, WA.

**12**   **Utilisation of an Environmental Challenge Chamber (ECC) to Explore Allergen Induced Bronchial Hyperresponsiveness (BHR) in Mild Asthmatic Patients with Co-morbid Rhinitis**

**N. Krug** ^1^, J. M. Hohlfeld^1^, A. Bruns^1^, P. Russell^2^, A. Weeks^2^, M. Larbig^1^, R. D. Murdoch^2^; ^1^Fraunhofer ITEM, Hannover, GERMANY, ^2^GSK, Stevenage, UNITED KINGDOM.

**13**   **Exercise-Induced Bronchospasm (EIB) in Obese and Non-Obese Adolescents**

W. A. Lopes^1^, N. Leite^2^, G. C. Santos^2^, A. L. Prestes^2^, V. F. Dressler^2^, **N. A. Rosario** ^2^; ^1^Department of Physical Education, University of Parana, Curitiba, BRAZIL, ^2^Department of Pediatrics, University of Parana, Curitiba, BRAZIL.

**14**   **Lung Function in Children with Stable, Controlled Asthma: A Critical Look at Inclusion Criteria for Clinical Trials in Childhood Asthma**

**A. Baatenburg de Jong**, R. J. Roorda, P. L. P. Brand; Pediatrics, Princess Amalia Children\'s Clinic, Zwolle, THE NETHERLANDS.

**15**   **Impaired Bronchodilatory Effect of Deep Inspiration With Increased Asthma Severity**

**S. Soresi** ^1^, N. Scichilone^2^, A. Togias^1^, V. Bellia^2^; ^1^Division of Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, MD, ^2^Cattedra di Malattie dell\'Apparato Respiratorio, Istituto di Medicina Generale e Pneumologia,Universita' degli Studi di Palermo, Palermo, ITALY.

**16**   **Comparison of Asthma and Allergy Symptoms in Recreational Roadrunners with Olympic Athletes**

**C. C. RANDOLPH** ^1^, D. Bangalore^2^; ^1^ALLERGY, YALE, WATERBURY, CT, ^2^Medicine /Information Services, Yale Affiliate Waterbury Hospital, WATERBURY, CT.

**17**   **Underlying Aspiration Exacerbating Asthma in a Boy Treated for IgG Subclass Deficiency**

**P. Hemmers** ^1^, R. Giusti^2^, B. Silverman^1^, A. T. Schneider^1^; ^1^Allergy & Immunology, Long Island College Hospital, Brooklyn, NY, ^2^Pediatric Pulmonology, Long Island College Hospital, Brooklyn, NY.

**18**   **Matrix Metalloproteinase-1 Polymorphism is Associated with Persistent Airway Obstruction in Chronic Stable Asthma in the Taiwanese Population**

**C. D. Huang**, S. M. Lin, C. H. Wang, C. Y. Liu, H. C. Lin, H. P. Kuo; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan, TAIWAN REPUBLIC OF CHINA.

**19**   **Risk Factors Associated with Repeat Emergency Department Visits for Children with Asthma in South Korea**

**Y. Rha** ^1^, S. Choi^1^, S. Kim^2^, D. Lee^3^, G. Park^4^, J. Park^5^; ^1^Dept. of Pediatrics, Kyung Hee Medical Center, Seoul, REPUBLIC OF KOREA, ^2^Dept. of Pediatrics, St. Benedict Hospital, Busan, REPUBLIC OF KOREA, ^3^Dept. of Pediatrics, Dong Kang Medical Center, Ulsan, REPUBLIC OF KOREA, ^4^Dept. of Pediatrics, Presbyterian Hospital, Jeonju, REPUBLIC OF KOREA, ^5^Dept. of Pediatrics, Soon Chun Hyang Hospital, Cheonan, REPUBLIC OF KOREA.

**20**   **A Study Using the In-Check Dial^®^ to Evaluate Peak Inspiratory Flow Rate from Thai Children Population Age 5-18 Years**

**T. Bunupuradah**; Allergy and Immunology, Pediatrics department, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND.

**21**   **Skin Test Reactivity in Children with Asthma and Rhinitis in New Orleans Prior to Hurricane Katrina**

**L. Kim** ^1^, J. M. El-Dahr^2^; ^1^Allergy/Immunology, Tulane University Health Sciences Center, New Orleans, LA, ^2^Pediatric Allergy/Immunology/Rheumatology, Tulane University Health Sciences Center, New Orleans, LA.
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**22**   **Zileuton, 600 mg QID, Provides Early and Sustained Improvement in Pulmonary Function Compared to Placebo in Moderate and Severe Asthmatic Patients Versus Placebo**

**W. E. Berger** ^1^, J. J. Murray^2^, G. N. Gross^3^, R. Menendez^4^, K. Walton-Bowen^5^; ^1^Allergy and Asthma Associates of Southern California and Southern California Research, Mission Viejo, CA, ^2^Vanderbilt ASAP Research, Vanderbilt University Medical Center, Nashville, TN, ^3^Pharmaceutical Research and Consulting, Dallas, TX, ^4^Allergy and Asthma Center of El Paso, El Paso, TX, ^5^Clinical Operations, Biostatistical Analysis, and Reporting, Critical Therapeutics, Inc., Lexington, MA.

**23**   **Monitoring of the Serum Levels of Endothelin and Eosinophil Cationic Protein in Children with Asthma Treated by Montelukast**

**F. Koprˇiva** ^1,2^; ^1^Dept. of Pediatrics, Palacky University, Olomouc, CZECH REPUBLIC, ^2^Pediatrics, Palacky University, Olomouc, CZECH REPUBLIC.

**24**   **Inhibitory Efficacy Of LTRA On Aspirin Induced Bronchospasm**

**J. Park**; Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi Do, REPUBLIC OF KOREA.

**25**   **The Improvement Combinational Effects of Oral Montelukast and Conventional Therapy on Airway Function for Treating Asthma Attacks**

**H. Sagara**, K. Sugiyama, T. Okada, M. Ota, T. Fukuda; Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, JAPAN.

**26**   **A Case Study of Churg Strauss Syndrome with Montelukast and Inhaled Corticosteroids**

S. A. Dyer^1^, **W. J. Geimeier** ^2^; ^1^Dept. of Medicine, Christiana Care, Newark, DE, ^2^Asthma & Allergy Care of Delaware, Newark, DE.

**27**   **Pharmacological Profile of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A~2~ Receptor (TP)**

**M. Ishimura**, M. Suda, S. Kataoka, T. Maeda, Y. Hiyama; Pharmacology Department, Kaken Pharmaceutical Co.,Ltd., Kyoto, JAPAN.

**28**   **Effects of KP-496DPI, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A~2~ Receptor (TP), on the Asthmatic Responses in Guinea Pigs**

**M. Suda** ^1^, K. Morizumi^2^, M. Ishimura^1^, T. Maeda^1^, S. Kataoka^1^, Y. Hiyama^1^; ^1^Pharmacology Department, Kaken Pharmaceutical Co., Ltd., Kyoto, JAPAN, ^2^Pharmacology Department, Panapharm Laboratories Co.,Ltd., Kumamoto, JAPAN.

**29**   **Leukotriene Receptor Antagonist May Prevent the Progression of Preschool Children Asthma**

**M. Ebisawa**, M. Ogata, T. Komata, T. Imai, M. Tomikawa, A. Shukuya, H. Tachimoto; Department of Allergy, Sagamihara National Hospital, Kanagawa, JAPAN.

**30**   **Clinically Relevant Improvements in Asthma-Related Quality of Life in Patients Receiving Omalizumab as Add-On Therapy**

**W. Busse** ^1^, H. Fox^2^, K. Surrey^2^, R. Maykut^3^, C. Reisner^3^; ^1^Department of Medicine, University of Wisconsin, Madison, WI, ^2^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, ^3^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**31**   **Omalizumab Induces Resolution of Fungal Sinusitis in a 15 Year Old Asthmatic Patient**

**R. Menendez**; Allergy & Asthma Center of El Paso, El Paso, TX.

**32**   **Add-On Omalizumab Improves Asthma Control across Multiple Measures of Response in Patients with Severe Persistent Allergic Asthma**

**W. Berger** ^1^, H. Fox^2^, G. Ayre^2^, M. Blogg^2^, M. Massanari^3^, C. Reisner^3^; ^1^Allergy and Asthma Associates of Southern California, Mission Viejo, CA, ^2^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, ^3^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**33**   **Safety of Anti-IgE Therapy with Omalizumab in Allergic Patients at Risk of Geohelminth Infection**

**P. J. Cooper** ^1^, F. Lima^2^, E. C. Sarinho^3^, G. Ayre^4^, C. Martin^4^, H. Fox^4^, A. A. Cruz^2^; ^1^Laboratorio de Investigaciones, Hospital Pedro Vicente Maldonado, Quito, ECUADOR, ^2^Centro de Enfermidades Respiratórias, Faculdade de Medicina da Bahia - UFBA, Salvador, BRAZIL, ^3^Departamento de Pediatria, Faculdade de Medicina da Universidade Federal de Pernambuco, Pernambuco, BRAZIL, ^4^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.

**34**   **Omalizumab Downregulates the Expression of CD23 (FceRII) on Human Bronchial Smooth Muscle Cells (HBSMC) in Vitro**

**M. R. Streck**, J. Tole, R. K. Gandhi, T. M. Loun, C. W. Stewart, D. B. Lew; Pediatrics, UT Memphis, Memphis, TN.

**35**   **Omalizumab, an Anti-IgE Monoclonal Antibody, Demonstrates Long-Term Asthma Control, Safety and Tolerability in Patients with Severe Allergic Asthma**

**J. Hébert** ^1^, M. Rolli^2^, J. Gao^2^, C. Reisner^2^; ^1^CRAAQ, Sainte-Foy, PQ, CANADA, ^2^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**36**   **Anti-IgE Treatment Improves Lung Function In Patients With Mild Persistent Allergic Asthma**

E. L. van Rensen^1^, C. E. Evertse^1^, S. A. Gauw^1^, G. Ayre^2^, P. J. Sterk^1^, **K. F. Rabe** ^1^; ^1^Pulmonology, Leiden University Medical Center, Leiden, THE NETHERLANDS, ^2^Novartis, Horsham, UNITED KINGDOM.

**37**   **Evaluating Response to Omalizumab Therapy in Clinical Practice**

**G. Ayre** ^1^, H. Fox^1^, C. Reisner^2^; ^1^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, ^2^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**38**   **Omalizumab Reduced Need for Steroid Bursts and Improved Treatment Effectiveness in Asthmatics on Inhaled Salmeterol and Fluticasone Combination Therapy**

**M. Massanari** ^1^, F. Kianifard^1^, R. Maykut^1^, R. Zeldin^1^, S. Hedgecock^2^, C. Reisner^1^, G. Geba^1^; ^1^Novartis Pharmaceuticals Corporation, East Hanover, NJ, ^2^Novartis Pharmaceuticals Corporation, Horsham, UNITED KINGDOM.

**39**   **In Moderate-Severe Asthma, Omalizumab Reduced the Need for Rescue Systemic Steroid Bursts and Improved Ratings of Treatment Effectiveness: A Pooled Analysis**

**R. Maykut** ^1^, M. Massanari^1^, R. Zeldin^1^, F. Kianifard^1^, Y. Deniz^2^, C. Reisner^1^, G. Geba^1^; ^1^Novartis, East Hanover, NJ, ^2^Genentech, So San Francisco, CA.

**40**   **Anaphylaxis to Omalizumab after 14 Months of Successful Therapy**

**K. S. Price**, L. Woodard, L. Pingle, M. Larson, K. Galloway, D. Graves; Allergy, Asthma and Dermatology Associates, PC., Portland, OR.

**41**   **Neovastat Inhibits the VEGF production via HIF-2α Suppression in Murine Model of Asthma**

**S. Lee**, S. Kwon, Y. Kim, S. Park; Internal Medicine, The Catholic University of Korea, Seoul, REPUBLIC OF KOREA.

**42**   **Ciclesonide 160 μg Once Daily is as Effective as Budesonide 400 μg Once Daily in Pediatric Patients with Persistent Asthma**

**A. von Berg** ^1^, M. L. Garcia^2^, S. Hellbardt^3^, T. D. Bethke^3^; ^1^Marien-Hospital Wesel, Wesel, GERMANY, ^2^Hospital Severo Ochoa, Madrid, SPAIN, ^3^ALTANA Pharma AG, Konstanz, GERMANY.

**43**   **Time of Achievement of Final Adult Height in Children Treated with Inhaled Budesonide**

**L. Agertoft**, S. Pedersen; Dept. of Pediatrics, University of Southern Denmark, Kolding, DENMARK.

**44**   **Ciclesonide, Administered Once Daily, has No Effect on Growth Velocity in Prepubertal Children with Mild, Persistent Asthma**

**D. Skoner** ^1^, J. Maspero^2^, S. Kundu^3^, M. Lloyd^3^, D. Banerji^3^; ^1^Allegheny General Hospital, Pittsburgh, PA, ^2^Sanatorio San José, Fundacion Cidea, Buenos Aires, ARGENTINA, ^3^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**45**   **Subpotentcy of a Compounded Budesonide for Nebulization Product in a Patient with Poorly Controlled Asthma**

**G. J. WHELAN**, J. D. SPAHN, E. E. BROWN, S. J. SZEFLER;

PEDIATRICS, NATIONAL JEWISH MEDICAL AND RESEARCH CENTER, DENVER, CO.

**46**   **Enrollment Update of the Epidemiologic Study of Xolair: Evaluating the Long-Term Safety and Clinical Effectiveness in Patients with Moderate to Severe Asthma (EXCELS)**

**M. K. Miller** ^1^, J. H. Lee^1^, D. Forer^1^, A. Vaghar^1^, E. Israel^2^, M. Kraft^3^, F. Martinez^4^, D. Miller^5^, G. Shaprio^6^, R. Tarone^7^, S. Szefler^8^; ^1^Genentech, Inc., South San Francisco, CA, ^2^Brigham and Women\'s Hospital, Boston, MA, ^3^Duke University Medical Center, Durham, NC, ^4^University of Arizona School of Medicine, Tucson, AZ, ^5^Harvard School of Public Health, Boston, MA, ^6^University of Washington, Seattle, WA, ^7^International Epidemiology Institute, Rockville, MD, ^8^National Jewish Medical and Research Center, Denver, CO.
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**47**   **Pregnancy but not the Allergic Status Influences Innate Cytokine Responses**

**P. E. Amoudruz**; Department of Immunology, Wenner-Gren Institute, Stockholm, SWEDEN.

**48**   **Natural Killer (NK) Cell Subsets in Allergic Patients**

**F. Scordamaglia**, G. Canonica, A. Scordamaglia; Allergy and Respiratory Diseases, University of Genoa, Genoa, ITALY.

**49**   **Activation of Epithelial Cells and Lymphocytes by Staphylococcal Enterotoxin B Induces Profound Expression of Inflammatory Cytokines and Chemokines**

**D. A. Wagner**, S. C. Shin, B. P. Tancowny, R. P. Schleimer, L. C. Grammer; Allergy and Immunology, Northwestern University, Chicago, IL.

**50**   **Differential Regulation of Toll-like Receptor 3, 7, and 8 mRNA Expression in Human Airway Epithelial Cells**

**J. Y. Lee** ^1^, B. L. Zuraw^2^, J. Eddleston^2^; ^1^Division of Allergy, Asthma, and Immunology, Scripps Clinic, La Jolla, CA, ^2^Department of Medicine, University of California, San Diego and Veterans Medical Research Foundation, La Jolla, CA.

**51**   **Role of Surfactant protein D in Murine and Human Allergic Airway Response**

**E. B. Brandt** ^1^, E. E. Muntel^2^, G. K. Hershey^1^, M. Stevenson^3^, J. A. Whitsett^1^, M. E. Rothenberg^1^; ^1^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^University of Cincinnati, Cincinnati, OH, ^3^Akron Children\'s Hospital, Akron, OH.

**52**   **The TLR7 Ligand Loxoribine Induces Pentraxin 3 Expression in Peripheral Blood Mononuclear Cells**

**J. I. Tirumalasetty** ^1^, S. C. Shin^2^, A. C. Miranowski^2^, Q. A. Truong-Tran^2^, L. C. Grammer^2^, P. A. Greenberger^2^, R. P. Schleimer^2^; ^1^Department of Allergy and Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, ^2^Northwestern University, Chicago, IL.

**53**   **Respiratory Syncytial Virus (rsv) Suppresses CD4 T Cell Proliferation through IFN-Alpha and IFN-Lambda**

**B. Chi**, M. Alston, R. Rabin; CBER, US Food and drug administration, Bethesda, MD.

**54**   **Expression of Acidic Mammalian Chitinase in Cord Blood Mononuclear Cells**

**M. Goldberg**, O. Nadiv, N. Luknar-Gabor, Y. Katz; Institute of Allergy and Immunology, Assaf Harofeh Medical Center, Zerifin, ISRAEL.

**55**   **Expression of Toll-Like Receptors on Neutrophils and Eosinophils Isolated from Individuals with and without Asthma**

**H. L. Peake**, A. C. Prosser, P. J. Thompson; Asthma and Allergy Research Institute, Nedlands, Perth, Western Australia, AUSTRALIA.

**56**   **Reduced Serum Levels of Innate Immune Molecules in Subjects with Frequent Asthma Exacerbations**

**E. T. Gardner** ^1^, C. Sheen^1^, L. M. Stierman^2^, B. Jovanovic^2^, J. J. Shannon^3^, C. A. Saltoun^1^, L. C. Grammer^1^, R. P. Schleimer^1^; ^1^Allergy & Immunology, Northwestern University Feinberg School, Chicago, IL, ^2^Northwestern University, Chicago, IL, ^3^Medicine/Pulmonary & Critical Care, Cook County Hospital/ University of Illinois Medical School, Chicago, IL.

**57**   **TLR3 Stimulation Induces Production of B Cell-Activating Factor of the TNF Family (BAFF) in Human Airway Epithelial Cells**

**A. Kato** ^1^, A. Q. Truong-Tran^1^, A. Scott^2^, K. Matsumoto^3^, R. P. Schleimer^1^; ^1^Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, ^2^Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ^3^Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**58**   **Stat6 Activation by IL-4 Downregulates Toll-Like Receptor-4 Expression**

**P. O. Fiset**, M. K. Tulic, S. M. Grover, P. S. A. Skrablin, S. Létuvé, B. D. Mazer, Q. Hamid; Medicine, Meakins Christie Laboratories, McGill University, Montreal, PQ, CANADA.

**59**   **Requirement for the Classical Pathway of NF-kB Activation in NK Cell Cytotolytic Function**

**R. Pandey**, R. P. Deering, M. Kienzle, P. P. Banerjee, J. S. Orange;

Division of Allergy and Immunology, University of Pennsylvania School of Medicine, Children\'s Hospital of Philadelphia, Philadelphia, PA.

**60**   **Human Eosinophils Express Granzyme B and Perforin: Potential Role in Tumour Killing in Oral Squamous Cancer**

**F. Davoine** ^1^, A. Sim^2^, T. Wierzbicki^3^, C. Leong^3^, L. Puttagunta^2^, T. McGaw^1^, D. Yu^3^, R. Moqbel^1^; ^1^Medicine, University of Alberta, Edmonton, AB, CANADA, ^2^Pathology, University of Alberta, Edmonton, AB, CANADA, ^3^Oral Medicine, University of Alberta, Edmonton, AB, CANADA.

**61**   **TNFa Release Results in Increased Expression of the Innate Immune Regulatory Molecule Surfactant Protein D (SP-D) in a Model of Aspergillus fumigatus (Af) and Ozone-Induced Airway Inflammation**

**S. Kierstein** ^1^, Y. Cao^1^, X. Yang^1^, A. Das^2^, A. Haczku^1^; ^1^Pulmonary, Allergy and Critical Care, University of Pennsylvania, Philadelphia, PA, ^2^Centocor, King of Prussia, PA.

**62**   **House Dust Mite Allergen Der f Increase Bronchial Epithelial Cell Cytokine Expression**

**B. Sun**; Dept of Medicine, Guangzhou Institute of Respiratory Diseases, Guangzhou, CHINA.

**63**   **Il-21 Augments Function of Human Dendritic Cells**

**S. Desai**, R. Pahwa, S. Pahwa; University of Miami, Miami, FL.

**64**   **Enhancement of Host Defense Gene Expression by Glucocorticoids (GC) is Mediated by CCAAT-Enhancer Binding Protein (C/EBP)**

**N. Zhang**, A. Q. Troung-Tran, B. Tancowny, R. P. Schleimer; Allergy and Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL.

**65**   **Impaired TLR Signaling in Mononuclear Cells from Patients with Food Allergy**

**L. C. Grammer**; Feinberg School of Medicine, Northwestern University, Chicago, IL.

**66**   **Expression of Plasminogen Activator Inhibitor 2 (PAI-2) in Response to Rhinovirus Infection**

**H. Dagher** ^1^, K. Hanson^1^, R. Brockman-Schneider^1^, W. Lee^2^, A. Mosser^3^, J. Gern^1^; ^1^Department of Pediatrics, University of Wisconsin, Madison, WI, ^2^Department of Pediatric and Medicine, University of Wisconsin, Madison, WI, ^3^Department of Medicine, University of Wisconsin, Madison, WI.

**67**   **Human Mast Cell Cytotoxicity against Human Lymphoma and Myeloid Leukemia Cells**

**O. Ozdemir**; Pediatric Allergy/Immunology, Louisiana State University Health Sciences Ctr., New Orleans, LA.
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**68**   **Observation of Sjögren\'s Syndrome in IL-14a Transgenic Mice**

**C. XU**; Allergy, immunology and rheumatology, SUNY at Buffalo School of Medicine and Biomedical sciences, Buffalo, NY.

**69**   **Oral Administration Decreases Autoimmune Hearing Loss Lesion in the Mice**

**Q. Cai**, T. Yoo; Allergy and immunology, Medicine, Memphis, TN.

**70**   **Somatic Mosaicism of CIAS1 in a Patient with Chronic Infantile Neurologic, Cutaneous, Articular Syndrome**

**M. Saito** ^1^, R. Nishikomori^1^, A. Fujisawa^2^, N. Kambe^2^, M. N. Hizume^1^, I. Okafuji^1^, T. Yoshioka^1^, M. Yoshimoto^1^, K. Omori^3^, T. Kusunoki^1^, T. Heike^1^, Y. Miyachi^2^, T. Nakahata^1^; ^1^Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, JAPAN, ^2^Dermatology, Kyoto University Graduate School of Medicine, Kyoto, JAPAN, ^3^Central Clinical Laboratory, Kyoto University Hospital, Kyoto, JAPAN.

**71**   **Overproduction of IL-4 Leads to Lymphocyte Hyper-Activation, Elevated IgE, and Autoimmunity in the Flaky Skin (fsn) Mouse**

**B. L. Hill**; Applied Medical Sciences, University of Southern Maine, Portland, ME.

**72**   **IL-14 RNA Levels in the Peripheral Blood Leukocytes of Patients with SLE**

**S. Kiratiseavee**, L. Shen, A. N. Baer, J. L. Ambrus, Jr.; Allergy/Immunology/Rheumatology, SUNY at Buffalo, Buffalo, NY.

**73**   **Resolution of PANDAS Like Symptoms by IVIG in a Patient with Specific Antibody Deficiency against Polysaccharide Antigens**

**A. L. B. Hersh**, L. Geng, A. Cushing-Ruby, H. Jyonouchi; Allergy and Immunology, UMDNJ, Newark, NJ.

**74**   **ABR and DPOAE in Tubulin Based Induced Autoimmune Hearing Loss**

**M. Habiby Kermany**, B. Zhou, M. Yoon, T. Yoo; Allergy/ Immunology, University of Tennessee, Memphis, TN.

**75**   **Functional Regulation of Normal and SLE Plasma Cells by DCC (Deleted in Colon Cancer) and its Ligand Netrin-1**

**P. L. Lugar** ^1^, R. Slota^1^, R. T. Fischer^1^, D. Withers^1^, P. Pisitkun^1^, P. E. Lipsky^2^, A. C. Grammer^1^; ^1^Niams, dhhs, NIH, Bethesda, MD, ^2^Niams, dhhs, Autoimmunity Branch, NIH, Bethesda, MD.

**76**   **Infliximab Related Lupus and Associated Valvulitis**

**T. Chadha**, J. E. Hernandez; Baylor College of Medicine, Houston, TX.

**77**   **Characterization of Immune Response In b-tubulin Induced Murine Autoimmune Hearing Loss**

**C. CAI**, B. ZHOU, J. GLICKSTEIN, T. J. YOO; UNIVERSITY OF TENNEESSEE, MEMPHIS, TN.

**78**   **Activin A Deficiency: Association with Autoimmune Lung Disease**

**M. J. Thomassen** ^1^, T. L. Bonfield^2^, B. P. Barna^2^, N. John^2^, M. S. Kavuru^1^; ^1^Pulmonary and Critical Care, East Carolina University, Greenville, NC, ^2^Dept of Pulmonary, Allergy & Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH.

**79**   **\[Withdrawn\]**

**80**   **The Spontaneous and Induced Production of Fas-ligand by Eosinophils from Subjects with Aspirin Hypersensitivity, Allergic Rhinitis and Healthy Volunteers**

**I. Kuprys-Lipinska**, M. Kupczyk, M. Bochenska-Marciniak, P. Gorski, P. Kuna; Allergy and Pneumonology, Barlicki University Hospital, Lodz, POLAND.

**81**   **The *il14* Gene is a Candidate Gene for *sle2***

**L. Shen**, C. Zhang, T. Wang, C. Xu, S. Brooks, J. L. Ambrsu, Jr.;

Medicine, University at Buffalo, SUNY, Buffalo, NY.

**82**   **Diagnostic and Prognostic Value of Soluble P-Selectin and D-Dimer in Juvenile Rheumatoid Arthritis**

**Y. M. El-Gamal** ^1^, N. M. Heshmat^1^, E. M. Hossny^1^, H. M. Afifi^2^, A. M. El-Shibiny^3^, Z. E. Hasan^1^; ^1^Pediatrics, Ain Shams University, Cairo, EGYPT, ^2^Clinical pathology, Ain Shams University, Cairo, EGYPT, ^3^Radiology, Ain Shams University, Cairo, EGYPT.

**83**   **T-Cell Regulated Neutrophilic Inflammation in Auto-Inflammatory Diseases**

**M. Keller** ^1^, Z. Spanou^1^, P. Schaerli^2^, M. Britschgi^1^, N. Yawalkar^3^, M. Seitz^1^, P. M. Villiger^1^, W. J. Pichler^1^; ^1^Clinic of Rheumatology and Clinical Immunology/Allergology, University Hospital, Bern, SWITZERLAND, ^2^Department of Pathology, The CBR Institute for Biomedical Research, Harvard Medical School, Boston MA 02115, MA, ^3^Department of Dermatology, University Hospital, Bern, SWITZERLAND.

**84**   **Serum Levels of Vascular Endothelial Growth Factor in Children and Adolescents with Systemic Lupus Erythematosus**

**N. M. Heshmat** ^1^, T. H. El-Kerdany^2^; ^1^Pediatrics, Ain Shams University, Cairo, EGYPT, ^2^Clinical Pathology, Ain Shams University, Cairo, EGYPT.

**85**   **Raising the Curtain on PFAPA Syndrome - New Aspects Revealed**

**I. Dalal**, D. Tesher, E. Somekh; Pediatric Infectious/Allergy/ Immunology Unit, Pediatric Department, E. Wolfson Medical Center, Holon, ISRAEL.

**86**   **Angioedema in a Girl with Primary C4B Deficiency**

**L. Yao** ^1^, Y. L. Wu^2^, Y. Yu^2^, R. Sorensen^1^; ^1^Allergy & Immunology, LSUHSC-NO, New Orleans, LA, ^2^Pediatrics, Columbus Children Research Institute, Columbus, OH.
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**87**   **Effect of Endotoxin on Metal Working Fluid Induced Hypersensitivity Pneumonitis in Mice**

**M. C. Zacharisen** ^1^, C. Barrios^2^, V. P. Kurup^2^, J. N. Fink^1^; ^1^Pediatrics, Medical College Of Wisconsin, Milwaukee, WI, ^2^Pediatrics, VA Medical Center, Milwaukee, WI.

**88**   **The Implications of Hypersensitivity Pneumonitis (HP) Precipitin Assays in the Diagnosis of Immune Lung Diseases**

**M. R. Murali**; Medicine, Division of Rheumatology, Allergy and Clinical Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

**89**   **VEGF Driven Airway Inflammation was Augmented in Subjects with NK2R 7853 CC Genotype among the Toluene Diisocyanate Exposed Workers**

**Y. Ye** ^1^, J. Choi^2^, S. Kim^3^, S. Kim^1^, D. Nahm^1^, H. Park^1^; ^1^Dept. of Allergy & Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Dept. of Pulmonology & Allergy, Bundang Jesaeng General Hospital, Seongnam, REPUBLIC OF KOREA, ^3^Dept. of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, REPUBLIC OF KOREA.

**90**   **Relationship between Inflammation and Phase II Enzymes in Response to Diesel Exhaust Particles**

**E. M. Lin**, D. Diaz-Sanchez; Clinical Immunology and Allergy, University of California at Los Angeles, Los Angeles, CA.

**91**   **Low Exposure To Inhaled Formaldehyde: Effect On Allergen Bronchial Response In Asthmatics Sensitized To Mite**

**A. CASSET** ^1,2^, C. MARCHAND^3^, A. PUROHIT^1^, S. LE CALVE^3^, C. DONNAY^1^, P. MEYER^4^, G. PAULI^1,2^, F. DE BLAY^1,2^; ^1^Hôpital Lyautey, Hôpitaux Universitaires de Strasbourg, Strasbourg, FRANCE, ^2^Ea 3771, Université Louis Pasteur, Strasbourg, FRANCE, ^3^Centre de Géochimie de la Surface, CNRS (UMR 7517), Strasbourg, FRANCE, ^4^Service de Biostatistiques et Informatique Médicale, Faculté de Médecine, Strasbourg, FRANCE.

**92**   **Exercise in Cold Air Increases Cough Sensitivity to Capsaicin in Patients with Chronic Cough due to Sensory Hyperreactivity**

**E. Millqvist**, E. Ternesten-Hasséus, E. Johansson, O. Löwhagen;

Department of Respiratory Medicine and Allergy, The Sahlgrenska Academy at Göteborg University, Göteborg, SWEDEN.

**93**   **Low Dose Inhaled Endotoxin Induces Elevated Neutrophils in the Airways, A Response Not Observed in Normal Volunteers**

**N. Alexis** ^1,2^, J. C. Lay^1,2^, D. B. Peden^1,2^; ^1^Pediatrics, Center Environmental Med Asthma & Lung Biology, Chapel Hill, NC, ^2^UNC Chapel Hill, Chapel Hill, NC.

**94**   **The Effects of Three Polycyclic-Aromatic Hydrocarbons on Interleukin-4 and Interferon Gamma Production among Atopic Individuals**

**J. S. Collins**, X. Mao, C. Wang, R. L. Miller; Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University, New York, NY.

**95**   **Expression of Latex Allergens on Inner and Outer Surfaces of Latex Surgical Gloves**

**P. M. Tavares** ^1^, C. M. A. Peixinho^1^, M. R. T. Tomás^2^, L. M. P. Taborda-Barata^1^, C. A. T. Tomaz^1^; ^1^Department of Medical Sciences, University of Beira Interior, Health Sciences Research Centre, Covilha, PORTUGAL, ^2^Department of Internal Medicine, Viseu District Hospital, Viseu, PORTUGAL.

**96**   **Occupational Allergy Caused by Inhalation of Pancreatic Extracts in Medical Personnel and Identification of The Major Allergens**

**S. H. Kim** ^1^, H. S. Park^2^, Y. M. Ye^2^, K. C. Shin^1^, S. J. Yong^1^; ^1^Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, REPUBLIC OF KOREA, ^2^Allergy and Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA.

**97**   **Receiver Operating Characteristics (ROC) Analysis of the IMMULITE^®-^2000 3gAllergy^™^ for the Diagnosis of Latex Allergy**

**R. E. Biagini** ^1^, B. A. MacKenzie^1^, D. L. Sammons^1^, S. A. Robertson^1^, E. F. Krieg, Jr.^1^, R. G. Hamilton^2^; ^1^CDC/NIOSH, Cincinnati, OH, ^2^Johns Hopkins University School of Medicine, Baltimore, MD.

**98**   **Occupational Asthma Caused by Styrene in an Autobody Shop Worker**

**M. Fernandez-Nieto** ^1^, S. Quirce^1^, J. Fraj^2^, V. del Pozo^3^, B. Sastre^3^, C. Seoane^3^, C. Lahoz^3^, J. Sastre^1^; ^1^Allergy, Fundacion Jimenez Diaz, Madrid, SPAIN, ^2^Allergy, Hospital Clinico, Zaragoza, SPAIN, ^3^Immunology, Fundacion Jimenez Diaz, Madrid, SPAIN.

**99**   **Clarinettist´s Cheilitis by Allergy to Cane Reed**

**J. Ruiz-Hornillos** ^1^, E. Alonso^1^, C. Perez^1^, G. Davila^1^, M. Lombardero^2^, L. Zapatero^1^, I. Martinez-Molero^1^; ^1^Hospital General Universitario Gregorio Marañon, Madrid, SPAIN, ^2^ALK-ABELLO, Madrid, SPAIN.

**100**   **Occupationally Induced Allergy to the Soybean Cyst Nematode, Heterodera Glycines**

**J. K. Lemmon**, P. S. Hutcheson, H. C. Gray, R. G. Slavin; Division of Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO.

**101**   **Cigarette Smoke-Induced Gene Expression Analysis in Normal Human Bronchial Epithelial Cells**

**A. R. Jones** ^1,2^, J. W. Beckstead^2^, R. F. Lockey^1,3^, S. S. Mohapatra^1,3^;

^1^University of South Florida, Tampa, FL, ^2^College of Nursing, University of South Florida, Tampa, FL, ^3^James A. Haley Veterans' Administration Hospital, Tampa, FL.

**102**   **High Indoor Air Pollution in Public Housing Homes**

**E. Horowitz** ^1^, D. A. Collins^1^, J. Poyser^1^, T. Green^1^, T. Richards^1^, R. Morgan^1^, D. A. Williams^2^, P. N. Breysse^2^, A. Togias^1^; ^1^Johns Hopkins Asthma and Allergy Center, Baltimore, MD, ^2^Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

**103**   **Indoor Fungal Spore Levels Before and After Simple Home Repair and Asthma Education**

**P. Dowling**, F. Hu, L. Johnson, K. Kennedy, C. S. Barnes; Allergy/ Asthma/Immunology, Children\'s Mercy Hospital, Kansas City, MO.

**104**   **Tobacco and Other Drug Use Among High School Students with Asthma**

**S. Merkle** ^1^, S. Everett Jones^1^, L. Wheeler^1^, D. M. Mannino^2^, L. Crossett^1^;

^1^Division of Adolescent and School Health, Centers for Disease Control and Prevention, Atlanta, GA, ^2^Division of Environmental Hazards and Health Effects, Centers for Disease Control and Prevention, Atlanta, GA.

**105**   **Indoor Air Quality (IAQ) and Water Damages in Finnish Hospitals**

**K. E. Reijula**;

Finnish Institute of Occupational Health, Helsinki, FINLAND.

**106**   **Fungal Ergosterol Levels in Typical Homes**

**K. Wagoner**, L. D. Johnson, F. Pacheco, J. Portnoy, C. S. Barnes;

Allergy/Asthma/Immunology, Children\'s Mercy Hospital, Kansas City, MO.
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**107**   **Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes-A Randomized Control Trial**

**M. Sever** ^1^, S. J. Arbes, Jr.^1^, J. C. Gore^2^, R. G. Santangelo^2^, B. Vaughn^3^, H. Mitchell^3^, C. Schal^2^, D. C. Zeldin^1^; ^1^Division of Intramural Research, NIEHS/NIH, Research Triangle Park, NC, ^2^Department of Entomology, North Carolina State University, Raleigh, NC, ^3^Rho, Inc., Chapel Hill, NC.

**108**   **Mite-proof covers: Mite Penetration of Different Types of Materials Claimed to be Mite-proof by the Siriraj Chamber Method**

**V. Mahakittikun** ^1^, C. Sirikasemlert^2^, N. Rungsimuntakul^2^, P. Deemark^3^, J. J. Boitano^4^, E. Tovey^5^, T. Matsumoto^6^, C. Andre^7^; ^1^Parasitology, Mahidol University, Bangkok, THAILAND, ^2^Thailand Textile Institute, Bangkok, THAILAND, ^3^Thailand Textile Institute, Bangkok, THAILAND, ^4^Mahidol University, Stratford, CT, ^5^Woolcock Institute of Medical Research, Sydney, AUSTRALIA, ^6^Child Development, Kumamoto University, JAPAN, ^7^Scientific and Medical Department, FRANCE.

**109**   **Adjuvant Activity of Ambient Particulate Matter on Allergic Immune Response to Alternaria Alternata**

**H. M. Vijay**, V. Kumar, M. Abebe, S. Sevinc, R. Vincent; Environmental health, Environmental Health Directorate, Ottawa, ON, CANADA.

**110**   **The Type of Clinically Relevant Allergen Influences the Course of Respiratory Allergy: 3-Year Prospective Study**

**M. Marogna** ^1^, A. Massolo^2^, G. Passalacqua^3^; ^1^Pneumology Unit, Macchi Hospital, Varese, ITALY, ^2^Allergy and Respiratory Diseases, University of Siena, Siena, ITALY, ^3^Allergy & Respiratory Diseases Dept of Internal Medicine, Genoa University, Genova, ITALY.

**111**   **High Throughput Fluorescent Multiplex Array for Indoor Allergen Exposure Assessment**

**C. D. Earle** ^1^, A. Tsay^1^, B. Saric^1^, R. Godbout^2^, K. G. Oliver^2^, M. D. Chapman^1^; ^1^Indoor Biotechnologies Inc., Charlottesville, VA, ^2^Radix Biosolutions Inc., Austin, TX.

**112**   **Ultraviolet C Exposure is Fatal to American House Dust Mite Eggs**

**G. Needham** ^1^, C. Begg^2^, S. Buchanan^3^; ^1^Entomology, The Ohio State University, Columbus, OH, ^2^Materials Science Engineering, The Ohio State University, Columbus, OH, ^3^Molecular, Cellular and Developmental Biology, The Ohio State University, Columbus, OH.

**113**   **Effectiveness of Vital Oxide for Controlling Fungal Contamination on Building Materials**

**E. Levetin**; Biological Science, University of Tulsa, Tulsa, OK.

**114**   **Harmonia Axyridis (Asian Lady Bug) an Evolving Indoor Allergen**

**T. NAKAZAWA**, L. Naccara, L. E. Goddard, T. A. Platts-Mills; Asthma & Allergy Center, University of Virginia, Charlottesville, VA.

**115**   **Diurnal Variation of Airborne Ragweed Pollen in A Metropolitan Area - An 8 Year Perspective**

**B. Jones**, C. Barnes, J. Portnoy, F. Hu; Allergy/Immunology, Children\'s Mercy Hospital, Kansas City, MO.

**116**   ***Harmonia axyridis* Ladybug Hypersensitivity in Clinical Allergy Practice**

**D. W. Goetz**; Exemplar Allergy and Asthma, Morgantown, WV.

**117**   **Initial Characterization of Monoclonal Antibodies Against the Fungal Hemolysin Stachylysin from *Stachybotrys chartarum***

**D. Schmechel** ^1^, B. J. Green^1^, F. M. Blachere^1^, S. J. Vesper^2^, D. Beezhold^1^; ^1^Health Effects Laboratory Division, CDC/Natl. Inst. Occup. Safety & Health, Morgantown, WV, ^2^National Exposure Research Laboratory, U.S. Environmental Protection Agency, Cincinnati, OH.

**118**   **Ladybug Hypersensitivity Among Residents of Homes Infested with Ladybugs in Kentucky**

**K. Sharma** ^1^, S. Muldoon^1^, M. F. Potter^2^, H. L. Pence^1^; ^1^University of Louisville School of Medicine, Louisville, KY, ^2^University of Kentucky, Lexington, KY.

**119**   **IgE Antibodies to Mouse Urinary Allergens in Sera from Urban Asthmatics: How do we tell if it is an Important Allergen?**

**L. M. Naccara** ^1^, M. Carter^2^, E. Peters^3^, E. Erwin^1^, T. A. E. Platts-Mills^1^; ^1^Division of Asthma, Allergy, and Immunology, University of Virginia, Charlottesville, VA, ^2^Division of Asthma, Allergy, and Immunology, National Institute of Health, Bethesda, MD, ^3^Allergy & Immunology, Austin, TX.

**120**   **Bed Encasings Reduce Reservoir Allergens but not Aeroallergens**

J. Y. Lau, J. K. Sercombe, J. S. Rimmer, **E. R. Tovey**; Woolcock Institute of Medical Research, Sydney, AUSTRALIA.

**121**   **Localization of Species-Specific Antibody Binding Sites to *Stachybotrys Chartarum* Using the Halogen Immunoassay**

**B. J. Green**, D. Schmechel, L. Millecchia, F. Blachere, D. Beezhold; National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV.

**122**   **Application of Building Science Principles to Reduction of Indoor Air Pathogens**

**W. P. Dean, Jr.**; The Phoenix Group, Naples, FL.

**123**   **A Survey Analysis of Allergist\'s Attitudes Toward Environmental Control**

**D. M. Brandt** ^1^, L. Levin^2^, J. A. Bernstein^1^; ^1^Internal Medicine, University of Cincinnati, Cincinnati, OH, ^2^Environmental Health, University of Cincinnati, Cincinnati, OH.

**124**   **Environmental Factors Found in Homes of Asthmatics**

**M. C. Amado**, F. Pacheco, K. Kennedy, L. Johnson, C. S. Barnes; Allergy/Asthma/Immunology, Children\'s Mercy Hospital, Kansas City, MO.

**125**   **Predictors of Clinical Food Allergy in Patients with Pollen Rhinitis**

**M. Corominas**, R. Lleonart; Allergology, Hospital Universitari de Bellvitge, L\'Hospitalet Llobregat (Barcelona), SPAIN.

**126**   **Prevalence and Characteristics of Sensitization to Rabbit in Italy. A Multicentric Survey**

**G. Passalacqua** ^1^, G. Liccardi^2^; ^1^Allergy & Respiratory Diseases Dept of Internal Medicine, Genoa University, Genova, ITALY, ^2^Dept of Chest Diseases, Pneumology and Allergology, A. Cardarelli Hospital, Naples, ITALY.
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**127**   **Cross-Reactivity Among Almond, Peanut and Other Tree Nuts in Almond Allergic Patients**

**A. Kewalramani** ^1^, S. J. Maleki^2^, H. Cheng^2^, S. Teuber^3^; ^1^Division of Clinical Immunology, Allergy & Rheumatology, Tulane University Health Sciences Center, New Orleans, LA, ^2^Southern Regional Research Center, United States Department of Agriculture, New Orleans, LA, ^3^Division of Rheumatology, Allergy & Clinical Immunology, Univeristy of California, Davis, School of Medicine, Davis, CA.

**128**   **Assessing the Impact of Government Advice to Pregnant Mothers to Avoid Peanut on the Prevalence of Peanut Allergy in UK Children at School Entry**

**J. O. Hourihane** ^1^, R. Aiken^2^, R. A. Briggs^3^, S. R. Roberts^2^; ^1^Paediatrics and Child Health, University College Cork, Cork, IRELAND, ^2^Paediatrics, South Manchester University Hospitals Trust, Manchester, UNITED KINGDOM, ^3^Infection, Inflammation and Repair, University of Southampton, Southampton, UNITED KINGDOM.

**129**   **Re-establishment of Oral Tolerance to Peanut in Allergic Mice by the Chinese Herbal Medicine Formula FAHF-2 is Associated with Up-regulation of Mesenteric IFN-g producing CD8^+^ Cells**

**J. Ko**, C. Qu, K. Srivastava, T. Zhang, H. A. Sampson, X. Li; Mount Sinai Medical Center, New York, NY.

**130**   **Different Prevalence of Peanut Allergy in Children in Israel and UK is Not Due to Differences in Atopy**

**G. Du Toit** ^1^, Y. Katz^2^, P. Sasieni^3^, D. Nitzan Kaluski^4^, I. Irit Livne^5^, G. Lack^1^; ^1^Department of Paediatric Allergy, St Marys Hospital, London, UNITED KINGDOM, ^2^Sackler School of Medicine, Allergy & Immunology Institute, Assaf-Harofeh, Tel-Aviv University, ISRAEL, ^3^Cancer Research UK Centre for Epidemiology, Mathematics & Statistics, Queen Mary, University of London, London, UNITED KINGDOM, ^4^Food & Nutrition Administration, Ministry of Health, Israel, Tel Aviv, ISRAEL, ^5^School Health and Health Education, Jerusalem, ISRAEL.

**131**   **Anti-Peanut Ige in 130 Patients According to the Sensitization to Grass Pollens**

**L. GUILLOUX** ^1^, D. Moneret-Vautrin^2^, M. Morisset^2^, F. Codreanu^2^, L. Parisot^2^, G. Kanny^2^; ^1^Marcel Merieux Laboratory, Lyon, FRANCE, ^2^Central Hospital, Nancy, FRANCE.

**132**   **Peanut Specific IgG4 and its Association with Peanut Allergy**

S. Hingley, **G. Du Toit**, G. Roberts, V. Turcanu, G. Lack, H. Fisher, P. Lau; Department of Paediatric Allergy, Imperial College at St Marys Hospital, London, UNITED KINGDOM.

**133**   **Pharmacologic and Immunologic Effects of Individual Herbs of Food Allergy Herbal Formula 2 in a Murine Model of Peanut Allergy**

**J. D. Kattan**, K. D. Srivastava, H. A. Sampson, X. Li; Pediatrics, Mount Sinai School of Medicine, New York City, NY.

**134**   **Peanut Allergen Exposure through Kissing (Saliva): Assessment and Intervention**

**J. M. Maloney** ^1^, M. Chapman^2^, S. H. Sicherer^1^; ^1^ALLERGY/ iMMUNOLOGY, Mount Sinai Medical Center, NY, NY, ^2^ALLERGY/iMMUNOLOGY, INDOOR Biotechnologies Inc, Charlottesville, VA.

**135**   **Determination of Allergenic Cross-Reactivity between 11S-Globulins (Seed Storage Proteins) in Peanut, Tree-Nut and Sesame Allergic Patients Using Peptide Microarray Immunoassay**

**D. A. Lencer** ^1^, L. Rosenfeld^2^, L. Bardina^1^, W. G. Shreffler^1^, H. A. Sampson^1^, K. Beyer^2^; ^1^Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY, ^2^Pediatric Allergy and Immumology, Charite Berlin, Berlin, GERMANY.

**136**   **Peanut Allergy Diagnosis : Comparison of Three Commercial Specific IgE Assays**

**H. Malandain** ^1^, J. L. Fauquert^2^, A. Tridon^3^, H. Susini de Luca^4^, S. Ughetto^5^, Y. Cano^1^; ^1^Clinical Biochemistry Laboratory, Chubert Hospital, Vannes, FRANCE, ^2^Department of Pediatrics, University Hospital, Clermont-Ferrand, FRANCE, ^3^Department of Immunology, University Hospital, Clermont-Ferrand, FRANCE, ^4^L.A.B.M., Fouesnant, FRANCE, ^5^Department of Public Health, Medical University, Clermont-Ferrand, FRANCE.

**137**   **Clinical Characteristics of Patients with Peanut Allergy**

**T. D. Green** ^1^, G. S. Labelle^1^, P. H. Steele^1^, L. A. Lee^1^, V. S. Mankad^1^, L. W. Williams^1^, K. J. Anstrom^2^, A. W. Burks^1^; ^1^Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC, ^2^Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

**138**   **Early Exposures to Peanut and Sensitization at a Children\'s Hospital Clinic**

**A. P. Stallings**, A. D. Hogan; Pediatrics, Children\'s Hospital of the King\'s Daughters, Eastern Virginia Medical School, Norfolk, VA.

**139**   **Development of an ELISA for Digestion-Resistant Ara h 2 Peptide: Monitoring the Peptide in Body Fluids of Healthy Volunteers Who Consumed Peanut**

**J. L. Baumert** ^1^, K. A. Peeters^2^, A. C. Knulst^2^, S. J. Koppelman^2^, S. J. Maleki^3^, E. Knol^2^, S. L. Hefle^1^; ^1^Food Allergy Research & Resource Program, University of Nebraska, Lincoln, NE, ^2^Department of Dermatology/Allergology, University Medical Center, Utrecht, THE NETHERLANDS, ^3^Agricultural Research Service, Southern Regional Research Center, U.S. Department of Agriculture, New Orleans, LA.

**140**   **Risk of Peanut Allergy Associated with High Household Exposure to Peanut in Infancy**

**A. T. Fox** ^1^, G. L. du Toit^1^, H. Syed^2^, P. Sasieni^2^, G. Lack^1^; ^1^Paediatric Allergy, Imperial College, London, London, UNITED KINGDOM, ^2^Cancer Research UK Centre of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, UNITED KINGDOM.

**141**   **Lunch Guidelines Are Effective in Reducing Peanut Substances in Primary School Classrooms in Montreal, Canada**

**D. K. Banerjee** ^1,2^, R. S. Kagan^1^, E. Turnbull^3^, L. Joseph^4^, Y. St. Pierre^3^, C. Dufresne^5^, K. Gray-Donald^6^, A. E. Clarke^1,3^; ^1^Division of Clinical Immunology/Allergy, McGill University Health Centre, Montreal, PQ, CANADA, ^2^Rockefeller University, New York City, NY, ^3^Clinical Epidemiology, McGill University Health Centre, Montreal, PQ, CANADA, ^4^Epidemiology and Biostatistics, McGill University, Montreal, PQ, CANADA, ^5^Association Québécoise des Allergies Alimentaires, Montreal, PQ, CANADA, ^6^School of Dietetics and Human Nutrition, McGill University, Ste. Anne de Bellevue, PQ, CANADA.

**142**   **Food Allergy Management from the Perspective of Restaurant/Food Establishment Personnel**

R. N. Ahuja^1^, J. Hsi^1^, **S. H. Sicherer** ^2^; ^1^Valley Stream South High School, New York, NY, ^2^Pediatrics, Mt Sinai School Of Medicine, New York, NY.

**143**   **Frequency and Significance of Immediate Contact Reactions to Peanut in Food-Sensitive Children**

**B. Wainstein** ^1^, J. B. Ziegler^1^, A. Yee^1^, M. Ziegler^1^, D. Jelley^1^, S. Kashef^2^; ^1^Immunology, Sydney Children\'s Hospital, Sydney, AUSTRALIA, ^2^Shiraz University of Medical Sciences, Shiraz, IRAN (ISLAMIC REPUBLIC OF).

**144**   **Avidity of IgG and IgE in Peanut Allergic Individuals**

**S. A. Lewis** ^1,2^, F. El-Khouly^1^, L. Pons^3^, W. Burks^3^, J. O. Hourihane^1^; ^1^IIR, University of Southampton, Southampton, UNITED KINGDOM, ^2^Safety and Environmental Assurance Centre, Unilever, Sharnbrook, UNITED KINGDOM, ^3^Division of Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC.

**145**   **Food Allergy in Lebanon : Is Sesame the "Middle Eastern" Peanut**

**C. Irani** ^1,2^, M. Germanos^3^, H. Kazma^4^, V. Merhej^3^; ^1^Internal Medicine-Allergy/Immunology Section, Hotel Dieu de France University Medical Center, Beirut, LEBANON, ^2^Internal Medicine, Hammoud Hospital University Medical Center, Saida, LEBANON, ^3^Laboratory of Hematology/Immunology, Hotel Dieu de France University Medical Center, Beirut, LEBANON, ^4^Hematology/Immunology, Hammoud Hospital University Medical Center, Saida, LEBANON.

**146**   **First Allergic Reaction to Nuts or Peanuts From Candy Bars Labelled "May Contain Nuts/Peanuts" in Older Children**

**M. Primeau**; Pediatirc, Sainte-Justine Hospital, University of Montreal, Montreal, PQ, CANADA.

**147**   **Cosensitization of Peanut and Soybean in Children Under 3 Years with Atopic Dermatitis**

**Y. Shin** ^1^, K. Chun^2^, N. Koo^2^, S. Oh^2^, M. Sohn^3^, K. Kim^3^, S. Lee^2^; ^1^Department of Pediatrics, Pochon CHA University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, ^3^Department of Pediatrics and Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.

**148**   **Risk of Peanut Allergy in Tree Nut Allergic Patient**

**J. M. DeMasi** ^1^, J. C. DeMasi^2^; ^1^Pediatrics, Albany Medical College, Albany, NY, ^2^Biology, University of North Carolina, Chapel Hill, NC.

**149**   **Changing Ethnicity in Peanut Allergy**

**A. T. Fox**, H. Kaymakcalan, G. Lack; Paediatric Allergy, Imperial College at St Mary\'s Hospital, London, London, UNITED KINGDOM.

**150**   **Relevance of Peanut-Specific Ige Levels to the Development of Food Hypersensitivity in Atopic Young Children**

**S. Shin**, J. Oh, H. Lee; Department of Pediatrics, Hanyang University School of Medicine, Seoul, REPUBLIC OF KOREA.

**151**   **Effect of Phytic Acid on IgE Binding to Peanut Allergens**

**S. Chung**, E. T. Champagne; USDA-ARS, SRRC, New Orleans, LA.

**152**   ***Cortex Phellodendron* (huang Bai) but not its Major Ingredient Berberine Blocks Anaphylactic Reactions in a Murine Model of Peanut Allergy**

**T. Zhang**, Z. Zou, H. A. Sampson, X. Li; Pediatrics, Allergy & Immunology, Mount Sinai School of Medicine, New York, NY.

**153**   **Maillard Reaction Alters The IgE and Antibody Binding Properties of Ara h 6**

J. Sotolongo, H. Cheng, **S. J. Maleki**; Food Allergy Unit, USDA-Agricultural Research Service, New Orleans, LA.

**154**   **In Vitro Cross-Reactivity of Peanut Allergens with Other Legumes**

**R. S. Bonds** ^1^, S. J. Maleki^2^, J. McBride^2^, H. Cheng^2^; ^1^Ochsner Clinic Foundation, New Orleans, LA, ^2^USDA-SRRC, New Orleans, LA.
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**155**   **Determination of Epitope Diversity in Cow\'s Milk Hypersensitivity Using Microarray Immunoassay**

**J. Wang**, L. Bardina, D. Lencer, W. G. Shreffler, H. A. Sampson;

Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.

**156**   **Evaluation of Cellular Immune Reactivity to Candida Antigen in Young Children with Non-Allergic Food Hypersensitivity (NFH) to Cow\'s Milk Protein (CMP)**

**N. S. Ogden**, L. Geng, H. Jyonouchi; Allergy & Immunology, UMDNJ-Newark, New York, NY.

**157**   **Allergy to an Amino-Acid Formula in Infants: Residual Soy Allergens in Soybean Oil are Incriminated**

**M. Morisset** ^1^, T. Lee^2^, F. Codreanu^1^, V. Cordebar^1^, S. Fremont^3^, L. Guenard^1^, G. Kanny^1^, D. Moneret-Vautrin^1^; ^1^Department of Internal Medicine, Clinical Immunology and Allergology, University Hospital, Nancy, FRANCE, ^2^Molelucar and Therapeutic Medicine, Genclis. Vandoeuvre, FRANCE, ^3^Biochemistry Laboratory, Hopital Central, Nancy University Hospital, Nancy University Hospital, FRANCE.

**158**   **The Natural History of Cow\'s Milk Allergy (CMA)**

**J. M. Skripak**, E. C. Matsui, R. A. Wood; Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD.

**159**   **Novel in Vitro Method for Diagnosis of Food Allergy in Children: Utilization Of CD203c Expression in Basophils**

**M. Nagao** ^1,2^, R. Tokuda^1,3^, Y. Noma^1,4^, S. Nakayama^5^, T. Fujisawa^1,2^; ^1^Institute for Clinical Research, Mie National Hospital, Tsu, JAPAN, ^2^Pediatrics, Mie National Hospital, Tsu, JAPAN, ^3^Tokuda Family Clinic, Ise, JAPAN, ^4^Pediatrics, Mie Prefectural General Medical Center, Yokkaichi, JAPAN, ^5^Biomedical Research, Beckman Coulter KK, Tokyo, JAPAN.

**160**   **Validity of Diagnostic Tests in Egg Allergy**

**M. DIEGUEZ** ^1^, A. MURIEL^2^, B. DE LA HOZ^1^, I. CERECEDO^1^, M. ANTON^1^, E. CAMACHO^1^, M. SANCHEZ CANO^1^; ^1^ALLERGY, HOSPITAL RAMON Y CAJAL, MADRID, SPAIN, ^2^Unidad de bioestadistica, HOSPITAL RAMON Y CAJAL, MADRID, SPAIN.

**161**   **What Specific IgE Levels to Milk Protein Fractions May Contribute to Cow\'s Milk (CM) Allergy Diagnosis?**

**A. P. M. Castro**, A. K. F. Gushken, A. C. Pastorino, E. Ciccone, A. C. Brandao, C. M. A. Jacob; Department of Pediatrics, University of Sao Paulo, Sao Paulo, BRAZIL.

**162**   **Cow\'s Milk Allergy: A Pilot Trial of Sublingual Immunotherapy**

**d. de boissieu**, C. Dupont; St Vincent de Paul Hospital, Paris, FRANCE.

**163**   **Seafood Allergic Reactions in Restaurants**

**T. J. Furlong** ^1^, J. M. Maloney^2^, S. H. Sicherer^2^; ^1^Food Allergy Network, Fairfax, VA, ^2^Allergy/Immunology, Mount Sinai Medical Center, NY, NY.

**164**   **Detection of Parvalbumin in Various Fish Species by 1D and 2D Electrophoresis and Western Blots Using a Commercially Available Anti-frog Parvalbumin MAb**

**L. Chen**, S. L. Hefle, R. E. Goodman; Food Allergy Research and Resource Program, University of Nebraska-Lincoln, Lincoln, NE.

**165**   **CD4+CD25^high^ T Regulatory Cells in Egg-Allergic Children Undergoing Oral Desensitization**

**L. Pons** ^1^, A. D. Buchanan^1^, P. H. Steele^1^, H. F. Staats^2^, A. W. Burks^1^; ^1^Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC, ^2^Pathology, Duke University Medical Center, Durham, NC.

**166**   **Casein As An "Hidden" Allergen In Manufactured Foods**

**E. Novembre**, C. Caparrelli, F. Mori, C. Calogero, A. Vierucci, M. De Martino; Pediatric Pulmonology and Respiratory Pathophysilogy Hospital Unit, University Children\'s Hospital, Florence, ITALY.

**167**   **Allergy to Caribou and Seal Meats in Inuit Children: A Report of Three Cases**

**J. R. Roberts** ^1,2^, T. V. Gerstner^1,2^, D. A. Grewar^2^, D. J. Dilay^1^, R. D. Cochrane-Fones^1^, T. S. Bouwman^1^; ^1^Meadowood Medical Centre, Winnipeg, MB, CANADA, ^2^Pediatrics, University of Manitoba, Winnipeg, MB, CANADA.

**168**   **Timing of Initial Exposure to Cereal Grains and the Risk of Wheat Allergy**

**J. A. Poole** ^1^, K. Barriga^2^, D. Y. M. Leung^3^, M. Hoffman^2^, G. S. Eisenbarth^4^, M. Rewers^4^, J. M. Norris^2^; ^1^Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ^2^Department of Preventive Medicine and Biometrics, University of Colorado at Denver and Health Sciences Center, Denver, CO, ^3^Pediatrics, National Jewish Medical and Research Center, Denver, CO, ^4^Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Denver, CO.

**169**   **Are Consumer Goods Made from Spun Milk Fibers a Hazard to Milk-Allergic Patients**

**S. L. Hefle**, J. A. Nordlee, D. M. Lambrecht; Food Allergy Research & Resource Program, University of Nebraska, Lincoln, NE.

**170**   **Food Allergy Education for Non-Allergist Physicians: A Needs Assessment Survey**

**A. Kumar** ^1^, C. Bruhn^2^, S. S. Teuber^1^, S. H. Sicherer^3^; ^1^Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, Davis, CA, ^2^Food Science and Technology, University of California, Davis, Davis, CA, ^3^Allergy and Clinical Immunology, Mount Sinai School of Medicine, New York, NY.

**171**   **Identification and Standardization of the Anti Food Allergy Chinese Herbal Formula, FAHF-2, by HPLC Chromatographic Fingerprinting**

**Y. Chen** ^1^, Z. Zou^1^, D. Chen^1^, H. A. Sampson^1^, X. Li^2^; ^1^Mt. Sinai, New York, NY, ^2^Pediatrics, Mt. Sinai, New York, NY.

**172**   **Cloning and Characterization of Walnut Lipid Transfer Protein: Not a Major Allergen in Walnut-Allergic U.S. Patients**

**S. S. Teuber** ^1^, E. Pastorello^2^, W. R. Peterson^1^, A. M. Dandekar^3^, S. Uratsu^3^; ^1^Internal Medicine, UC Davis School of Medicine, Davis, CA, ^2^Internal Medicine and Dermatology, Ospedale Maggiore IRCCS, Milan, ITALY, ^3^Pomology, UC Davis, Davis, CA.

**173**   **Risk-taking and Coping Strategies of Food Allergic Adolescents and Young Adults**

M. Sampson^1^, A. Munoz-Furlong^2^, **S. H. Sicherer** ^1^; ^1^Pediatrics, Mt Sinai School Of Medicine, New York, NY, ^2^Food Allergy & Anaphylaxis Network, Fairfax, VA.

**174**   **Continuing Avoidance Diets after Negative Food Challenges**

**P. A. Eigenmann**, J. C. Caubet, S. A. Zamora; Children\'s University Hospital, Geneva, SWITZERLAND.

**175**   **IgE from Some Green Kiwifruit Allergic Individuals Binds to Proteins in Hardy Kiwifruit, a Third Cultivated Species of the Genus Actinidia**

**R. E. Goodman** ^1^, L. Chen^1^, J. Lucas^2^, J. O. Hourihane^2^, S. L. Taylor^1^; ^1^Food Science & Technology, University of Nebraska, Lincoln, NE, ^2^Allergy and Inflammation Sciences, University of Southampton, Southampton, UNITED KINGDOM.

**176**   **Establishing a Milk Specific IgE Decision Point in IgE Mediated Cow\'S Milk Allergy (CMA) Patients from a Tertiary Pediatric Brazilian Center**

**A. K. F. Gushken**, A. P. M. Castro, A. C. Pastorino, E. Ciccone, R. F. F. Gonçalves, C. M. A. Jacob; Department of Pediatrics, University of Sao Paulo, Sao Paulo, BRAZIL.

**177**   **Blackcurrant Allergy**

**M. Vazquez de la Torre Gaspar**; Alergia, Hospital Gregorio Marañon, Madrid, SPAIN.

**178**   **Allergenicity and Antigenicity of Wild-type and Mutant, Monomeric and Dimeric Carrot Major Allergen Dau c 1**

**G. Reese** ^1^, A. Wangorsch^1^, S. Randow^1^, B. K. Ballmer-Weber^2^, S. Vieths^1^; ^1^Allergology, Paul-Ehrlich-Institut, Langen, GERMANY, ^2^UniversitätsSpital Zürich, Langen, SWITZERLAND.

**179**   **Seal and Whale Meat: A Newly Recognized Food Allergy**

**L. M. Moore** ^1^, J. G. Demain^2^, C. J. Sanner^3^, B. Whisman^1^, M. M. Rathkopf^1^; ^1^Allergy/Immunology, Wilford Hall Medical Center, Lackland AFB, TX, ^2^Allergy/Immunology, Allergy, Asthma and Immunology Center of Alaska, LLC, Anchorage, AK, ^3^U.S. Army Core of Engineers, Anchorage, AK.

**180**   **Germin-like Protein (Cit c 1) And Profilin (Cit s 2) Are Major Allergens In Orange (*Citrus sinensis*) Fruits**

**S. Scheurer** ^1^, M. Retzek^1^, K. Fötisch^1^, E. Sierra-Maestro^2^, A. B. Cid-Sanchez^2^, C. Y. Pascual^2^, A. Conti^3^, A. Feliu^4^, J. Rodriguez^4^, S. Vieths^1^, J. F. Crespo^4^; ^1^Allergology, Paul Ehrlich Institut, Langen, GERMANY, ^2^Hospital Universitario La Paz, Madrid, SPAIN, ^3^Proteome Lab, CNR-ISPA, Colleretto Giacosa, ITALY, ^4^Hospital Universitario Doce de Octubre, Madrid, SPAIN.

**181**   **Selective Allergy To Sheep\'S And Goat\'S Milk Proteins: 4 Cases**

**A. Vereda** ^1^, M. A. Sampson^2^, M. Ibanez^3^, L. Bardina^2^, E. Thanik^2^, H. A. Sampson^2^; ^1^Alergologia, Fundación Jiménez Díaz, Madrid, SPAIN, ^2^Pediatric Allergy and Immumology, Mount Sinai School of Medicine, New York, NY, ^3^Alergologia, Hospital Nino Jesus, Madrid, SPAIN.

**182**   **Allergy To Sheep´s And Goat´s Milk Cheese With Good Tolerance to Cow´s Milk**

**D. Ibañez** ^1^, G. Gonzalez^1^, G. Jimenez^1^, C. Escudero^1^, T. Laso^1^, I. Moneo^2^; ^1^Allergy, Hospital Niño Jesus, Madrid, SPAIN, ^2^Immunology, Centro de Investigación Clínica y Medicina Preventiva. Instituto de Salud Carlos III, Madrid, SPAIN.

**183**   **Inmediate Reaction after Ingestion of Cooked Mushrooms**

**C. INMACULADA** ^1^, R. GARCIA KARMAN^1^, A. LOSADA^1^, M. DIEGUEZ^1^, M. CUEVAS^2^, B. BARTOLOMÉ^3^, B. DE LA HOZ^1^, M. SÁNCHEZ CANO^1^; ^1^ALLERGY, RAMON Y CAJAL, MADRID, SPAIN, ^2^IMMUNOLOGY, RAMON Y CAJAL, MADRID, SPAIN, ^3^BIAL-ARISTEGUI, BILBAO, SPAIN.

**184**   **Sunflower Seed Allergy**

**S. I. Hungness**, A. M. Singer, J. L. Baldwin; Division of Allergy and Immunology, University of Michigan, Ann Arbor, MI.

**185**   **Usefulness of Diagnostic Tests in Cows' Milk Allergy**

**I. CERECEDO** ^1^, M. DIEGUEZ^1^, A. MURIEL^2^, A. GARCIA BALDA^1^, S. TERRADOS^1^, M. SANCHEZ CANO^1^, B. DE LA HOZ^1^; ^1^ALLERGY, RAMON Y CAJAL, MADRID, SPAIN, ^2^Unidad de bioestadistica, RAMON Y CAJAL, MADRID, SPAIN.

**186**   **Cas S 8, the Lipid Transfer Protein from Chestnut Seeds, is a Major Allergen in Chestnut Allergic Patients without Associated Latex Allergy, but not in those with the Latex-Fruit Syndrome**

**C. Blanco** ^1^, R. Sánchez-Monge^2^, M. Recas^2^, G. López-Torrejón^2^, J. Cumplido^1^, J. Figueroa^1^, T. Carrillo^1^, G. Salcedo^2^; ^1^Hospital Universitario Dr. Negrín, Las Palmas de GC, SPAIN, ^2^E.T.S. Ingenieros Agrónomos, Madrid, SPAIN.

**187**   **Sensitization to Non-Specific Lipid Transfer Protein from *Parietaria Judaica* Pollen and Cross Sensitization to Foods**

**M. Ibero** ^1^, M. Castillo^1^, M. Viñas^1^, B. Bartolomé^2^; ^1^Unitat d\'Al·lèrgia, Hospital de Terrassa, Terrassa, SPAIN, ^2^I + D, Laboratorios BIAL-Aristegui, Bilbao, SPAIN.

**188**   **Analysis of Ag-specific Ige Antibody, Total Serum Ige and Blood Eosinophil in Food Allergic Children**

**J. Kim** ^1^, Y. Kim^2^, H. Lee^2^; ^1^Department of Pediatrics, Catholic University Medical College, Uijongbu-city, REPUBLIC OF KOREA, ^2^Department of Clinical Pathology, Catholic University Medical College, Uijongbu-city, REPUBLIC OF KOREA.

**189**   **A Survey of Treatment and Referral of Food Allergy Cases by Primary Care Physicians in San Diego County**

M. S. Wolf^1^, **B. M. Prenner** ^2^; ^1^UC Berkeley, Berkeley, CA, ^2^UCSD Associate Clinical Professor, La Jolla, CA.

**190**   **Scurvy Associated with Oral Allergy Syndrome**

**A. Des Roches** ^1^, L. Paradis^2^, J. Paradis^2^, M. Masse^2^, S. Singer^1^;

^1^Allergy-immunology, Hôpital Sainte-Justine, Montréal, PQ, CANADA, ^2^Allergy-immunology, CHUM, Pavillon St-Luc, Montréal, PQ, CANADA.

**191**   **Angioedema and Urticaria Caused by Sliced Soft Bread**

**A. Enriquez-Matas** ^1^, S. Quirce^1^, M. Fernández-Nieto^1^, C. Pastor^2^, M. de las Heras^1^, J. Sastre^1^; ^1^Allergy Department, Fundación Jimenez Díaz, Madrid, SPAIN, ^2^Immunology Department, Fundación Jimenez Díaz, Madrid, SPAIN.

**192**   **Cow\'s Milk Protein Allergy in Thai Children**

**P. Tansupapol;** Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, THAILAND.

**193**   **Secretion of Food Allergen Proteins in Saliva**

**S. J. Maleki** ^1^, H. Cheng^1^, B. Perelman^2^, S. Hefle^3^, P. Vadas^2^; ^1^Food Allergy Unit, USDA-Agricultural Research Service, New Orleans, LA, ^2^Immunology and Allergy, St. Michael\'s Hospital, Toronto, ON, CANADA, ^3^Department of Food Science & Technology, University of Nebraska, Lincoln, NE.

**194**   **IgE Cross-reactivity between the Cysteine Proteases Der p 1 and Act c 1, the Major Allergens from House Dust Mites and Kiwifruit**

**B. Merima** ^1^, C. Radauer^1^, C. Ebner^2^, D. Allwardth^1^, W. R. Thomas^3^, A. Mari^4^, A. Knulst^5^, O. Scheiner^1^, H. Breiteneder^1^; ^1^Department of Pathophisiology, Medical University Vienna, Vienna, AUSTRIA, ^2^Allergieambulatorium Reumanplatz, Vienna, AUSTRIA, ^3^Division of Molecular Biology, TVW Telethon Institute for Child Health Research, West Perth, AUSTRALIA, ^4^National Health Service, Rome, ITALY, ^5^Department of Dermatology/Allergology, University Medical Center, Utrecht, THE NETHERLANDS.

**195**   **Allergenic Fruit TLPs Possess Different Degrees of IgE Cross-reactivity**

**U. Smole** ^1^, M. Bublin^1^, C. Radauer^1^, C. Ebner^2^, O. Scheiner^1^, H. Breiteneder^1^; ^1^Dept. of Pathophysiology, Medical University of Vienna, Vienna, AUSTRIA, ^2^Allergieambulatorium Reumannplatz, Vienna, AUSTRIA.

**196**   **IgE-Reactive Proteins in Cashew Apple Juice Concentrate are Removed by Filtration**

**S. S. Comstock** ^1^, H. Kshirsagar^2^, J. M. Robotham^3^, K. H. Roux^3^, S. K. Sathe^2^, S. S. Teuber^1^; ^1^Internal Medicine, University of California, Davis, Davis, CA, ^2^Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL, ^3^Biological Science, Florida State University, Tallahassee, FL.

**197**   **Outcomes of Oral Food Challenge with Undetectable Allergen-Specific IgE**

**S. Desai**, L. Kerns, R. Seshadri, J. A. Pongracic; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.

**198**   **Using Human Basophil Donors to Assess the Clinical Relevance of Sesame 11S Globulin, Ses i 6**

**M. L. Wallowitz** ^1^, R. J. Y. Chen^2^, J. T. C. Tzen^2^, S. S. Teuber^1^; ^1^Division of Rheumatology, UC Davis, Davis, CA, ^2^Graduate Institute of Agricultural Biotechnology, National Chung-Hsing University, Taichung, TAIWAN REPUBLIC OF CHINA.

**199**   **Evaluation of Food-Allergen Specific IgE in Hyper-IgE Sera**

**J. Popov**, Q. Nguyen, L. Londono, A. Sferruzza, M. Glovsky; Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA.

**200**   **Parvalbumin was Not Responsible for the Cross-Reactivity between Tuna and Marlin: A Case Report**

**Y. Kondo** ^1^, R. Komatsubara^1^, Y. Nakajima^1^, M. Kawamura^1^, M. Kakami^1^, I. Tsuge^1^, T. Yasuda^2^, A. Urisu^1^; ^1^Pediatrics, Fujita Health University, Toyoake, Aichi, JAPAN, ^2^Toyo Suisan Kaisha, Ltd, Tokyo, JAPAN.

**201**   **Analysis of Placebo Reactions in Double-Blind, Placebo-Controlled Food Challenge Tests in Children**

**B. J. Vlieg-Boerstra** ^1^, S. van der Heide^2^, J. Kukler^1^, C. M. A. Bijleveld^1^, B. J. Beusekamp^3^, E. J. Duiverman^1^, A. E. J. Dubois^4^;

^1^Dept. of Paediatrics, University Medical Center Groningen, University of Groningen, Groningen, THE NETHERLANDS, ^2^Dept. of Allergology, University Medical Center Groningen, University of Groningen, Groningen, THE NETHERLANDS, ^3^Dept. of Dietetics, University Medical Center Groningen, University of Groningen, Groningen, THE NETHERLANDS, ^4^Dept of Allergology and Dept of Paediatrics, University Medical Center Groningen, University of Groningen, Groningen, THE NETHERLANDS.

**202**   **Physician Advice and Action Plans in Severe Food Allergy**

**J. S. W. Kong** ^1^, L. A. D. Haapanen^1^, L. J. Phillipo^2^, C. M. Bruhn^2^, S. S. Teuber^1^; ^1^Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, Davis, CA, ^2^Food Science and Technology, University of California at Davis, Davis, CA.

**203**   **Tropomyosin: Is it Responsible for the Cross-Reactivity Crustaceans-Dust Mites**

**A. Mendes**, M. C. Santos, E. Pedro, M. A. Pereira-Barbosa; Unidade Imunoalergologia, Hospital Santa Maria, Lisboa, PORTUGAL.

**204**   **Treatment of Pregnant Females with Anti-Acids Induces Sensitization in Mothers and a Perinatal Th2-Dominated Immune Response in Offsprings: a BALB/c Mouse Model**

**I. Schöll** ^1^, U. Ackermann^2^, C. Özdemir^3^, N. Blümer^2^, T. Dicke^2^, S. Sel^2^, S. Sel^2^, M. Wegmann^2^, E. Untersmayr^1^, H. Garn^2^, E. Jensen-Jarolim^1^, H. Renz^2^; ^1^Center of Physiology and Pathophysiology, Inst. of Pathophysiology, Vienna, AUSTRIA, ^2^Hospital of the Philipps-University Marburg, Dept. of Clinical Chemistry and Molecular Diagnostics, Marburg, GERMANY, ^3^School of Medicine Marmara University, Pediatric Allergy and Immunology Division, Istanbul, TURKEY.

**205**   **Case Reports of Seed Anaphylaxis: Mustard, Flax and Sunflower Seed**

**L. A. Connors** ^1^, W. H. Yang^2^, G. A. Lacuesta^1^; ^1^Dalhousie University, Halifax, NS, CANADA, ^2^University of Ottawa, Ottawa, ON, CANADA.
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**206**   **Coping with Asthma in Immigrant Hispanic Families: A Focus Group Study**

**G. S. Mosnaim** ^1,2^, C. Kohrman^3^, L. K. Sharp^4^, M. E. Wolf^5^, L. S. Sadowski^6^, L. Ramos^7^, L. Grammer^8^; ^1^Department of Immunology and Microbiology, Rush University Medical Center, Chicago, IL, ^2^Division of Allergy and Immunology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, ^3^Community Research and Training Consultant, Chicago, IL, ^4^Department of Family Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ^5^International Neuropsychiatry Consultants, Chicago, IL, ^6^Department of Medicine Collaborative Research Unit, Cook County Bureau of Health Services, Chicago, IL, ^7^Centro San Bonifacio, Chicago, IL, ^8^Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL.

**207**   **Cultural Perceptions on Identification and Treatment of Childhood Asthma in the US and China**

**H. L. Leo**, A. Wang, M. Gong, N. Clark; School of Public Health, University of Michigan, Ann Arbor, MI.

**208**   **A Community Based Approach to Reducing Hispanic Pediatric Asthma Disparities: A Collaborative Effort to Deliver Care between a Bicultural Bilingual Allergist/Immunologist (BC/BL/A/I)and Community Health Workers (CHWs)**

**J. J. Kulik** ^1,2^, L. G. Hwang^1^, C. A. Jackson^1^, J. Mora^1^, J. N. Moy^1,2^, G. S. Mosnaim^1,2^; ^1^Allergy and Immunology, Rush University Medical Center, Chicago, IL, ^2^Allergy and Immunology, Stroger Hospital of Cook County, Chicago, IL.

**209**   **Health Status and Functional Limitations in Elderly vs Younger Patients with Asthma, Diabetes, or Hypertension: An analysis of the Medical Expenditure Panel Survey.**

J. Chang^1^, J. Sung^2^, D. Gause^2^, **G. P. Geba** ^3^; ^1^Duke Clinical Research, Durham, NC, ^2^Health Economics and Outcomes Research, Novartis Pharmaceuticals Corp., E Hanover, NJ, ^3^USCDMA, Novartis Pharmaceuticals Corp., E Hanover, NJ.

**210**   **Using CBPR to Recruit Physicians and Develop Partnerships with Community Clinics for Asthma Disparities Research**

**D. P. Williams**, R. I. Quartey; Epidemiology, Howard University College of Medicine, Washington, DC.

**211**   **Communication between Educators and Parents of Asthmatic Children Improves Academic and Medical Outcomes in Beijing and Detroit**

**H. L. Leo**, A. Wang, M. Gong, N. Clark; School of Public Health, University of Michigan, Ann Arbor, MI.

**212**   **Stories of Four Women with Asthma in an Inner City Clinic Setting: A Narrative Analysis**

**L. A. Martin**; The Mount Sinai Hospital, New York, NY.
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**213**   **A Content Analysis of Web-Based Expert Forum on Asthma and Allergy**

**K. Sade** ^1^, Y. Levo^2^, S. Kivity^1^; ^1^Allergy & Asthma, Tel-aviv Sourasky Medical Center, Tel-aviv, ISRAEL, ^2^Internal Medicine "T", Tel-aviv Sourasky Medical Center, Tel-aviv, ISRAEL.

**214**   **Increasing Long-Term Control Medication Usage Among Children with Asthma**

**V. K. Owen** ^1^, L. M. Morris^2^, A. D. Robinson^1^; ^1^Anthem BCBS, Mason, OH, ^2^Anthem RX Service, Mason, OH.

**215**   **Impact of an Asthma Educational Program on Children at an Asthma Camp**

**A. T. Vu** ^1^, M. C. Glaum^1^, E. G. Naik^1^, M. Grandstaff^2^, M. N. Shah^1^, P. Panagos^1^, R. Franck^1^, J. T. Ramey^1^, R. F. Lockey^1^; ^1^University of South Florida - College of Medicine and James A. Haley Veterans' Hospital, Tampa, FL, ^2^University of South Florida - Clinical Research Unit, Tampa, FL.

**216**   **Primary Care Provider (PCP) Asthma Communication and Quality of Asthma Care**

**K. A. Riekert** ^1^, B. Kalesan^1^, A. M. Butz^2^, M. E. Bollinger^3^, K. Walton^1^, K. Mudd^3^, C. S. Rand^1^; ^1^Medicine, Johns Hopkins University, Baltimore, MD, ^2^Pediatrics, Johns Hopkins University, Baltimore, MD, ^3^Pediatrics, University of Maryland, Baltimore, MD.

**217**   **Teaching with Style: Utilizing Active Learning Strategies in Asthma and Allergy Education**

**D. S. Clark**; Stafford County Schools, Stafford, VA.
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**218**   **Eotaxin-1 & -2 Induced Migration of CD34+/CCR3+ Bone marrow and Blood Eosinophil-lineage Committed Cells**

**J. Lötvall** ^1^, A. Bossios^1^, M. Sjöstrand^1^, J. J. Lee^2^, M. Rådinger^1^; ^1^Dept. of Respiratory Medicine and Allergology, Lung Pharmacology Group, Göteborg University, Göteborg, SWEDEN, ^2^Divison of Pulmonary Medicine, Mayo Clinic, Scottsdale, AZ.

**219**   **Effect of Cysteinyl Leukotrienes on Eosinophilopoiesis during the Onset of Asthma**

**P. R. Ogershok** ^1^, D. Piktel^2^, K. S. Landreth^2^, M. B. Hogan^1^; ^1^Pediatrics, West Virginia University School of Medicine, Morgantown, WV, ^2^Immunology, West Virginia University School of Medicine, Morgantown, WV.

**220**   **CpG Oligodeoxynucleotide Prolongs Human Eosinophil Survival through Activation of B Cells or Plasmacytoid Dendritic Cells in vitro**

**K. Matsumoto** ^1^, S. Fukuda^1^, M. Terakawa^1,2^, A. Kato^1^, H. Saito^1^;

^1^Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN, ^2^Daiichi Suntory Pharma Co. Ltd., Osaka, JAPAN.

**221**   **Eosinophils do Not Modify Trans-Basement Membrane Migration of Neutrophils**

**T. Kobayashi**, I. Kikuchi, K. Hagiwara, M. Kanazawa, M. Nagata; Department of Respiratory Medicine, Saitama Medical School, Saitama, JAPAN.

**222**   **Aeroallergen Sensitization in Children with Eosinophilic Esophagitis**

**J. M. Norvell**, D. Hummell; Department of Medicine, Vanderbilt University, Nashville, TN.

**223**   **Dipeptidyl-Peptidase IV Modulates CCL11/Eotaxin-Induced Mobilization and Recruitment of Eosinophils**

**U. Forssmann**; Pharmacology, IPF Pharmaceuticals, Hannover, GERMANY.

**224**   **A Novel Model of Transgene-Induced Eosinophilic Esophagitis**

**C. Fischetti**, P. Fulkerson, M. Rothenberg; Cincinnati Children\'s Hospital, Cincinnati, OH.

**225**   **Anti-IL-5 Therapy (Mepolizumab) in Hypereosinophilic Syndromes and Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood Eosinophilia**

**M. L. Stein** ^1^, J. M. Villanueva^2^, S. C. Jameson^1^, B. Buckmeier^1^, A. H. Filipovich^2^, M. H. Collins^3^, Y. Yamada^1^, A. H. Assa\'ad^1^, M. E. Rothenberg^1^; ^1^Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Hematology/Oncology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^3^Pathology and Laboratory Medicine, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**226**   **Newly Produced Eosinophil-Lineage Committed Cells Proliferate in the Lung of Allergen-Challenged Mice**

**M. Rådinger**, A. Bossios, M. Sjöstrand, J. Lötvall; Dept. of Respiratory Medicine and Allergology, Lung Pharmacology Group, Göteborg University, Gothenburg, SWEDEN.

**227**   **CD30-Induced Apoptosis of Human Blood Eosinophils is Mediated by Nitric Oxide Production and JNK Pathway Activation**

**A. I. Berro**, D. K. Agrawal; Center for Allergy, Asthma, and Immunology, Creighton University, Omaha, NE.

**228**   **Osteopontin (Opn) is Expressed and Functional in Human Peripheral Blood Eosinophils**

**I. Puxeddu** ^1^, D. Ribatti^2^, R. Bader^3^, N. Berkman^3^, F. Levi-Schaffer^1^; ^1^Hebrew University of Jerusalem, Jerusalem, ISRAEL, ^2^University of Bari, Bari, ITALY, ^3^Hadassah-Hebrew University Medical Center, Jerusalem, ISRAEL.

**229**   **Urokinase-type Plasminogen Activator (uPA) Primes FMLP-Activated Airway Eosinophil (EOS) Adhesion to ICAM-1 and VCAM-1 Following Segmental Bronchoprovocation with Allergen (SBP-AG)**

**A. M. Brooks**, J. B. Sedgwick; Medicine, University of Wisconsin, Madison, WI.

**230**   **15d-PGJ2 Primes Eotaxin-induced Eosinophil Chemotaxis Through PPAR-Gamma Ligation**

**S. Ueki** ^1^, Y. Kobayashi^2^, G. Mahemuti^2^, T. Chiba^2^, N. Saito^2^, A. Kanda^2^, H. Kayaba^2^, K. Ohta^1^, J. Chihara^2^; ^1^Department of Internal Medicine, Teikyo University School of Medicine, Itabashi-ku, JAPAN, ^2^Depertment of Clinical and Laboratory Medicine, Akita University School of Medicine, Akita, JAPAN.

**231**   **Phosphoproteomic Profiling of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)-Dependent Activation of Human Eosinophils**

**T. W. Young** ^1^, K. Pazdrak^1^, S. Stafford^1^, A. Brasier^2^, J. Wiktorowicz^1^, H. Spratt^1^, A. Kurosky^1^; ^1^Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, TX, ^2^Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.

**232**   **Exaggerated Airway Wall Eosinophilia and Physiologic Dysfunction in Asthma-like Airways after Chronic *Alternaria* Exposure in Rats**

**R. L. Sorkness** ^1^, K. M. Herricks^1^, R. J. Szakaly^2^, R. F. Lemanske, Jr.^2^, L. A. Rosenthal^2^; ^1^School of Pharmacy, University of Wisconsin, Madison, WI, ^2^Medicine, University of Wisconsin, Madison, WI.

**233**   **Systemic Effects of Chronic Asthma on Bone Marrow Eosinophil Development**

**M. B. Hogan** ^1^, D. Piktel^1^, A. F. Hubbs^2^, L. McPherson^2^, K. S. Landreth^1^; ^1^West Virginia University, Morgantown, WV, ^2^NIOSH, Morgantown, WV.

**234**   **Molecular Markers of Eosinophilopoiesis at Birth: Kinetics of Cord Blood GATA-1, MBP and IL-5 Receptor Expression**

**A. K. Ellis**, L. Crawford, J. A. Denburg; Division of Allergy & Clinical Immunology, McMaster University, Hamilton, ON, CANADA.

**235**   **Urokinase-type Plasminogen Activator (uPA) Primes Eosinophil (EOS) Chemotaxis**

**J. B. Sedgwick**, E. A. Durocher, A. M. Brooks; Department of Medicine, University of Wisconsin - Madison, Madison, WI.

**236**   **A Role for the Ectoenzyme, CD38, in Human Eosinophil Functions**

**T. A. White**, Y. Matsuwaki, H. Kita; Mayo Clinic, Rochester, MN.

**237**   **House Dust Mite Extract Induces Interleukin-9 Expression in Human Eosinophils.**

**H. Katsumata** ^1,2^, Y. Kato^1^, T. Fujisawa^1^; ^1^Institute for Clinical Research, Mie National Hospital, Tsu, JAPAN, ^2^Allergy, Immunology and Infectious diseases, Shizuoka Children\'s Hospital, Shizuoka, JAPAN.

**238**   **Neurotrophins Produced by Airway Epithelial Cells Promote the Survival of Eosinophils During Allergic Asthma**

**C. Hahn**, A. Pyraesh, H. Renz, W. A. Nockher; Department of Clinical Chemistry and Molecular Diagnostics, Medical Faculty of the Philipps University, Marburg, GERMANY.

**239**   **Association of Tumor Necrosis Factor-a and Neutrophilic Inflammation in Severe Asthma**

**M. Nagata**, S. Kikuchi, I. Kikuchi, K. Hagiwara, M. Kanazawa; Department of Respiratory Medicine, Saitama Medical School, Saitama, JAPAN.

**240**   **Eosinophilic Oophoritis**

**J. H. Butterfield** ^1^, G. M. Kephart^1^, J. Frankson^2^; ^1^Mayo Clinic, Rochester, MN, ^2^Marshfield Clinic, Wausau, WI.

**241**   **Human Eosinophils Enhance Staphylococcal Enterotoxin B Stimulation of CD4^+^ T-cells**

**S. K. Mathur**, E. A. Durocher, L. Liu, E. A. B. Kelly, J. B. Sedgwick, N. N. Jarjour, W. W. Busse; University of Wisconsin, Madison, WI.

**242**   **Lymphocytic Infiltrates in Eosinophilic Gastroenteropathy**

**S. J. McGeady**; Pediatrics, Thomas Jefferson University, Philadelphia, PA.

**243**   **The Effect of Lipopolysaccharide (LPS) on Cord Blood (CB) Hemopoietic Progenitor Cytokine Receptor Expression**

**M. M. Cyr**, F. Bandukwala, J. A. Denburg; Medicine, McMaster University, Hamilton, ON, CANADA.

**244**   **A Case of Eosinophilia**

**C. C. Hassett**, A. Kewalramani, L. Wild, D. DeMerell; Clinical Immunology, Allergy and Rheumatology, Tulane University Health Science Center, New Orleans, LA.

**245**   **Rexflavon Inhibits Eosinophil Recruitement And Bronchial Reactivity In Mice Asthma Model**

**M. Kim** ^1^, Y. Kim^2^, C. Hahn^1^, H. Sung^3^; ^1^Internal Medicine, Chungbuk National University, Cheongjoo, REPUBLIC OF KOREA, ^2^College of Pharmacy, Chungbuk National University, Cheongjoo, REPUBLIC OF KOREA, ^3^College of pharmacy, Chungbuk National University, Cheongjoo, REPUBLIC OF KOREA.

**246**   **Macrophage Derived Non-Specific Esterase and Allergen Stimulation**

**D. R. Howell** ^1^, T. Hackett^1^, W. C. Moore^2^, J. A. Warner^1^; ^1^School of biological sciences, Southampton University, Southampton, UNITED KINGDOM, ^2^Medicine, Wake forest University, Winston-Salem, NC.

**247**   **Demographics and Risk Factors for Eosinophilic Esophagitis**

**L. R. Tuchman** ^1^, J. M. Spergel^2,3^; ^1^University of Pennsylvania, Philadelphia, PA, ^2^Division of Allergy and Immunology, University of Pennsylvania, Philadelphia, PA, ^3^Divison of Allergy and Immunology, The Children\'s Hospital of Philadelphia, Philadelphia, PA.

**248**   **Utility of Anti-parasite Antibodies in the Differential Diagnosis of Chronic Hypereosinophilia**

**B. G. Wilson**, P. B. Boggs, C. Mayer; Section of Allergy & Immunology, Louisiana State University-Shreveport, Shreveport, LA.

**249**   **Comparison of Leukolysin/MT6-MMP in Bronchoalveolar Lavage Fluid from Lung Transplant Patients and Asthmatics**

**J. P. Raasch** ^1^, C. L. Liebeler^1^, C. H. Wendt^1^, J. B. Sweet^1^, N. N. Jarjour^2^, R. S. DeGrauw^2^, D. Pei^3^, M. N. Blumenthal^1^; ^1^Pulmonology, Allergy and Critical Care, University of Minnesota, Minneapolis, MN, ^2^Pulmonology, University of Wisconsin, Madison, WI, ^3^Pharmacology, University of Minnesota, Minneapolis, MN.

**250**   **Prevalence and Causes of Moderate-Severe Eosinophilia in Children**

**N. Segal**, Y. Levy, B. Garty, Y. L. Danon; Scneider Children Medical Center of Israel, Petah Tikva, ISRAEL.

**251**   **Direct Interaction of Recombinant Human Surfactant Protein-D (rhSP-D) Modulates Human Eosinophil Activation, Their Rate of Apoptosis and Clearance by Macrophages**

**L. Mahajan** ^1^, S. D. Telang^2^, U. Kishore^3^, V. K. Singh^4^, C. N. Ramchand^5^, P. U. Sarma^6^, T. Madan^1^; ^1^Institute of Genomics and Integrative Biology, Delhi, INDIA, ^2^Department of Biochemistry, M.S. University of Baroda, Vadodara, INDIA, ^3^Weatherall Institute of Molecular Medicine, Oxford, UNITED KINGDOM, ^4^V,P, Chest Institute, Delhi, INDIA, ^5^Kemin Nutritional Technologies, Tamilnadu, INDIA, ^6^Indian Agriculture Research Institute, Pusa, Delhi, INDIA.
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**252**   **Estradiol Enhances the Release of Allergic Mediator from Bone Marrow-derived Mast Cells (BMMCs) Via Estrogen Receptor a (ERa)**

**S. Narita**, R. M. Goldblum, C. K. Lambert, M. Zaitsu, M. D. Estes, E. G. Brooks, T. Midoro-Horiuti; Pediatrics, UTMB, Galveston, TX.

**253**   **Alpha 4 Integrins and VCAM-1, but not MAdCAM-1, are Essential for Recruitment of Mast Cell Progenitors to Inflamed Lung**

**M. F. Gurish** ^1^, J. Hallgren^1^, T. Jones^1^, J. Boyce^1^, J. Abonia^2^; ^1^Rheumatology, Immunology, Allergy, Brigham and Women\'s Hospital, Boston, MA, ^2^Pediatric Allergy and Immunology, Cincinnati Children\'s Hospital, Cincinnati, OH.

**254**   **Expression of Neuropilin-1 (NP-1) on Human Basophils Following In Vitro IL-3 Exposure: Implications for NP-1 as a Marker of Basophil Priming**

**J. T. Schroeder**, A. P. Bieneman, M. C. Liu; Department of Medicine, Johns Hopkins University, Baltimore, MD.

**255**   **Human Mast Cells Express Neurokinin and Vasoactive Intestinal Peptide Receptors**

**M. Kulka**, C. Sheen, S. Toth, B. P. Tancowny, L. C. Grammer, R. P. Schleimer; Allgery-Immunology Division, Northwestern University Feinberg Sch. Med., Chicago, IL.

**256**   **Human Hematopoietic PGD~2~ Synthase: Inhibition by 15-deoxy\--^12,14^-PGJ~2~ and Sulindac Sulfide, and Localization to Mast Cells**

**G. M. Greig**, F. Masse, F. Nantel, A. Chateauneuf, G. O\'Neill, G. O\'Neill; Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Kirkland, PQ, CANADA.

**257**   **Mast Cell-Derived Plasminogen Activator Inhibitor-1 in the Airways of a Murine Asthma Model and Its Regulation by Cysteinyl Leukotrienes**

**S. H. Cho** ^1^, J. A. Boyce^2^, T. J. Yoo^1^, C. K. Oh^3^; ^1^Internal Medicine, University of Tennessee HSC, Memphis, TN, ^2^Internal Medicine, Brigham and Women\'s Hospital, Boston, MA, ^3^Pediatrics, Harbor-UCLA Medical Center, Torrance, CA.

**258**   **TLR3 Stimulation Enhanced FceRI -Mediated MIP-1a Production from Cultured Human Mast Cells**

**H. Tachimoto**, S. Sato, Y. Yanagihara, M. Ebisawa; Department of Pediatrics, National Hospital Organization, Sagamihara National Hospital, Kanagawa, JAPAN.

**259**   **Human Lung Mast Cells Express the Orphan G-Protein Receptor GPR80/GPR99**

**H. Nishi**, P. Amir, E. S. Schulman; Pulmonary and Critical Care Medicine, Drexel University College of Medicine, Philadelphia, PA.

**260**   **Serotonin Induces Mast Cell Adhesion and Chemotaxis through the 5-HT1A Receptor**

**N. M. Kushnir-Sukhov** ^1^, A. M. Gilfillan^1^, J. W. Coleman^1^, M. Toth^2^, S. Bruening^2^, D. D. Metcalfe^1^; ^1^Laboratory of Allergic Diseases, NIH/NIAID, Bethesda, MD, ^2^Department of Pharmacology, Weill Medical College of Cornell University, New York, NY.

**261**   **Development of Tryptase and Chymase Double Positive Mature Mast Cells from Cynomolgus Monkey Embryonic Stem Cells**

**N. Kambe** ^1^, F. Ma^2^, Y. Miyachi^1^, T. Nakahata^2^; ^1^Dermatology, Kyoto University, Kyoto, JAPAN, ^2^Pediatrics, Kyoto University, Kyoto, JAPAN.

**262**   **Distinct Basophil Functional Phenotypes in Chronic Idiopathic Urticaria (CIU)**

**L. M. Gober**, N. U. Ohameje, K. Vasagar, B. M. Vonakis, S. S. Saini; Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, MD.

**263**   **Human Mast Cells Release Oncostatin M (OSM) Specifically on Contact with Activated T Cells**

P. Salamon^1^, N. Shoham^1^, I. Puxeddu^2^, F. Levi-Schaffer^2^, **Y. A. Mekori** ^1^; ^1^Medicine B, Meir Hospital, Kfar-Saba, ISRAEL, ^2^Pharmacology, Hebrew University, Jerusalem, ISRAEL.

**264**   **Vespid Venom-Induced IL-4- and IL-13-Production of Basophils is Inhibited By IL-10**

**C. Bauer**, J. Walter, F. Ruëff, B. Przybilla; Ludwig-Maximilians-Universität München, Klinik und Poliklinik für Dermatologie und Allergologie, München, GERMANY.

**265**   **CysLT1 and CysLT2 Receptors Form Functional Heterodimers on Human Mast Cells and Neutrophils**

Y. Jiang, **J. Boyce**; Medicine, Brigham and Women\'s Hospital, Boston, MA.

**266**   **Neuropeptides Activate Human Mast Cell Degranulation and Chemokine Production**

**B. P. Tancowny**, C. Sheen, L. C. Grammer, R. P. Schleimer, M. Kulka; Allergy-Immunology, Northwestern University Feinberg Sch. Med., Chicago, IL.

**267**   **Opiates Activate Human Mast Cell Chemokine Production**

**C. Sheen**, L. C. Grammer, R. P. Schleimer, M. Kulka; Allgery-Immunology Division, Northwestern University Feinberg Sch. Med., Chicago, IL.

**268**   **Antigen-Induced Production of S1P Leads to Cell Migration Independently of S1P Receptor in RBL-2H3 Cells**

**I. JUNG**, O. H. CHOI; JHAAC, Johns Hopkins University, Baltimore, MD.

**269**   **Analysis of Global Protein Content in Mast Cell Exosomes**

**K. Ekström**, H. Valadi, N. Almqvist, A. Bossios, M. Sjöstrand, J. Lötvall; Lung Pharmacology Group. Dept. of Resp. Med and Allergol, Göteborg, SWEDEN.

**270**   **Carboxypeptidase as a Marker of Mast Cell Heterogeneity in Human Tissues**

M. G. Buckley, S. He, Y. He, S. Goda, J. Gelnar, **A. F. Walls**; Immunopharmacology Group, University of Southampton, Southampton, UNITED KINGDOM.

**271**   **Rate of Negativization of the Basophil Activation Test (BASOTEST) and RAST in Patients with Immediate Allergic Reactions to Amoxicillin**

T. D. Fernandez^1^, M. J. Torres^2^, C. Mayorga^1^, E. Martin^2^, J. L. Rodriguez-Bada^1^, C. Antunez^1^, N. Blanca^2^, J. A. Cornejo-Garcia^1^, **M. Blanca** ^2^; ^1^Research Laboratory, Carlos Haya Hospital, Malaga, SPAIN, ^2^Allergy Service, Carlos Haya Hospital, Malaga, SPAIN.

**272**   **Examination of Toxicological Effects of Aldehyde Air Pollutants on Mast Cells (RBL-2H3)**

**D. J. Hochman** ^1^, C. Collaco^2^, E. G. Brooks^2^; ^1^Experimental Pathology, University of Texas Medical Branch, Galveston, TX, ^2^Pediatrics, University of Texas Medical Branch, Galveston, TX.

**273**   **Gene Expression Profiling of Human Mast Cell Subtypes**

**H. Saito** ^1,2^, K. Matsumoto^1,2^, Y. Okayama^2^; ^1^Department of Allergy & Immunology, National Research Institute for Child Health & Development, Tokyo, JAPAN, ^2^Research Unit for Allergy Transcriptome, RIKEN Research Center for Allergy & Immunology, Yokohama, JAPAN.

**274**   **Management of Type II Systemic Mastocytosis (SM-AHNMD) with Hydroxyurea**

**J. Sheikh** ^1^, R. E. Drews^1^, R. Nunez^2^, A. G. Montero^3^, M. Jara^3^, A. Orfao^3^, L. Escribano^2^; ^1^Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, ^2^Mast Cell Unit, Hospital Ramon y Cajal, Madrid, SPAIN, ^3^Servicio de Citometría, CIC, Salamanca, SPAIN.

**275**   **Regulation by Complement of the Release of Basophil Mediators in Asthmatic Patients**

**M. C. Nelson**, S. K. Wust, B. A. Benson, M. N. Blumenthal, A. P. Dalmasso; University of Minnesota, Minneapolis, MN.

**276**   **Protocol for *in vitro* Desensitization of Human Basophils that Mimics the Up Dosing Approach used in SCIT - Monitored Measuring CD63 and CD203c Activation Markers**

**G. Lund**, H. Jacobi, J. Holm, K. Lund; Research Department, ALK-ABELLÓ A/S, Hørsholm, DENMARK.
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**277**   **Detection of *Staphylococcus Aureus* by Real-Time PCR in Chronic Rhinosinusitis with Nasal Polyps**

**A. Tripathi** ^1^, B. Tancowny^1^, Q. Truong-Tran^1^, S. Retsema^2^, R. Kern^2^, D. Conley^2^, L. Suh^1^, R. Schleimer^1^, L. Grammer^1^; ^1^Medicine, Northwestern University Medical School, Chicago, IL, ^2^Otolaryngology - Head and Neck Surgery, Northwestern University Medical School, Chicago, IL.

**278**   **The Association of Total IgE and Specific IgE Anti-Staphylococcal Enterotoxin with Chronic Hyperplastic Rhinosinusitis**

**P. S. Hutcheson** ^1^, D. A. Oliver^2^, M. S. Schubert^3^, R. G. Slavin^1^; ^1^Internal Medicine/Allergy & Immunology, Saint Louis University School of Medicine, Saint Louis, MO, ^2^Cancer Center, Saint Louis University School of Medicine, Saint Louis, MO, ^3^Allergy Asthma Clinic, Ltd., Phoenix, AZ.

**279**   **Aspirin-induced 15-HETE Generation in Nasal Polyp Tissue from Aspirin-Sensitive Patients**

**M. L. Kowalski** ^1^, A. Lewandowska-Polak^1^, M. Jedrzejczak^1^, A. Jankowski^2^; ^1^Department of Clinical Immunology and Allergy, Medical University of Lodz, Lodz, POLAND, ^2^Department of Otorhinolaryngology, Medical University of Lodz, Lodz, POLAND.

**280**   **Nares: Local Cytokine Pattern in Nasal Secretions**

**C. Klemens**, D. Liebl, E. Pfrogner, F. Jund, M. Kramer; Klinikum Grosshadern, Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Munich, GERMANY.

**281**   **Local Activation of the Complement System in Nasal Polyps.**

**T. Van Zele**, G. Holtappels, P. Van Cauwenberge, C. Bachert; ENT department 1P1, University hospital of Ghent, Gent, BELGIUM.

**282**   **Characterization of Responses of Human Nasal Epithelial Cells to Pro-inflammatory Mediators and Secretagogues**

**J. L. Stahl**, E. B. Cook, F. M. Graziano; Medicine, University of Wisconsin-Madison, Madison, WI.

**283**   **Ultrastructural Findings In Patients with Allergic Rhinitis**

**S. Knipping**; ENT Department, Martin Luther University, Halle/ Saale, GERMANY.

**284**   **Relationship Between Promoter Methylation of Multiple Genes and inflammatory Cell infiltration in Nasal Polyps**

**c. li** ^1^, Y. Pang^1^, Q. Tao^2^, D. Wang^1^; ^1^Otolaryngology, National University of Singapore, Singapore, SINGAPORE, ^2^Chinese University of Hong Kong, Hong Kong, CHINA.

**285**   **Unique Genetic Expression in Nasal Mucosa and Blood of Patients with Nasal Polyposis and Inflammatory Nasal Conditions**

**T. A. Miller** ^1^, J. Kukowska-Latallo^2^, A. M. Singer^1^, M. A. Pynnonen^3^, J. E. Terrell^3^, J. R. Baker, Jr.^4^; ^1^Department Of Internal Medicine, Division of Allergy & Clinical Immunology, University of Michigan Health System, Ann Arbor, MI, ^2^Michigan Nanotechnology Institute for Medicine & Biological Sciences, University of Michigan, Ann Arbor, MI, ^3^Department Of Otolaryngology, University of Michigan Health System, Ann Arbor, MI, ^4^Michigan Nanotechnology Institute for Medicine & Biological Sciences, University of Michigan Health System, Ann Arbor, MI.

**286**   **Heterogeneity of Effects in the Appearance of Rhinitis and/or Asthma According to Gender and Atopy**

**M. A. Tejedor**, A. Rosado, C. Vila, M. Moro, M. D. Alonso, M. Mugica, M. Fernández-Rivas, T. Verdura; Unidad de alergia, FUNDACION HOSPITAL ALCORCON, ALCORCON, SPAIN.

**287**   **Hypoxic Induction of Inflammatory Responses in Chronic Sinusitis**

**J. W. Steinke**, S. B. Early, K. Hise, L. Borish; Asthma and Allergic Diseases Center, University of Virginia, Charlottesville, VA.

**288**   **Nasal Eosinophilia in Infants with Atopic Dermatitis**

**K. A. DeMuth** ^1^, W. Zhao^2^, C. Koenig^2^, D. Mitchell^2^, A. Irani^2^; ^1^Allergy-Immunology, Washington University in St. Louis, St. Louis, MO, ^2^Allergy-Immunology, Virginia Commonwealth University, Richmond, VA.

**289**   **Risk Factors for Bronchial Hyperresponsiveness in Children with Allergic Rhinitis**

**J. Kim**; Pediatrics, Inha University Hospital, Incheon, REPUBLIC OF KOREA.

**290**   **Asthma and Allergic Rhinitis in Patients with Beta-Thalassemia Minor**

**L. Palma-Carlos**, A. G. Palma-Carlos; Allergy, CAIC - Clinical Allergy Immunology Center, Lisbon, PORTUGAL.

**291**   **Breathe Right Strips(R) (BRS) Improve Respiratory Index (RI) in Patients with Rhinitis and Obstructive Sleep Apnea (OSA)**

**M. R. Rupp**, A. S. Baran, G. D. Marshall; Allergy and Immunology, University of Mississippi Medical Center, Jackson, MS.
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**292**   **Production and Proteomic Characterization of Mite Extracts for Allergy Vaccines**

**P. MOINGEON** ^1^, T. BATARD^1^, H. CHABRE^1^, P. LEMOINE^1^, F. T. CHEW^2^; ^1^R&D, Stallergenes SA, Antony, FRANCE, ^2^Biological Sciences, National University Singapore, Singapore, SINGAPORE.

**293**   **Automated Measurement of Skin Prick Tests**

**S. Wöhrl** ^1^, K. Vigl^1^, M. Binder^2^, G. Stingl^1^, M. Prinz^3^; ^1^Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases (DIAID), Medical University of Vienna, Vienna, AUSTRIA, ^2^Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Vienna, AUSTRIA, ^3^Core unit for Medical Statistics and Informatics, Section on Medical Computer Vision, Medical University of Vienna, Vienna, AUSTRIA.

**294**   **The Value of Measuring Total Ige Levels to Judge Atopy in Children with Negative Prick Skin Tests**

**S. R. Lucas**, D. Murphy, H. Carper, L. Heymann, T. A. E. Platts-Mills, P. Heymann; Allergy, Asthma, & Immunology, University of Virginia, Charlottesville, VA.

**295**   **A Novel Approach to the Identification of Allergen Extract Dilutions for Quality Control in the Production Oo Immunotherapy Extract Kits**

**R. Arora**, S. Kosisky, M. Nelson; Department of Allergy/ Immunology, Walter Reed Army Medical Center, Washington, DC.

**296**   **Phenotyping Allergen Sensitization Using Protein Arrays**

**K. A. Vigh** ^1^, R. Palanivelu^2^, M. C. Cummings^2^, D. Preuss^2,3^; ^1^Human Genetics, The University of Chicago, Chicago, IL, ^2^Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL, ^3^Howard Hughes Medical Institute, Chicago, IL.

**297**   **The Relationship between Low Total Serum IgE and Rhinosinusitis**

**T. Levin** ^1^, D. Ownby^1^, P. Smith^1^, J. Ford^1^, P. Young^1^, E. Peterson^2^, G. Wegienka^2^, M. Maliarik^2^, C. Johnson^2^; ^1^Section of Allergy and Immunology, Medical College of Georgia, Augusta, GA, ^2^Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, MI.

**298**   **A Retrospective Review of Patient\'s Experience and Response to Dog Immunotherapy**

**T. L. Johnson**, II^1^, J. P. Forester^2^, C. A. Coop^1^, J. P. Dice^1^; ^1^Allergy/ Immunology, Wilford Hall Medical Center, Lackland AFB, TX, ^2^Pediatrics, Wilford Hall Medical Center, Lackland AFB, TX.

**299**   **Concomitant Histopathological Findings of Allergic Fungal Sinusitis and Fungal Ball in the Same Sinus: A Rare Case Report**

**V. Mehta**, K. Parks, A. Bewtra; Center for Allergy, Asthma and Immunology, Creighton University Medical Center, Omaha, NE.
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**300**   **Individualized Asthma Education in Subsidized Preschools: Improving the Health of a Low-Income Urban Community**

**J. Purmort**, S. Bonner, M. H. Coady, A. Bucciarelli; Center for Urban Epidemiologic Studies, The New York Academy of Medicine, New York, NY.

**301**   **Carboplatin Desensitization**

**R. MIELGO**, M. GARCIMARTÍN, N. FERNANDEZ, A. AMORES, M. QUINTANA, M. GOYACHE, C. MENDIOLA, J. RODRIGUEZ, G. CANTO; ALLERGY, HOSPITAL 12 DE OCTUBRE, MADRID, SPAIN.

**302**   **Systemic Reactions (SR) to Immunotherapy (IT) Using Standardized Extract in Over 700,000 Injections**

**S. L. Delancy** ^1^, W. V. Filley^2^, C. E. Aston^3^, J. R. Claflin^2^; ^1^Nursing, Oklahoma Allergy & Asthma Clinic, Oklahoma City, OK, ^2^Oklahoma Allergy & Asthma Clinic, Oklahoma City, OK, ^3^General Clinical Research Center, OUHSC-GCRC, Oklahoma City, OK.

**303**   **Research Bronchoscopy: an Audit of the Volunteers' Experience**

**K. K. Jones**; Dept of Asthma, Allergy & Respiratory Science, King\'s College London, London, UNITED KINGDOM.

**304**   **Infantile Eczema as a Predictor of Asthma and Asthma Severity in Preschool Children**

**K. A. Callahan** ^1^, E. C. Matsui^1^, J. Curtin-Brosnan^1^, P. A. Eggleston^1^, G. B. Diette^2^; ^1^Pediatric Immunology, Johns Hopkins University, School of Medicine, Baltimore, MD, ^2^Pulmonary, Johns Hopkins University, School of Medicine, Baltimore, MD.

**305**   **Control of Asthma and Written Asthma Action Plans**

**R. Chooniedass** ^1,2^; ^1^Pediatric Allergy, University of Manitoba, Winnipeg, MB, CANADA, ^2^Manitoba Institute of Child Health, Winnipeg, MB, CANADA.

**306**   **Prevalence of Sensitization and Latex Allergy in Operating Room Workers of the Worker\'s Hospital, Santiago, Chile**

**C. R. RODAS**, Sr.^1^, M. A. Guzman, Sr.^1^, S. Rojas, Sr.^2^; ^1^IMMUNOLOGY, HOSPITAL CLINICO U CHILE, SANTIAGO, CHILE, ^2^Medicine, HOSPITAL Trabajador, SANTIAGO, CHILE.

**307**   **Seasonal and Diurnal Variation in the Aeroallergen Concentration in the Atmosphere of Texas Panhandle**

**N. GHOSH** ^1^, C. Saadeh^2^, M. Gaylor^3^, N. Aurora^1^; ^1^Life Sciences, West Texas A & M UNiversity, Canyon, TX, ^2^Allergy A.R.T.S., Amarillo Center for Clinical Research 6842 Plum Creek Drive, TX 79124, Amarillo, TX, ^3^Allergy A.R.T.S., Amarillo Center for Clinical Research 6842 Plum Creek Drive, TX 79124, Amarillo, TX.

**308**   **A Comparative Study of the Relationship of Anxiety Between Allergy and Primary Care Patients**

**D. González de Olano** ^1^, L. Moñino Fernández^2^, M. J. Martínez Irazusta^3^, A. García Morena^1^, A. Henriquez Santana^1^, G. González Balmaseda^4^; ^1^Allergy, Hospital Ramón y Cajal, Madrid, SPAIN, ^2^Psychiatry, Hospital Gregorio Marañón, Madrid, SPAIN, ^3^Primary Care Doctor, Centro de Salud Juan de Austria, Madrid, SPAIN, ^4^Psychiatry, Clínica San Miguel, Madrid, SPAIN.

**309**   **The Role of the Pediatric Nurse Practitioner in an Inpatient Asthma Program**

**A. E. Borgmeyer**, P. M. Gyr, L. D. Henry, P. A. Jamerson; St. Louis Children\'s Hospital, Saint Louis, MO.

**310**   **Mold Damage in New Orleans Homes and Allergic Sensitization in Asthmatic Children**

**G. E. Eroglu** ^1,2^, F. Rabito^3^; ^1^Allergy- Immunology, Tulane University, New Orleans, LA, ^2^Allergy-Immunology and Asthma, Louisiana State University Health Sciences Center, New Orleans, LA, ^3^School of Public Health, Tulane University, New Orleans, LA.

**311**   **The Prevalence and Diagnostic Value of Toxocariasis in Unknown Eosinophilia**

**N. Kwon** ^1^, J. Lee^1^, M. Oh^1^, S. Lee^2^, D. Choi^1^; ^1^Division of Allergy, Dept. of Medicine, Samsung Medical Center, Seoul, REPUBLIC OF KOREA, ^2^Division of Allergy and Pulmonology, Gil Hospital, Gacheon Medical College, Incheon, REPUBLIC OF KOREA.

**312**   **Result of Survey on Asthma in Hanoi Pupils**

**P. L. Tuan**; Hanoi Department of Health, Hanoi, VIET NAM.

**313**   **Clinical and Immunological Peculiarities in Patients with Pollen Allergy and Concomitant Secondary Immunodeficiency**

**M. Rudenko**; Research Institute of Clinical Immunology and Allergology, Rostov State Medical University, Rostov-on-Don, RUSSIAN FEDERATION.

**314**   **Impact of an Education Program on Children Presenting Persistente Bronchial Asthma (PBA)**

**M. A. Calvo** ^1^, B. Graff^1^, F. Marín^2^; ^1^Pediatrics Institute, Austral University, Valdivia, CHILE, ^2^Health Public Institute, Austral University, Valdivia, CHILE.

**315**   **The Use of Subcutaneous Immunoglobulin in Imminodeficient Children with Limited IV Access**

**A. R. Zampelli**; Pediatric Rheumatology, Allergy & Immunology, Hershey Medical Center, Hershey, PA.

**316**   **Emotional Bother, Rather than Disease Severity, Determines Environmental Control Practices in Inner-City Preschool Children**

**J. Curtin-Brosnan**, P. A. Eggleston, E. C. Matsui, N. N. Hansel, C. S. Rand, K. A. Callahan, G. B. Diette; Johns Hopkins University, Baltimore, MD.

**317**   **Pharmoeconomics of Penicillin Skin Testing (PST) on Inpatient Antibiotic Use in Patients with Penicillin Allergy (PA)**

**S. Nootheti**, E. Kavosh, L. Bielory; Dept. of Allergy and Immunology, UMDNJ, Newark, NJ.

**318**   **Use of Respiratory Protection in a Mouse Research and Production Facility and Risk of Allergic Sensitization**

**E. A. O\'Neil** ^1^, K. A. Hagberg^1^, B. J. Paigen^2^, P. A. Eggleston^3^, K. A. Callahan^3^, E. C. Matsui^3^; ^1^Employee Health Center, The Jackson Laboratory, Bar Harbor, ME, ^2^Research, The Jackson Laboratory, Bar Harbor, ME, ^3^School of Medicine, Johns Hopkins University, Baltimore, MD.

**319**   **Smoke Free Laws and Asthma Outcomes**

**E. J. Hahn**, P. Burkhart, M. Rayens, D. Moser, S. Lee; College of Nursing, University of Kentucky, Lexington, KY.

**320**   **Modern Technology Making Immunotherapy Safer**

**R. G. Houser**, J. B. Hunter, S. Shaeffer, L. H. Fisher, T. J. Craig; Allergy/Immunology, Penn State Hershey Medical Center, Hershey, PA.
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**321**   **Identification of Novel Chromosomal Regions Associated with Airway Hyperresponsiveness (AHR) in Recombinant Congenic Strains of Mice**

**P. Camateros** ^1^, J. Moisan^1^, P. D. Lee^2^, R. Marino^1^, T. J. Hudson^2^, D. Radzioch^1^; ^1^Medicine, Division of Experimental Medicine, McGill University, Montreal, PQ, CANADA, ^2^Montreal Genome Centre, McGill University Health Centre, Montreal, PQ, CANADA.

**322**   **Improved Efficiency of Pulmonary Delivery of Budesonide with Respimat^®^ Soft Mist™ Inhaler Compared with Turbohaler or pMDI**

**C. C. Wood** ^1^, B. van Toor^2^, V. Hasselbarth^2^, H. Stammer^2^, H. Voss^2^; ^1^Respiratory and Immunology Clinical Operations, Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, ^2^Human Pharmacology, Boehringer Ingelheim Pharma KG, Ingelheim, GERMANY.

**323**   **A Study to Evaluate the Handling Performance of Ventolin HFA MDI with Counter in Subjects with Asthma or COPD**

**R. L. Wasserman** ^1^, N. W. Locantore^2^, J. Carranza Rosenzweig^2^, C. Crim^2^, W. R. Lincourt^2^; ^1^Pediatric Allergy/Immunology Associates, PA, Dallas, TX, ^2^GlaxoSmithkline, Research Triangle Park, NC.

**324**   **Single and Multiple Doses of Indacaterol, A Novel Once-Daily b~2~-Agonist, Are Well Tolerated in Patients with Mild Asthma**

**L. Brookman** ^1^, H. Knight^1^, J. Wood^1^, S. Perry^1^, A. Tarral^2^, B. Elharrar^3^, S. Pascoe^1^; ^1^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, ^2^Biotrial, Paris, FRANCE, ^3^Aster-Cephac, Paris, FRANCE.
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**325**   **Rescue of Foxp3 Deficiency by Inducible Activation of a Bicistronic Foxp3/EGFP Allele**

**W. Lin** ^1^, N. Truong^1^, D. Haribhai^2^, C. B. Williams^2^, T. A. Chatila^1^; ^1^Department of Pediatrics, UCLA, Los Angeles, CA, ^2^Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.

**326**   **CD103 is a Marker of Human Suppressor Cells**

**Z. Allakhverdi** ^1^, D. Fitzpatrick^2^, M. Comeau^2^, S. Bouguermouh^1^, M. Sarfati^1^, G. Delespesse^1^; ^1^Notre-Dame Hospital, CHUM Research Center, Montreal, PQ, CANADA, ^2^Immunological Systems, Amgen Inc, Seattle, WA.

**327**   **Daily Subcutaneous Injections of Low-Dose Ovalbumin Antigen Induces CD4^+^ CD25^+^ T Regulatory Cells in DO 11 RAG -/- Mice**

**P. E. Dahlberg** ^1^, C. M. Seroogy^2^; ^1^Internal Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, ^2^Pediatrics, University of Wisconsin Hospital and Clinics, Madison, WI.

**328**   **Therapeutic Administration of Allergen-specific CD4^+^CD25^+^ Regulatory T Cells Suppresses Chronic Allergen-induced Airway Inflammation and Remodelling in a Murine Model**

**J. Kearley**, D. S. Robinson, C. M. Lloyd; Leukocyte Biology Section, NHLI, Faculty of Medicine, Imperial College, London, UNITED KINGDOM.
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**329**   **Occurrence of Wheezing and Being Overweight in the First Five Years of Life in a Birth Cohort at High Risk for the Development of Asthma/Allergy**

**Z. Zhang** ^1^, H. Lai^1^, M. Evans^2^, R. Gangnon^2^, E. Anderson^3^, J. Gern^3^, R. Lemanske^4^; ^1^Nutritional Sciences, University of Wisconsin-Madison, Madison, WI, ^2^Biostatistics and medical informatics, University of Wisconsin-Madison, Madison, WI, ^3^Pediatrics, University of Wisconsin-Madison, Madison, WI, ^4^Pediatrics, Medicine, University of Wisconsin-Madison, Madison, WI.

**330**   **The Relationship of Breastfeeding, Overweight and Asthma in School Children**

**X. Mai** ^1^, A. L. Kozyrskyj^1,2^, E. A. C. Sellers^2^, J. J. Liem^2^, A. B. Becker^2^; ^1^Faculty of Pharmacy, University of Manitoba, Winnipeg, MB, CANADA, ^2^Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, CANADA.

**331**   **Elevated BMI at Age 3 Years Predicts Wheeze at Age 5, Independent of Wheeze Earlier in Life**

**M. S. Perzanowski**, I. F. Goldstein, R. G. Barr, B. Sheares, G. L. Chew, R. S. Garfinkel, C. P. Pulgarin, R. M. Whyatt, F. P. Perera, R. L. Miller; Columbia Children\'s Center for Environmental Health (CCCEH), Columbia University, New York, NY.

**332**   **Body Mass Index (BMI) in Asthmatics is Associated with Airway Neutrophil Response to Inhaled Endotoxin: A Role for Atopic Inflammation**

**N. E. Alexis** ^1,2^, M. Almond^1,2^, D. B. Peden^1,2^; ^1^Pediatrics, Center Environmental Med Asthma & Lung Biology, Chapel Hill, NC, ^2^UNC Chapel Hill, Chapel Hill, NC.
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**333**   **Mast Cell Carboxypeptidase as a New Clinical Marker for Anaphylaxis**

X. Zhou^1^, M. G. Buckley^1^, L. C. Lau^1^, C. Summers^2^, R. S. H. Pumphrey^2^, **A. F. Walls** ^1^; ^1^Immunopharmacology Group, University of Southampton, Southampton, UNITED KINGDOM, ^2^Department of Immunology, St Mary\'s Hospital, Manchester, UNITED KINGDOM.

**334**   **Sublingual Epinephrine Tablets Versus EpiPen: Dose Equivalence for Potential First-Aid Treatment of Anaphylaxis**

M. M. Rawas-Qalaji^1^, F. E. R. Simons^2^, **K. J. Simons** ^1^; ^1^Faculty of Pharmacy, University of Manitoba, Winnipeg, MB, CANADA, ^2^Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, CANADA.

**335**   **Strict Avoidance of Exposure to Natural Rubber Latex (NRL) Glove Products is Associated with Longitudinal Reduction in Percutaneous Reactivity to NAL and Hev B Proteins**

**H. S. Amin** ^1^, H. Kalra^1^, R. E. Biagini^2^, R. G. Hamilton^3^, H. Y. Yeang^4^, S. A. M. Arif^4^, D. I. Bernstein^1^; ^1^Allergy/Immunology, University of Cincinnati Medical Center, Cincinnati, OH, ^2^CDC/NIOSH, Cincinnati, OH, ^3^Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD, ^4^Biotechnology and Strategic Research Unit, Rubber Research Institute of Malaysia, Kuala Lumpur, MALAYSIA.

**336**   **Gastrointestinal Allergic Inflammation: IL-9, Mast Cells and Intestinal Anaphylaxis**

**E. E. Forbes** ^1^, K. I. Matthaei^1^, M. J. Newhouse^1^, P. S. Foster^1,2^, S. P. Hogan^3^; ^1^Division of Molecular Bioscience, John Curtin School of Medical Research, Canberra, AUSTRALIA, ^2^Asthma, Allergy and Inflammation Research Centre, University of Newcastle, Newcastle, AUSTRALIA, ^3^Division of Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.
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**337**   **Allergic Sensitization to Cat as Major Predictor of Incident Respiratory Allergy in Children**

**T. Schaefer** ^1^, G. Woelke^2^, J. Ring^3^, H. Wichmann^4^, J. Heinrich^4^; ^1^Institute of Social Medicine, Medical University, Luebeck, GERMANY, ^2^GSF - National Research Center for Environment nad Health, Neuherberg, GERMANY, ^3^Dept. of Dermatology and Allergy, Technical University, Munich, GERMANY, ^4^GSF - National Research Center for Environment and Health, Neuherberg, GERMANY.

**338**   **Maternal Asthma and the Risk of Prematurity**

**J. J. Liem** ^1^, A. L. Kozyrskyj^2^, S. F. Mustapha^1^, A. B. Becker^1^; ^1^Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, CANADA, ^2^Faculty of Pharmacy, Community Health Sciences and Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, CANADA.

**339**   **Early Life Exposure to Maternal Stress is Associated with Asthma**

**A. L. Kozyrskyj** ^1,2^, P. McGrath^3^, B. MacNeil^4^, X. Mai^1,5^, A. B. Becker^2^, K. T. HayGlass^5^; ^1^Faculty of Pharmacy, University of Manitoba, Winnipeg, MB, CANADA, ^2^Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, CANADA, ^3^Psychology, Dalhousie University, Halifax, NS, CANADA, ^4^School of Medical Rehabilitation, University of Manitoba, Winnipeg, MB, CANADA, ^5^Immunology, University of Manitoba, Winnipeg, MB, CANADA.

**340**   **Acetaminophen (APAP) Use Predicts Physician Diagnosis Of Asthma: A Multivariate Analysis of the NHANES III Database**

**G. P. Geba** ^1^, R. R. Arons^2^; ^1^Mailman School of Public Health, Environmental Health Sciences, Columbia University, New York, NY, ^2^Mailman School of Public Health, Sociomedical Sciences, Columbia University, New York, NY.
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**341**   **The Major Allergen from Peanut, Ara h 1, is a Ligand of DC-SIGN**

**W. G. Shreffler** ^1^, Z. Charlop-Powers^1^, R. R. Castro^1^, Z. Y. Kucuk^1^, A. W. Burks^2^, H. A. Sampson^1^; ^1^Pediatrics, Division of Allergy & Immunology, Mount Sinai School of Medicine, New York, NY, ^2^Department of Pediatrics, Division of Allergy/ Immunology, Duke University, Durham, NC.

**342**   **Maintenance and Progression of Human T Helper Type 2 Central Memory T Cells by Thymic Stromal Lymphopoietin Activated Dendritic Cells through OX40-ligand**

**Y. Wang**; Immunology, University of Texas, MD Anderson Cancer Center, Houston, TX.

**343**   **Tgf- b and Volume-Regulated Chloride Channel in the Apoptosis of Human Airway Epithelial Cells**

**G. Cheng** ^1^, M. Kim^1^, D. Agrawal^2^; ^1^Biomedical Science, Creighton University School of Medicine, Omaha, NE, ^2^Biomedical Science, Microbiology and Immunology and Allergy, Creighton University School of Medicine, Omaha, NE.

**344**   **A Novel Ige-cd300a Bispecific Antibody Fragment Abolishes Allergic Responses**

**I. Bachelet**, A. Munitz, F. Levi-Schaffer; The School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, ISRAEL.
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**345**   **Phase 2/3 Study of the Novel Vaccine Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate AIC in Ragweed-Allergic Adults**

**W. Busse** ^1^, G. Gross^2^, P. Korenblat^3^, N. Nayak^4^, M. Tarpay^5^, D. Levitt^6^; ^1^Medicine, University of Wisconsin Medical School, Madison, WI, ^2^Pharmaceutical Research and Consulting, Inc., Dallas, TX, ^3^The Clinical Research Center, LLC, St. Louis, MO, ^4^Sneeze, Wheeze and Itch Associates, Normal, IL, ^5^Allergy, Asthma and Clinical Research Center, Oklahoma City, OK, ^6^Dynavax Technologies, Berkeley, CA.

**346**   **Efficacy of Sublingual Immunotherapy (SLIT) with Grass Pollen Allergen in Children and Adolescents**

**E. Röder** ^1^, M. Y. Berger^2^, W. C. J. Hop^3^, R. M. D. Bernsen^2^, H. de Groot^1^, R. Gerth van Wijk^1^; ^1^Dept of Allergology, ErasmusMC, Rotterdam, THE NETHERLANDS, ^2^Dept of General Practice, ErasmusMC, Rotterdam, THE NETHERLANDS, ^3^Dept of Epidemiology and Biostatistics, ErasmusMC, Rotterdam, THE NETHERLANDS.

**347**   **Anti-IgE Therapy Inhibits IgE-facilitated Allergen Presentation and Increases the Efficacy of Ragweed Immunotherapy**

**S. Klunker** ^1^, J. N. Francis^1^, T. B. Casale^2^, S. R. Durham^1^; ^1^Allergy and Clinical Immunology, Upper Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, UNITED KINGDOM, ^2^Creighton University School of Medicine, Creighton University, Omaha, NE.

**348**   **Sublingual-Oral Administration of Standardized Allergenic Extracts/Vaccines: Safety and Dosing Studies**

**R. E. Esch** ^1^, R. K. Bush^1,2^, D. Peden^3^, R. F. Lockey^4^; ^1^Greer Laboratories, Lenoir, NC, ^2^Allergy & Immunology/ Research, William S Middleton Veterans Memorial Hospital, Madison, WI, ^3^Pediatrics, University of North Carolina, Chapel Hill, NC, ^4^Allergy & Immunology, University of South Florida, Tampa, FL.
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**349**   **Asthma Medication Health Beliefs and Controller Medication Use in Inner City Children**

**A. M. Butz** ^1^, K. Mudd^2^, C. Lewis^1^, M. Donithan^3^, J. Walker^1^, A. Manning^1^, M. D. Sellers^1^, M. Tsoukleris^4^, M. E. Bollinger^5^; ^1^General Pediatrics, Johns Hopkins University, Baltimore, MD, ^2^Pediatric Allergy and Pulmonology, Univeristy of Maryland, Baltimore, MD, ^3^Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, ^4^School of Pharmacy, University of Maryland, Baltimore, MD, ^5^Pediatric Allergy and Pulmonology, University of Maryland, Baltimore, MD.

**350**   **Asthma Outcomes Improve with Peak Flow Monitoring**

**P. V. Burkhart** ^1^, M. K. Rayens^1^, W. R. Revelette^2^; ^1^College of Nursing, University Of Kentucky, Lexington, KY, ^2^Pediatric and Adolescent Associates, Lexington, KY.

**351**   **Asthma Educational Intervention Effect on Medical Cost and Time Spent Within Rural Households of Children with Asthma**

**C. J. Lewis** ^1^, J. Walker^1^, L. Lewis-Boyer^2^, K. Hill^2^, L. Pham^3^, M. Winkelstein^2^, K. Huss^4^, A. Butz^1^; ^1^School of Medicine, Johns Hopkins University, Baltimore, MD, ^2^School of Nursing, Johns Hopkins University, Baltimore, MD, ^3^School of Public Health, Johns Hopkins University, Baltimore, MD, ^4^National Institute of Nursing Research, National Institutes of Health, Bethesdia, MD.

**352**   **Asthma Medication Use in Young Inner-City Asthmatic Children**

**K. E. Mudd** ^1^, M. E. Bollinger^1^, V. D. Hsu^2^, A. Butz^3^; ^1^Pediatrics, University Of Maryland, Baltimore, MD, ^2^School of Pharmacy, University Of Maryland, Baltimore, MD, ^3^Pediatrics, Johns Hopkins University, Baltimore, MD.
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**353**   **Progress Toward the Development of Inhibitors of 11beta-Hydroxysteroid dehydrogenase 2: Inhibition of Cortisol Catabolism in the Lung**

**R. Bateman** ^1^, D. Rauh^2^, K. Shokat^2^; ^1^U.C. San Francisco, San Francisco, CA, ^2^Cellular and Molecular Pharmacology, U.C. San Francisco, San Francisco, CA.

**354**   **Relative Amount of Fluticasone Delivered by HFA-MDI to Children of Different Ages**

**Y. R. Khan**; University of Florida, Gainesville, FL.

**355**   **Novel Pressurised Metered Dose Inhaler Aerosol Delivery of Fluticasone Propionate via Tempo^®^ in Humans**

**S. B. Shrewsbury** ^1^, N. M. Mohsen^2^, S. P. Newman^3^, G. Pitcairn^3^, T. A. Armer^4^; ^1^Clinical & Regulatory Affairs, MAP Pharmaceuticals, Mountain View, CA, ^2^Senior Scientist, Sheffield Pharmaceuticals, Ann Arbor, MI, ^3^Pharmaceutical Profiles, Nottingham, UNITED KINGDOM, ^4^Product Development, MAP Pharmaceuticals, Mountain View, CA.

**356**   **Efficacy and Safety of Budesonide Inhalation Suspension in Pediatric Asthma: Japan, Phase III Clinical Trials**

**A. Akasawa** ^1^, H. Mikawa^2^, S. Nishima^3^; ^1^National Center for Child Health and Development, Tokyo, JAPAN, ^2^Kansai Denryoku Hospital School of Nursing for Advanced Practice, Osaka, JAPAN, ^3^National Hospital Organization Fukuoka National Hospital, Fukuoka, JAPAN.

**357**   **Budesonide prevents Cytokine-induced Decrease of the Relaxant Response to b~2~-agonists in Mouse Trachea**

**M. Adner** ^1^, L. Cardell^1^, A. Miller-Larsson^2^; ^1^ENT, Lab Clin Exp Allergy Research, Malmö University Hospital, Malmö, SWEDEN, ^2^Medical Science, AstraZeneca R&D Lund, Lund, SWEDEN.

**358**   **Inhaled Corticosteroids and the Risk of Oropharyngeal Adverse Events: Results from a Meta-Analysis**

**G. S. Rachelefsky** ^1^, H. Li^2^, N. Liao^2^, Y. Liao^2^, N. J. Combates^2^, R. Faruqi^2^, S. T. Varghese^2^; ^1^Allergy Research Foundation, Inc, Los Angeles, CA, ^2^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**359**   **Genome-Scale Analysis of Posttranscriptional Effects of Glucocorticoids (GC)**

**J. Fan** ^1^, S. L. Curry^1^, U. X. Atasoy^2^, K. G. Becker^3^, M. Gorospe^3^, C. Stellato^1^; ^1^Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, ^2^University of Missouri-Columbia, Columbia, MO, ^3^National Institute of Aging, NIH, Baltimore, MD.

**360**   **Control of Airway Inflammation in Asthma Patients Receiving Fluticasone Propionate (FP)/Salmeterol, FP Alone or FP Plus Montelukast**

N. Jarjour^1^, **P. Dorinsky** ^2^, J. Stauffer^2^, D. Reilly^2^, S. Yancey^2^, L. Edwards^2^, L. Sutton^2^; ^1^University of Wisconsin School of Medicine, Madison, WI, ^2^GlaxoSmithKline, Research Triangle Park, NC.

**361**   **Budesonide and Montelukast Once Daily Inhibits Exercise-Induced Bronchoconstriction in 6- to 18-Year-Old Children with Asthma**

T. Grzelewski, J. Jerzynska, **I. Stelmach**; Department of Pediatrics and Allergy, Medical University of Lodz, M Curie Hospital, Zgierz, POLAND.

**362**   **Treatment of Inhaled Corticosteroid and Leukotriene Receptor Antagonistin Korean Young Cough-Variant Asthma Children**

**J. Jung** ^1^, J. Lee^2^, J. Kim^3^; ^1^Dong-A University Hospital, Busan, REPUBLIC OF KOREA, ^2^Masan Samsung Hospital, Masan, REPUBLIC OF KOREA, ^3^Ulsa University Hospital, Ulsan, REPUBLIC OF KOREA.

**363**   **Early Intervention with High-Dose Inhaled Corticosteroids for Control of Acute Asthma Exacerbations and Improved Outcomes; A Randomized Controlled Trial**

**E. W. Skorpinski** ^1,2^, E. Yousef^1,2^, S. J. McGeady^1,2^; ^1^Division of Allergy/Immunology, A.I. duPont Hospital for Children, Wilmington, DE, ^2^Thomas Jefferson University, Philadelphia, PA.

**364**   **Effect of Once-Daily Evening Administration of Low-Dose Mometasone Furoate on Peak Expiratory Flow in Subjects With Mild-to-Moderate Persistent Asthma**

**B. Prenner** ^1^, R. Yao^2^, B. N. Lutsky^2^; ^1^Allergy Associates Medical Group, Inc., San Diego, CA, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**365**   **Mometasone Furoate Dry Powder Inhaler Improves Lung Function in Patients With Persistent Asthma and Allergic Rhinitis History**

**E. J. Schenkel** ^1^, P. Stryszak^2^, H. Staudinger^2^; ^1^Valley Clinical Research Center, Easton, PA, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**366**   **The Effect of Protein Binding on Adrenal Suppression Potential of Inhaled Corticosteroids**

**H. Derendorf**, G. Hochhaus; Department of Pharmaceutics, University of Florida, Gainesville, FL.

**367**   **Ciclesonide Once Daily is Well Tolerated in Children with Mild, Persistent Asthma: a 1-year, Double-blind, Placebo-Controlled Study**

**J. Maspero** ^1^, S. Malka^2^, S. Kundu^3^, M. Lloyd^3^, D. Banerji^3^; ^1^Sanatorio San José, Fundacion Cidea, Buenos Aires, ARGENTINA, ^2^Hospital De Clinicas Caracas, Caracas, VENEZUELA, ^3^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**368**   **Osteoporosis and its Therapy in Children Treated for Asthma**

**J. Novak**; Paediatric dpt. Hospital, Litomysl, CZECH REPUBLIC.

**369**   **Allergy to Cow Milk Proteins Contaminating Lactose, Common Excipient of Dry Powder Inhalers for Asthma**

**M. Morisset** ^1^, D. Moneret-Vautrin^1^, N. Commun^2^, A. Schuller^1^, G. Kanny^1^; ^1^Department of Internal Medecine, Clinical Immunology and Allergology, University Hospital, Nancy, FRANCE, ^2^Hospital Central\'s Pharmacy, University Hospital, Nancy, FRANCE.

**370**   **Heliox in the Treatment of Patients Hospitalized for Asthma Exacerbations**

**B. D. Tano** ^1^, A. L. Bilderback^1^, C. S. Rand^1^, J. A. Krishnan^2^; ^1^Johns Hopkins University School of Medicine, Baltimore, MD, ^2^Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD.

**371**   **Steroid Myopathy Masquerading as Restrictive Lung Disease in an Asthmatic Patient**

**S. E. Owen** ^1^, C. Glazer^2^, D. Khan^1^; ^1^Department of Internal Medicine: Division of Allergy and Immunology, University of Texas Southwestern, Dallas, TX, ^2^Department of Internal Medicine: Division of Pulmonary and Critical Care, University of Texas Southwestern, Dallas, TX.
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**372**   **Effect of Once-Daily Evening Dosing of Low-Dose Mometasone Furoate on Nocturnal Awakenings in Subjects with Mild-to-Moderate Persistent Asthma**

**F. C. Hampel, Jr.** ^1^, R. Yao^2^, H. Staudinger^2^; ^1^Central Texas Health Research, New Braunfels, TX, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**373**   **Efficacy of Prolonged Budesonide Therapy on Inflammation and Airway Reactivity in a Murine Model of Asthma**

**S. D. Nandedkar** ^1^, K. S. Konduri^1^, S. Deenamsetty^1^, D. A. Rickaby^2^, N. Duzgunes^3^; ^1^Pediatrics, Medical College Of Wisconsin, Milwaukee, WI, ^2^Physiology, Zablocki VA Medical Center, Milwaukee, WI, ^3^Microbiology, University of Pacific School of Dentistry, San Franscisco, CA.

**374**   **Lung Growth and Linear Growth in Pre-pubertal Asthmatic Children Under Inhaled Corticosteroid Therapy (ICS)**

**M. Malucelli**, F. Tigrinho, L. Kovalhuk, C. A. Riedi, M. S. Cramer, R. Miyagi, N. Rosario; University of Parana, Curitiba, BRAZIL.

**375**   **The Beclometazone\'s Impact on Immune and Cytokine Status of Asthma Patients**

**A. Oliinyk**; Allergology, City Allergology Center, Kiev, UKRAINE.

**376**   **Stable Asthma: Unnecessary Over-Exposure to Inhaled Corticosteroid Therapy?**

**D. K. C. Lee**; Department of Respiratory Medicine, Ipswich Hospital, Ipswich, UNITED KINGDOM.

**377**   **Prevention of ICU Admission of Asthmatic Children**

**G. E. Eroglu**; Allergy, Immunology and Asthma, Lousiana Health Scinces Center and Tulane University Medical Center, New Orleans, LA.

**378**   **Value of Determination of Specific IgE Against Recombinant *Aspergillus fumigatus* Allergens rAsp f1, 2, 3, 4 e 6 in the Diagnosis of Allergic Bronchopulmonary Aspergillosis**

E. Oliveira, **P. Giavina-Bianchi**, J. Kalil; Clinical Immunology and Allergy, FMUSP, São Paulo, BRAZIL.

**379**   **The Chinese Herbal Medicine Formula SA-2121 Inhibits Secretion of Histamine and Interleukin-4 in the Airways of a Murine Model of Allergic Asthma**

**s. baik, Sr.**; harbor ucla medical center, torrance, CA.

**380**   **Effects of High Dose SLIT on Quality of Life in Patients with Seasonal Asthma**

**C. Incorvaia** ^1^, G. Riario Sforza^1^, C. Pravettoni^1^, M. Mauro^2^, P. Puccinelli^3^, F. Frati^3^; ^1^Allergy/Rheumatology, ICP Hospital, Milan, ITALY, ^2^Allergy, Sant\'Anna Hospital, Como, ITALY, ^3^Medical Department, Stallergenes Italy, Milan, ITALY.

**381**   **Improvement of the Symptoms and Respiratory Function of Patients with Bronchial Asthma (BA) by Regular Intake of Tomato Juice (TJ)**

**N. Tamura** ^1^, N. Nakamura^2^, H. Suganuma^2^, T. Inakuma^2^; ^1^Department of Respiratory Medicine, Koto Hospital, Tokyo, JAPAN, ^2^Research Institute, Kagome, Tochigi, JAPAN.

**382**   **Thiolated Chitosan Nanoparticles Enhanced Anti-Inflammatory Effects of Intranasally Delivered Theophylline**

**D. Lee**, S. Shirley, X. Kong, R. F. Lockey, S. Mohapatra; Internal Medicine, Univ. of South Florida, Tampa, FL.

**383**   **Association of IL-4 alpha Chain Receptor (IL-4Ra) Polymorphisms and HLA-DR2/DR5 Restriction in Allergic Bronchopulmonary Aspergillosis**

**A. P. Knutsen**, B. Kariuki, P. S. Hutcheson, J. Consolino, R. G. Slavin; Allergy & immunology, Saint Louis University, St. Louis, MO.

**384**   **Mattress Lung: Acrylonitrile-induced Asthma in a Mattress Factory Worker**

M. Mohan, **S. Kagen**, R. Muthiah; Kagen Allergy Clinic, Appleton, WI.

**385**   **Increased Expression in Cd30+ and Cd57+ Molecules on Cd4+ T-cells in Atopic Asthmatic Children: A Preliminary Report**

N. E. Martinez-Jimenez, **E. Rojas-Ramos**; Clinical Immunology and Allergy, ISSSTE, Mexico, D.F., MEXICO.

**386**   **Screening Asthma among Allergic Rhinitis Patients with Peak Expiratory Flow Measurments**

**M. Herrag**; Pulmonary Medecine, Hospital, Rabat, MOROCCO.

**387**   **Prevalance of Pulmonary Nocardiosis in Allergic Bronchopulmonary Disease (Raised Ige Level)**

**R. S. -.-. ABDUL**; -, NATIONAL ALLERGY & ASTHMA CENTRE, KARACHI, PAKISTAN.

**388**   **Timeliness of Diagnosis of Asthma in Children and Associated Factors**

**W. E. Molis** ^1^, H. Kita^1^, L. A. Lee^2^, R. J. Maki^2^, R. Smith^3^, T. Chang^2^, A. Weaver^4^, V. Pankratz^4^, R. M. Jacobson^2^, G. A. Poland^5^, Y. J. Juhn^2^; ^1^Division of Allergic Diseases, Mayo Clinic Rochester, Rochester, MN, ^2^Pediatric and Adolescent Medicine, Mayo Clinic Rochester, Rochester, MN, ^3^Mayo Medical School, Mayo Clinic Rochester, Rochester, MN, ^4^Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, MN, ^5^Internal Medicine, Mayo Clinic Rochester, Rochester, MN.

**389**   **Risk Factor for Asthma Severity in Children: Family History, Atopic Sensitization or Rhinitis**

**H. L. B. S. Santos** ^1^, L. G. Möller^1^, N. P. Duarte, Jr.^1^, R. Morihisa^1^, C. A. Riedi^2^, N. A. Rosario^2^; ^1^Hospital de Clinicas - Universidade Federal do Paraná, Curitiba, BRAZIL, ^2^Pediatric Immunology and Pneumology, Hospital de Clinicas - Universidade Federal do Paraná, Curitiba, BRAZIL.
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**390**   **Lung Features of Infection with Corona Virus in Wistar Rats**

**M. T. Glocker** ^1^, H. Cabaral^1^, J. C. Muiño^2^; ^1^Instituto de Biología Celular, Facultad de Ciencias Médicas - Universidad Nacional de Córdoba, Cordoba, ARGENTINA, ^2^Medicina III - UHMI N° 4, Facultad de Ciencias Médicas - Universidad Nacional de Córdoba, Cordoba, ARGENTINA.

**391**   **Influence of Il-4 on Prostaglandin and Leukotriene Metabolic Pathways**

**E. B. Barekzi** ^1^, J. W. Steinke^1^, R. Caughey^2^, L. Borish^1^; ^1^Asthma and Allergic Diseases Center, University of Virginia, Charlottesville, VA, ^2^Otolaryngology, University of Virginia, Charlottesville, VA.

**392**   **Transgenic Mice Expressing Catalytically Inactive RAG-1 Exhibit Hypogammaglobulinemia and Altered B Cell Development, but not Autoreactivity**

**K. W. Parks** ^1^, A. E. Hassaballa^2^, D. K. Anderson^2^, Q. Hu^3^, T. B. Casale^1^, P. C. Swanson^2,1^; ^1^Allergy and Immunology, Creighton University, Omaha, NE, ^2^Medical Microbiology and Immunology, Creighton University, Omaha, NE, ^3^Pathology, Creighton University, Omaha, NE.

**393**   **Signaling of Human Naïve B Cells Via Toll-like Receptor 7 Induces Immunoglobulin Isotype Switch**

S. Narula^1^, M. Glaum^2^, D. Song^1^, A. Anderson^1^, Y. Zheng^1^, **A. I. Levinson** ^1^; ^1^Medicine, University of Pennsylvania, Philadelphia, PA, ^2^Medicine, University of South Florida College of Medicine, Tampa, FL.

**394**   **The Absence of HLA B8 and B44 is Associated with Decreased Absolute B Cell Numbers in Common Variable Immunodeficiency**

**D. T. Johnston**, H. W. Schroeder, Jr.; Clinical and Developmental Immunology, University of Alabama at Birmingham, Birmingham, AL.

**395**   **Impaired Maturation of Monocyte Derived Dendritic Cells from Birch Allergic Individuals**

**R. Casas** ^1^, K. Duchén^1^, O. Zetterström^2^, O. Vaarala^1^; ^1^Molecular and Clinical Medicine, Paediatrics, Linköping University, SWEDEN, ^2^Molecular and Clinical Medicine, Allergy Centrum, Linköping University, SWEDEN.

**396**   **Using the Pneumococcal Conjugate Vaccine PCV7 (Prevnar) to Evaluate the Functional Antibody Response in Adults with Recurrent Sinopulmonary Infections**

J. Caicedo, **S. Skoda-Smith**; Pediatrics, University of Florida, Gainesville, FL.

**397**   **Clinical Status, Serum Immunoglobulin G Subclasses and Sputum Il-10 and Mpo Levels in Cf Patients**

**A. Korzeniewska**, J. Jerzynska, I. Stelmach; Department of Pediatrics and Allergy, Medical University of Lodz, M Curie Hospital, Zgierz, POLAND.

**398**   **Evaluation of NK T Cells in Patients with Schistosomiasis and Asthma**

**R. A. Campos**, M. S. Teles, M. J. Martins, O. F. Jesus, B. B. Andrade, A. A. Cruz, M. Araújo, E. M. Carvalho; Internal Medicine, Universidade Federal da Bahia, Salvador-BA, BRAZIL.

**399**   **Successful Treatment Using Interleukin-2 (IL-2) in a Patient with Idiopathic CD4+ Lymphopenia (ICL) and Mycobacterium avium (M.avium)**

**B. Mandal** ^1^, V. Bhushan^2^, D. Khan^1^; ^1^Allergy and Immunology, UT Southwestern, Dallas, TX, ^2^Hematology/Oncology, UT Southwestern, Dallas, TX.

**400**   **Characterization of the Suppressive Properties of Human CD4+CD25+ T Cells in Atopic and Non-Atopic Individuals**

**A. M. L. Fonseca**, C. Torres, O. M. M. Lourenco, L. M. P. Taborda-Barata; Department of Medical Sciences, Health Sciences Medical Center, University of Beira interior, Covilhã, PORTUGAL.

**401**   **The Effect of Household Endotoxin (ET) Exposure on IgE in Infancy**

**N. Aichbhaumik** ^1^, C. C. Johnson^1^, S. Havstad^1^, D. R. Ownby^2^, L. K. Williams^1^, E. M. Zoratti^1^; ^1^Center for Allergy, Asthma, and Immunology Research, Henry Ford Health System, Detroit, MI, ^2^Division of Allergy, Medical College of Georgia, Augusta, GA.

**402**   **Interleukin-12 Inhibits Eosinophil Degranulation and Migration but Does not Promote Eosinophil Apoptosis**

**F. Davoine** ^1^, C. Ferland^2^, J. Chakir^2^, D. Adamko^3^, R. Moqbel^1^, M. Laviolette^2^; ^1^Dept of Medicine, University of Alberta, Edmonton, AB, CANADA, ^2^Institut universitaire de cardiologie et de pneumologie de l\'Université Laval, Hôpital Laval, Québec, PQ, CANADA, ^3^Dept of Pediatrics and Medicine, University of Alberta, Edmonton, AB, CANADA.

**403**   **Autoimmune Lymphoproliferative Syndrome Caused by Defects in Mitochondria-Mediated Apoptotic Pathways**

**J. B. Oliveira** ^1^, M. J. Lenardo^2^, T. A. Fleisher^1^; ^1^Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, ^2^Laboratory of Immunology, NIAID, National Institutes of Health, Bethesda, MD.

**404**   **Analysis of the Memory CD8+ T Cell Response to RSV Infection**

**W. W. Stevens** ^1,2^, J. P. Castillo^1^, T. J. Braciale^1,3^; ^1^Beirne Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville, VA, ^2^Microbiology, University of Virginia Health Sciences Center, Charlottesville, VA, ^3^Pathology, University of Virginia Health Sciences Center, Charlottesville, VA.

**405**   **Asthmatic Children Display Increased Th1 Biased Immunity to Human Metapneumovirus**

**R. N. Douville** ^1^, Y. Li^2^, N. Bastien^3^, A. Becker^4^, A. Kozyrskyj^5^, K. T. HayGlass^4^; ^1^Department of Immunology, University of Manitoba/CIHR National Training Program in Allergy and Asthma Research, Winnipeg, MB, CANADA, ^2^Department of Medical Microbiology, University of Manitoba/Canadian Science Center for Human and Animal, Winnipeg, MB, CANADA, ^3^Canadian Science Center for Human and Animal Health, Winnipeg, MB, CANADA, ^4^Depts of Immunology/Medical Microbiology/Pediatrics/Child Health, University of Manitoba/CIHR National Training Program in Allergy and Asthma Research, Winnipeg, MB, CANADA, ^5^Depts of Immunology/Pediatrics/Child Health/Community Health Sciences, University of Manitoba/CIHR National Training Program in Allergy and Asthma Research, Winnipeg, MB, CANADA.

**406**   **Recurrent Respiratory Papillomatosis (RRP): Increased T~H~2-Like Chemokine Expression**

**D. W. Rosenthal** ^1,2^, J. A. Devoti^1,2^, R. Wu^3,2^, H. Schmidtmayerova^4^, B. M. Steinberg^3,2^, V. R. Bonagura^1,2^; ^1^Allergy/Immunology, Long Island Jewish Medical Center, Great Neck, NY, ^2^Institute for Medical Research of North Shore-Long Island Jewish Health System, New Hyde Park, NY, ^3^Otolaryngology, Long Island Jewish Medical Center, New Hyde Park, NY, ^4^Institute for Medical Research of North Shore-Long Island Jewish Health System, Manhasset, NY.

**407**   **Suppression of Toll-like Receptors 3-, 7- and 9-induced B cell Activation and Antibody Production by Repetitive Oligonucleotides from Mammalian Telomere**

**C. Sackesen** ^1,2^, M. Akdis^1^, J. Zumkehr^1^, S. S. Alkan^3^, K. Blaser^1^, I. Gursel^4^, C. A. Akdis^1^; ^1^Swiss Institute of Allergy and Asthma Research (SIAF), Davos, SWITZERLAND, ^2^Dept. of Pediatric Allergy and Asthma, Hacettepe University School of Medicine, Ankara, TURKEY, ^3^3M Pharmaceuticals, St. Paul, MN, ^4^Section of Retroviral Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD.

**408**   **Role of Dendritic Cells in the Induction of Tolerant Versus Effector T Lymphocytes-Mediated Responses to Amoxicillin**

R. R-Pena^1^, S. Lopez^1^, C. Mayorga^1^, C. Antunez^2^, M. J. Torres^2^, J. A. Cornejo-Garcia^1^, T. D. Fernandez^1^, **M. Blanca** ^2^; ^1^Research Lab, Carlos Haya Hospital, Malaga, SPAIN, ^2^Allergy Service, Carlos Haya Hospital, Malaga, SPAIN.

**409**   **CTLA-4 + and CD25+ T Cells Down Regulation are Associated to Severe Respiratory Syncytial Virus Infection**

**P. V. Díaz** ^1^, R. A. Pinto^2^, A. A. Gaggero^3^, S. M. Arredondo^4^, M. Bono^5^; ^1^Pathophysiology Program, ICBM, Faculty of Medicine, University of Chile, Santiago, CHILE, ^2^Pediatric Department, Faculty of Medicine, University of Chile, Santiago, CHILE, ^3^Virology Program , ICBM, Faculty of Medicine, University of Chile, Santiago, CHILE, ^4^Immunology, National Institute of Chest Disease, Santiago, CHILE, ^5^Immunology, Faculty of Science, University of Chile, Santiago, CHILE.
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**410**   **Loss of Memory B Cells May be an Early Marker for Common Variable Immune Deficiency**

**C. T. Cady** ^1,2^, R. J. Harbeck^1^, C. H. Kirkpatrick^2^; ^1^Medicine, NJMRC, Denver, CO, ^2^University of Colorado Health Sciences Center, Denver, CO.

**411**   **Population Prevalence of Diagnosed Primary Immune Deficiency Diseases in the United States**

**J. M. Boyle** ^1^, R. H. Buckley^2^; ^1^Immune Deficiency Foundation, Towson, MD, ^2^Duke University School of Medicine, Durham, NC.

**412**   **In Vitro Induction of IgA Expression in Ataxia Telangiectasia (A-T) Patients with IgA Deficiency (IgAD)**

**T. V. Le**, H. M. Lederman; Pediatrics, Johns Hopkins Medical Institute, Baltimore, MD.

**413**   **Rituximab Treatment to Control Epstein-Barr Virus (EBV) Infection in X-Linked Lymphoproliferative Disorder (XLP)**

**B. J. Mark** ^1^, A. P. Knutsen^2^; ^1^Department of Internal Medicine, Division of Allergy and Immunology, Saint Louis University School of Medicine, St. Louis, MO, ^2^Department of Pediatrics, Division of Allergy and Immunology, Saint Louis University School of Medicine, St. Louis, MO.

**414**   **Decreased Lymphocyte Mitogen Responses at Diagnosis Are Associated with Increased Morbidity in Common Variable Immunodeficiency Patients**

**C. M. Davis**, C. A. Kozinetz, L. M. Noroski; Pediatrics, Baylor College of Medicine, Houston, TX.

**415**   **Hypergammaglobulinemia, IgG~2~ Subclass Deficiency and Recurrent Infections in Adults**

**C. B. Lauter**; Division of Allergy & Clinical Immunology, William Beaumont Hospital, Royal Oak, MI.

**416**   **Peripheral Naive B-Cell Phenotype in X-Linked Severe Combined Immunodeficiency (XSCID) Patients with Hypogammaglobulinemia After Bone Marrow Transplantation**

**J. Chinen** ^1^, D. Moratto^1^, M. R. Kirby^1^, G. F. Linton^2^, H. L. Malech^2^, J. M. Puck^1^; ^1^Genetics and Molecular Biology Branch, NHGRI-NIH, Bethesda, MD, ^2^Laboratory of Host Defenses, NIAID-NIH, Bethesda, MD.

**417**   **Chronic Rhinosinusitis (crs) in Primary Immunodeficient Patients**

**A. B. F. Fomin** ^1^, E. B. Farah^1^, M. S. Nascimento^1^, A. B. M. Castro^1^, A. C. Pastorino^1^, E. M. G. Carnide^1^, C. M. A. Jacob^1^, L. A. N. Oliveira^2^; ^1^Unidade de Alergia e imunologia, Hospital das Clínicas - Instituto da Criança, São paulo, BRAZIL, ^2^Unidade de Radiologia, Hospital das Clínicas - Instituto da Criança, São paulo, BRAZIL.

**418**   **Lung Involvement During Follow-Up of 12 patients with Agammaglobulinemia**

**E. G. Marins** ^1^, M. B. Dorna^2^, E. M. G. Carnide^2^, A. C. Pastorino^2^, A. B. F. Fomin^2^, A. P. B. M. Castro^2^, C. M. A. Jacob^2^; ^1^Departamento de Imunologia e Alergia, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRAZIL, ^2^Allergy and Immunology, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRAZIL.

**419**   **Results of the us Pivotal Trial Of Self-Administered Subcutaneous Immunoglobulin Replacement Therapy in Primary Immune Deficiency Diseases**

**H. D. Ochs** ^1,2^; ^1^Immunology, University of Washington, Seattle, WA, ^2^Childrens Hospital and Regional Medical Center, Seattle, WA.

**420**   **Parathyroid Gland Transplantation without Posttransplantation Immunosuppression**

**I. K. Chinn**, B. H. Devlin, M. A. Alexieff, J. Li, E. McCarthy, M. A. Skinner, J. A. Olson, Jr., M. L. Markert; Pediatrics, Duke University Medical Center, Durham, NC.

**421**   **Percentage of Patients Experiencing Local Infusion-site Reactions During Subcutaneous Immunoglobulin Therapy Decreases Rapidly Upon Repeated Infusions**

**M. R. Stein** ^1^, H. D. Ochs^2^, C. Investigators^3^; ^1^Allergy Associates of the Palm Beaches, North Palm Beach, FL, ^2^Pediatrics, University of Washington School of Medicine, Seattle, WA, ^3^ZLB Behring, Marburg, GERMANY.

**422**   **Clinical and Immunologic Manifestations of Transplacentally Acquired Maternal T-Cells in SCID**

**K. Palmer** ^1^, T. D. Green^1^, J. L. Roberts^1^, E. Sajaroff^1^, M. Cooney^1^, K. Coyne^1^, D. Chen^2^, N. L. Reinsmoen^2^, R. H. Buckley^1^; ^1^Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC, ^2^Department of Pathology, Duke University Medical Center, Durham, NC.

**423**   **The Effect of Desloratadine (D) and Montelukast (M) both on Antigen Specific Immune Response and Lymphoid Apoptosis in Rats**

**I. Kaidashev** ^1^, N. Kutzenko^1^, I. Yastremskaya^1^, L. M. DuBuske^2^; ^1^Ukrainian Medical Stomatological Academy, Poltava, UKRAINE, ^2^Immunology Research Institute of New England, Gardner, MA.

**424**   **Conversion from Intravenous to Subcutaneous Immunolgobulin Therapy: Relationship Between Dose, Serum Trough IgG Concentration and Infection Rate in Patients with Primary Immune Deficiency Diseases**

**M. Berger** ^1^, H. Ochs^2^, &. CE1200 Investigators^3^; ^1^Pediatrics, Case Western Reserve University, Cleveland, OH, ^2^Pediatrics, University of Washington School of Medicine, Seattle, WA, ^3^ZLB Behring, King of Prussia, PA.

**425**   **The Clinical Syndrome of Specific Antibody Deficiency (SAD) in Children**

**R. J. Boyle** ^1^, C. Le^2^, A. Balloch^1^, M. L. Tang^1^; ^1^Infection and Environment Division, Murdoch Children\'s Research Institute, Parkville, AUSTRALIA, ^2^Intensive Care, Royal Children\'s Hospital, Parkville, AUSTRALIA.

**426**   **Evaluation of Immunological Features in IgM Deficiency**

**S. Ramanuja**, S. Gupta, L. Yel; Department of Medicine, University of California at Irvine, Irvine, CA.

**427**   **Immune Defects in Rubinstein-Taybi Syndrome With and Without Deletion of CREBBP**

**D. R. Naimi** ^1^, J. Munoz^2^, J. Rubinstein^3^, R. W. Hostoffer, Jr.^4^; ^1^Division of Allergy and Immunology, The Children\'s Hospital of Philadelphia, Philadelphia, PA, ^2^Pediatric Infectious Diseases, Maria Fareri Children\'s Hospital, Valhalla, NY, ^3^Pediatrics, Cincinnatti Children\'s Hospital, Cincinnatti, OH, ^4^Pediatrics, Case Western Reserve University, Cleveland, OH.

**428**   **Monoclonal Gammopathy in Patients with B Cell Immunodeficiency**

**R. Herzog**, A. Rubinstein; Allergy and Immunology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.

**429**   **Antibody Deficiency in the New Millennium: Illnesses, Absences, and Concomitant Medications- 100 Patient Years Experience**

**E. A. Cassidy** ^1^, P. J. Pinciaro^2^, M. Berger^1^, \*. for the Grifols 04, 04-OLE, IG201 Investigators^3^; ^1^Rainbow Babies and Children\'s Hospital, Cleveland, OH, ^2^Probitas Pharma, Inc., Millersville, MD, ^3^Instituto Grifols, Barcelona, SPAIN.

**430**   **A Case of a Child with Lymphangiectasia and Lymphedema Associated with Hypogammaglobulinemia and Lymphopenia**

**A. L. Cox**, P. Ponda, V. R. Bonagura; Allergy & Immunology, North Shore-Long Island Jewish Health System, New Hyde Park, NY.

**431**   **Common Variable Immunodeficiency Presenting as Lymphonodular Hyperplasia, Pernicious Anemia and Breast Cancer**

**M. W. Reder**, L. Wild; Allergy and Clinical Immunology, Tulane University Medical Center, New Orleans, LA.

**432**   **Beta Blockers, Ace Inhibitors, and Angiotensin Receptor Blockers in Hymenoptera Allergy: A 5 Year Chart Review**

**R. T. Misiak**; Internal Medicine, University of Michigan, Ann Arbor, MI.

Poster Session {#sec28}
==============

3205

Sunday, March 05, 2006 9:45 am to 10:45 am

Aerobiology, allergens, infections and immune reponses {#sec28.1}
------------------------------------------------------

43**3**   **Indoor Spore Levels in Asthmatic and Control Homes**

**F. Hu**, L. D. Johnson, K. Kennedy, J. M. Portnoy, C. S. Barnes; Allergy/Asthma/Immunology, Children\'s Mercy Hospital, Kansas City, MO.

**434**   **Date Palm Pollen: A Significant Asthma and Allergy Inducer**

R. A. Radwan^1^, M. M. Barakat^2^, M. A. Selim^3^, **E. E. Fouda** ^4^; ^1^Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, EGYPT, ^2^Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, EGYPT, ^3^Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, EGYPT, ^4^Allergy and Immunology Center, Al-Azhar University, Cairo, EGYPT.

**435**   **Comparison of Pollen Allergy versus Mold Allergy in Asthmatic and Allergic Rhinitis Patients**

**C. E. Lowe, III**, P. J. Dowling, M. C. Amado, C. S. Barnes; Allergy/Asthma/Immunology, Children\'s Mercy Hospital, Kansas City, MO.

**436**   **Fungal Presence in Typical Midwest Homes**

**C. S. Barnes**, K. Wagoner, F. HU, L. D. Johnson, K. Kennedy, J. M. Portnoy; Allergy/Asthma/Immunology, Children\'s Mercy Hospital, Kansas City, MO.

**437**   **Typical Outdoor Levels of Airborne Non-Viable Fungal Spores Collected at the Ground Level During the Spring and Early Summer in Florida**

**R. Codina**, J. J. Mele, L. S. Cohen, Jr.; Environmental, SDII Global Corporation, Tampa, FL.

**438**   **Description of *Platanus* (London Plane Tree) Pollen Levels and Pollen Sensitization in an Australian Population**

**P. K. Burton** ^1,2^; ^1^Immunology, Westmead Hospital, Westmead, AUSTRALIA, ^2^Department of Clinical Immunlogy/Allergy, Immunology/Allergy, Sydney, AUSTRALIA.

**439**   **Epidemiology and Aerobiology of *Ambrosia Artemisiifolia* between 1988 to 2004**

**F. Della Torre** ^1^, A. Limonta^2^, A. Molinari^3^, P. Benaglio^3^, S. Vercelloni^3^, E. Della Torre^2^; ^1^Pneumologic Department (Chief dr.E.Marchi), INRCA, Casatenovo (LC), ITALY, ^2^Pneumologic Department, INRCA, Casatenovo (LC), ITALY, ^3^Pubblic Health Laboratory, ASL LECCO, Oggiono (LC), ITALY.

**440**   **Changes in Immune Responses to Cat Allergens during Prolonged Avoidance: Is Tolerance Reversible**

**E. A. Erwin**, A. J. Reefer, L. Naccara, D. Bunyan, J. A. Woodfolk, T. A. E. Platts-Mills; University VA, Charlottesville, VA.

**441**   **Allergen-Specific T-Cell Reactivity at Physiologically Relevant Allergen Concentrations**

K. Lund, A. Millner, T. Lenhard, H. Ipsen, **P. A. Würtzen**; Experimental Immunology, ALK-Abello, Hørsholm, DENMARK.

**442**   **Immunological Evaluation of Patients with Mold Related Symptoms**

**D. A. Edmondson** ^1^, C. S. Barrios^1^, T. L. Brasel^2^, D. C. Straus^2^, V. P. Kurup^1^, J. N. Fink^1^; ^1^Allergy and Immunology, Medical College of Wisconsin, Milwaukee, WI, ^2^Microbiology and Immunology, Texas Tech University, Lubbock, TX.

**443**   **Effects of Allergen Challenge on a Chronic Animal Model of *Alternaria* Sensitivity**

**J. E. Knuffman** ^1,2^, H. Sanchez^2^, M. A. Opsahl^3^, R. L. Sorkness^1^, R. K. Bush^2^; ^1^Allergy, University of Wisconsin, Madison, WI, ^2^Allergy, William S. Middleton VA Hospital, Madison, WI, ^3^Allergy, Wiliam S. Middleton VA Hospital, Madison, WI.

**444**   **Trichophyton Allergy: Role in Asthma, Rhinitis and Urticaria/Angioedema**

R. D. R. Oliveira^1^, M. Thiesen^1^, F. R. Oliveira^1^, A. S. Zampolo^1^, M. C. Rodrigues^1^, L. R. Roberti^2^, **L. Arruda** ^1^; ^1^Medicine, School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, ^2^Pediatrics, School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL.

**445**   **Oral Pathogens and Asthma: A Potential Connection**

**S. J. Arbes, Jr.**, E. A. Cohen, M. L. Sever, D. C. Zeldin; NIEHS/NIH, Research Triangle Park, NC.

**446**   **Toll-like Receptor 3 (TLR3) Ligand Exacerbates Pre-existing Allergic Airway Inflammation in Murine Asthma Model**

**H. Nagase** ^1^, N. Yamashita^2^, T. Adachi^1^, J. Nakano^1^, K. Ohta^1^; ^1^Department of Internal Medicine, Teikyo University, Tokyo, JAPAN, ^2^Department of Pharmacy, Musashino University, Nishi-Tokyo, JAPAN.

**447**   **Infection with Rhinovirus Induces a Systemic IP-10 Response**

**S. Kakumanu**, M. Evans, W. W. Busse, J. E. Gern; Allergy/ Immunology, UW Madison, Madison, WI.

**448**   **Expression of Matrix Metalloproteinase-12 in Persistent Alveolar Macrophage Clusters in Rats with a Chronic Asthma-Like Phenotype**

**L. A. Rosenthal** ^1^, R. J. Szakaly^1^, R. F. Lemanske, Jr.^1^, R. L. Sorkness^1,2^; ^1^University of Wisconsin Medical School, Madison, WI, ^2^School of Pharmacy, University of Wisconsin-Madison, Madison, WI.

**449**   **Immunological Characterization of a Hypoallergenic Folding Variant of rBet v 1**

**H. Fiebig**, H. Kahlert, R. Suck, B. Weber, O. Cromwell; Allergopharma Joachim Ganzer KG, Reinbek, GERMANY.
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**450**   **Identification and Characterization of Per a 2, the Bla g 2 Allergen Homologue from American Cockroach (*Periplaneta americana)***

**Q. R. Pan**, S. M. Wang, H. S. Shang, F. T. Chew; Biological Sciences, National University of Singapore, Singapore, SINGAPORE.

**451**   **What is House Dust Mite Allergy in a Community with no House Dust Mites?**

**S. T. Sigurdardottir** ^1,2^, B. Adalsteinsdottir^1,2^, T. Gislason^1,2^, B. Kristensen^3^, D. Gislason^1^; ^1^Landspitali University Hospital, Reykjavik, ICELAND, ^2^University of Iceland, Reykjavik, ICELAND, ^3^Pharmacia Diagnostic, Copenhagen, DENMARK.

**452**   **\[Withdrawn\]**

**453**   **Purification and Characterization of *Blattella germanica* Serine Protease**

**S. Wünschmann** ^1^, S. M. Satinover^2^, J. A. Woodfolk^2^, M. D. Chapman^1^, A. Pomés^1^; ^1^INDOOR Biotechnologies Inc., Charlottesville, VA, ^2^Allergy Division, University of Virginia, Charlottesville, VA.

**454**   **Differential IgE Binding to Recombinant Tropomyosin Orthologs from Different Dust Mite Species Localizes Critical Epitope Regions**

**H. L. Nah**, A. S. L. Tay, A. H. B. Loo, F. T. Chew; Department of Biological Sciences, National University of Singapore, Singapore, SINGAPORE.

**455**   **Epitope Mapping of Der f 13, a Group 13 Allergen from Dust Mite *Dermatophagoides farinae* and Generation of Triple Mutant 3A as a Potential Hypoallergen**

**S. L. Chan**, F. T. Chew, Y. K. Mok; Department of Biological Sciences, National University of Singapore, Singapore, SINGAPORE.

**456**   **Allergic Reactions to Common Allergens may be Due to Evolutionary Immune Response to Conserved Domains (CDs) Present in Parasites and Allergens**

B. P. Bielory^1^, T. John^2^, **L. Bielory** ^3^; ^1^University of Michigan, Ann Arbor, MI, ^2^UMDNJ - New Jersey Medical School, Newark, NJ, ^3^Medicine, Pediatrics & Ophthalmology, UMDNJ - New Jersey Medical School, Newark, NJ.

**457**   **Use of Cross-reacting Carbohydrate Determinants (CCD) in Specific IgE Detection**

**U. Banik**; Product Support Allergy & Infectious Disease, Diagnostic Products Corporation, Los Angeles, CA.

**458**   **Bla g 6: A Calcium Binding German Cockroach Allergen Involved in Muscle Contraction**

**J. Hindley** ^1^, S. Wünschmann^1^, L. D. Vailes^1^, S. M. Satinover^2^, J. A. Woodfolk^2^, M. D. Chapman^1^, A. Pomés^1^; ^1^R&D, INDOOR Biotechnologies, Inc., Charlottesville, VA, ^2^Allergy Division, University of Virginia, Charlottesville, VA.

**459**   **Screening for Conformational Epitopes Using Heat Denaturation of Allergens on ELISA Plates**

**B. Ning**, R. M. Goldblum, D. M. Estes, M. A. Endsley, M. Watanabe, T. Midoro-Horiuti; Pediatrics, University TX Medical Branch, Galveston, TX.

**460**   **Biochemical Characterization of Intact Allergen Extracts and Chemically Modified Allergoids Representing Grass, Birch and House Dust Mite Allergen Extracts**

**H. Henmar**, K. Meno, L. Friberg, G. N. Hansen, A. Giselsson, H. Ipsen; Research Department, ALK-Abelló A/S, Hørsholm, DENMARK.

**461**   **Cloning and Characterization of Art v 2 from *Artemisia Vulgaris* Pollen**

J. Asturias1, C. Arilla1, I. Ibarrola1, J. Daza2, Y. Puente3, **A. Martinez** ^1^; 1R & D, Bial-Arístegui, Bilbao, SPAIN, 2Alergia, Hospital Virgen Macarena, Sevilla, SPAIN, 3Alergoclínica Virgen de Loreto, Córdoba, SPAIN.

**462**   **Potential Alternative ELISA Assays to Detect Alt A1 Using IgM and IgG Antibodies**

**M. Abebe**, V. Kumar, S. Sevinc, H. M. Vijay; Environmental Health, Health Canada, Ottawa, ON, CANADA.

**463**   **Epitope Mapping of Der p 2 by Site-directed Mutagenesis: Differential IgE Binding Epitope Profiles among Individuals Sensitized to Only *Dermatophagoides* spp. and those with Non-pyroglyphid Mite Responses**

**K. Reginald**, F. T. Chew; Department of Biological Science, National University of Singapore, Singapore, SINGAPORE.

**464**   **Sensitization to *Thyreophagus Entomophagus* and other Mite Species in Cuban Patients with Allergic Asthma and/or Rhinoconjunctivitis**

**F. de la Torre Morín** ^1^, R. Aguila de la Coba^2^, M. Gallego^3^, V. Iraola^3^, E. Fernández-Caldas^3^; ^1^Hospital Virgen de la Candelaria, Tenerife, SPAIN, ^2^Hospital Pediatrico el Cerro, La Habana, CUBA, ^3^Laboratorios LETI, S.L., Tres Cantos, SPAIN.

**465**   **Analysis of N-Glycosylation in *Vespula Vulgaris* Hyaluronidase Ves v 2**

**U. R. Seppälä** ^1^, K. Mutenda^2^, R. Monsalve^3^, L. Skov^4^, T. P. King^5^, H. Ipsen^1^, P. Roepstorff^2^, M. D. Spangfort^6^; ^1^Vaccine Research, ALK-Abello´, Horsholm, DENMARK, ^2^Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, DENMARK, ^3^Biochemical Research, ALK-Abello´, Madrid, SPAIN, ^4^Biostructural Research, Department of Medicinal Chemistry,, The Danish University of Pharmaceutical Sciences, Copenhagen, DENMARK, ^5^Rockefeller University, New York, NY, ^6^Research Department, ALK-Abello´, Horsholm, DENMARK.

**466**   **Co-sensitization Not Due to Cross-reactivity Between Paralogs of Group 5 Allergens from *Blomia tropicalis* and *Dermatophagoides Farinae***

**Y. Gao** ^1^, D. Y. Wang^2^, F. T. Chew^1^; ^1^Biological Sciences, National University of Singapore, Singapore, SINGAPORE, ^2^Otolaryngology, National University of Singapore, Singapore, SINGAPORE.

**467**   **Purification and Characterization of *Pen b* 26 Allergen of *Penicillium brevicompactum Expressed* in *Escherichia coli***

**S. Sevinc**, V. Kumar, M. Abebe, H. Vijay; Inhalation Toxicology and Aerobiology, Health Canada, Ottawa, ON, CANADA.

**468**   **Genomic Organization and Characterization of Group 2 Allergen Paralogs from Dermatophagoides Farinae**

**C. L. Tan**, K. Reginald, F. T. Chew; Biological Sciences, National University of Singapore, Singapore, SINGAPORE.

**469**   **Cross Comparison between the IgE Binding Profiles of Cyclophilins from Human, Mouse, Dust Mites and Fungi**

**S. S. Joshi**, H. Y. Gan, F. T. Chew; Biological Science, National University of Singapore, Singapore, SINGAPORE.
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**470**   **Use of the LAD-2 Mast Cell Line to Assess Mast Cell Degranulation Induced by Sera From Chronic Idiopathic Urticaria Patients**

**A. M. Ditto**, R. P. Schleimer, C. Sheen, M. Kulka; Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL.

**471**   **Levocetirizine: H~1~-Receptor Occupancy in Allergic Children Age 6-11 Years**

**K. J. Simons** ^1^, F. E. R. Simons^2^, M. Strolin-Benedetti^3^, M. Gillard^3^, E. Baltes^3^; ^1^Faculty of Pharmacy, University of Manitoba, Winnipeg, MB, CANADA, ^2^Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, CANADA, ^3^Pharma Sector, UCB S.A., Braine-l\'Alleud, BELGIUM.

**472**   **Study of the Role of Basophils in Skin Biopsies of Urticaria**

**M. M. Ferrer** ^1^, M. A. Idoate^2^, P. Gil^3^; ^1^Allergy and Clinical Immunology, Clinica Universitaria Navarra, Pamplona, SPAIN, ^2^Pathology, Clinica Universitaria Navarra, Pamplona, SPAIN, ^3^Dermatology, Clinica Universitaria Navarra, Pamplona, SPAIN.

**473**   **Severity of Autoimmune Urticaria is not Different than in Children with Chronic Urticaria from Other Causes**

**P. Sangacharoenkit**, S. Pongpreuksa, S. Boonchoo, P. Vichyanond, N. Visitsunthorn, O. Jirapongsananuruk; Allergy and Immunology division, Pediatric department, Siriraj Hospital, Mahidol University, Bangkok, THAILAND.

**474**   **The Utility of Skin Biopsy in the Diagnosis and Management of Chronic Urticaria: Correlation with Response to Antihistamine Therapy**

**M. Punar** ^1^, S. Patel^2^, A. Carlson^1^, M. Pasha^3^; ^1^Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, ^2^Medicine, Albany Medical College, Albany, NY, ^3^Allergy and Immunology, Albany Medical College, Albany, NY.

**475**   **Clinical Evaluation of Tolerance and Viral Safety of Human C1-inhibitor Concentrate in Patients with Recurrent Angioedema Due to Hereditary (HAE) or Acquired (AAE) C1 Inhibitor Deficiency**

**M. Bulnes**; Allergy, Hospital La Paz, Spain, SPAIN.

**476**   **Comparison of Autologous Serum Test (AST) Between Healthy Volunteers and Patients with Chronic Idiopathic Urticaria (CIU).PK Vedanthan\* PA Mahesh\^, AD Holla\^, AK Prabhakar\^. \*Univ. of Colorado Health Sciences Center, Denver, Colorado USA; \^ Allergy, Asthma and Chest Center, Mysore, INDIA**

**P. K. Vedanthan**; Medicine, Univ. of Colorado Health Sciences Center, Lakewood, CO.

**477**   **Serum Concentration of Dehydroepiandrosterone Sulphate (DHEA-S) in Female Patients with Chronic Idiopathic Urticaria (CIU)**

**A. Kasperska-Zajac**, Z. Brzoza, B. Rogala; Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Zabrze, POLAND.

**478**   **Sulfasalazine is Beneficial in the Treatment of Recalcitrant Chronic Idiopathic Urticaria**

**L. Y. McGirt**, L. A. Beck; Medicine - Clinical Immunology, Johns Hopkins School of Medicine, Baltimore, MD.

**479**   **Hereditary Angioedema Due to C1 Inhibitor Deficiency: New Findings Concerning Symptoms and Affected Organs**

**K. Bork**, P. Staubach, G. Meng; Department of Dermatology, University of Mainz, Mainz, GERMANY.

**480**   **Successful Treatment of Refractory Chronic Idiopathic Urticaria with Mycophenolate Mofetil**

**S. L. Ridz**, D. A. Khan; Division of Allergy and Immunology, UT Southwestern Medical Center, Dallas, TX.

**481**   **Autoantibodies Against the High Affinity IgE Receptor (FceR1a) are Equally Prevalent in Patients with Auto-Immune Thyroid Disease, Chronic Idiopathic Urticaria and Controls**

**J. Mozena**, J. W. Steinke, L. Borish; University Of Virginia Health Systems, Charlottesville, VA.

**482**   **Basophil Histamine Release (HR) Activity and Disease Severity in Chronic Idiopathic Urticaria (CIU)**

R. Baker^1^, N. Ohameje^1^, K. Vasagar^1^, L. Gober^1^, S. Chen^2^, B. M. Vonakis^1^, **S. S. Saini** ^1^; ^1^Johns Hopkins Allergy Asthma Center, Baltimore, MD, ^2^Emory University, Atlanta, GA.

**483**   **C Reactive Protein (CRP) & IgG Anti-IgE/IgE Receptor (FCeR1) Antibodies in Chronic Idiopathic Urticaria (CIU)**

**M. Kaviani**, R. J. Warrington; Adult Allergy & Clinical Immunology, University of Manitoba, Winnipeg, MB, CANADA.

**484**   **Temperature-dependent, Aquagenic Urticaria/anaphylaxis (tdaa)**

**K. Shamir** ^1^, G. Browne^2^, V. Beltrani^3^, L. Bielory^4^; ^1^Allergy and Immunology, UMDNJ-New Jersey Medical School, Newark, NJ, ^2^Internal Medicine, UMDNJ-Robert Wood Johnson University Hospital, New Brunswick, NJ, ^3^Dermatology, Columbia University College of Physicians & Surgeons, New York, NY, ^4^Allergy, Immunology, & Rheumatology, UMDNJ-New Jersey Medical School, Newark, NJ.

**485**   **Hereditary Angioedema: Safety of Long-Term Androgen Therapy**

**C. Lee**; Rheumatology, Immunology, and Allergy, Brigham and Women\'s Hospital, Boston, MA.

**486**   **Pharmacokinetics of Pasteurized C1-Inhibitor Concentrate (Berinert P) in 40 Patients with Hereditary Angioedema**

**I. Martinez-Saguer**, E. Rusicke, E. Aygören-Pürsün, W. Kreuz; Centre of Pediatrics III, Department of Hematology, Hemostaseology and Oncology, Comprehensive Care, J.-W. Goethe University Hospital Frankfurt, Germany, Frankfurt, GERMANY.

**487**   **Ten Year Retrospective Study of the Contributing Factors to Angioedema in the Inpatient Allergy/Immunology Consult Service**

**A. Banerji**, P. Hesterberg, Y. Hsu, H. J. Chen, J. T. Wong; Department of Rheumatology, Allergy & Immunology, MGH, Boston, MA.

**488**   **Indolent Systemic Mastocitosis with Germline D816V Somatic c-kit Mutation Evolving to an Acute Myeloid Leukemia**

**L. Escribano** ^1^, R. Núñez-López^1^, M. Jara^2^, A. García-Montero^2^, A. Prados^1^, C. Teodosio^2^, A. Iglesias^1^, M. Sanchez^2^, A. Orfao^2^; ^1^Mast Cell Unit, Hospital Ramón y Cajal, Madrid, SPAIN, ^2^Servicio de Citometría, Centro de Investigación del Cáncer y Departamento de Medicina, Universidad de Salamanca, Salamanca, SPAIN.

**489**   **Longitudinal Disease Progression in Mastocytosis Syndromes: a Retrospective Chart Review**

**N. M. Vogel** ^1^, A. E. Lichtin^2^, F. H. Hsieh^1^; ^1^Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, ^2^Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH.

**490**   **Acquired Angioedema Type I (AAE-I) Associated to Non-Hodgkin Lymphoma**

P. Vasquez, M. A. Sgrazzutti, P. Domenichini, A. E. Romanelli, R. D. Rebagliati, **G. D. Ramón**, S. Garbiero; Allergy and Immunology, Hospital Italiano Regional del Sur, Bahía Blanca, ARGENTINA.

**491**   **Mastocytosis in the Child**

**A. C. Zenea-Capote** ^1^, J. Moneda^2^; ^1^Pediatric, Health Center Montesa, Madrid, SPAIN, ^2^Dermatology, "William Soler" Pediatric Hospital, La Habana, CUBA.

**492**   **Mastocytosis in the Child**

**A. C. Zenea-Capote** ^1^, J. Moneda^2^, A. Piñero-Fernandez^3^, R. Rodriguez-Gavalda^1^; ^1^Allergology, "William Soler" Pediatric Hospital, La Habana, CUBA, ^2^Dermatology, "William Soler" Pediatric Hospital, La Habana, CUBA, ^3^Library, Institute of Hematology and Immunology, La Habana, CUBA.

**493**   **Urticarial vasculitis and Thyroid autoimmunity: A study of 21 patients**

**I. M. CHERREZ-OJEDA** ^1^, T. Cazar^2^, T. Guerrero^1^, R. Mantilla^1^, E. Uraga^3^, A. Tafur^1^; ^1^ALLERGY, KENNEDY HOSPITAL, GUAYAQUIL, ECUADOR, ^2^Dermatology, Luis Vernaza Hospital, GUAYAQUIL, ECUADOR, ^3^Dermatology, LUIS VERNAZA HOSPITAL, GUAYAQUIL, ECUADOR.

**494**   **A Case Report of Cold-Induced Urticaria with Atypical Results to Ice-Cube Testing**

**A. S. Kim**, B. Yu, J. Moy; Allergy & Immunology, Rush University Medical Center & Stroger Hospital of Cook County, chicago, IL.

**495**   **Desensitization to Clopidogrel and Ticlopidine in Two Patients with Coronary Artery Disease and Indwelling Drug-Eluting Stents**

**N. J. Nam**, D. Chau, R. L. Miller, S. M. Canfield; Medicine, Columbia University College of Phys. & Surg., New York, NY.

**496**   **Etiology of Chronic Urticaria in Latinoamerican people**

**I. M. CHERREZ-OJEDA** ^1^, T. CAZAR^2^, E. URAGA^2^, R. MANTILLA^1^, T. GUERRERO^1^, J. MORENO^1^; ^1^ALLERGY, KENNEDY HOSPITAL, GUAYAQUIL, ECUADOR, ^2^Dermatology, LUIS VERNAZA HOSPITAL, GUAYAQUIL, ECUADOR.

**497**   **Clinical Improvement in a Pediatric Male with Hereditary Angioedema Treated with Oxandrolone**

**S. Baxi** ^1^, P. C. Giclas^2^, N. Johnson^3^, R. P. Nelson, Jr.^4^; ^1^Pediatrics, Section of Allergy/Immunology, Children\'s Mercy Hospital, Kansas City, MO, ^2^National Jewish Medical and Research Center, Denver, CO, ^3^Pediatrics, Division of Pediatric Endocrinology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, ^4^Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN.

**498**   **Severe Angioedema and Hypocomplementemic Vasculitis in a Patient with Systemic Lupus Erythematosus (SLE): Rapid Response to IV Cyclophosphamide**

**J. C. Martin**, L. D. Truong, N. M. Janssen; Baylor College of Medicine, Houston, TX.

**499**   **The Cerebral Processing of Itch - An Investigation with Functional Magnetic Resonance Tomography**

**U. Darsow** ^1^, M. Valet^2^, F. Pfab^1^, H. Behrendt^1^, T. R. Toelle^2^, J. Ring^1^; ^1^Dept. of Dermatology and Allergy Biederstein/Center for Allergy and Environment, TU Munich, Muenchen, GERMANY, ^2^Dept. of Neurology, TU Munich, Muenchen, GERMANY.
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**500**   **Epidemiology of Mosquito Bite Allergy in the Centre of Allergy and Clinical Immunology of Monterrey, Mexico**

**A. Arias-Cruz**, E. Avitia-Valenzuela, S. N. González-Díaz, G. Galindo-Rodríguez; Allergy and Clinical Immunology, University Hospital, Monterrey, N.L., MEXICO.

**501**   **Circulating Specific IgE to Gliadin Can be a Useful Marker for Diagnosing Wheat-Dependent Exercise-Induced Anaphylaxis Patients Among the Wheat-Sensitized Patients**

**J. Lee** ^1^, S. Yoon^2^, Y. Ye^2^, S. Kim^2^, H. Park^2^; ^1^Department of internal medicine, College of medicine, Hallym University, Chunchon, REPUBLIC OF KOREA, ^2^Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA.

**502**   **Anaphylaxis in Children in Central Israel**

**B. Garty**, V. Hoffer, N. Marcus, O. Schoerman, Y. Levy, Y. Finkelstein, Y. L. Danon; Schneider Children Medical Center of Israel, Petah Tikva, ISRAEL.

**503**   **Purification of Insect Venom Proteins**

**D. R. Hoffman**; Pathology and Laboratory Medicine, Brody School of Medicine, Greenville, NC.

**504**   **Comparison of Quality of Life in Dermal Reactors Referred to an Out-Patient Clinic Versus Patients Recruited by Advertisement**

**H. N. G. Oude Elberink** ^1^, G. H. Guyatt^2^, A. E. J. Dubois^1^; ^1^Allergology, University Medical Center Groningen, Groningen, THE NETHERLANDS, ^2^Epidemiology, McMaster University, Hamilton, ON, CANADA.

**505**   **Anaphylaxis to *Pachycondyla Chinensis***

**T. M. Leath** ^1^, T. J. Grier^2^, R. S. Jacobson^2^, M. E. Fontana-Penn^1^; ^1^Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest University School of Medicine, Winston-Salem, NC, ^2^Research & Development Laboratory, Greer Laboratories Inc., Lenoir, NC.

**506**   **Bullous Pemphigoid in a Newborn with Evidence of Maternal Transmission**

**A. S. Hartel**, J. W. Sleasman, N. Tangsinmankong; Allergy and Immunology, University of South Florida, Saint Petersburg, FL.

**507**   **Allergic Contact Dermatitis to Diallyl Disulphide in Spain**

**J. L. Garcia-Abujeta** ^1^, M. Ferrer^2^, P. Gaig^3^, C. Martinez-Cocera^4^, A. Gonzalo-Garijo^5^, M. Garces^6^, F. Rodriguez^7^, P. Iriarte^8^, T. Soto^9^, D. Muñoz^10^, I. Sanchez^11^, T. Lobera^12^; ^1^Consulta de Alergología, Centro Especialidades, Benidorm, SPAIN, ^2^Servicio de Alergología, Clinica Universitaria de Navarra, Pamplona, SPAIN, ^3^Servicio de Alergología, Hospital Universitario Juan XXIII, Tarragona, SPAIN, ^4^Servicio de Alergología, Hospital San Carlos, Madrid, SPAIN, ^5^Servicio de Alergología, Hospital Infanta Cristina, Badajoz, SPAIN, ^6^Servicio de Alergología, Hospital Clinico, Zaragoza, SPAIN, ^7^Sección de Alergología, Hospital Marques de Valdecilla, Santander, SPAIN, ^8^Sección de Alergología, Hospital Arquitecto Marcide, El Ferrol, SPAIN, ^9^Servicio de Alergología, Hospital Clinico, Pontevedra, SPAIN, ^10^Servicio de Alergología e Inmunologia, Hospital Santiago Apostol, Vitoria-Gasteiz, SPAIN, ^11^Servicio de Alergología, Hospital Virgen de la Candelaria, Tenerife, SPAIN, ^12^Serviciio de Alergología, Hospital San Millan-San Pedro, Logroño, SPAIN.

**508**   **Adverse Reactions to Orthodontic Appliances in Nickel-Allergic Patients**

**K. K. Volkman**, M. C. Zacharisen; Medical College of Wisconsin, Milwaukee, WI.

**509**   **Frequency of Contact Allergy to Fragrances (CAF) in an Unselected Patch Test Population**

**T. Oppel**, E. Scharrer, B. Przybilla; Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians University, Munich, GERMANY.

**510**   **New Important Allergens in Cosmetics**

**H. D. Oei** ^1^, S. B. Tjiook^1^, W. L. Kartanegara^1^, R. L. Oei^2^; ^1^Department of Allergology, Albert Schweitzer Hospital, Dordrecht, THE NETHERLANDS, ^2^Faculty of Medicine, University of Maastricht, Maastricht, THE NETHERLANDS.

**511**   **A Modified Latex Hevein (Hev b 6.02) Retains Lymphozyte Proliferation Response**

**C. Hafner** ^1^, S. Wagner^2^, J. Jasinska^3^, D. Allwardt^2,1^, O. Scheiner^2^, U. Wiedermann^3^, H. Breiteneder^2^; ^1^Department of Dermatology, Medical University of Vienna, Vienna, AUSTRIA, ^2^Department of Pathophysiology, Medical University of Vienna, Vienna, AUSTRIA, ^3^Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, AUSTRIA.

**512**   **Safety of Sublingual Latex Immunotherapy. Are Specific IgE to Recombinant Latex Allergens a Risk Factor?**

**A. Spínola Santos** ^1^, M. Branco Ferreira^1^, A. Lopes Pregal^1^, S. Lopes da Silva^1^, A. Mendes^1^, E. Pedro^1^, F. Nunes^2^, M. L. Palma-Carlos^3^, M. C. Santos^4^, A. G. Palma-Carlos^3^, M. Pereira Barbosa^1^; ^1^Immunoalergology Unit, Hospital Santa Maria, Lisbon, PORTUGAL, ^2^PharmaciaDiagnostics, Lisbon, PORTUGAL, ^3^CHIUL, Faculdade de Medicina de Lisboa, Lisbon, PORTUGAL, ^4^Unidade de Imunologia Clínica, Instituto de Medicina Molecular-FML, Lisbon, PORTUGAL.

**513**   **Immune Responses Induced by Latex Allergens after Gastrointestinal Challenge in Mice**

**C. S. Barrios** ^1^, V. P. Kurup^1,2^, J. D. Henderson, Jr.^3^, J. N. Fink^1^, K. J. Kelly^1^; ^1^Pediatrics, Medical College Of Wisconsin, Milwaukee, WI, ^2^Research Service, VA Medical Center, Milwaukee, WI, ^3^Surgery, Medical College Of Wisconsin, Milwaukee, WI.

**514**   **Comparison of Microarray-Based IgE Profiling with Established Diagnostic Methods in Patients with Latex Allergy**

**C. M. Schroeder** ^1^, H. Ott^1^, S. Stanzel^2^, V. Mahler^3^, M. Raulf-Heimsoth^4^, H. F. Merk^1^, J. M. Baron^1^; ^1^Dept. of Dermatology, RWTH Aachen, Aachen, GERMANY, ^2^Institue of Medical Statistics, RWTH Aachen, Aachen, GERMANY, ^3^Dept. of Dermatology, Universitiy of Erlangen, Erlangen, GERMANY, ^4^Professionals Associations´ Research Institute for Occupational Medicine, University Bochum, Bochum, GERMANY.

**515**   **The Role of Glycosylation of nHev b 2, The ß-1,3-Glucanase from Hevea Brasiliensis Latex, in IgE Recognition**

**U. Seifert** ^1^, S. Wagner^1^, M. Bublin^1^, C. Ebner^2^, C. Hafner^3^, A. Mari^4^, S. Arija M Arif^5^, H. Y. Yeang^5^, O. Scheiner^1^, H. Breiteneder^1^; ^1^Department of Pathophysiology, Medical University of Vienna, Vienna, AUSTRIA, ^2^Allergieambulatorium Reumannplatz, Vienna, AUSTRIA, ^3^Department of Dermatology, Medical University of Vienna, Vienna, AUSTRIA, ^4^National Health Service, Rome, ITALY, ^5^Rubber Research Institute of Malaysia, Sungai Buloh, MALAYSIA.

**516**   **Allergen Concentration in Natural Rubber Latex**

**H. Y. Yeang** ^1^, R. G. Hamilton^2^, D. I. Bernstein^3^, S. A. M. Arif^1^, K. S. Chow^1^, Y. H. Loke^1^, M. Raulf-Heimsoth^4^, S. Wagner^5^, H. Breiteneder^5^, R. E. Biagini^6^; ^1^Biotechnology and Strategic Research Unit, Rubber Research Institute of Malaysia, Sungei Buloh, MALAYSIA, ^2^Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD, ^3^Division of Allergy/Immunology, University of Cincinnati College of Medicine, Cincinnati, OH, ^4^Allergy/Immunology Division, Institute of Occupational Medicine, Bochum, GERMANY, ^5^Department of Pathophysiology, Medical University of Vienna, Vienna, AUSTRIA, ^6^Biomonitoring and Health Assessment Branch, National Institute of Occupational Safety and Health, Cincinnati, OH.

**517**   **The Association between Alcohol Consumption and Atopy in Danish Adults**

**A. Linneberg**, I. Hertzum; Research Centre for Prevention and Health, Copenhagen, DENMARK.

**518**   **Transfer of Experimental Asthma by CD4 T-Cells from Mice with Food-Induced Intestinal Immediate Type Hypersensitivity**

**C. Ozdemir** ^1^, S. Sel^2^, I. Schöll^3^, A. O. Yildirim^4^, N. Blümer^2^, H. Fehrenbach^4^, I. B. Barlan^1^, H. Renz^2^, S. Sel^2^; ^1^Marmara University Division of Pediatric Allergy and Immunology, Istanbul, TURKEY, ^2^Department of Clinical Chemistry and Molecular Diagnostics, Hospital of the Philipps-University Marburg, Marburg, GERMANY, ^3^Institute of Pathophysiology, Medical University of Vienna, Vienna, AUSTRIA, ^4^Department of Internal Medicine (Respiratory Medicine), Philipps-University of Marburg, Marburg, GERMANY.

**519**   **Urticaria after Local Anesthetic Skin Testing with a History of Local Anesthetic Anaphylactic Reaction**

**G. M. Sanders**; Univ. MI Medical Center, Ann Arbor, MI.

**520**   **A Case of Prolonged Anaphylaxis Caused by Persistent Exposure to Food Antigen**

**L. S. Greos**; Colorado Allergy and Asthma Centers, P.C., Englewood, CO.

**521**   **Occupational Contact Anaphylaxis from Piperacillin in a Nurse with Atopic Dermatitis**

**J. Bahn, Sr.**, J. Lee, Sr., K. Eom, Sr., S. Jang, Sr., K. Jung, Sr.; Pulmonary, Allergy, and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, REPUBLIC OF KOREA.

**522**   **A Child Case of Anaphylaxis to Polyvinylpyrrolidone Containing Medicines**

**T. Itazawa**, Y. Adachi, Y. Okabe, Y. S. Adachi, M. Nakabayashi, T. Harai, K. Miya, K. Uese, T. Miyawaki; Dept of Pediatrics, Toyama University, Toyama, JAPAN.

**523**   **Immunotherapy Shot Reaction Manifesting with Delayed-Onset of Severe, Rapidly Progressive Anaphylaxis: Case Report and Post-Event Analysis**

**S. N. Marks** ^1^, D. H. Summers^1^, R. J. M. Engler^2^; ^1^Allergy-Immunology, Landstuhl Regional Medical Center, Landstuhl, GERMANY, ^2^Allergy-Immunology, Walter Reed Army Medical Center, Washington, DC.

**524**   **Management of Food-Induced Anaphylaxis by Caregivers and Medical Professionals: A Survey**

**E. Simons** ^1^, C. Weiss^2^, A. Muñoz-Furlong^2^, T. J. Furlong^2^, S. H. Sicherer^1^; ^1^Division of Allergy and Immunology, Mount Sinai School of Medicine, New York, NY, ^2^Food Allergy & Anaphylaxis Network, Fairfax, VA.

**525**   **Essential Role of Sphingosine Kinase in IgE-mediated Allergic Response *in vivo and ex vivo***

**P. N. Pushparaj**, A. J. Melendez; Department of Physiology, National University of Singapore, Singapore, SINGAPORE.

**526**   **Specific siRNA Targeting of Sphingosine Kinase 1 *in vivo* Ameliorates IgE-Mediated Anaphylaxis**

**P. N. Pushparaj**, A. J. Melendez; Department of Physiology, National University of Singapore, Singapore, SINGAPORE.
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**527**   **Asthma Control in Spain. Do Seasonal Period and Treatment Pattern Matter? ESCASE Study**

**A. Fueyo** ^1^, M. Ruiz^2^, J. Ancochea^2^, M. Guilera^3^, X. Badia^3^; ^1^GlaxoSmithKline, Madrid, SPAIN, ^2^Hospital La Princesa, Madrid, SPAIN, ^3^HOR-Europe, Barcelona, SPAIN.

**528**   **Cost-effectiveness Analysis of Using Allergy Tests in Primary Care in Italian Children**

U. Ytterström-Ahlstedt†^1^, N. Zethraeus^2^, C. J. Petersson^1^, **S. Ahlstedt** ^1,3^; ^1^Pharmacia Diagnostics AB, Uppsala, SWEDEN, ^2^Central for Health Economics, Stockholm School of Economics, Stockholm, SWEDEN, ^3^Dep of Environmental Medicine and Center of Allergy Research, Karolinska Institute, Stockholm, SWEDEN.

**529**   **Trends for Inpatient A&I Consultations for Asthma at a Tertiary Referral Center**

**K. S. Tsai**, I. Hussain; Allergy and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO.

**530**   **Clinic Care Patterns of Patients with Suspected Immunodefects**

**A. Shah** ^1^, P. Sidi^2^, J. Doucette^3^, L. Estrella^4^, C. Cunningham-Rundles^4^; ^1^Department of Internal Medicine, Mt. Sinai Hospital, New York, NY, ^2^Information Technology, Mt. Sinai Hospital, New York, NY, ^3^Department of Community & Preventive Medicine, Mt. Sinai Hospital, New York, NY, ^4^Departments of Medicine and Pediatrics, Mt. Sinai Hospital, New York, NY.

**531**   **National Survey of Hospitalization Rate of Asthma in Taiwan, 1996-2003**

**K. Yeh**, L. Ou, J. Huang; Department of Pediatrics, Chang Gung Children\'s Hospital, Taoyuan, TAIWAN REPUBLIC OF CHINA.

**532**   **Allergic Diseases : Insight and Reallity inThailand**

**N. Siriwaradon**, T. Thongkaew, P. Chatchatee, J. Ngamphaiboon; Division of Allergy and Clinical Immunology, Department of Pediatrics, Chulalongkorn University Hospital, Bangkok, THAILAND.

**533**   **Cost-Effectiveness of Sublingual Specific Immuno-Therapy Versus Current Symptomatic Treatments in Adults with Allergic Rhinitis and Asthma, in the Societal Perspective**

**P. Berto** ^1,2^, G. W. Canonica^3^, N. Crimi^4^, F. Frati^5,6^, C. Ortolani^7^, G. Passalacqua^3^, G. Senna^8^; ^1^pbe consulting, Verona, ITALY, ^2^Facoltà di Farmacia, Università di Padova, Padova, ITALY, ^3^Clinica di Malattie dell\'Apparato Respiratorio e Allergologia Dipartimento di Medicina Interna, Università di Genova, Genova, ITALY, ^4^Cattedra di Malattie dell\'Apparato Respiratorio, Università degli Studi di Catania, Catania, ITALY, ^5^Stallergenes Italia Srl, Scientific Department, Milano, ITALY, ^6^Clinica Pediatrica, Università di Perugia, Perugia, ITALY, ^7^Istituto Sacra Famiglia, Istituto Allergologico Lombardo OnLus, Cesano Boscone (Milano), ITALY, ^8^Unità Operativa di Allergologia, Azienda Ospedaliera di Verona - Ospedale Civile Maggiore, Verona, ITALY.

**534**   **Reversal of Italian Reimbursement Restriction on Antihistamines is Associated with Better Clinical Outcomes among Children with Allergy-Induced Asthma**

**D. S. Battleman** ^1^, C. Burudtakdee^1^, J. Tierce^1^, M. Sturkenboom^2,3^, C. Giaquinto^2,4^, G. Picelli^2,3^, L. Cantarutti^2^, P. Berto^5^, G. Canonica^6^; ^1^ValueMedics Research, LLC, Falls Church, VA, ^2^Pedianet, Padova, ITALY, ^3^International Pharmacoepidemiology and Pharmacoeconomics Research Center, Desio (MI), ITALY, ^4^Department of Paediatrics, University of Padova, Padova, ITALY, ^5^PBE Consulting, Verona, ITALY, ^6^Department of Internal Medicine, University of Genoa, Genoa, ITALY.

**535**   **Medicare Reimbursement of IGIV Negatively Impacts Patients' Access to Care**

**J. B. Scharpf** ^1^, J. M. Boyle^2^, M. B. Vogel^1^; ^1^Immune Deficiency Foundation, Towson, MD, ^2^Schulman, Ronca and Bucuvalas, Inc., Rockville, MD.

**536**   **Children with RSV Infection Who Sought Medical Care Had High Prevalence of Family History of Atopy**

**E. K. Miller**, T. V. Hartert, K. A. Poehling, M. R. Griffin, K. E. Edwards; Vanderbilt University Medical Center, Nashville, TN.

**537**   **The Trend of Atopic Disease in Transylvania, Romania**

**D. M. Dumitrascu**, D. Arion, S. Tatar; 3rd Medical Clinic, Allergy Dept, University of Medicine @ Pharmacy, Cluj-Napoca, ROMANIA.

**538**   **School Survey Shows Asthma and Eczema are Still Increasing in Tokyo**

**M. Futamura** ^1,2^, Y. Ohya^1,2^, M. Akashi^1,2^, N. Kojima^1,2^, K. Akiyama^2^, K. Takahashi^2^, T. Nakagawa^2^, F. Kobayashi^2^, A. Eboshida^2^, H. Nakamura^2^, H. Odajima^2^, Y. Adachi^2^, A. Akasawa^1,2^; ^1^National Center for Child Health and Development, Tokyo, JAPAN, ^2^Japanese Asthma Survey Group, Tokyo, JAPAN.

**539**   **Epidemiology of Medication "Allergy" at a Tertiary Care Center**

**D. M. Lang**, N. M. Vogel, A. Jain; Allergy/Immunology, Cleveland Clinic Foundation, Cleveland, OH.

**540**   **Environmental Exposures In Rural Homes: Parent Report vs. Allergen Dust Samples**

**L. L. Lewis-Boyer, Sr.** ^1^, K. L. Hill^1^, J. M. Walker^1^, C. J. Lewis^1^, M. Winkelstein^1^, L. Pham^2^, A. Butz^2^; ^1^School of Nursing, Johns Hopkins University, Baltimore, MD, ^2^School of Medicine, Johns Hopkins University, Baltimore, MD.

**541**   **Regional Differences in EpiPen Prescriptions in the United States**

**C. A. Camargo, Jr.** ^1^, S. Clark^1^, M. S. Kaplan^2^, P. Lieberman^3^, R. A. Wood^4^; ^1^Emergency Medicine, Massachusetts General Hospital, Boston, MA, ^2^Kaiser Permanente, Los Angeles, CA, ^3^Allergy & Asthma Care, Cordova, TN, ^4^Johns Hopkins Medical Center, Baltimore, MD.
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**542**   **Effect on Quality of Life Of Multidisciplinary Psycho-educational Group Interventions - A Randomized Controlled Trial**

**L. Fernandes** ^1^, J. A. Fonseca^2,3^, A. Costa-pereira^2^, L. Delgado^4^, S. Martins^3^, A. Moreira^3^, A. Feteira^3^, V. Abreu^3^, M. Vaz^3^, M. Castel-Branco^3^; ^1^Psiquiatria, Faculdade Medicina Universidade do Porto, Porto, PORTUGAL, ^2^Bioestatística e Informática Médica, Faculdade Medicina Universidade do Porto, Porto, PORTUGAL, ^3^Serviço de Imunoalergologia do HSJ, Porto, PORTUGAL, ^4^Imunologia, Faculdade Medicina Universidade do Porto, Porto, PORTUGAL.

**543**   **The Impact of Asthma on Child and Parental Quality of Life in Lithuania**

**E. Vaitkaitiene**; Social Pediatrics, Biomedical Research Institute of Kaunas University of Medicine, Kaunas, LITHUANIA.

**544**   **Quality of Life of Children with Allergic Diseases**

**Y. Adachi** ^1^, Y. Okabe^1^, T. Itazawa^1^, Y. S. Adachi^1^, M. Nakabayashi^1^, T. Fuchizawa^1^, T. Miyawaki^1^, H. Odajima^2^; ^1^Dept of Pediatrics, Toyama Medical & Pharmaceutical University, Toyama, JAPAN, ^2^Dept of Pediatrics, Fukuoka National Hospital, Fukuoka, JAPAN.

**545**   **Impaired Quality of Life in Child Asthmatics in Tokyo, Japan**

**N. Kojima** ^1,2^, Y. Ohya^1,2^, M. Futamura^1,2^, M. Akashi^1,2^, K. Akiyama^2^, K. Takahashi^2^, T. Nakagawa^2^, F. Kobayashi^2^, A. Eboshida^2^, H. Nakamura^2^, H. Odajima^2^, Y. Adachi^2^, A. Akasawa^1,2^; ^1^National Center for Child Health and Development, Tokyo, JAPAN, ^2^Japanese Asthma Survey Group, Tokyo, JAPAN.
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**546**   **Masking of Corticosteroid-induced Inhibition of NF-kB activation by (S)-Albuterol in Human Airway Smooth Muscle Cells and Human Blood Lymphocytes**

**D. K. Agrawal** ^1^, G. Cheng^1^, P. W. Kelbe^2^; ^1^Biomedical Sciences, Creighton University School of Medicine, Omaha, NE, ^2^Medical Liason, Sepracor Inc., Marlborough, MA.

**547**   **Expression of Cysteinyl Leukotriene Receptors by CD34+ Umbilical Cord Blood (CB) - Progenitor Cells: Relevance to Atopic Development**

**J. A. ROA**, A. J. BAATJES, L. D. SALEH, M. M. CYR, G. M. GAUVREAU, J. A. DENBURG; Division of clinical immunology and allergy, department of medicine, FACULTY OF HEALTH SCIENCES, McMASTER UNIVERSITY, HAMILTON, ON, CANADA.

**548**   **Genetic Variability in Pulmonary Physiological Responses to Cockroach and Dust Mite Allergen in A/J and C56BL/6 Mice**

**S. B. Sarpong** ^1^, E. Asamoa-Odei^2^, V. Kamendi^3^, J. Okomo-Awich^4^; ^1^Howard University, Washington, DC, ^2^College Of Medicine, Howard University, Washington, WA, ^3^Nursing, Howard University, Washington, DC, ^4^Microbiology, Howard University, Washington, DC.

**549**   **LTC4S(A-444C) Polymorphism is Associated with Severity of Exercise-Induced Asthma in Children**

**M. Kang** ^1^, H. Kim^1^, S. Lee^2^, J. Kim^1^, B. Kim^1^, S. Jang^1^, J. Shim^3^, S. Hong^1^; ^1^Pediatrics, Asan Medical Center, Seoul, REPUBLIC OF KOREA, ^2^Pediatrics, Hallym Medical Center, Seoul, REPUBLIC OF KOREA, ^3^Pediatrics, SungKyunKwan University, Seoul, REPUBLIC OF KOREA.

**550**   **A Polymorphism in the HLA-G 3'-UTR Influences Targeting of mir-148 and is Associated with Asthma**

**Z. Tan** ^1^, J. Fan^2^, A. M. Shon^1^, M. G. Schwartz^1^, B. Camoretti-Mercado^3^, C. Ober^1^; ^1^Department of Human Genetics, University of Chicago, Chicago, IL, ^2^Skirball Institute, New York University School of Medicine, New York, NY, ^3^Department of Medicine, University of Chicago, Chicago, IL.

**551**   **Prostaglandin E2 Induces Exocytosis and Eicosanoid Generation by Human Mast Cells through an Il-4-Dependent Mechanism**

C. Feng, **J. A. Boyce**; Medicine, Brigham and Women\'s Hospital, Boston, MA.

**552**   **Trefoil Factor 2 (TFF2) is Induced by Allergen and IL-13 in Lung Goblet Cells and Modulates Airway Inflammatory Cell Number**

**N. M. Nikolaidis** ^1^, P. C. Fulkerson^2^, T. C. Wang^3^, M. E. Rothenberg^4^; ^1^Cell and Molecular Biology, University of Cincinnati, Cincinnati, OH, ^2^Molecular Genetics, University Of Cincinnati, Cincinnati, OH, ^3^Division of Digestive and Liver Diseases, Columbia University, New York, NY, ^4^Division of Allergy and Immunology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH.

**553**   **Signaling by the CysLT2 Receptor: Involvement of PKA, PKC and Downstream AP-1 and NF-kB Elements in IL-8 Gene Transcription**

**C. Thompson** ^1^, A. Cloutier^2^, Y. Bossé^1^, P. Larivée^2^, P. McDonald^2^, J. Stankova^1^, M. Rola-Pleszczynski^1^; ^1^Immunology division, Université de Sherbrooke, Sherbrooke, PQ, CANADA, ^2^Pulmonary division, Université de Sherbrooke, Sherbrooke, PQ, CANADA.

**554**   **The Mechanism of Self-Perpetuated Activation of ERK1/2 in Airway Cells in the Absence of Allergen Exposure in a Mouse Model of Chronic Asthma**

**R. Alam**, Q. Liang, N. Goplen, W. Liu, S. Rozario, R. Vepachedu, L. Guo, M. M. Gorska; Medicine, National Jewish Medical and Research Center, Denver, CO.

**555**   **Direct Stimulation of Guinea Pig Nasal Sensory Nerves by Leukotriene D4 and Histamine**

**T. E. Taylor-Clark**, M. Lee, B. J. Undem; Allergy & Clinical Immunology, Johns Hopkins Medicine, Baltimore, MD.

**556**   **Crystal Structure of Human Carbonyl Reductase 1 Implications for Structure Based Drug Design**

**D. Rauh**; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA.

**557**   **Stat6 Nuclear Export Elements are Unique from other Stat Family Members**

**M. B. Ericksen**, M. O. Daines, G. K. Khurana Hershey; CCHMC, Cincinnati, OH.

**558**   **Involvement of Adhesion Signaling in GM-CSF-induced Activation of Eosinophils; Evidence of Shp2- Slp76-mediated Cross-talk Between the bc Receptor and ICAM-1**

**K. Pazdrak** ^1^, T. W. Young^1^, J. Wiktorowicz^1^, A. R. Brasier^2^, A. Kurosky^1^; ^1^Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, TX, ^2^Internal Medicine, University of Texas Medical Branch, Galveston, TX.

**559**   **Potential Role of the Glucocorticoid Receptor (GCR) Beta in Glucocorticoid (GC) Dependent Histone H4 Acetylation**

**L. B. Li**, D. Y. M. Leung, E. Goleva; National Jewish Medical and Research Center, Denver, CO.

**560**   **Lipoxin A~4~ (LXA~4~) and Leukotriene C~4~ (LTC~4~) Levels in Nasal Lavages after Intranasal Provocation with Aspirin in Aspirin Sensitive and Aspirin Tolerant Patients**

**M. Kupczyk**, I. Kuprys´-Lipin´ska, M. Bochen´ska-Marciniak, A. Antczak, P. Górski, P. Kuna; Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, POLAND.

**561**   **Bronchoalveolar Lavage Leukotriene C~4~/D~4~/E~4~ Levels in Acute Asthma and Acute Bronchiolitis**

**C. K. Kim** ^1^, J. Y. Koh^1^, M. Hoekendijk^1^, Y. Y. Koh^2^; ^1^Pediatric Asthma/Allergy Center, Inje University, Sanggyepaik Hospital, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Seoul National University Hospital, Seoul, REPUBLIC OF KOREA.

**562**   **Unc119, a Novel Src Kinase Activator, Enhances Myofibroblast Transformation of Human Lung Fibroblasts**

**R. S. Vepachedu**, N. A. Singhania, M. M. Gorska, R. Alam; Medicine, National Jewish Medical and Research Center, Denver, CO.

**563**   **PI-3 Kinase Upregulation: a Constituent of Pollen NADPH Oxidase-induced Signal 1?**

**C. C. Horner** ^1^, N. Dharajiya^1^, I. Boldogh^2^, S. Sur^1^; ^1^Allergy, Pulmonary, Immunology, Critical Care & Sleep, University of Texas Medical Branch, Galveston, TX, ^2^Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX.

**564**   **Resolution of Airway Eosinophilia is Associated with Upregulation of Fas Ligand (FasL) Expression After a Single *Aspergillus fumigatus* (*Af*) Challenge of Sensitized Mice**

**S. K. Sharma** ^1^, S. Kierstein^2^, A. Pitt^3^, F. Almeida^3^, J. Peterson^1^, X. Yang^2^, J. Zangrilli^1,3^, A. Haczku^2^; ^1^Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, ^2^Pulmonary, Allergy and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, ^3^Division of Critical Care, Pulmonary, Allergic and Immunologic Diseases, Thomas Jefferson University, Philadelphia, PA.

**565**   **Dexamethasone Modulates CysLT1R Expression in Human Monocytes**

**J. Stankova**; Immunology division, Pediatrics, Université de Sherbrooke, Sherbrooke, PQ, CANADA.

**566**   **Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition is not Dependent on 5-Lipoxygenase or IL-5, but is IL-13 Dependent**

**R. Peebles, Jr.** ^1^, K. Hashimoto^2^, J. R. Sheller^1^, M. L. Moore^1^, J. D. Morrow^1^, S. Ji^3^, J. A. Elias^4^, K. Goleniewska^1^, J. F. O\'Neal^1^, D. B. Mitchell^1^, B. S. Graham^5^, W. Zhou^1^; ^1^Vanderbilt Univ School Of Medicine, Nashville, TN, ^2^Microbiology, Fukushima Medical University, Fukushima, JAPAN, ^3^LINCO Research, St. Charles, MO, ^4^Yale Univ School Of Medicine, New Haven, CT, ^5^NIAID, Bethesda, MD.

**567**   **Involvement of PKCj in the Development of Airway Hyperreactivity and Inflammation in a Mouse Model of Asthma**

**K. S. Park** ^1^, J. Do^2^, S. Nam^2^; ^1^Pediatrics, Presbyterian Medical Center, Jeonju, REPUBLIC OF KOREA, ^2^Biological Science, Jeonju University, Jeonju, REPUBLIC OF KOREA.

**568**   **Synergy for Glucocorticoid Receptor \[GR\] Translocation by Dexamethasone and Albuterol: Effects of Receptor Antagonists**

**N. Bulayeva** ^1^, J. L. Rabbitt^1^, S. Friday^2^, W. J. Calhoun^1^; ^1^Allergy, Pulmonary, Immunology, CCM, and Sleep, University of Texas Medical Branch, Galveston, TX, ^2^PACCM, University of Pittsburgh, Pittsburgh, PA.

**569**   **Calcium-Calmodulin Mediates House Dust Mite-Induced ERK Activation and Interleukin-8 Production in Human Respiratory Epithelial Cells**

**E. Kim** ^1^, K. Lee^1^, C. Kim^2^, Y. Shin^3^, M. Sohn^1^, K. Kim^1^; ^1^Pediatrics and Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Pediatrics, Kwandong University, Seoul, REPUBLIC OF KOREA, ^3^Pediatrics, Pochon CHA University College of Medicine, Seoul, REPUBLIC OF KOREA.

**570**   **Induction of Interleukin-13 Receptor Expression Via Nuclear Factor-Kappab Activation in Human Tonsillar B Cells**

**O. Hajoui**, H. Zheng, J. Guay, B. Mazer; Meakins Christie Lab, McGill University, Montréal, PQ, CANADA.

**571**   **Immunomodulation by Dietary n3-Polyunsaturated Fatty Acids (PUFA) In Vitro**

**C. Koch** ^1^, L. Brovkina^1,2^, R. Ruehl^3^, M. Worm^1^; ^1^Dpt. of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, GERMANY, ^2^Institute of Nutritional Science, University of Potsdam, Potsdam, GERMANY, ^3^Dpt. of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, HUNGARY.

**572**   **The Role of MyD88 and TNF-a in the Inflammatory Response in the Middle Ear**

**S. I. Wasserman**, J. Ebmeyer, K. Pak, A. Ryan; Medicine, UCSD, La Jolla, CA.

**573**   **Monitoring of Endotoxin-Induced Pulmonary Inflammation *In Vivo* in NF*-*kB Luciferase Transgenic Mice**

**P. S. Thorne** ^1^, S. Hadina^1^, K. Kulhankova^1^, C. Wohlford-Lenane^2^, P. B. McCray^2^, J. P. Weiss^3^; ^1^Occupational & Environmental Health, University of Iowa, College of Public Health, Iowa City, IA, ^2^Pediatrics, University of Iowa, College of Medicine, Iowa City, IA, ^3^Internal Medicine and Microbiology, University of Iowa, College of Medicine, Iowa City, IA.

**574**   **Lyso-Phosphatidylserine (Lyso-ps) Generated by Activated Neutrophils Signals in an Autocrine/paracrine Manner Via G2a- And Rho-dependent Pathways**

**D. L. Bratton** ^1^, S. C. Frasch^1^, K. Zemski-Berry^2^, M. Fessler^1^, C. Shearn^1^, R. C. Murphy^2^, P. M. Henson^1^; ^1^Pediatrics, National Jewish Medical and Research Center, Denver, CO, ^2^Pharmacology, University of Colorado Denver and Health Sciences Center, Aurora, CO.

**575**   **Distribution of IL-13Ra2: Impact of Allergen Exposure and Level of Expression**

**M. O. Daines** ^1^, J. A. Masino^2^, A. M. Gibson^1^, W. Chen^1^, B. A. Walker^3^, M. R. Warrier^1^, Y. Tabata^1^, G. K. Khurana Hershey^1^; ^1^Pediatric Allergy and Immunology, Cincinnati Children\'s Hospital, Cincinnati, OH, ^2^Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, ^3^Washington University in St. Louis, St. Louis, MO.

**576**   **Importance of Leukotrienes in Vulvovaginal Itch and Pain as Evident by Response to Montelukast**

**L. H. Fisher** ^1^, N. Kamdar^2^, T. Craig^1^, C. MacNeill^3^; ^1^Allergy/Immunology, Penn State Hershey Medical Center, Hershey, PA, ^2^Obstetrics and Gynecology, University Of Wisconsin, Madison, WI, ^3^Obstetrics/ Gynecology, Penn State Hershey Medical Center, Hershey, PA.

**577**   **Lack of Association of a New LTC4S Promoter Polymorphism (-1702G\>A) with Aspirin-Intolerant Asthma (AIA)**

**J. H. Choi** ^1^, J. S. Bae, II^2^, S. H. Kim^3^, C. H. Suh^3^, D. H. Nahm^4^, H. S. Park^4^; ^1^Dept of Pulmonology and Allergy, Bundang JeSaeng General Hospital, Seongnam-si, Kyunggido, REPUBLIC OF KOREA, ^2^Dept of Allergy and Rheumatology, Ajou University Hospital, Suwon-si, Kyunggido, REPUBLIC OF KOREA, ^3^Allegy and Rheumatology, Ajou University Hospital, Suwon-si, Kyunggido, REPUBLIC OF KOREA, ^4^Allergy and Rheumatology, Ajou University Hospital, Suwon-si, Kyunggido, REPUBLIC OF KOREA.

**578**   **Il-10 Regulate Smad Protein Expression in Cultured Airway Epithelial Cells**

**N. Fueki** ^1^, H. Sagara^2^, M. Ota^2^, K. Akimoto^2^, T. Okada^2^, K. Sugiyama^2^, M. Fueki^1^; ^1^Jobu Hospital for respiratory Disease, Maebashi Gunma, JAPAN, ^2^Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Mibu Tochigi, JAPAN.

**579**   **Lipooligosaccharide Inhalation Produces Dose- and Time-Dependant Lung Inflammation and Cytokine Release in Mice**

**S. Hadina** ^1^, P. S. Thorne^1^, K. Kulhankova^1^, P. B. McCray^2^, J. P. Weiss^3^; ^1^Occupational & Environmental Health, University of Iowa, College of Public Health, Iowa City, IA, ^2^Pediatrics, University of Iowa, College of Medicine, Iowa City, IA, ^3^Internal Medicine and Microbiology, University of Iowa, College of Medicine, Iowa City, IA.

**580**   **Leukolysin (MMP-25): A Potential Metabolic Marker Airway Inflammation in Asthma**

**J. B. Sweet**; Pulmonary, Allergy & Critical Care, U of MN, Minneapolis, MN.
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**581**   **Haplotype Structure and Natural Selection in an Olfactory Receptor (OR) Gene on Chromosome 6p Associated with Asthma Susceptibility**

**E. E. Thompson** ^1^, C. Murray^1^, M. C. Burkart^1^, D. Nicolae^2^, Y. Gilad^1^, C. Ober^1^; ^1^Human Genetics, University of Chicago, Chicago, IL, ^2^Statistics, University of Chicago, Chicago, IL.

**582**   **Novel Small-Molecules Isolated from a Marine Microbial Library Inhibit IL-5 Production In Vitro**

**W. K. Strangman** ^1^, D. Broide^2^, W. Fenical^1^; ^1^Scripps Institution of Oceanography, UC San Diego, La Jolla, CA, ^2^Medicine, UC San Diego, La Jolla, CA.

**583**   **Therapeutic Effect of Flt3-Ligand in Cockroach Antigen Induced Allergic Airway Inflammation and Airway Hyper-Responsiveness**

**J. H. Edwan** ^1^, D. K. Agrawal^1,2^; ^1^Biomedical Sciences Department, Creighton University School of Medicine, Omaha, NE, ^2^Medical Microbiology and Immunology Department, Creighton University School of Medicine, Omaha, NE.

**584**   **Persistent Aeroallergen Sensitization at Ages One and Two in the Cincinnati Childhood Allergy and Air Pollution Study**

**P. H. Ryan** ^1^, G. K. LeMasters^1^, J. E. Lockey^1^, G. K. Hershey^2^, M. Villareal^1^, D. I. Bernstein^1^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**585**   **IL-13 Receptor Alpha 2 Lung-transgenic Mice Displayed Reduced Airway Hyperresponsiveness and Inflammation in a House Dust Mite Challenged Model**

**W. Chen**, C. M. Cunningham, M. O. Daines, M. R. Warrier, A. M. Gibson, G. K. Khurana Hershey; Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**586**   **The Antioxidants, Glutathione-S-Transferase-Omega1-1 (GST1-1) and Glutathione Peroxidase2 (GPX2), Are Increased in Allergic Airway Inflammation**

**D. Quarcoo**, A. M. Dittrich, M. Krokowski, A. Awagjan, B. Ahrens, E. H. Hamelmann; Pediatric Pneumology and Immunology, Charité University Medicine, Berlin, GERMANY.

**587**   **Functional Alteration of Steroid Responses in Steroid Resistant (SR) Asthma by Increased Glucocorticoid Receptor (GCR) Beta Expression**

**E. Goleva** ^1^, L. Li^1^, R. J. Martin^2^, D. Y. Leung^1^; ^1^Pediatrics, National Jewish Medical and Research Ctr., Denver, CO, ^2^Medicine, National Jewish Medical and Research Ctr., Denver, CO.

**588**   **Comparison of Cellular Inflammation and Molecular Activation in Asthma and Eosinophilic Bronchitis**

**V. DEL POZO** ^1^, C. Seoane^1^, M. Fernández -Nieto^2^, J. Sastre^2^, C. Lahoz^1^, S. Quirce^2^, B. Sastre^1^; ^1^Immunology, Fundación Jimenéz Diáz, Madrid, SPAIN, ^2^Allergy, Fundación Jimenéz Diáz, Madrid, SPAIN.

**589**   **Presence of Eosinophils in the Nasal Secretion during Acute Upper Respiratory Tract Infection (URI) in Young Children Predicts Wheeze in Subsequent 2 Months**

**M. Shinohara** ^1,2^, H. Wakiguchi^1^, H. Saito^2^, K. Matsumoto^2^; ^1^Department of Pediatrics, Faculty of Medicine, Kochi University, Kochi, JAPAN, ^2^Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**590**   **The PPARg Agonist Ciglitazone Upregulates GILZ, a Novel Anti-inflammatory Protein, in Airway Epithelial Cells**

**A. L. Wagelie-Steffen** ^1^, J. Eddleston^2^, J. Hirshbach^2^, B. L. Zuraw^2^; ^1^Medicine, Division of Allergy / Immunology, University of California, San Diego, San Diego, CA, ^2^Medicine, University of California, San Diego and Veteran\'s Medical Research Foundation, San Diego, CA.

**591**   **Modulation of Immune Response by a Novel Kaliuretic Peptide**

**S. A. Shirley** ^1^, R. Singham^1^, X. Kong^2^, R. F. Lockey^2^, S. S. Mohapatra^2^; ^1^Medical Microbiology and Immunology, University of South Florida, Tampa, FL, ^2^Internal Medicine, University of South Florida, Tampa, FL.

**592**   **Eicosanoids in Induced Sputum (IS): Influence of Aspirin Hypersensitivity and Atopy**

**A. Kania**, E. Nizankowska, G. Bochenek, A. Gielicz, A. Szczeklik; Department of Medicine, Jagiellonian University School of Medicine, Krakow, POLAND.

**593**   **The Induction of Distinct Immunologic and Morphologic Changes in a Model of Chronical Allergen Exposure**

**B. Ahrens**, A. Dittrich, D. Quarcoo, E. Hamelmann; Department of Pediatric Pneumology and Immunology, Charité University Medicine, Berlin, GERMANY.

**594**   **Identification & Characterisation of Proteins Associated with Allergic Airways Disease (AAD)**

**C. M. Dixon** ^1^, J. Christie^2^, K. I. Matthaei^1^, P. S. Foster^1,3^, D. C. Webb^1^; ^1^Division of Molecular Biosciences, John Curtin School of Medical Research, Canberra, AUSTRALIA, ^2^School Proteomics and Microarray Facility, Research School of Biological Sciences, Canberra, AUSTRALIA, ^3^Asthma, Allergy and Inflammation Research Centre, University of Newcastle, Newcastle, AUSTRALIA.

**595**   **Pathophysiology of Late Onset Atopic Asthma in a Murine Model**

**P. J. Busse** ^1^, T. Zhang^2^, S. Termanini^2^, K. Srivastava^2^, B. Schofield^3^, X. Li^2^; ^1^Medicine, Div of Clinical Immunology, Mount Sinai School of Medicine, New York, NY, ^2^Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY, ^3^Environmental Health Sciences, Bloomberg School of Public Health, Baltimore, MD.

**596**   **The Role of Adipokines in Childhood Asthma and Their Effect on Bronchial Hyperresponsiveness**

**K. Kim** ^1^, Y. Shin^2^, E. Kim^1^, G. Jang^3^, M. Sohn^1^, K. Kim^1^; ^1^Department of Pediatrics and Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Pochon CHA University College of Medicine, Seoul, REPUBLIC OF KOREA, ^3^Department of Pediatrics, NHIC Ilsan Hospital, Seoul, REPUBLIC OF KOREA.

**597**   **Genome-wide Gene Expression Analysis of the Human Intestinal Epithelial Cells after Stimulation with Lactic Acid Bacteria**

**S. Toki** ^1,2^, S. Kagaya^1^, M. Shinohara^1^, T. Matsumoto^2^, Y. Takahata^2^, H. Saito^1^, K. Matsumoto^1^; ^1^Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN, ^2^R&D center, Nippon meet packers INC., Tsukuba, JAPAN.

**598**   **Blood Collection, Processing Methods and Maternal Characteristics and the Potential Impact on Study Results in a Longitudinal Birth Cohort Study**

**K. A. Roberg** ^1^, K. T. Sullivan-Dillie^1^, K. S. Anklam^1^, L. A. Rosenthal^1^, D. F. DaSilva^1^, C. J. Tisler^1^, T. E. Pappas^1^, R. E. Gangnon^2^, J. E. Gern^1^, R. F. Lemanske, Jr.^1^; ^1^Allergy Asthma Research, UW Medical School, Madison, WI, ^2^Biostatistics and Medical Informatics and Population Health Sciences, UW Madison, Madison, WI.

**599**   **The Effect of Etanercept on the Human Cutaneous Allergic Response**

**E. R. Conner** ^1^, M. Brummet^1^, C. Bickel^1^, L. Bankova^1^, L. McGirt^1^, T. Meusel^1^, S. Stevens^2^, B. S. Bochner^1^, L. A. Beck^1^; ^1^Johns Hopkins University School of Medicine, Baltimore, MD, ^2^Amgen, Thousand Oaks, CA.

**600**   **In Vivo Efficacy in Mouse Asthma Model of Basic Fibroblast Growth Factor**

**I. Lee** ^1^, M. Son^1^, J. Jeong^1^, B. Kim^1^, S. Kang^1^, Y. Kim^2^; ^1^DONG-A PHARM. CO., LTD, Yongin, REPUBLIC OF KOREA, ^2^College of medicine, Seoul National University, Seoul, REPUBLIC OF KOREA.

**601**   **Development of Autoreactive Antibodies in Allergic Mice after Chronic Respiratory Allergen Exposure**

**H. Garn** ^1^, I. Mittermann^2^, R. Valenta^2^, H. Renz^1^; ^1^Department of Clinical Chemistry and Molecular Diagnostics, Medical Faculty, Philipps University of Marburg, Marburg, GERMANY, ^2^Division of Immunopathology, Department of Pathophysiology, Center of Physiology and Pathophysiology, Medical University of Vienna, Vienna, AUSTRIA.

**602**   **History of Parental Allergy and Asthma as Predictors of Allergic Sensitization in their Offspring**

**E. L. Anderson** ^1^, M. D. Evans^2^, D. F. G. DaSilva^1^, T. E. Pappas^1^, L. E. Pleiss^1^, K. A. Roberg^1^, K. T. Sullivan Dillie^1^, C. J. Tisler^1^, R. E. Gangnon^2^, J. E. Gern^3^, R. F. Lemanske, Jr.^3^; ^1^Pediatrics, UW Medical School, Madison, WI, ^2^Biostatistics and Medical Informatics and Population Health Sciences, UW Medical School, Madison, WI, ^3^Medicine, UW Medical School, Madison, WI.

**603**   **Asthma Symptoms Under Two Years Old after Suffering Meconium Aspiration Syndrome**

**F. Vazquez-Nava**; Unidad de Investigación en Epidemiología Clínica, Social Securirty Mexican Institute. Universidad Autonoma de Tamaulipas., Ciudad Madero, MEXICO.

**604**   **Atopy and Sensitization to Inhalant Allergens may be Risk Factor for Bronchial Hyperresponsiveness but not Pulmonary Function**

**J. Kim** ^1^, H. Kim^2^, S. Lee^2^, B. Kim^2^, H. Seo^2^, S. Hong^2^; ^1^Ulsan University Hospital, Ulsan, REPUBLIC OF KOREA, ^2^Pediatrics, Asan Medical Center, Ulsan University College of Medicine, Seoul, REPUBLIC OF KOREA.

**605**   **10-6M (RR)-Formoterol, but Not (SS)-Formoterol or (S)/(R)-Albuterol, Inhibits RANTES Secretion by RSV Antigen-Stimulated Confluent Human Alveolar Epithelial Cells (cA549)**

**G. Puglisi**, A. Capetandes, M. Frieri; Division of Allergy Immunology, Nassau University Medical Center, East Meadow, NY.

**606**   **Chinese Herbal Extract *Glycyrrhiza uralensis* (Gu), in the Absence or Presence of IL-1b, Decreases Nitrite Production and Proliferation of Human Type II Alveolar Epithelial Cells (A549)**

**A. R. Narayan** ^1^, Y. C. Huang^1^, Y. H. Zhang^2^, X. M. Li^3^, M. Frieri^1^; ^1^Division of Allergy & Immunology, Nassau University Medical Center, East Meadow, NY, ^2^Department of Pathology, Nassau University Medical Center, East Meadow, NY, ^3^Division of Pediatric Allergy & Immunobiology, Mount Sinai School of Medicine, New York, NY.

**607**   **Cell Death and Survival in Response to Immunostimulatory Sequence Oligodeoxynucleotides Treatment in a Murine Model of Allergic Asthma**

Y. Higaki^1,2^, **J. M. Zubeldia** ^1^, L. Conejero^1,2^, M. L. Baeza^1^, I. Varela-Nieto^2^; ^1^Allergy Department, Hospital Gregorio Maranon, Madrid, SPAIN, ^2^Instituto Investigaciones Biomedicas Alberto Sols, Madrid, SPAIN.

**608**   **Association between Systemic and Local Immune Response Parameters in Children with Bronchial Asthma**

**A. Nakonechna** ^1^, T. Umanets^2^, V. Lapshin^2^, A. R. D. van Bergen^3^; ^1^National Medical University, Kiev, UKRAINE, ^2^Institute of Pediatry, Obstetrics and Gynaecology, Kiev, UKRAINE, ^3^Novidec Ltd, Neston, UNITED KINGDOM.

**609**   **Zileuton Provides Significant Improvement in Asthma Symptoms and b-agonist and Rescue Medication Use Compared to Placebo in Asthma Patients with Reduced or Low Lung Function**

**R. A. Nathan** ^1^, B. M. Prenner^2^, J. A. Bernstein^3^, K. Walton-Bowen^4^; ^1^Asthma and Allergy Associates, P.C. and Research Center, Colorado Springs, CO, ^2^Allergy Associates Medical Group, San Diego, CA, ^3^Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH, ^4^Clinical Operations, Biostatistical Analysis, and Reporting, Critical Therapeutics, Inc., Lexington, MA.

**610**   **Effects of Electric Fields on Pollen Rupture**

**V. Vaidyanathan** ^1^, A. G. Miguel^1^, P. E. Taylor^1^, R. C. Flagan^1^, M. M. Glovsky^2^; ^1^Chemical Engineering, CalTech, Pasadena, CA, ^2^Huntington Asthma and Allergy Center, HMRI, Pasadena, CA.

**611**   **Plasmacytoid Dendritic Cells (PDC) and B Cells Are the Origin of IL-10 in Human PBMC Stimulated by Immunostimulatory Sequence Oligodeoxynucleotides (ISS-ODN)**

**J. Lee** ^1^, H. Park^2^, J. Bahn^1^, Y. Kim^2^, S. Cho^2^, K. Min^2^, Y. Kim^2^, K. Jung^1^; ^1^Internal Medicine, College of medicine, Hallym University, Chunchon, REPUBLIC OF KOREA, ^2^Internal Medicine, Seoul National University College of Medicine, Seoul, REPUBLIC OF KOREA.

**612**   **Antibody Production Against rPhl p 1 and rPhl p 5 After The Immunization of Rabbits with a Depigmented and Polymerized Extract of Phleum Pratense**

M. Casanovas, M. Gallego, E. Fernández-Caldas; Laboratorios LETI S.L., Tres Cantos, SPAIN.

**613**   **Expression of Acidic Mammalian Chitinase in Cord Blood Mononuclear Cells**

M. R. Goldberg, O. Nadiv, N. Luknar-Gabor, **Y. Katz**; Allergy&Immunology, Assaf Harofeh Medical Center, Beer Yaakov, ISRAEL.

**614**   **Palatal Itching as an Indicator of Atopy to Pollens**

**E. K. Dicken**, B. Miller; University of Kentucky, Lexington, KY.

**615**   **Bronchial Remodeling: Pathologic Findings of Whole Bronchial Tree in a Case of Chronic Bronchial Asthma**

**Y. W. Lee** ^1^, H. S. Chung^1^, J. H. Park^1^, J. W. Park^1,2^, S. H. Cho^3^, C. S. Hong^1,2^; ^1^Internal Medicine, Yonsei University, College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Institute of Allergy, Yonsei University, College of Medicine, Seoul, REPUBLIC OF KOREA, ^3^Pathology, Yonsei University, College of Medicine, Seoul, REPUBLIC OF KOREA.

**616**   **MMP-9/TIMP-1 Ratio in Confluent Human Alveoloar Epithelial Cells (cA549) Stimulated by D. Pteronyssinus**

**J. Zimmermann**, A. Capetandes, M. Frieri; Nassau University Medical Center, East Meadow, NY.

**617**   **Persistence of Airway Hyper-Responsiveness (AHR) after Resolution of Bronchial Mucosal Inflammation Following Allergen Inhalation Challenge in Mild Asthmatics**

**H. H. Kariyawasam**, M. Aizen, J. Barkans, D. S. Robinson, A. B. Kay; National Heart & Lung Institute, Imperial College, London, UNITED KINGDOM.

**618**   **Association between Genetic Variations in FGF receptors and Airway Hyperresponsiveness**

**S. Sohn** ^1^, H. Kwon^1^, K. Kim^1^, C. Park^1^, H. Kim^1^, S. Kim^1^, H. Park^1^, H. Park^2^, Y. Jeong^3^, S. Kim^1^, Y. Jang^1^, Y. Kim^1^, S. Cho^1^, K. Min^1^, Y. Kim^1^; ^1^Internal Medicine, Seoul National University Hospitial, Seoul, REPUBLIC OF KOREA, ^2^Internal Medicine, Busan National University Hospitial, Busan, REPUBLIC OF KOREA, ^3^Internal Medicine, Kyeongsang National University Hospitial, Jinju, REPUBLIC OF KOREA.
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**619**   **High dose SLIT with a Juniperus Ashei Extract Improves Quality of Life in Patients with Cypress Pollinosis**

**V. Di Rienzo** ^1^, S. Pucci^2^, A. Romano^3^, S. D\'Alò^2^, C. Incorvaia^4^, F. Frati^5^; ^1^Allergy Center, ASL, Latina, ITALY, ^2^Allergy Center, General Hospital, Civitanova Marche, ITALY, ^3^Allergy Center, Cattolica University, Roma, ITALY, ^4^Allergy/Rheumatology, ICP Hospital, Milan, ITALY, ^5^Medical Department, Stallergenes Italy, Milan, ITALY.

**620**   **Novel Amb a 1 CpG Oligodeoxyribonucleotide Conjugate Ragweed Vaccine Administered to Children**

**A. S. Nayak** ^1^, I. Tripathy^2^, D. Levitt^3^; ^1^Peoria School of Medicine, University of Illinois, Normal, IL, ^2^Clinical Research of the Ozarks, Inc.-Rolla, Rolla, MO, ^3^Dynavax Tchnologies, Inc., Berkeley, CA.

**621**   **Safety of Home Immunotherapy**

**W. V. Filley** ^1^, C. E. Aston^2^, R. E. Coifman^3^, J. R. Claflin^1^, D. L. Kough^1^, P. J. Mills^1^; ^1^OK Allergy Asthma Clinic, Inc., Oklahoma City, OK, ^2^OUHSC-GCRC, Oklahoma City, OK, ^3^Allergy & Asthma of South Jersey, P.A., Millville, NJ.

**622**   **Can Nasal ECP Help to Predict Clinical Outcome of Specific Immunotherapy in Mite-allergic Rhinitis Patients**

**M. A. R. Branco-Ferreira** ^1^, A. Spinola-Santos^1^, M. Pereira-Santos^2^, M. Palma-Carlos^3^, M. A. Pereira-Barbosa^1^, A. G. Palma-Carlos^3^; ^1^Unidade de Imunoalergologia, Hospital de Santa Maria, LISBON, PORTUGAL, ^2^Faculdade de Medicina de Lisboa, LISBON, PORTUGAL, ^3^CHIUL, LISBON, PORTUGAL.

**623**   **National Utlization Rates of Allergen Immunotherapy in the Medicare Population**

**D. P. Woodmansee** ^1^, C. Chang^2^, M. K. Wolfson^1^, M. S. Shaker^1^, D. C. Goodman^2^; ^1^Section of Allergy and Clinical Immunology, Dartmouth-Hitchcock Medical Ctr, Lebanon, NH, ^2^Center for the Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, NH.

**624**   **Sublingual Immunotherapy Reduce Allergic Symptoms in a Mouse Model of Rhinitis**

**J. Brimnes**, J. KIldsgaard, H. Jacobi, K. Lund; Experimental Immunology, ALK-Abello, Hoersholm, DENMARK.

**625**   **Community Based Experience with Cluster Immunotherapy**

**R. P. Harvey**, J. Poole, K. Beaudry, D. Soteres, L. Headrick, W. Silvers; Allergy Asthma Colorado, Denver, CO.

**626**   **Evolution of Skin Prick Tests During Long Term Specific Immunotherapy**

**A. G. Palma-Carlos**, M. Palma-Carlos; Immunotherapy, CAIC - Clinical Allergy Immunology Center, Lisbon, PORTUGAL.

**627**   **A 3-Year Randomized Controlled Study with Sublingual Immunotherapy in Mite-Induced Respiratory Allergy**

**G. Passalacqua** ^1^, C. Lombardi^2^, R. Ariano^3^, M. Pasquali^1^, I. Baiardini^1^, A. Giardini^4^, G. Maiani^4^, M. Bruno^5^, P. Falagiani^5^, G. W. Canonica^1^; ^1^Allergy & Respiratory Diseases Dept of Internal Medicine, Genoa University, Genova, ITALY, ^2^Pneumoallergology Unit, Ospedale S. Orsola, Brescia, ITALY, ^3^Internal Medicine Division, Bordighera Hospital, Bordighera, ITALY, ^4^Salvatore Maugeri, IRCCS, Pavia, ITALY, ^5^Lofarma SpA, Milano, ITALY.

**628**   **Quantitative Assessment of the Compliance with Sublingual Immunotherapy in Real Life: Easy Project**

**G. Senna** ^1^, A. Musarra^2^, S. Pecora^3^, G. Passalacqua^4^; ^1^Allergy Unit, Verona General Hospital, Verona, ITALY, ^2^Allergy Unit, National Healthcare, Reggio Calabria, ITALY, ^3^ALK-AbellÃ^2^, Lainate (Milan), ITALY, ^4^Allergy & Respiratory Diseases Dept of Internal Medicine, Genoa University, Verona, ITALY.

**629**   **Effectiveness and Satisfaction with Immunotherapy of Patients with Allergic Rhinitis Unsatisfied with Free Optimal Pharmacotherapy.**

**J. E. Gereda**; Alergia e Inmunologia, Clinica Ricardo Palma, Lima, PERU.

**630**   **Seasonal Sublingual Versus Subcutaneous Immunotherapy for Juniper Pollenosis**

**D. Cooke**; Allergy and Asthma Specialists, Durango, CO.

**631**   **Assessment of a New Treatment Schedule in Sublingual Immunotherapy. A Randomised Double-Blind Placebo-Controlled Multicentre Study**

**M. BOQUETE** ^1^, F. RODRIGUEZ^2^, A. TABAR^3^, D. IBAÑEZ^4^, A. NIETO^5^, F. TORRE-MARTINEZ^6^; ^1^ALLERGY, HOSPITAL XERAL CALDE, LUGO, SPAIN, ^2^ALLERGY, HOSPITAL MARQUES DE VALDECILLA, SANTANDER, SPAIN, ^3^ALLERGY, HOSPITAL VIRGEN DEL CAMINO, PAMPLONA, SPAIN, ^4^ALLERGY, HOSPITAL NIÑO JESUS, MADRID, SPAIN, ^5^ALLERGY, HOSPITAL LA FE, VALENCIA, SPAIN, ^6^ALK-ABELLO, S.A., MADRID, SPAIN.
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**632**   **Gene Transcripts of Peripheral Blood as Potential Biomarkers for Allergic Changes in Upper Airways**

**D. N. Grigoryev** ^1^, S. F. Ma^2^, S. Q. Ye^2^, J. G. N. Garcia^2^, K. C. Barnes^1^; ^1^Division of Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, MD, ^2^Center for Integrated Sciences, University of Chicago, Chicago, IL.

**633**   **Ethnic Differences in Frequencies of Single Nucleotide Polymorphisms for Glutathione S-Transferase (GST) and IL13**

**K. M. Donohue** ^1^, D. Tang^1^, D. Chau^1^, H. Andrews^1^, R. Chen^2^, S. Yadavalli^2^, F. Perera^1^, S. Chanock^2^, R. L. Miller^1^; ^1^CCEH Columbia University, New York, NY, ^2^National Cancer Institute, Bethesda, MD.

**634**   **Anti-MHC Class II Alpha Chain Antibodies Block Staphylococcal Enterotoxin B Induced T-cell Proliferation**

**M. M. Sen** ^1^, R. Govindarajan^2^, C. S. David^2^; ^1^Molecular Immunology, Cincinnati Children\'s Hospital, Cincinnati, OH, ^2^Immunology, Mayo Clinic, Rochester, MN.

**635**   **Leukolysin and Asthma**

**M. N. Blumenthal**, G. Lind, R. Willaert, M. Miller, R. King, W. Oetting, D. Pei; University of Minnesota, Minneapolis, MN.

**636**   **CTLA-4 Gene Exon-1 +49 A/G Polymorphism is not Associated with Susceptibility to Autoimmune Disease in Patients with Common Variable Immune Deficiency**

**A. K. Knight** ^1^, D. Serrano^1^, Y. Tomer^2^, C. Cunningham-Rundles^1^; ^1^Clinical Immunology, Mount Sinai Medical Center, New York, NY, ^2^Division of Endocrinology, Mount Sinai Medical Center, New York, NY.

**637**   ***TNFRSF1A* Mutation in a Heterozygous Carrier of *MEFV* P369S: Case Study Of Periodic Fever Syndrome**

**E. Hahn** ^1^, A. White^2^; ^1^Department of Pediatrics, Division of Allergy and Pulmonary Medicine, Washington University, St. Louis Children\'s Hospital, St.Louis, MO, ^2^Department of Pediatrics, Division of Rheumatology and Immunology, Washington University School of Medicine, St. Louis Children\'s Hospital, St.Louis, MO.

**638**   **The Association of Atopic Diseases with Hla Status**

**A. Bozek** ^1^, J. Jarzab^1^, J. Krajewska^2^, L. Dymek^3^, A. Dymek^3^; ^1^Clinical Department of Internal Medicine and Dermatology, Silesian University School of Medicine, Zabrze, POLAND, ^2^Institute Oncology, M.Sklodowska-Curie Memorial Cancer Center, Gliwice, POLAND, ^3^Medical Center, Strzelce Opolskie, POLAND.
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**639**   **Nasal Nitric Oxide (NNO) in Patients with Allergic Rhinitis and Healthy Volunteers Following Pollen Exposure in an Environmental Challenge Chamber (ECC)**

**J. M. Hohlfeld** ^1^, M. Larbig^1^, I. Paczkowski^1^, H. Hecker^2^, N. Krug^1^, a. ALMA-Study Group^3^; ^1^Fraunhofer ITEM, Hannover, GERMANY, ^2^Hanover Medical School, Hannover, GERMANY, ^3^Ruhr-University, Bochum, GERMANY.

**640**   **The Effect of Environmental Control and Intranasal Corticosteroid in Brazilian Children with Persistent Allergic Rhinitis**

**A. P. Reis**; Immunology, ICB-UFMG, Belo Horizonte, BRAZIL.

**641**   **Nasal Flow Cytometry in the Diagnosis of Persistent Allergic Rhinitis and Persistent Idiopathic Non-Allergic Rhinitis**

S. Lopez^1^, C. Rondon^2^, R. R-Pena^1^, C. Mayorga^1^, M. J. Torres^2^, C. Antunez^1^, J. J. Romero^2^, J. A. Cornejo-Garcia^1^, **M. Blanca** ^2^; ^1^Research Laboratory, Carlos Haya Hospital, Malaga, SPAIN, ^2^Allergy Service, Carlos Haya Hospital, Malaga, SPAIN.

**642**   **Combination Therapy with Montelukast and Antihistamines (desloratadine or Levocetirizine) Improves Quality of Life in Patients with Persistent Allergic Rhinitis: a Double Blind Placebo Controlled Study**

M. Ciebiada^1^, M. Górska-Ciebiada^1^, L. M. DuBuske^2^, **P. Gorski** ^1^; ^1^Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, POLAND, ^2^Immunology Research Institute of New England, Gardner, MA.

**643**   **Prescription Medication Use Following Rhinitis Diagnosis: An Examination of Pharmacy Claims in the Integrated Healthcare Information Services (IHCIS) Database**

**M. A. Corrao**, D. W. Clark, R. A. Fleenor, K. J. Davis; Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC.

**644**   **Allergic Responses Induced by Grass Pollen in an Environmental Challenge Chamber (ECC) Reflect Changes During Seasonal High Pollen Counts in Allergic Rhinitis Patients**

**N. Krug** ^1^, T. Holland-Letz^2^, E. Wierenga^3^, R. van Ree^4^, A. Hüsing^2^, M. Larbig^1^, J. M. Hohlfeld^1^, A. Bufe^2^, a. ALMA-Study Group^2^; ^1^Fraunhofer ITEM, Hannover, GERMANY, ^2^University of Bochum, Bochum, GERMANY, ^3^University of Amsterdam, Amsterdam, THE NETHERLANDS, ^4^Sanquin Research, Amsterdam, THE NETHERLANDS.

**645**   **Safety and Efficacy of Olopatadine Hydrochloride Nasal Spray 665 mcg (Patanase^®^ Nasal Spray) in Patients with Perennial Allergic Rhinitis**

**B. Q. Lanier**; North TX Institute for Clinical Trials, Fort Worth, TX.

**646**   **Nasolacrimal Reflux - A New Clinical Finding**

N. W. Chang^1^, T. M. Foss^1^, T. Y. Chang^1^, **K. C. Chang** ^1^, M. J. Barrett^2^, J. M. Carney^1^, H. D. Nguyen^1^; ^1^Asthma Allergy Centre, Tigard, OR, ^2^Allergy Department, Kaiser Permanente Northwest Region, Portland, OR.

**647**   **Effect of Nasal Corticosteroids on Adenoidal Hypertrophy in Children with Non-Allergic Rhinitis**

**S. Kung**, E. Yousef, S. J. McGeady; Division of Allergy and Immunology, Thomas Jefferson University, Philadelphia, PA.

**648**   **MUC8 as a Ciliated Cell Marker in Human Nasal Epithelium**

**C. Kim** ^1,2^, J. Yoon^1,2^; ^1^Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^The Airway Mucus Institute, Seoul, REPUBLIC OF KOREA.

**649**   **The Importance of Specific IgG, IgE Antibodies to Retinal S Protein, Type II Collagen and Alternaria in Idiopathic Central Serous Chorioretinopathy**

**J. C. Muino** ^1^, R. Smith^2^, J. D. Luna^2^, M. D. Romero^3^, M. Ferrero^3^, C. P. Juárez^2^; ^1^Medicine III - UHMI N° 4 - Hospital Misericordia, Facultad de Ciencias Médicas Universidad Nacional de Córdoba, Cordoba, ARGENTINA, ^2^Oftalmología, Fundación Ver, Cordoba, ARGENTINA, ^3^Inmunología, LIIDO, Cordoba, ARGENTINA.

**650**   **Esterases Involved in the Metabolism of Ciclesonide (CIC) in Human Nasal Epithelial Cells (HNEC)**

M. A. Wingertzahn^1^, **H. Sato** ^2^, R. Nave^3^, T. Nonaka,^2^, T. Mochizuki^2^, S. Takahama^2^, S. Kondo^2^; ^1^Altana Pharma, Florham Park, NJ, ^2^Teijin Institute for Biomedical Research, Tokyo, JAPAN, ^3^Altana Pharma, Konstanz, GERMANY.

**651**   **Effect of Mometasone Furoate Nasal Spray Therapy on Nasal Congestion and Sleep-Related Outcomes in Rhinosinusitis and Nasal Polyposis**

**G. M. Gottschlich**; New Horizons Clinical Research, Cincinnati, OH.

**652**   **Reversibility of Desisobutyryl-Ciclesonide Conversion to Fatty Acid Conjugates**

M. Wingertzahn^1^, T. Nonaka^2^, T. Mochizuki^2^, **H. Sato** ^2^, S. Kondo^2^; ^1^Altana Pharma, Florham Park, NJ, ^2^Teijin Institute for Biomedical Research, Tokyo, JAPAN.

**653**   **Efficacy and Safety of Ciclesonide Nasal Spray for the Treatment of Seasonal Allergic Rhinitis**

**P. H. Ratner** ^1^, J. H. van Bavel^2^, P. Darken^3^, N. Hall^4^, T. Shah^5^, M. A. Wingertzahn^6^; ^1^Sylvana Research, San Antonio, TX, ^2^Allergy & Asthma Associates, Austin, TX, ^3^Director, Biostatistics and Data Management, Altana Pharma, Florham Park, NJ, ^4^Associate Director, Biostatistics, Altana Pharma, Florham Park, NJ, ^5^Scientific and Clinical Development, Altana Pharma, Florham Park, NJ, ^6^Clinical Project Head, Altana Pharma, Florham Park, NJ.

**654**   **A Double-Blind Comparison of Efficacy of 0.1% Tacrolimus Ophthalmic Ointment and 2% Cyclosporine Eye Drop Vernal Keratoconjunctivitis (vkc)**

**P. Labcharoenwongs** ^1^, W. Durongpisitkul^2^, P. Dumrongkigchaiporn^3^, O. Jirapongsananuruk^1^, N. Visitsunthorn^1^, P. Kosrirukvongs^4^, W. Booranapong^4^, P. Vichyanond^1^; ^1^Pediatric, Siriraj hospital, Bangkok, THAILAND, ^2^Pediatric, Police general hospital, Bangkok, THAILAND, ^3^Pediatric, Bangkok Pattaya hospital, Chonburi, THAILAND, ^4^Opthalmology, Siriraj hospital, Bangkok, THAILAND.

**655**   **Effect of Anti-Allergic Herbal Extract, SA-2121, on the Development of Allergic Conjunctivitis**

**J. Davidson** ^1^, S. Baik^1^, Z. Yao^2^, R. Martin^2^, C. K. Oh^1^; ^1^Harbor-UCLA Medical Center, Torrance, CA, ^2^Tanox Inc., Houston, TX.

**656**   **House Dust Mite Allergy causing Otitis Externa**

**R. S. Kaulsay** ^1^, P. P^1^, Y. Yeow^1^, L. Rampal^2^, I. Hidayah^3^; ^1^Dept of ENT Surgery, University Putra Malaysia, Kuala Lumpur, MALAYSIA, ^2^Dept of Community Health Medicine, University Putra Malaysia, Kuala Lumpur, MALAYSIA, ^3^Dept of Biomedical Science, University Technology Malaysia, Kuala Lumpur, MALAYSIA.

**657**   **Serum Leukocyte Protease Inhibitor Levels in Patients with Uveitis**

**V. E. Reviglio** ^1^, M. D. Romero^2^, M. Ferrero^3^, J. D. Luna^1^, C. P. Juárez^1^, J. C. Muiño^4^; ^1^Oftalmología, Fundación Ver, Cordoba, ARGENTINA, ^2^Inmuología, LIIDO, Cordoba, ARGENTINA, ^3^Inmunología, LIIDO, Cordoba, ARGENTINA, ^4^Medicina III - UHMI N° 4, Facultad de Ciencias Médicas Universidad Nacional de Córdoba, Cordoba, ARGENTINA.

**658**   **Sensorineural Hearing Loss Due to Allergic Rhinitis. Case Report**

**C. Lombardi** ^1^, A. Tansini^2^, G. Passalacqua^3^; ^1^Pneumoallergology Unit, S. Orsola Hospital, Brescia, ITALY, ^2^Radiology Unit, S. Orsola Hospital, Brescia, ITALY, ^3^Allergy & Respiratory Diseases Dept of Internal Medicine, Genoa University, Genova, ITALY.
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**659**   **Idiopathic Cd4 + Lymphocytopenia Associated with Cryptococcal Meningitis in One Pediatric Patient.**

**M. R. SANCHEZ**, G. GUIDOS, J. G. HUERTA; Allergy and immunology, Instituto Nacional de Pediatria, Mexico city, MEXICO.

**660**   **CVID and Severe Persistent Asthma-A Case Report**

**L. B. Moreno**; North Shore-Long Island Jewish Health System, corona, NY.

**661**   **Adenosine Deaminase Deficiency and Storage Pool Deficiency: A Case report**

**C. S. Taylor** ^1^, M. Patruzzi^2^, M. Ballow^3^; ^1^Allergy, SUNY Buffalo, Amherst, NY, ^2^Hematology, SUNY Buffalo, Buffalo, NY, ^3^Allergy, SUNY Buffalo, Buffalo, NY.

**662**   **Cholecystitis and Pancreatitis from Obstructing Lymphadenopathy in a Patient with CVID**

**E. L. Pratt**, L. H. Fisher, S. Chegini, J. Gibbs, G. Ghaffari, J. Larson, T. J. Craig; Pulmonary/Allergy/Critical Care, Penn State Milton S. Hershey Medical Center, Hershey, PA.

**663**   **Toddler Boy with Recurrent Abscesses from Infancy Secondary to G6PD Deficiency**

**D. Paek** ^1^, M. Singla^2^; ^1^Wake Forest University School of Medicine, Winston-Salem, NC, ^2^Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest University School of Medicine, Winston-Salem, NC.

**664**   **Recurrent Pneumonia Associated with Hydroxychloroquine**

**J. G. Gibbs**, E. L. Pratt, L. H. Fisher, S. F. Chegini, T. J. Craig; Pulmonary, Allergy, Critical Care, Milton S. Hershey Medical Center, Hershey, PA.

**665**   **Deficient Humoral Response to *Haemophilus Influenza* Type b Meningitis In a 7 Month Old Vaccinated Child**

**D. A. Ramirez** ^1^, V. N. Madrigal^1^, W. Blouin^2^, M. Laufer^3^, V. P. Hernandez-Trujillo^2^; ^1^Miami Children\'s Hospital, Miami, FL, ^2^Allergy & Immunology, Miami Children\'s Hospital, Miami, FL, ^3^Infectious Disease, Miami Children\'s Hospital, Miami, FL.

**666**   **Successful Use of Daily Intravenous Infusion of C1 INH Concentrate (Berinert P^®^) in the Treatment of a Hereditary Angioedema (HAE) Subject with Renal and Respiratory Failure**

**W. H. Yang**; Medicine, University of Ottawa, Ottawa, ON, CANADA.

**667**   **Membranous Glomerulonephritis in an Individual with X-linked Agammaglobulinemia on Intravenous Immunoglobulin**

**L. M. Endo** ^1^, J. Foote^2^, D. G. Warnock^3^, W. J. Cook^4^, H. W. Schroeder, Jr.^5^; ^1^Allergy and Immunology, University of Alabama at Birmingham, Birmingham, AL, ^2^University of Alabama at Birmingham, Birmingham, AL, ^3^Nephrology, University of Alabama at Birmingham, Birmingham, AL, ^4^Clinical Pathology, University of Alabama at Birmingham, Birmingham, AL, ^5^Developmental & Clinical Immunology, University of Alabama at Birmingham, Birmingham, AL.

**668**   **Idiopathic Pulmonary Hemosiderosis in a Patient with CVID**

**C. Kelly**; Pediatrics, Eastern Virginia Medical School, Norfolk, VA.

**669**   **Transient Hypogammaglobulinemia of Infancy, a Possible Autosomal Dominant Inheritance Pattern in Certain Families**

**S. R. Patel** ^1^, R. Roberts^2^; ^1^Department of Medicine, University of California at Los Angeles, Los Angeles, CA, ^2^Department of Pediatrics, University of California at Los Angeles, Los Angeles, CA.

**670**   **The Sisters Who Would not Inflame - Two Cases of Suspected Irak-4 Deficency**

**S. S. Mehr**, J. Smart, M. Tang; Immunology Department, Royal Children\'s Hospital, Melbourne, Victoria, Melbourne, Victoria, AUSTRALIA.

**671**   **Two Patients With Idiopathic CD4 (+) T-lymphocytopenia Presenting With Opportunistic Infections**

**N. Gupta** ^1^, D. Alcid^2^, R. Sharma^3^, B. Silverman^1^, A. T. Schneider^1^; ^1^Dept. of Allergy & Immunology, Long Island College Hospital, Brooklyn, NY, ^2^Infectious Disease, Drexel University College of Medicine, New Brunswick, NJ, ^3^Dept. of Internal Medicine, Robert Wood Johnson Medical School-UMDNJ, New Brunswick, NJ.

**672**   **Neutropenia and Hypogammaglobulinemia in Propionic Acidemia**

**M. H. Land**, R. L. Roberts; Department of Pediatrics, UCLA Medical Center, Los Angeles, CA.

**673**   **Purine Nucleoside Phosphorylase Deficiency in Saudi Arabia**

**A. A. A. Alangari** ^1^, A. Al-Harbi^2^, A. Alghonaium^2^, M. Hershfied^3^; ^1^Pediatrics, King Saud University, Riyadh, SAUDI ARABIA, ^2^Pediatrics, King Faisal Specialist Hospital, Riyadh, SAUDI ARABIA, ^3^Pediatrics, Duke University Medical Center, Durham, NC.

**674**   **Combined Chronic Granulomatous Disease (CGD) and G-6-PD Deficiency in an Infant**

**C. W. Mayer** ^1^, S. Bahgash^1^, J. A. Bocchini, Jr.^2^, S. L. Bahna^1^; ^1^Allergy/Immunology Section, LSUHSC, Shreveport, LA, ^2^Pediatric Infectious Disease Section, LSUHSC, Shreveport, LA.

**675**   **Chronic Granulomatous Disease Presenting with CD4 Lymphopenia**

**R. Tachdjian**, R. L. Roberts; Allergy, Immunology, Rheumatology, UCLA School of Medicine, Los Angeles, CA.

**676**   **Recurrent Meningitis Secondary to Metronidazole used as Helicobacter Eradication Therapy**

S. Khan^1^, B. Sharrack^2^, **W. A. C. Sewell** ^1^; ^1^Path Links Immunology, North Lincolnshire, UNITED KINGDOM, ^2^Lincoln County Hospital, Lincoln, UNITED KINGDOM.

**677**   **Subcutaneous Versus Intravenous Immunoglobulin for the Treatment of DiGeorge Syndrome Related Hypogammaglobulinemia**

**S. MacLeish**, R. Hostoffer, Jr.; Pediatrics, Case Western Reserve University, Cleveland, OH.

**678**   **An Uncommon Presentation of Chronic Diarrhea and Common Variable Immunodeficiency Improved with IVIG Therapy**

**S. J. McEldowney**, M. H. Moss; Allergy and Clinical Immunology, University of Wisconsin, Madison, WI.

**679**   **Diagnosis of Common Variable Immunodeficiency in a Patient with Evan\'s Syndrome**

**K. R. Lowe**, C. P. Mikita, M. M. Klote, M. R. Nelson; Allergy/Immunology, Walter Reed Army Medical Center, Washington, DC.

**680**   **Rare Intestinal Manifestation in a Patient with Common Variable Immunodeficiency and Strongyloidiasis**

**P. Giavina-Bianchi**, F. Collet e Silva, D. Birolini, J. Kalil, L. V. Rizzo; Clinical Immunology and Allergy, FMUSP, São Paulo, BRAZIL.

**681**   **T Lymphocyte Profile in Schwachman Diamond Syndrome**

**R. Sullivan**, N. Y. Olson; Pediatrics, University of Kansas, Kansas City, KS.

**682**   **An Unusual Immunoglobulin Profile in an Adult Patient**

**R. Ayuso**; Allergy and Clinical Immunology, Mount Sinai Medical Center, NY, NY.

**683**   **Ulcerative Colitis in a Pediatric Patient with IgA Deficiency**

**A. Kounavis** ^1^, T. B. Fausnight^2^; ^1^Pediatrics, Penn State Children\'s Hospital, Hershey, PA, ^2^Pediatric Asthma and Immunology, Penn State Children\'s Hospital, Hershey, PA.

**684**   **Skeletal Abnormalities Associated with DiGeorge Syndrome: Report of an Unusual Case**

**S. J. Khiani** ^1^, J. A. Kleinfeld^2^, K. J. Khiani^3^, A. T. Gewurz^2^; ^1^Immunology/Microbiology (RUMC) & Pediatrics (SHCC), Rush University Medical Center-Stroger Hospital of Cook County A/I Program, Chicago, IL, ^2^Immunology/Microbiology (RUMC) & Pediatrics (SHCC)), Rush University Medical Center-Stroger Hospital of Cook County A/I Program, Chicago, IL, ^3^Radiology, Geisinger Medical Center, Danville, PA.

**685**   **The Case of the Polysaccharide Blues**

**R. Gupta**, H. J. Wedner; Internal Medicine, Barnes Jewish Hospital, St. Louis, MO.
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**686**   **Efficacy of Airway Anti-Inflammatory Treatments Evaluated with Airway Inflammation Markers in Patients with Cough Variant Asthma: Budesonide versus Montelukast**

**T. T. Shimoda**, R. R. Kishikawa, S. S. Shoji, S. S. Nishima; Clinical Research Center, Fukuoka National Hospital, Fukuoka, JAPAN.

**687**   **Urine LTE4 Levels and Lung Function Declines are Highly Correlated in Urban Children with Moderate to Severe Asthma Despite Use of Inhaled Corticosteroids and Long-acting Bronchodilators**

**N. Rabinovitch**; Pediatrics, National Jewish Medical and Research Center, Denver, CO.

**688**   **Relationship between Exhaled Nitric Oxide and Methacholine Bronchial Provocative Test in Asthmatic Children**

**C. Direkwattanachai** ^1^, W. Teawsomboonkit^1^, C. Sasisakulporn^2^; ^1^Division of Allergy/Immunology, Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, ^2^Research Center, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND.

**689**   **FENO 35ppb - Is it Associated with Asthma Control**

**C. Lopes**; Hospital S. João, Porto, PORTUGAL.
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**690**   **Differential Expression of NF-kB Molecular Species in Th1 and Th2 Cells**

R. J. Kurnat, U. De Fanis, W. Lee, S. N. Georas, J. Guo, **V. Casolaro**; Johns Hopkins University, Baltimore, MD.

**691**   **Immunomodulation of T Cells by Targeting Allergen to Antigen Presenting Cells**

**K. Hulse** ^1^, A. J. Reefer^1^, S. M. Satinover^1^, M. D. Chapman^2^, V. Engelhard^1^, J. A. Woodfolk^1^; ^1^University of Virginia, Charlottesville, VA, ^2^Indoor Biotechnologies, Charlottesville, VA.

**692**   **CD4 T Cells Receive Costimulatory Signals from CpG DNA during Antigen-Specific Stimulation**

**D. F. LaRosa**, A. E. Gelman, L. A. Turka; University of Pennsylvania, Philadelphia, PA.

**693**   **Therapeutic Use of The Co-Administration of Immunostimulatory DNA Sequence with Allergen Extract in a Mouse Model of Timothy Allergy**

**J. W. Kim**, J. Lee, S. Lee, T. Yoo; Allery/Immunology, University of Tennessee, Memphis, TN.
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**694**   **Association of Mouse, Cockroach and Dustmite IgE Levels at Age 2 with Traffic-Related Air Pollution Exposure and Respiratory Symptoms in an Inner City Birth Cohort**

**U. Al-alem** ^1^, C. Lendor^1^, J. Kong^1^, R. Garfinkel^2^, G. Chew^2^, M. Perzanowski^2^, D. Camann^3^, R. M. Whyatt^2^, P. L. Kinney^2^, F. Perera^2^, R. L. Miller^1^; ^1^Department of Medicine, Division of Pulmonary, Allergy, Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY, ^2^Columbia Center for Children\'s Environmental Health (CCCEH), Mailman School of Public Health, Columbia University, New York, NY, ^3^Department of Analytical and Environmental Chemistry, Southwest Research Institute, San Antonio, TX.

**695**   **Risk Factors for the Persistent Expression of Atopic Dermatitis in a High-Risk Birth Cohort**

**A. Singh** ^1^, R. Gangnon^2^, M. Evans^2^, K. Roberg^3^, C. Tisler^3^, D. DaSilva^3^, T. Pappas^3^, L. Pleiss^3^, J. E. Gern^3^, R. F. Lemanske, Jr.^4^; ^1^Medicine, University of Wisconsin-Madison, Madison, WI, ^2^Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, ^3^Pediatrics, University of Wisconsin-Madison, Madison, WI, ^4^Pediatrics and Medicine, University of Wisconsin-Madison, Madison, WI.

**696**   **Exposure to Allergens and Endotoxin in Early Life and Recurrent Wheezing in Infants: a Cohort Study**

V. E. Rullo^1^, D. Solé^1^, **L. Arruda** ^2^, V. Valente^1^, C. Nakamura^1^, A. S. Zampolo^2^, L. R. Roberti^3^, F. J. Nóbrega^4^, C. K. Naspitz^1^; ^1^Pediatrics, Federal University of São Paulo, São Paulo, BRAZIL, ^2^Medicine, School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, ^3^Pediatrics, School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, ^4^Pediatrics, Albert Einstein Hospital, São Paulo, BRAZIL.

**697**   **Symptoms at Age One as Predictors of Aeroallergen Sensitization During Infancy: The Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)**

**G. K. LeMasters** ^1^, J. E. Lockey^1^, P. H. Ryan^1^, L. Levin^1^, G. Hershey^2^, M. Villareal^3^, D. I. Bernstein^3^; ^1^Environmental Health, University of Cincinnati, Cincinnati, OH, ^2^Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^3^Internal Medicine, Division of Immunology, University of Cincinnati, Cincinnati, OH.
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**698**   **Treatment with Pasteurized C1 Inhibitor Concentrate in Abdominal Pain Attacks of Patients with Hereditary Angioedema**

**P. Staubach**, G. Meng, K. Bork; Department of Dermatology, Mainz, GERMANY.

**699**   **Interim Results of EDEMA2, a Multicenter, Open-label, Repeat-Dosing Study of Intravenous and Subcutaneous Administration of Ecallantide (DX-88) in Hereditary Angioedema**

**W. Lumry** ^1^, B. Ritchie^2^, T. Beck^3^, J. Morrison^3^; ^1^Allergy & Asthma Specialists, Dallas, TX, ^2^University of Alberta, Edmonton, AB, CANADA, ^3^Dyax Corp., Cambridge, MA.

**700**   **Home Treatment in Patients with Hereditary Angiodema (HAE)**

**E. Rusicke**, I. Martinez-Saguer, E. Aygören-Pürsün, W. Kreuz; Centre of Pediatrics III Department of Hematology, Hemostaseologie, Oncology and Immunodeficiency, JWG-University Hospital Frankfurt/Germany, Frankfurt/Main, GERMANY.

**701**   **Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - A Prospective Study**

**I. Martinez-Saguer**, E. Rusicke, E. Aygören-Pürsün, W. Kreuz; Centre of Pediatrics III, Department of Hematology, Hemostaseology, Oncology and Immunodeficiency, J.-W. Goethe University Hospital Frankfurt, Germany, Frankfurt, GERMANY.
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**702**   **Using Geographic Information System (GIS) Software to Examine US Adult Asthma Prevalence and Healthcare Services Disparities**

**H. J. Zeitz** ^1^, M. N. Lutfiyya^2^, J. E. McCullough^3^, E. Henley^2^; ^1^National Center for Rural Health Professions, University of Illinois, Rockford, IL, ^2^Family and Community Medicine, University of Illinois, Rockford, IL, ^3^Chicago Department of Public Health, Chicago, IL.

**703**   **Life Stressors, Depression and Adult Asthma Morbidity**

**M. U. Shalowitz** ^1^, J. J. Shannon^2^, K. Weiss^3^; ^1^Pediatrics, Northwestern University Feinberg School of Medicine, Evanston, IL, ^2^Internal Medicine, John H. Stroger Hospital of Cook County, Chicago, IL, ^3^Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.

**704**   **Reduced Prevalence of Childhood Wheeze in Children Given Neonatal BCG Vaccination**

**M. F. Linehan** ^1^, T. L. Frank^1^, M. L. Hazell^1^, H. C. Francis^2^, D. N. Baxter^3^, J. Morris^4^, R. M. Niven^2^; ^1^GP Research Unit, North West Lung Research Centre, Manchester, UNITED KINGDOM, ^2^North West Lung Research Centre, Manchester, UNITED KINGDOM, ^3^School of Epidemiology and Health Science, University of Manchester, Manchester, UNITED KINGDOM, ^4^Department of Statistics, Wythenshawe Hospital, Manchester, UNITED KINGDOM.

**705**   **Assessing Productivity Impairment in Patients with Severe or Difficult-to-Treat Asthma: Validation of the Work Productivity Activity Impairment - Asthma Questionnaire**

**H. Chen** ^1,2^, P. D. Blanc^1^, A. Chawla^2^, M. Hayden^3^, E. R. Bleecker^4^, J. H. Lee^2^; ^1^Department of Medicine, UCSF, San Francisco, CA, ^2^Genentech, Inc., South San Francisco, CA, ^3^School of Nursing, University of Virginia, Charlottesville, VA, ^4^Wake Forest University, Winston-Salem, NC.
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**706**   **Osteopontin: A Novel Regulator in Antigen-Induced IgE and Allergic Responses**

**M. Kurokawa**, Q. Liu, S. Konno, S. C. Hsu, B. Plunkett, H. Rohde, S. Y. Oh, T. Zheng, Z. Zhu, A. C. Myers, S. K. Huang; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.

**707**   **Ribonomic Analysis of Airway Epithelial Cell Gene Expression: Identification of Chemokine Transcripts as Targets of the RNA-Binding Protein HuR**

**C. Stellato** ^1^, S. L. Curry^1^, U. X. Atasoy^2^, M. Gorospe^3^, J. Fan^1^; ^1^Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, ^2^University of Missouri-Columbia, Columbia, MO, ^3^National Institute of Aging, NIH, Baltimore, MD.

**708**   **Lipocalin2 (lcn2) is Upregulated and May Serve as a Novel Protective Factor in Allergic Airway Disease**

**A. M. Dittrich**, D. Quarcoo, M. Krokowski, A. Awagjan, B. Ahrens, E. H. Hamelmann; Pediatric Pneumology and Immunology, Charité University Medicine, Berlin, GERMANY.

**709**   **Role of Resistin-Like Molecule (RELM)-b in Allergic Airway Inflammation**

**A. Haczku** ^1^, S. Ying^2^, S. Kierstein^1^, Q. Meng^2^, L. D. McVay^1^, C. J. Corrigan^2^, G. D. Wu^1^; ^1^Medicine, University of PA School of Medicine, Philadelphia, PA, ^2^Guy\'s, King\'s & St. Thomas' School of Medicine, London, UNITED KINGDOM.
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**710**   **Aspirine Sensitive Rhinosinusitis is Associated with Reduced E-prostanoid 2(EP2) Receptor Expression on Nasal Mucosal Inflammatory Cells**

**S. Ying** ^1^, Q. Meng^1^, G. Scadding^2^, A. Parikh^2^, C. J. Corrigan^1^, T. H. Lee^1^; ^1^Asthma, Allergy & Respiratory Science, GKS Medical School, London, UNITED KINGDOM, ^2^Royal National Throat, Nose and Ear Hospital, London, UNITED KINGDOM.

**711**   **Enhanced Expression of Innate Immune Genes in Chronic Rhinosinusitis**

**A. Q. Truong-Tran** ^1^, R. Kern^2^, D. Conley^2^, S. Retsema^2^, L. Grammer, III^1^, L. Suh^1^, J. Tirumalasetty^1^, B. Tancowny^1^, A. Tripathi^1^, R. Schleimer^1^; ^1^Allergy-Immunology, Northwestern University, Chicago, IL, ^2^Otolaryngology, Northwestern University, Chicago, IL.

**712**   **Total and Specific Nasal IgE to *Dermatophagoides Pteronyssinus* in Patients with Persistent Rhinitis**

C. Rondon1, S. Lopez2, R. R-Pena2, J. J. Romero1, T. D. Fernandez2, C. Antunez2, I. Dona1, M. S. Fuentes1, J. L. Rodriguez-Bada2, **M. Blanca1**; 1Allergy Service, Carlos Haya Hospital, Malaga, SPAIN, 2Research Laboratory, Carlos Haya Hospital, Malaga, SPAIN.

**713**   **A Genomewide Screen for Chronic Rhinosinusitis Genes Identifies a Locus on Chromosome 7q**

**J. M. Pinto** ^1^, M. G. Hayes^2^, D. Schneider^3^, N. Phillips^4^, J. Hyuen^4^, N. J. Cox^2^, R. M. Naclerio^1^, C. Ober^4^; ^1^Section of Otolaryngology-Head and Neck Surgery, The University of Chicago, Chicago, IL, ^2^Section of Genetic Medicine, Department of Medicine and Department of Human Genetics, The University of Chicago, Chicago, IL, ^3^Departmenr of Human Genetics, The University of Chicago, Chicago, IL, ^4^Department of Human Genetics, The University of Chicago, Chicago, IL.

Featured Poster Session {#sec47}
=======================

3801

Sunday, March 05, 2006

5:30 pm to 7:30 pm

Featured Poster Session {#sec47.1}
-----------------------

**714**   **Ciclesonide, Administered Once Daily, has No Effect on Skeletal Maturity in Prepubertal Children with Mild, Persistent Asthma**

**H. Neffen** ^1^, M. Ruff^2^, P. Zhang^3^, M. Lloyd^3^, D. Banerji^3^; ^1^Centro de Alergia e Inmunologia, Santa Fe, ARGENTINA, ^2^Dallas Allergy & Asthma Center, Dallas, TX, ^3^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**715**   **Once-daily Ciclesonide has No Effect on Hypothalamic-Pituitary-Adrenal-axis Function in Prepubertal Children with Mild, Persistent Asthma**

**D. Bernstein** ^1^, F. Caballero-Fonseca^2^, P. Zhang^3^, M. Lloyd^3^, D. Banerji^3^; ^1^Bernstein Clinical Research, Cincinnati, OH, ^2^Centro Medico Docente La Trinidad, Caracas, VENEZUELA, ^3^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**716**   **Quality of Life is Improved by Ciclesonide 160 μg Once Daily and Budesonide 400 μg Once Daily in Pediatric Patients with Persistent Asthma**

**J. H. Vermeulen** ^1^, T. Latos^2^, T. Müller^3^, R. Engelstätter^3^; ^1^Parow, Cape Town, SOUTH AFRICA, ^2^Centrum Pulmonologii i Alergologii, Karpacz, POLAND, ^3^ALTANA Pharma AG, Konstanz, GERMANY.
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**717**   **Gene-Environment Interaction between *CD14 -159*C→T and Diesel Exhaust Particle (DEP) Exposure Underlying Aero Allergen Sensitization**

**N. Wang** ^1^, N. Huey^1^, S. Sutton^1^, M. Rao^2^, R. Chakraborty^2^, G. LeMasters^2^, D. Bernstein^2^, T. Reponen^2^, J. Lockey^2^, S. Grinshpun^2^, G. K. K. Hershey^1^; ^1^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^University of Cincinnati, Cincinnati, OH.

**718**   **Gene-environment Interactions with CD14: Sorting Out The Effects of Pets and Endotoxin on Serum IgE Levels**

L. K. Williams^1^, R. A. McPhee^1^, E. L. Peterson^1^, D. R. Ownby^2^, M. James^1^, E. M. Zoratti^1^, C. C. Johnson^1^; ^1^Henry Ford Health System, Detroit, MI, ^2^Medical College of Georgia, Augusta, GA.

**719**   **Single Nucleotide Polymorphisms in Gene Encoding Myosin Light Chain Kinase (MLCK) are Associated with Increased Risk of Asthma**

**L. GAO** ^1^, A. Ilano^2^, A. Grant^1^, M. Campbell^1^, S. Zhang^1^, T. H. Beaty^3^, J. G. N. Garcia^4^, K. Barnes^1^; ^1^Division of Allergy & Clinical Immunology, Johns Hopkins University, Baltimore, MD, ^2^Seton Hall University, South Orange, NJ, ^3^Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, ^4^Department of Medicine, The University of Chicago Biological Sciences, Chicago, IL.
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**720**   **Home Environment Related to Respiratory and Allergic Diseases in Children Taking Into Account Early Exposure**

**C. Pénard-Morand** ^1^, C. Raherison^2^, D. Moreau^1^, C. Kopferschmitt^3^, F. Lavaud^4^, D. Caillaud^5^, D. Charpin^6^, I. Annesi-Maesano^1^; ^1^U472, INSERM, Villejuif, FRANCE, ^2^Hôpital du Haut-Lévèque, Bordeaux, FRANCE, ^3^Hôpitaux Civils, Strasbourg, FRANCE, ^4^Hôpital Maison Blanche, Reims, FRANCE, ^5^Hôpital Montpied, Clermont-Ferrand, FRANCE, ^6^Hôpital Nord, Marseille, FRANCE.

**721**   **Time-dependent Effects of Dog Exposure and Genotype at Immune-Related Genes on Wheezing and Atopy in Early Childhood**

**J. Bufford** ^1^, Z. Li^2^, C. Reardon^3^, K. A. Roberg^3^, C. Tisler^3^, E. Anderson^3^, D. DaSilva^3^, I. Ostrovnaja^4^, S. Hoffjan^5^, D. Nicolae^4^, R. Gangnon^2^, C. Ober^5^, R. F. Lemanske, Jr.^6^, J. E. Gern^3^; ^1^Medicine, University of Wisconsin-Madison, Madison, WI, ^2^Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, ^3^Pediatrics, University of Wisconsin-Madison, Madison, WI, ^4^Department of Statistics, University of Chicago, Chicago, IL, ^5^Department of Human Genetics, University of Chicago, Chicago, IL, ^6^Pediatrics and Medicine, University of Wisconsin-Madison, Madison, WI.

**722**   **Combined Effects of the Glutathione S-transferase P1 (GST-P1) Gene Polymorphism and Environmental Tobacco Smoke (ETS) Exposure on the Development of Asthma**

**K. T. Shair** ^1^, J. M. Biagini^2^, G. K. LeMasters^2^, D. I. Bernstein^3^, J. E. Lockey^2^, G. K. Khurana Hershey^1^; ^1^Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Environmental Health, University of Cincinnati, Cincinnati, OH, ^3^Internal Medicine, University of Cincinnati, Cincinnati, OH.
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**723**   **Deficient HBD-3 in the Skin of Atopic Dermatitis (AD) Patients Increases Susceptibility to Recurrent Viral Skin Infections**

**M. D. Howell** ^1^, J. E. Streib^1^, N. Novak^2^, T. Bieber^2^, M. Boguniewicz^1^, S. Pastore^3^, G. Girolomoni^3^, D. Y. M. Leung^1^; ^1^National Jewish Med. and Research Center, Denver, CO, ^2^University of Bonn, Bonn, GERMANY, ^3^Instituto Dermopatico dell\'Immacolata, Roma, ITALY.

**724**   **A Role for Circulating Pro-Inflammatory CD25^hi^CCR6^+^CD4^+^ T Cells in Atopic Dermatitis**

A. J. Reefer^1^, S. M. Satinover^1^, M. Solga^2^, B. Wilson^3^, **J. A. Woodfolk** ^1^; ^1^Department of Medicine, University of Virginia, Charlottesville, VA, ^2^Department of Microbiology, University of Virginia, Charlottesville, VA, ^3^Department of Dermatology, University of Virginia, Charlottesville, VA.

**725**   **Atopic Dermatitis (AD) and Eczema Herpeticum (EH): Role of Cathelicidins in Herpes Simplex Virus (HSV) Infection**

**D. Y. M. Leung** ^1^, A. Wollenberg^2^, R. L. Gallo^3^, M. Flaig^2^, N. Novak^4^, T. Bieber^4^, M. Boguniewicz^1^, J. E. Streib^1^, C. Wong^3^, T. Pavicic^2^, M. D. Howell^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Ludwig Maximilian\'s University, Munich, GERMANY, ^3^University of California at San Diego, San Diego, CA, ^4^University of Bonn, Bonn, GERMANY.

Featured Poster Session {#sec51}
=======================

3805

Sunday, March 05, 2006

5:30 pm to 7:30 pm

Featured Poster Session {#sec51.1}
-----------------------

**726**   **Impact of Atopic Dermatitis on Quality of Life and Patient Attitudes Towards Current Management Options**

**T. Zuberbier**; Dept. of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, GERMANY.

**727**   **A Cost-Effectiveness Analysis of Aspirin Desensitization in Aspirin Sensitive Patients**

**M. S. Shaker**, M. E. Goodrich, A. L. Lobb, F. Jaffrey, M. S. Verdi; Section of Allergy and Clinical Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

**728**   **Improving the Safety of Immunotherapy: A Systematic Approach**

**T. Bingemann**, C. Oslie, W. Molis, J. T. Li; Mayo Clinic and Foundation, Rochester, MN.
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**729**   **Airway Expression of Calcitonin Gene-Related Peptide in T-Cell Peptide-Induced Late Asthmatic Reactions**

**F. R. Ali** ^1^, L. G. Heaney^2^, F. Benyahia^1^, J. Barkans^1^, C. P. Soh^3^, A. Mochizuki^4^, A. F. Walls^4^, A. Humbles^5^, H. Renz^6^, S. Ying^3^, T. Lee^3^, M. Larché^1^, A. B. Kay^1^; ^1^Dept. of Allergy and Clinical Immunology, and Leukocyte Biology, National Heart & Lung Institute, Imperial College, London, UNITED KINGDOM, ^2^Queen\'s University, Belfast, UNITED KINGDOM, ^3^GKT School of Medicine, Guy\'s campus, London, UNITED KINGDOM, ^4^Immunopharmacology, University of Southampton, Southampton, UNITED KINGDOM, ^5^Ina Sue Perlmutter Laboratory, Children\'s Hospital, Harvard Medical School, Boston, MA, ^6^Department of Clinical Chemistry and Molecular Diagnostics, Philipps-University Marburg, Marburg, GERMANY.

**730**   **Innate Immune Response to an Environmental Fungus, Alternaria, Facilitates Th2-Type Airway Sensitization to a Bystander Antigen**

**T. Kobayashi** ^1^, K. Iijima^1^, S. Radhakrishnan^2^, V. Mehta^1^, R. Vassallo^3^, L. R. Pease^2^, H. Kita^1^; ^1^Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, MN, ^2^Department of Immunology, Mayo Clinic Rochester, Rochester, MN, ^3^Division of Pulmonary and Critical Care and Internal Medicine, Mayo Clinic Rochester, Rochester, MN.

**731**   **Human Peripheral Blood Eosinophils Express Functional Glutamate Receptors**

**S. O. Odemuyiwa** ^1^, V. Lam^1^, M. Benn^1^, A. Ghahary^1^, M. Duszyk^2^, R. Moqbel^1^; ^1^Department of Medicine, Pulmonary Research Group, University of Alberta, Edmonton, AB, CANADA, ^2^Department of Physiology, Pulmonary Research Group, University of Alberta, Edmonton, AB, CANADA.

**732**   **Exogeneous Chitinases Activate and Induce Degranulation of Human Eosinophils through a Protease-Activated Receptor-2 (PAR-2)**

**Y. MATSUWAKI**, W. Thomas, K. Hotta, H. Kita; Department of Allergic Research labo., Mayo Clinic Rochester, Rochester, MN.
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**733**   **Allergy Skin Prick Testing, Self-Reported Hay Fever Diagnosis and Self-Reported Allergy Symptoms in the Third National Health and Nutrition Examination Survey (NHANES III)**

**L. Watson** ^1^, D. W. Clark^2^, K. J. Davis^2^, M. A. Corrao^2^; ^1^Worldwide Epidemiology, GlaxoSmithKline, Greenford, UNITED KINGDOM, ^2^Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC.

**734**   **Comparison of Two Single-Headed and Two Multiheaded Prick Skin Test Devices**

**I. Yoon** ^1^, B. L. Martin^1^, W. W. Carr^2^; ^1^Allergy-Immunology, Walter Reed Army Medical Center, Washington, DC, ^2^Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, MD.

**735**   **Testing a Direct, Highly Sensitivity Method for Quantitation of Fluticasone Propionate in Human Plasma: Contrasting Nasal and Inhaled Exposure**

P. Patel^1^, P. Benninger^1^, A. Cooper^1^, R. Moisan^1^, **J. J. Thiessen** ^2^; ^1^Allied Research International, Mississauga, ON, CANADA, ^2^Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, CANADA.
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**736**   **The Effect of Dexamethasone on TGF-ß-Induced Hyperplasia of Bronchial Smooth Muscle Cells**

T. Basinski^1^, K. Blaser^2^, C. Akdis^2^, **M. Jutel** ^1^; ^1^Department of Internal Medicine and Allergology, Wroclaw Medical University, Wroclaw, POLAND, ^2^Swiss Institute of Allergy and Asthma Research (SIAF), Davos, SWITZERLAND.

**737**   **Once-daily Ciclesonide has No Effect on Growth in Children with Mild, Persistent Asthma: a Subgroup Analysis of North and South American Populations**

**C. E. Baena-Cagnani** ^1^, L. Mansfield^2^, P. Zhang^3^, M. Lloyd^3^, D. Banerji^3^; ^1^University of Cordoba, Cordoba, ARGENTINA, ^2^El Paso Institute for Medical Research and Development, El Paso, TX, ^3^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**738**   **Ciclesonide has No Effect on Growth in Prepubertal Children with Mild, Persistent Asthma, Irrespective of Age and Gender**

**A. Nayak** ^1^, O. Herrera^2^, S. Kundu^3^, M. Lloyd^3^, D. Banerji^3^; ^1^Sneeze, Wheeze, and Itch Associates, LLC, Normal, IL, ^2^Hospital Luis Calvo Mackena, Providencia-Santiago, CHILE, ^3^Aventis Pharmaceuticals, a member of the sanofi-aventis Group, Bridgewater, NJ.

**739**   **The Effect of Budesonide on IgE and IgG Subclasses in Asthmatic Children**

**M. Bobrowska-Korzeniowska**, J. Jerzynska, I. Stelmach; Department of Pediatrics and Allergy, Medical University of Lodz, M Curie Hospital, Zgierz, POLAND.

**740**   **Tissue Distribution of Ciclesonide and Budesonide in Mice**

**U. Mars** ^1^, A. Johansson^1^, E. Evetovics^2^, P. Sjolin^2^, A. Miller-Larsson^2^, S. Edsbacker^2^; ^1^Safety Assessment, AstraZeneca R&D, Sodertalje, SWEDEN, ^2^AstraZeneca R&D, Lund, SWEDEN.

**741**   **Asthma Control and Exhaled Nitric Oxide in Real Life**

**A. Michils**, A. Van Muylem; Chest Department, Erasme University Hospital, Brussels, BELGIUM.

**742**   **Never-Smoking Senile-Onset Asthmatics Show Atypical and Mild Asthma Symptoms**

**C. Oshikata**, M. Taniguchi, Y. Takeuchi, E. Ono, T. Tsuburai, N. Tsurikisawa, M. Ohtomo, Y. Maeda, A. Mori, M. Hasegawa, H. Mita, K. Akiyama; Asthma reseach devision, National Sagamihara Hospital, Sagamihara, JAPAN.

**743**   **Effect of Feedback Education of a Respiratory Service Program(RSP) on Inhaler**

**J. CHUNG**, K. SHIN, K. LEE; Department of internal medicine, YEUNGNAM UNIVERSITY HOSPITAL, DAEGU, REPUBLIC OF KOREA.

**744**   **Fungi Play an Important Role in Bronchial Asthma**

**T. Hofman**, A. M. Hofman, A. Urbanowicz, J. Michalik; Center of Allergology, Poznan, POLAND.

**745**   **Measurement of Exhaled Breath Temperature to Assess Changes in Airway Inflammation**

**T. Popov** ^1^, S. Dunev^1^, T. Kralimarkova^1^, L. M. DuBuske^2^; ^1^Medical University of Sofia, Sofia, BULGARIA, ^2^Immunology Research Institute of New England, Gardner, MA.

**746**   **The Role of Histamine Challenge and Progressive Exercise Testing in the Diagnosis of Vocal Cord Dysfunction**

**A. E. Stanton** ^1^, K. MacKenzie^2^, R. Carter^1^, C. E. Bucknall^1^; ^1^Department of Respiratory Medicine, Glasgow Royal Infirmary, Glasgow, UNITED KINGDOM, ^2^Department of Otolaryngology, Glasgow Royal Infirmary, Glasgow, UNITED KINGDOM.

**747**   **Cytokines Epistasis Contributes to Childhood Asthma**

**I. R. Genov** ^1^, A. Goncalves-Primo, Jr.^1^, A. Yambartsev^2^, L. K. Arruda^3^, A. S. Zampolo^3^, V. P. L. Ferriani^4^, D. Solé^1^, C. K. Naspitz^1^, M. Gerbase-DeLima^1^, A. Morgun^1^; ^1^Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, BRAZIL, ^2^Mathematics and Statistics Institute, University of Sao Paulo, Sao Paulo, BRAZIL, ^3^Department of Medicine, University of Sao Paulo, Ribeirao Preto, BRAZIL, ^4^Department of Pediatrics, University of Sao Paulo, Ribeirao Preto, BRAZIL.

**748**   **Asthma Biomarkers in Exhaled Breath Condensate (EBC)**

**S. L. Limb** ^1^, W. C. Hubbard^2^, R. A. Wood^3^, N. Adkinson, Jr.^4^; ^1^Johns Hopkins School of Medicine, Baltimore, MD, ^2^Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, MD, ^3^Pediatric Allergy and Immunology, Johns Hopkins School of Medicine, Baltimore, MD, ^4^Allergy and Clinical Immunology, Johns Hopkins School of Medicine, Baltimore, MD.

**749**   **Corticosteroid Resistant (CR) Asthma Is Associated with Classical Activation Of Airway Macrophages and Exposure To Lipopolysaccharide (LPS)**

**P. J. Hauk** ^1^, E. Goleva^1^, A. H. Liu^1^, C. F. Hall^1^, D. W. H. Riches^1^, R. J. Martin^2^, D. Y. M. Leung^1^; ^1^Pediatrics, National Jewish Medical and Research Center, Denver, CO, ^2^Medicine, National Jewish Medical and Research Center, Denver, CO.

**750**   **History of Smoking is Strongly Correlated with Decreased Exhaled Nitric Oxide, Eosinophils, and Serum Ecp in White but not African American Patients**

E. Peters^1^, **J. Platts-Mills** ^2^, L. Naccara^2^, S. Crater^3^, S. Lucas^2^, T. A. E. Platts-Mills^2^; ^1^Allergy, Seton Hospital, Austin, TX, ^2^Allergy, University of Virginia, Charlottesville, VA, ^3^Dermatology, Charleston, SC.

**751**   **Atopy and House Dust Mite Sensitization as Risk Factors for Asthma in Children**

**S. Jung Wook** ^1^, K. Eun Soo^1^, K. Kyung Won^1^, J. Gwang Cheon^2^, S. Myung Hyun^1^, K. Kyu-Earn^1^, J. Y. Park^1^; ^1^Department of Pediatrics and Institute of Allergy, Yonsei University College of Medicine, seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, NHIC Ilsan Hospital, seoul, REPUBLIC OF KOREA.

**752**   **Phenotypic Assessment of a Functional Sequence Variant of the Gene Encoding Human Chemoattractant Receptor-homologous Molecule Expressed on Th~2~ Cells (crth2)**

**C. F. CHIAN**, P. S. Gao, U. D. Fanis, V. Casolaro, N. F. Adkinson, Jr., S. K. Huang; Allergy and clinical immunology, JOHNS HOPKINS UNIVERSITY, BALITIMORE, MD.

**753**   **Characteristics of Japanese Cedar/Cypress Pollen in 2005, Fukuoka, Japan**

**R. Kishikawa**, T. Shimoda, S. Shoji, S. Nishima, Sr.; Allergology, The National Hospital Organization Fukuoka National Hospital Clinical Reserch Center, Fukuoka, JAPAN.

**754**   **The Performance of a New Component-Based Allergen-Microarray in Clinical Practice**

**S. Wöhrl** ^1^, K. Vigl^1^, S. Zehetmayer^2^, R. Hiller^3^, R. Jarisch^4^, M. Prinz^5^, G. Stingl^1^, T. Kopp^1^; ^1^Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases (DIAID), Medical University of Vienna, Vienna, AUSTRIA, ^2^Core unit for Medical Statistics and Informatics, Section on Medical Statistics, Medical University of Vienna, Vienna, AUSTRIA, ^3^VBC-Genomics, Vienna, AUSTRIA, ^4^Floridsdorf Allergy Centre (FAZ), Vienna, AUSTRIA, ^5^Core unit for Medical Statistics and Informatics, Section on Medical Computer Vision, Medical University of Vienna, Vienna, AUSTRIA.
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**755**   **Safety of Foradil^®^ in the Treatment of Asthma: A Pooled Analysis of Randomized, Controlled Clinical Trials**

**G. P. Geba** ^1^, B. Ziehmer^2^, H. Staudinger^3^, D. Till^4^; ^1^USCDMA, Novartis Pharmaceuticals Corp., E Hanover, NJ, ^2^Global Development, Novartis Pharmaceuticals Corp., E Hanover, NJ, ^3^Schering-Plough Corporation, Kenilworth, NJ, ^4^Novartis Horsham Research Centre, Novartis Pharmaceuticals Corp., Horsham, UNITED KINGDOM.

**756**   **Safety of High-Dose Continuous Nebulized Levalbuterol**

**T. Andrews** ^1^, E. E. McGintee^2^, L. Tyler^3^, M. Mittal^4^, N. A. Pawlowski^2^, J. Zorc^4^; ^1^Allergy and Asthma Associates, Arnold, MD, ^2^Allergy and Immunology, Children\'s Hospital of Philadelphia, Philadelphia, PA, ^3^Respiratory Care, Children\'s Hospital of Philadelphia, Philadelphia, PA, ^4^Emergency Medicine, Children\'s Hospital of Philadelphia, Philadelphia, PA.

**757**   **Safety of Ventolin HFA^®^ MDI in Children Birth-\<24 Months Old With Symptoms of Bronchospasm**

**A. Davis-Allen**, W. Lincourt, R. Trivedi, A. Ellsworth, C. Crim; GlaxoSmithKline, Research Triangle Park, NC.

**758**   **Indacaterol, A Novel Once-Daily b~2~-Agonist, Demonstrates 24-hour Efficacy and is Well Tolerated in Patients with Persistent Asthma**

**F. Kanniess** ^1^, R. Cameron^2^, R. Owen^2^, M. Higgins^2^; ^1^Pulmonary Research Institute, Grosshansdorf, GERMANY, ^2^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.

**759**   **Formoterol Induces Higher Levels of Total cAMP in TNFa-Stimulated Human Monocytes than Salmeterol**

I. Nita^1^, A. Miller-Larsson^2^, **S. Janciauskiene** ^1^; ^1^Clinical Sciences, Lund University, Malmö, SWEDEN, ^2^AstraZeneca R&D Lund, Lund, SWEDEN.

**760**   **Normal Pulmonary Function in Alpha-1-Antitrypsin Deficiency ZZ Phenotype**

**M. L. Fajt** ^1^, J. Gibbs^2^, L. H. Fisher^3^, T. J. Craig^2^; ^1^Department of Medicine, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA, ^2^Department of Allergy-Immunology and Pulmonary Medicine, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA, ^3^Department of Allergy-Immunology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA.

**761**   **Asthma Hospitalizations in Children 2 Years Old or Less in New York State 1990-2004**

**T. J. Pitt** ^1^, R. Y. Lin^2,3^; ^1^St Vincent Hospital Manhattan-SVCMC, New York, NY, ^2^St Vincent Hospital Manhattan- SVCMC, New York, NY, ^3^New York Medical College, Valhalla, NY.

**762**   **Correlation between Exhaled Nitric Oxide (eNO) and Symptoms, Medication Use and Quality of Life in Patients Diagnosed with Mild to Moderate Persistent Asthma**

**J. Kaczmarek**, M. Bochen´ska-Marciniak, M. Kupczyk, P. Górski, P. Kuna; Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, POLAND.

**763**   **Sex Differences in Effects of Breastfeeding on Asthma and Allergy in Relation to Parental Atopy**

**P. J. Mandhane**, J. M. Greene, M. R. Sears; McMaster University, Hamilton, ON, CANADA.

**764**   **The Follow of Changes in Inflammatory Markers in Induced Sputum of Patients with Bronchial Asthma and Allergic Rhinitis in Relation to Exposure to Pollen Allergens**

**V. Hrasko, I. Malkusova, J. Hanzlikova, P. Panzner**; Medical Faculty Hospital, Plzen, CZECH REPUBLIC.

**765**   **Association between Peroxiredoxin (PRDX) VI Gene Polymorphism and Asthma and Its Intermediate Phenotypes**

**T. B. Kim**, Y. S. Cho, C. S. Park, K. Y. Lee, H. B. Moon; Department of Medicine, Clinical Research Center for Chronic Obstructive Airway Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA.

**766**   **Gene-Gene Interaction Between CD14 and IL-4Ra polymorphisms Is Associated with Asthma Susceptibility in Korean Children with Asthma**

**S. Lee** ^1^, H. Kim^2^, J. Kim^2^, B. Kim^2^, M. Kang^3^, S. Hong^2^; ^1^Department of Pediatrics, University of Hallym College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Asan Medical Center, Seoul, REPUBLIC OF KOREA, ^3^Asan Institute for Life Sciences, Seoul, REPUBLIC OF KOREA.

**767**   **Changes in Specific Ige Sensitization Rates in Children 1985-2003: Review of 9,365 Allergy Tests Performed in a Single Hospital Laboratory over a 19-Yr Period**

**P. L. P. Brand** ^1^, L. D. Dikkeschei^2^; ^1^Princess Amalia Children\'s Clinic, Isala klinieken, Zwolle, THE NETHERLANDS, ^2^Clinical Laboratory, Isala klinieken, Zwolle, THE NETHERLANDS.

**768**   **Accuracy of FDA-Cleared IgE Assays in the Presence of Omalizumab (Xolair)**

**R. G. Hamilton**; Allergy and Clinical Immunology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

**769**   **Nafamostat Mesilate (FUT) and Gabexate Mesilate (FOY) Attenuates Allergic Airway Inflammation and Eosinophilia in *Dermatophagoides pteronyssinus* - Sensitized Mice**

**C. Chen**; Division of Biomaterials and Tissue Engineering, BMEC, Industrial technology research institute, Hsinchu, TAIWAN REPUBLIC OF CHINA.

**770**   **Total IgE Level is Associated with Anti-Ascaris Specific IgE but not with Stool Parasites or Blood Eosinophilia in Young Allergic Patients in a Tropical Region (Recife - Brazil)**

D. Medeiros, A. R. Silva, J. A. Rizzo, M. E. Motta, **E. Sarinho**; Universidade Federal de Pernambuco, Recife, BRAZIL.

**771**   **Concentrations of 15-HETE and PGE~2~ in Induced Sputum of Allergic Asthma Patients**

**K. Kowal** ^1^, S. Zukowski^1^, O. Kowal-Bielecka^1^, L. M. DuBuske^2^, A. Bodzenta-Lukaszyk^1^; ^1^Medical University of Bialystok, Bialystok, POLAND, ^2^Immunology Research Institute of New England, Gardner, MA.

**772**   **Polymorphisms in the Cholinergic Receptor, Muscarinic 1 (CHRM1) Gene Confer Susceptibility to Asthma in Japanese**

**Y. Maeda**, N. Hizawa, E. Jinushi, D. Takahashi, Y. Fukui, S. Konno, E. Yamaguchi, M. Nishimura; First department of Medicine, Hokkaido University school of Medicine, Sapporo, JAPAN.

**773**   **Genetic Impacts of a Butyrophilin-like 2 (BTNL2) Gene Variation On Specific Ige Responsiveness to *Dermatophagoides Farinae* (Der F) in Japanese**

**D. Takahashi**, N. Hizawa, S. Konno, A. Isada, A. Takahashi, T. Hattori, Y. Maeda, M. Nishimura; First Department of Medicine, Hokkaido University Graduate School of Medicine, Sapporo, JAPAN.
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**774**   **Aspirin Exerts Opposite Regulation of CD154 and Cytokine Gene Expression in Human Th1 and Th2 Cells**

F. Mori, U. De Fanis, R. J. Kurnat, W. Lee, **V. Casolaro**; Johns Hopkins University, Baltimore, MD.

**775**   **Restoration of Immune Mediated Hearing Loss by Adoptive Cellular Gene Therapy**

**T. Yoo**, B. Zhou, M. Kermany, C. Cai, Q. Cai, P. Kim, J. Kim; Allery/Immunology,Molecular Sciences, University of Tennessee, Memphis, TN.

**776**   ***Sarcoptes scabiei* Suppresses Expression of Adhesion Molecules and IL-8 by Human Dermal Microvascular Endothelial Cells (HMVEC-D)**

B. L. Elder, M. S. Morgan, **L. G. Arlian**; Wright State University, Dayton, OH.

**777**   **Lipoteichoic Acid and Peptidoglycan Inhibit Fc Epsilon RI Expression by Mast Cells**

**M. Yoshioka**, S. Iriguchi, N. Imajo, M. Akagi, N. Fukuishi; Department of Pharmacology, Tokushima Bunri University, Tokushima, JAPAN.

**778**   **Immunological Abnormalities and Cutaneous Lesions in a Pediatric Patient with Crohn\'s Disease Treated by Infliximab**

Y. Wang, **R. L. Roberts**; Pediatrics, UCLA, Los Angeles, CA.

**779**   **Sophorolipids Decrease IgE Production in U266 Cells.**

**M. H. Bluth** ^1^, T. A. Smith-Norowitz^2^, M. Hagler^1^, R. Beckford^1^, S. Chice^3^, V. Shah^4^, R. Gross^4^, M. Nowakowski^3^, R. Schulze^1^, M. Zenilman^1^; ^1^Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY, ^2^Pediatrics, SUNY Downstate Medical Center, Brooklyn, NY, ^3^Pathology, Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY, ^4^NSF Center for Biocatalysis and Bioprocessing of Macromolecules, Polytechnic University, Brooklyn, NY.

**780**   **Immunomodulatory Effects of Yunzhi-Danshen on Nasopharyngeal Carcinoma Patients**

**Y. X. Bao** ^1,2^, C. K. Wong^1^, P. W. Li^1^, E. L. Wong^3^, A. T. Chan^4^, S. F. Leung^4^, P. C. Leung^3^, K. P. Fung^3^, Y. B. Yin^2^, W. K. Lam^1^; ^1^Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, CHINA, ^2^Department of Laboratory Medicine, The Chongqing University of Medical Sciences, Chongqing, CHINA, ^3^Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, CHINA, ^4^Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, CHINA.

**781**   **Bacterial Components Enhance Mast Cell Phagocytosis through the Expression of Complement Receptor 3**

**N. Imajo**, M. Yoshioka, A. Inukai, M. Akagi, N. Fukuishi; Pharmacology, Tokushima Bunri University, Tokushima city, JAPAN.

**782**   **Neonatal Exposure to Intranasal LPS Induces Immunological Tolerance via the Maturation of Specific Dendritic Cell Subsets and Subsequent Activation of Regulatory T Cells**

**Y. Wang**, C. McCusker; Montreal Children\'s Hospital Research Institute and Meakins-Christie Laboratories, McGill University, Montreal, PQ, CANADA.

**783**   **Interleukin 10 Functional Domain, Induces Human Monocytes Differentiation To T Cell Inhibitory Dendritic Cells**

**F. Salazar-Onfray**; Faculty of Medicine, University of Chile, Santiago, CHILE.

**784**   **Intragastric Curcumin Downregulates Aspergillus Antigen Induced Th2 Response in a Murine Model of Allergic Aspergillosis**

**V. P. Kurup** ^1,2^, C. S. Barrios^1^, B. D. Johnson^3^, J. N. Fink^1^; ^1^Pediatrics/Allergy-Immunology, Medical College of Wisconsin, Milwaukee, WI, ^2^Research Service, V A Medical Center, Milwaukee, WI, ^3^Pediatrics, Medical College of Wisconsin, Milwaukee, WI.

**785**   **Modulation and Upregulation of IL-5 and Mastocytosis in Hepatosplenic Schistosomiasis with Asthma**

**E. E. Fouda**, A. I. M. Ali, M. H. Hemida; Allergy and Immunology Center, Al-Azhar University, Cairo, EGYPT.

**786**   **DNA Vaccine Restores Hearing Loss Induced by b-Tubulin in Guinea Pig**

**J. Zhang**, B. Zhou, Q. Cai, P. Kim, T. Yoo; Department of Medicine, University of Tennessee, Memphis, TN.

**787**   **Regulatory Effect on Specific Ige Response of Bifido Bacterium Bifidum(bgn4 Strain) in Murine Model of Peanut Allergy**

**S. Lee**, N. Koo, S. Oh; Pediatrics, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA.

**788**   **Histamine Induces Expression of Cycloxygenase-2 and Regulates the Production of Prostacyclin(PGI~2~) and Thromboxane-A2(TXA~2~) in Human Coronary Artery Endothelial Cells(HCAEC)**

**S. Essengue** ^1^, J. Talreja^2^, D. J. Stechschulte^3^, K. N. Dileepan^4^; ^1^Pediatrics, University of Kansas Medical Center, Kansas City, KS, ^2^Division of Allergy, Clinical Immunology and Rheumatology, Departement of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, ^3^Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, ^4^Division of Allergy, Clinical and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.

**789**   **Inhibition of Indoleamine 2,3-Dioxygenase does not Impede Oral Tolerance**

**C. C. Bowman**, M. J. DeVito, D. G. Ross, M. J. K. Selgrade; NHEERL, USEPA, Research Triangle Park, NC.

**790**   **Atopy as a Predictor of Favorable Response to Treatment with Interferon-Alpha in Patients with Chronic Hepatitis B**

**M. R. Pijak** ^1^, F. Gazdik^2^, E. Jahnova^2^; ^1^1 Department of Internal Medicine, University Hospital, Bratislava, SLOVAKIA, ^2^Slovak Medical University, Bratislava, SLOVAKIA.

**791**   **Macrophage Activation Syndrome after Hematopoietic Cell Transplantation**

**A. Sreedharan**; Medicine, Indiana University School of Medicine, Indianapolis, IN.

**792**   **Assessment of Histamine Release and Immunomodulation Induced by Restorative Dental Materials**

**A. A. Babakhin** ^1^, A. I. Volozhin^2^, L. N. Kazarina^2^, O. O. Guschina^2^, J. A. Babakhina^2^, L. M. DuBuske^3^; ^1^National Research Center - Institute of Immunology, Ministry of Health of Russia, Moscow, RUSSIAN FEDERATION, ^2^Moscow Medical and Dental University, Moscow, RUSSIAN FEDERATION, ^3^Immunology Research Institute of New England, Gardner, MA.

**793**   **Cysteinyl Leukotrienes (CysLTs) Stimulate Eosinophil Degranulation in a CysLT1 Receptor Antagonist Independent Fashion**

**S. Early**, K. Hise, L. Borish, J. W. Steinke; Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA.

**794**   **BALB/c Mice Have Exaggerated IL-10 Response to Murine P. carinii.**

**D. G. Barstow, Jr.**, S. Ruan, X. Rudner, J. Shellito; LSU HSC, New Orleans, LA.
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**795**   **Respiratory Syncytial Virus-Induced Airway Dysfunction Depends on the Virus Strain**

**M. L. Moore** ^1^, N. W. Lukacs^2^, B. D. Rudd^2^, V. V. Polosukhin^1^, M. H. Chi^1^, K. Goleniewska^1^, J. F. O\'Neal^1^, R. S. Peebles, Jr.^1^; ^1^Division of Allergy, Pulmonary, & Critical Care Medicine, Vanderbilt University Medical School, Nashville, TN, ^2^Department of Pathology, University of Michigan Medical School, Ann Arbor, MI.

**796**   **Adsorption of Allergens to Aluminium Hydroxide Adjuvant Induces only Minor or No Structural Changes in Freshly Prepared Vaccines**

**C. Hejl**, K. Meno, H. Ipsen; Research Department, ALK-Abello, Hørsholm, DENMARK.

**797**   **Apoptosis Indices in Patients with Acute and Chronic Viral Hepatitis C and Mixed Hepatitis B and C**

V. V. Tarasiuk^1^, **L. P. Titov** ^1^, D. A. Charnashey^1^, L. S. Jmurovskaya^1^, L. M. DuBuske^2^; ^1^Research Institute for Epidemiology & Microbiology, Minsk, BELARUS, ^2^Immunology Research Institute of New England, Gardner, MA.

**798**   **Resveratrol Induces Apoptosis in an Activated B-Cell Lymphoma Line OCI-LY3**

**A. C. Faber**, T. C. Chiles; Boston College Department of Biology, Chestnut Hill, MA.

**799**   **Identification of Conformational Epitopes on Jun A 1, the Major Allergen of Mountain Cedar Pollen**

**R. Tiwari**, D. Matalon, B. Ning, E. Czerwinski, T. Midoro-Horiuti, R. M. Goldblum; Pediatrics, University of Texas Medical Branch, Galveston, TX.

**800**   **Chest Pain: An Unrecognized Side Effect Temporally Associated with Influenza Vaccine**

**M. R. Kaplan**, M. Nelson, M. Klote, R. Engler; Allergy/ Immunology, Walter Reed Army Medical Center, Washington, DC.

**801**   **A Simple Risk Score to Predict Intravenous Immunoglobulin Non-Responders in Patients with Kawasaki Disease**

**T. Kobayashi**; Department of Pediatrics and Developmental Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, JAPAN.

**802**   **Effect of Simvastatin on Nitric Oxide Production and Lipid Peroxidation of Chondrocytes.**

**E. J. Dombrecht**, K. Aerts, C. B. De Tollenaere, V. Seynhaeve, C. H. Bridts, D. G. Ebo, J. F. Van Offel, W. J. Stevens, L. S. De Clerck; Immunology - Allergology - Rheumatology, University Antwerp, Antwerp, BELGIUM.

**803**   **Evaluation of Clinical Outcomes in Children with Chronic Otitis Media (COM) and Chronic Rhinosinusitis (CRS) in Comparison with Pneumovax^®^ Responses and Immunoparameters**

**C. M. Ward**, L. Geng, A. Cushing-Ruby, H. Jyonouchi; UMDNJ, Newark, NJ.

**804**   **Immune Response to Influenza Vaccination in Subjects Self Reporting Seasonal Allergic Rhinitis**

**S. T. Chang**, M. M. Klote, M. R. Nelson, R. J. M. Engler; Walter Reed Army Medical Center, Washington, DC.

**805**   **Determination of Interleukin 6 (IL-6) and Secretory Immunoglobulin A (Ig As) in Human Milk (Colostrum)**

**D. C. Rodríguez**, D. M. Larrauri, J. L. Liporaci, E. Martinez, L. J. Feo, D. Fernandez, C. Rodriguez, M. A. Velasquez; Medicina Preventiva y Social, Universidad Centrooccidental Lisandro Alvarado, Barquisimeto, Estado Lara, VENEZUELA.

**806**   **Changes in Anti-Pertussis Titers in Adults Following Pertussis Vaccine**

**S. I. Krassilnikova**, C. Mende, T. J. Craig; Hershey Medical Center, Hershey, PA.

**807**   **Enhancement to the Immunogenicity DNA Vaccine Expressing Hepatitis B Virus Core Antigen by Co-injection Flt3 Ligand as a Gene Adjuvant**

**w. zhang** ^1^, S. Dong^2^; ^1^Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, ^2^Key laboratory of Medical Molecular Virology, Shanghai Medical College of Fudan University, Shanghai, CHINA.

**808**   **Intraepithelial Endocrine Cell Population in Larynx from Ovalbumin (OVA) Sensitized and Orally Challenged Rabbits**

**M. A. Vinuesa**, N. D. Bassan, G. H. Fontanella, S. Chaparro, N. Caviglia, G. Kieffer; Catedra de Histologia, Facultad de Ciencia Medicas, Rosario, ARGENTINA.

**809**   **Toll-Like Receptor 2 as a Functional Receptor to Respiratory Syncytial Virus**

**Y. Inoue**, N. Shimojo, T. Arima, Y. Kohno; Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, JAPAN.

**810**   **Idiopathic Granulomatous Myositis Successfully Treated with IVIG**

**J. Y. Patel**, D. P. Huston, G. F. Duna; Section of Immunology, Allergy, Rheumatology, Baylor College of Medicine, Houston, TX.

**811**   **Macrophage Activation Syndrome (MAS) as a Debut of Systemic Lupus Erythematosus (SLE) in a Child.**

**L. M. Kahn Benarroch**, G. Sterba, M. Bosque; Hospital de Clinicas Caracas, Caracas, VENEZUELA.

**812**   **Is Screening with C4 Complement Level Enough to Exclude Hereditary Angioedema?**

**S. Grigoriadou**, M. Duddridge; Immunology, University Hospitals of Leicester NHS Trust, Leicester, UNITED KINGDOM.

**813**   **Is Tissue Transglutaminase (tTG) IgA Sufficient for the Diagnosis of Celiac Disease**

**F. Zarabpouri**, J. Popov, D. Keno, M. Glovsky, A. Sferruzza; Immunology, Quest Diagnostics, San Juan Capistrano, CA.

**814**   **Variation of Basophil CD63 Expression in Drug Hypersensitivity Patients According to their in Vivo Test**

V. Kvedariene^1^, M. Rongier^2^, P. Demoly^1^, **B. Arnoux** ^2^; ^1^Maladies Respiratoires, Hopital A de Villeneuve, Service d\'Allergologie, Montpellier Cedex 05, FRANCE, ^2^U454, INSERM, Montpellier Cedex 05, FRANCE.

**815**   **Validation of a New ImmunoCAP^TM^ Test for Detecting Allergen-Specific IgE to Two Spotted Spider Mite**

**H. Park**, Y. Ye, S. Kim, C. Suh, D. Nahm; Allergy & Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA.

**816**   **Comparative Study of ImmunoCAP^TM^ and ELISA for Detecting Allergen-Specific IgE to Japanese Hop Pollen**

**H. Park**, Y. Ye, S. Kim, D. Nahm, C. Suh; Allergy & Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA.

**817**   **In Vitro Detection of Low Levels of Specific IgE**

**D. HOVANEC-BURNS**; Product Support Allergy & Infectious Disease, Diagnostic Products Corporation, Los Angeles, CA.

**818**   **Diagnosis of Chronic Granulomatous Disease (CGD) in Adults**

**J. Martín-Lázaro** ^1^, S. Urban^2^, V. García-Patos^2^, M. Hernández^2^, T. Español^2^, I. Caragol^2^; ^1^Allergy, Hospital Juan Canalejo, La Coruna, SPAIN, ^2^Immunology, Hospital Valle de Hebron, Barcelona, SPAIN.

**819**   **A Case of Adult-Onset pFAPA**

**M. A. Cavuoto**, V. R. Bonagura; Allergy and Immunology, North Shore-Long Island Jewish Health System, Great Neck, NY.

**820**   **Unusual Presentation of HTLV-induced Adult T-cell Lymphoma/leukemia**

**I. Tanaka** ^1^, A. Edwards^2^, K. Singh^3^, L. Bielory^4^; ^1^UMDNJ - New Jersey Medical School, Newark, NJ, ^2^Medicine, UMDNJ - New Jersey Medical School, Newark, NJ, ^3^Medicine and Pediatrics, UMDNJ - New Jersey Medical School, Newark, NJ, ^4^Allergy, Immunology and Rheumatology, UMDNJ - New Jersey Medical School, Newark, NJ.

**821**   **Suscefull Treatment of Posherpetic Neuralgia with Transfer Factor**

**E. Cervantes-Trujano**, A. Rodríguez-Flores, A. Portugués-Díaz, U. Pacheco-García, R. Ondarza-Aguilera, R. Cortés-Gómez, S. Estrada-Parra; Immunology, National School of Biological Science, National Polytechnic Institute, México, D.F., MEXICO.

**822**   **IgM - IgG Antibodies against Citomegalovirus and Epstein Barr Virus in SLE.**

**M. D. C. Petrola** ^1^, L. Rondon^2^, M. E. Flores Chávez^1^, M. T. Pacheco^1^; ^1^Immunology Unit, University of Carabobo, Valencia, VENEZUELA, ^2^Immunology Unit, CHET, Valencia, VENEZUELA.

**823**   **Serum Levels of Interleukin 6 in Patient with Diagnostic of IschemicCardiopathy**

**M. E. Flores Chávez**, C. G. Petrola, M. R. Chacon de Petrola, I. Petrola, M. T. Pacheco; Medicine, Universidad de Carabobo, Valencia, VENEZUELA.
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**824**   **Classification of Pre-School Wheezers Using Impulse Oscillometry and Atopy Distinguishes Those with Increased Morbidity**

**A. H. Liu** ^1,2^, M. Ellison^3,4^, S. Tong^1^, J. L. Robinson^5^, M. D. Klinnert^1,6^; ^1^Pediatrics, National Jewish Medical and Research Center, Denver, CO, ^2^Pediatrics, University of Colorado School of Medicine, Denver, CO, ^3^Biostatistics, National Jewish Medical and Research Center, Denver, CO, ^4^Biostatistics, University of Colorado School of Medicine, Denver, CO, ^5^Family Studies, University of Connecticut, Storrs, CT, ^6^Psychiatry, University of Colorado School of Medicine, Denver, CO.

**825**   **Asthma and Allergies in Preschool Children: Prevalence and Risk Factors**

**G. W. K. Wong**, T. F. Leung, E. K. H. Liu, T. F. Fok; Pediatrics, Chinese University of Hong Kong, Hong Kong SAR, CHINA.

**826**   **The Positive Relationship of Atopy to Obesity in Women is Negatively Correlated to Serum Leptin**

**M. R. Windt** ^1,2^, A. R. Tagliaferro^3^, V. J. Vieira^1^, A. M. Ronan^1^; ^1^Department of Animal & Nutritional Sciences, University of New Hampshire, Durham, NH, ^2^Center for Asthma Allergy and Respiratory Disease, North Hampton, NH, ^3^Department of Animal & Nutritional Sciences, University of New Hampshire, Durham, NH.

**827**   **Demographic and Clinical Characteristics of Children and Adolescents with Severe or Difficult-to-Treat Asthma**

**B. Chipps** ^1^, S. J. Szefler^2^, J. H. Lee^3^, T. Haselkorn^4^, D. R. Mink^5^, Y. Deniz^3^, F. E. Simons^6^; ^1^Capital Allergy and Respiratory Disease Center, Sacramento, CA, ^2^National Jewish Medical and Research Center, Denver, CO, ^3^Genentech, Inc., South San Francisco, CA, ^4^EpiMetrix, Inc., Sunnyvale, CA, ^5^Ovation Research Group, San Francisco, CA, ^6^University of Manitoba, Winnipeg, MB, CANADA.

**828**   **Mouse Allergen Exposure, Wheeze, and Atopy in the First Seven Years of Life**

**W. Phipatanakul** ^1,2^, J. C. Celedon^3^, C. D. Ramsey^2^, D. L. Sredl^4^, S. T. Weiss^3^, D. R. Gold^2^; ^1^Pediatric Allergy and Immunology, Children\'s Hospital, Boston, Harvard Medical School, Boston, MA, ^2^Respiratory Epidemiology, Channing Laboratory, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, ^3^Respiratory Epidemiology, Channing Laboratory, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, ^4^Respiratory Epidemiology, Channing Laboratory, Harvard Medical School, Boston, MA.

**829**   **Household Mouse Allergen Exposure Predicts Asthma Morbidity in Inner-city Pre-School Children**

**E. C. Matsui** ^1^, P. A. Eggleston^1^, J. A. Krishnan^2^, P. Breysse^3^, C. Rand^2^, G. B. Diette^2^; ^1^Department of Pediatrics, Johns Hopkins University School Medicine, Baltimore, MD, ^2^Department of Medicine, Johns Hopkins University School Medicine, Baltimore, MD, ^3^Department of Environmental Health Sciences, Johns Hopkins University School of Public Health, Baltimore, MD.

**830**   **Reduction of Endotoxin and Glucan Exposures in The Louisa/Keokuk Environmental Intervention Project (LEIP) for Rural Childhood Asthma**

**P. S. Thorne**, E. A. Chrischilles, A. K. W. Kuehl, K. M. Kelly, N. Metwali, L. M. Harris, M. E. O\'Neill, A. K. Quella, R. E. Walker; College of Public Health, The University of Iowa, Iowa City, IA.

**831**   **Sensitization and Asthma Severity in Inner City African Americans (AA) and Latino Americans (LA) in a Large Community Based Cohort**

**R. Kumar** ^1^, C. Saltoun^2^, G. Mosnaim^3^, L. C. Grammer^2^, R. Durazo-Arvizu^4^, L. Stierman^5^, J. Shannon^6^, K. B. Weiss^5,7^; ^1^Allergy, Childrens' Memorial Hospital, Chicago, IL, ^2^Allergy, Northwestern University, Chicago, IL, ^3^Allergy, Rush University, Chicago, IL, ^4^Biostatistics, Loyola University Medical School, Chicago, IL, ^5^Institute for Healthcare Studies, Northwestern University, Chicago, IL, ^6^Pulmonary and Critical Care Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, ^7^Institute for Healthcare Studies, Hines VA, Chicago, IL.

**832**   **Fractional Exhaled Nitric Oxide (FeNO) is a Marker of Allergic Inflammation in High Risk 5 Year Old Children**

**L. E. Pleiss**, M. Evans, E. L. Anderson, D. F. DaSilva, T. E. Pappas, K. A. Roberg, K. Sullivan - Dillie, C. J. Tisler, R. Gangnon, J. E. Gern, R. F. Lemanske; Medical School, University of Wisconsin- Madison, Madison, WI.

**833**   **Prevalence and Severity of Asthma among Adolescents and its Relationship with the Body Mass Index**

V. E. Cassol^1^, T. M. Rizzato^1^, S. P. Teche^1^, D. F. Basso^2^, V. N. Hirata^3^, M. Maldonado^4^, E. Colpo^5^, **D. Solé** ^6^; ^1^Pediatrics/Division of Pediatric Pneumology, Federal University of Santa Maria, Santa Maria, BRAZIL, ^2^Nutrition, Federal University of Santa Catarina, Florianópolis, BRAZIL, ^3^Epidemiology, Federal University of Pelotas, Pelotas, BRAZIL, ^4^Physiology of Exercise, Federal University of Santa Maria, Santa Maria, BRAZIL, ^5^Nutrition, Federal University of Santa Maria, Santa Maria, BRAZIL, ^6^Pediatrics/Division of Allergy and Clinical Immunology, Federal University of São Paulo-Escola Paulista de Medicina, São Paulo, BRAZIL.

**834**   **IgE to Cockroach Allergens and Asthma**

**A. Togias** ^1^, J. Poyser^1^, S. Satinover^2^, D. Collins^1^, T. Richards^1^, T. Green^1^, E. Horowitz^1^, J. Woodfolk^2^; ^1^Johns Hopkins University, Baltimore, MD, ^2^University of Virginia, Charlottesville, VA.

**835**   **A Clinical-Based Retrospective Cohort Study of Incidence Asthma in Adults with Allergic Rhinitis: Importance of Cigarette Smoking**

**R. Polosa**; Dipartimento di Medicina Interna, University of Catania, Catania, ITALY.

**836**   **A Study of Cord IgE and Birth Order**

**L. L. Shue**; Allergy and Immunology, HFHS, Detroit, MI.

**837**   **Can Parents Reliably Identify Asthma in Infants?**

**H. J. Chong Neto** ^1^, C. Dela Bianca^2^, D. Solé^2^, N. Rosario^1^, J. Mallol^3^; ^1^Allergy, University of Parana, Curitiba, BRAZIL, ^2^Allergy, University of Sao Paulo, Sao Paulo, BRAZIL, ^3^Respiratory Infant Diseases, University of Santiago, Santiago, CHILE.

**838**   **Characteristics of Children with Emergency Department Visits for Asthma**

**H. C. Wang** ^1^, S. E. Hodgdon^2^, A. K. Glasofer^2^, S. J. McGeady^1^, E. Yousef^1^; ^1^Division of Allergy and Immunology, Thomas Jefferson University, duPont Hospital for Children, Wilmington, DE, ^2^Department of Pediatrics, Thomas Jefferson University, duPont Hospital for Children, Wilmington, DE.

**839**   **Nation-wide Prevalence of Symptoms of Asthma and Wheezing in all Age Groups of Japanese Population Sampled by a Modified Random Digit Dialing Method**

**A. Aota** ^1,2^, Y. Ohya^1,2^, A. Saitoh^1,2^, M. Futamura^1,2^, M. Akashi^1,2^, N. Kojima^1,2^, K. Akiyama^2^, K. Takahashi^2^, T. Nakagawa^2^, F. Kobayashi^2^, A. Eboshida^2^, H. Nakamura^2^, H. Odajima^2^, Y. Adachi^2^, A. Akasawa^1,2^; ^1^National Center for Child Health and Development, Tokyo, JAPAN, ^2^Japanese Asthma Survey Group, Tokyo, JAPAN.

**840**   **Dietary Factors Associated with Wheezing in a Birth Cohort at High Risk for the Development of Asthma/Allergy at Age 5 Years**

**H. Lai** ^1^, Z. Zhang^1^, L. Davis^2^, S. Shoff^1^, M. Nord^1^, K. Roberg^1^, E. Anderson^3^, J. Gern^3^, R. Lemanske^1^; ^1^Nutritional Sciences, University of Wisconsin-Madison, Madison, WI, ^2^UW Hospital and Clinics, University of Wisconsin-Madison, Madison, WI, ^3^PEDIATRICS, University of Wisconsin-Madison, Madison, WI.

**841**   **Variation of Endotoxin Concentrations by Location within Homes**

**D. R. Ownby** ^1^, E. L. Peterson^2^, L. K. Williams^3^, G. Wegienka^2^, C. C. Johnson^2^; ^1^Pediatrics, Medical College of Georgia, Augusta, GA, ^2^Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, MI, ^3^Medicine, Henry Ford Health System, Detroit, MI.
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**842**   **Multiple Screening Test for Assessment of Environmental Allergen Exposure**

**A. Tsay**, C. Franck, A. Chapman, B. Saric, L. D. Vailes, M. D. Chapman; Indoor Biotechnologies, Inc., Charlottesville, VA.

**843**   **Use of Recombinant Proteins for Diagnosis of Cockroach Allergy in Patients with Asthma and/or Rhinitis Living in Brazil**

A. R. Santos^1^, M. C. Rodrigues^1^, M. Thiesen^1^, A. S. Zampolo^1^, V. P. L. Ferriani^2^, **L. Arruda** ^1^; ^1^Medicine, School of Medicine of Ribeirão Preto, Ribeirão Preto, BRAZIL, ^2^Pediatrics, School of Medicine of Ribeirão Preto, Ribeirão Preto, BRAZIL.

**844**   **A Semi Quantitative Poc Test for Rapid Detection of Specific Ige Antibodies**

M. Nystrand^1^, A. Kober^1^, **L. Soderstrom** ^2^; ^1^Pharmacia Diagnostics AB, Uppsala, SWEDEN, ^2^Pharmacia Doagnostics AB, Uppsala, SWEDEN.

**845**   **Quantitation of Mouse-Human Chimeric Allergen Specific IgE Antibodies with ImmunoCAP™ Technology**

**A. Kober**, H. Perborn; Pharmacia Diagnostics AB, Uppsala, SWEDEN.

**846**   **Group 1 Major Allergen, Art v 1, in *Artemisia* Species Found in the United States**

**G. Plunkett** ^1^, L. Jimeno^2^; ^1^ALK-Abello, Inc., Round Rock, TX, ^2^ALK-Abello, Madrid, SPAIN.

**847**   **Three Antigens for Screening in Perennial Allergic Airway Diseases**

**P. Supakthanasiri**, H. Chantaphakul, K. Ruxrungtham; Division of allergy and immunology, Department of medicine, Chulalongkorn university, Bangkok, THAILAND.

**848**   **Immunomodulatory Properties of Recombinant Lactic Acid Bacteria Encoding a Major House-dust Mite Allergen**

**P. Rigaux** ^1^, C. Daniel^2^, C. Ratajczak^3^, B. Pot^2^, J. Pestel^3^, A. Jacquet^1^; ^1^Service de Génétique Appliquée, Université Libre de Bruxelles, Gosselies, BELGIUM, ^2^Laboratoire de Bactériologie des Ecosytèmes, Institut de Biologie de Lille, Lille, FRANCE, ^3^Inserm U416, Institut Pasteur de Lille, Lille, FRANCE.

**849**   **Changes in the Levels of *D. farinae* Specific IgE, IgG~4~ and Their Immunoblotting Patterns After the Long-term House Dust Mite Specific Immunotherapy**

**Y. W. Lee** ^1^, S. Y. Choi^2^, E. K. Lee^2^, J. W. Park^1,2^, C. S. Hong^1,2^; ^1^Internal Medicine, Yonsei University, College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Institute of Allergy, Yonsei University, College of Medicine, Seoul, REPUBLIC OF KOREA.

**850**   **Comparison of Allergenicity and Immunogenicity of an Intact Allergen Extract (Alutard SQ^®^) and 4 Commercially Available Allergoid Products for Birch Pollen Immunotherapy**

**L. Lund**, P. A. Würtzen, G. Lund, H. Henmar; Research, ALK-Abelló, Hoersholm, DENMARK.

**851**   **Longitudinal Study of Sublingual Immunotherapy with SQ Standardized Grass Allergen Tablet - Interim Safety Results**

R. Dahl^1^, A. Kapp^2^, **M. Ribel** ^3^, S. R. Durham^4^; ^1^Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, DENMARK, ^2^Department of Dermatology and Allergology, Hannover Medical University, Hannover, GERMANY, ^3^Clinical Development, ALK-Abelló, Horsholm, DENMARK, ^4^Department of Allergy and Clinical Immunology, Royal Brompton Hospital, London, UNITED KINGDOM.

**852**   **New Onset Vaccine Hypersensitivity in a Child after Liver Transplant**

**P. P. Ponda** ^1^, A. Nowak-Wegrzyn^2^; ^1^Clinical Immunology, Mount Sinai Medical Center, New York, NY, ^2^Pediatric Allergy and Immunology, Mount Sinai Medical Center, New York, NY.

**853**   **Local Reactions and Pain to Trivalent Inactivated Influenza Vaccine (TIV): Impact of Gender and Dose/Volume (DV)**

**M. M. Klote**, M. R. Nelson, R. J. M. Engler; Allergy Immunology, Walter Reed Army Medical Center, Washington, DC.

**854**   **Comparison of Three Independently Produced Alternaria r Alt a1**

**H. Sanchez**, M. Opsahl, R. K. Bush; Research, William S. Middleton VA Hospital, Madison, WI.

**855**   **Real Time Monitoring of IgE Sensitization (ReTiME): A New Module of the Allergome Platform for Web-based Studies**

**A. Mari** ^1^, E. Scala^2^, G. Carabella^3^; ^1^Allergy Data Laboratories, s.c., Latina, ITALY, ^2^Experimental Allergology Unit, IDI-IRCCS, Rome, ITALY, ^3^Panservice, SAS, Latina, ITALY.
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**856**   **Time Course of Allergic Reactions to Drugs**

**P. Bousquet**, H. Co-Minh, B. Arnoux, J. Bousquet, P. Demoly; Allergology - Services des Maladies Respiratoires, University Hospital, Montpellier Cedex 5, FRANCE.

**857**   **291 Patients with Self-Reported Drug Reactions -is it Worth Testing?**

**S. Wöhrl**, K. Vigl, G. Stingl; Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases (DIAID), Medical University of Vienna, Vienna, AUSTRIA.

**858**   **Increased Adverse Drug Reactions to Cephalosporins in Patients with a Positive Penicillin Skin Test**

M. A. Park^1^, **P. J. Klemawesch** ^2^, P. J. Markus^1^; ^1^Allergy and Immunology, Mayo Clinic, Rochester, MN, ^2^Internal Medicine, Mayo Clinic, Jacksonville, FL.

**859**   **Benzocaine Anaphylaxis**

R. F. Lockey, **A. T. Vu**; University of South Florida - College of Medicine and James A. Haley Veterans' Hospital, Tampa, FL.

**860**   **Clinical Presentation, Evaluation, and Management of Patients with Carboplatin Hypersensitivity**

**P. E. Hesterberg** ^1^, A. Banerji^1^, E. Oren^1^, R. T. Penson^2^, M. V. Seiden^2^, C. N. Krasner^2^, J. T. Wong^1^; ^1^Allergy,Immunology, Rheumatology, Massachusetts General Hospital, Boston, MA, ^2^Gillette Center for Womens Cancers, Massachusetts General Hospital, Boston, MA.

**861**   **Adverse Events Associated with Home Administration of Parenteral Drugs**

**C. H. Katelaris** ^1^, E. A. Cheong^2^, C. Sisson^2^, E. A. Anderson^3^, K. Byth^4^; ^1^Dept Clinical Immunology and Allergy, Westmead Hospital, Sydney, AUSTRALIA, ^2^PACC, Westmead Hospital, Sydney, AUSTRALIA, ^3^Dept of Pharmacy, Westmead Hospital, Sydney, AUSTRALIA, ^4^Millenium Institute, Westmead Hospital, Sydney, AUSTRALIA.

**862**   **Solid Organ Transplant Acquired Food Allergy in Children Receiving Macrocyclic Lactones as Major Immunosuppressant**

**Ö. Özdemir**, A. A. Arrey-Mensah, R. U. Sorensen; Pediatric Allergy/Immunology, Louisiana State University Health Sciences Ctr., New Orleans, LA.

**863**   **The Penicillin Skin Test has a High Negative Predictive Value and Helps to Modify the Use of Antibiotics in Patiens with History of Beta-Lactam Allergy**

**G. Alvarez del Real** ^1^, M. E. Rose^1^, J. Hammel^2^, S. M. Gordon^3^, M. E. Arroliga^1^; ^1^Allergy and Immunology, The Cleveland Clinic Foundation, Cleveland, OH, ^2^Quantitative Health Sciences, The Cleveland Clinic Foundation, Cleveland, OH, ^3^Infectious Disease, The Cleveland Clinic Foundation, Cleveland, OH.

**864**   **Drug Provocation Test (DPT) in Patients with a History of Macrolide Allergy**

**N. Nguyen Luu**, A. DesRoches, M. Primeau; Pediatrics, Saint-Justine Hospital, University of Montreal, Montreal, PQ, CANADA.

**865**   **Management of Anaphylaxis from the Neuromuscular Blocking Agent Rocuronium Bromide: Can We Go with the Flow**

**C. H. Bridts**, D. G. Ebo, M. M. Hagendorens, C. H. Mertens, L. S. De Clerck, W. J. Stevens; Immunology - Allergology - Rheumatology, University Antwerp, Antwerp, BELGIUM.

**866**   **Use of Beta Blockers does not Affect the Performance of Penicillin Skin Testing**

M. E. Rose^1^, **G. Alvarez del Real** ^1^, J. Hammel^2^, M. E. Arroliga^1^; ^1^Allergy and Immunology, The Cleveland Clinic Foundation, Cleveland, OH, ^2^Quantitative Health Sciences, The Cleveland Clinic Foundation, Cleveland, OH.

**867**   **The Value of Skin Testing in the Diagnosis of Betalactam Allergy**

M. J. Torres^1^, E. Martin^1^, C. Rondon^1^, C. Mayorga^2^, J. L. Rodriguez-Bada^2^, M. S. Fuentes^1^, I. Doña^1^, N. Blanca^1^, **M. Blanca** ^1^; ^1^Allergy Service, Carlos Haya Hospital, Malaga, SPAIN, ^2^Research Laboratory, Carlos Haya Hospital, Malaga, SPAIN.

**868**   **Local Anesthetic Allergy Characterized by Type IV Reactions in Patients Who Received Dental Anesthesia**

**J. Melamed**, W. N. Beaucher; Allergy and Asthma Specialists, Chelmsford, MA.

**869**   **Successful Intravenous "Rush" Drug Desensitization to Meropenam Following Omalizumab Administration**

**L. R. Hennessey** ^1^, R. Honicky^2^, S. Sudhanthar^2^, A. P. Dumpit^3^; ^1^Internal Medicine, and Pediatrics and Human Development, Michigan State University College of Human Medicine, East Lansing, MI, ^2^Pediatrics and Human Development, Michigan State University College of Human Medicine, East Lansing, MI, ^3^Emergency Medicine, Edward W. Sparrow Hospital, Lansing, MI.

**870**   **Allergy Consultation and Skin Testing Benefits Significantly the Selection of the Antibiotic for Antibacterial Prophylaxis Preoperatively (ABPPO) in Patients Who Report Allergy to Penicillin (PRAP)**

**E. Frigas**, P. J. Markus, B. J. Narr, D. R. Danielson, P. A. Park, K. A. Bachman, P. A. Harris, M. M. O\'Byrne, K. E. Kloos, G. W. Volcheck, H. Kita, D. R. Schroeder; Division of Allergic Diseases & Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN.

**871**   **Low MMR Vaccine Uptake amongst Children with Egg Allergy**

**A. T. Fox** ^1^, D. Maisnam^1^, J. Eliahoo^2^; ^1^Paediatric Allergy, St Mary\'s Hospital, London, UNITED KINGDOM, ^2^Statistical Advisory Service, Imperial College, London, UNITED KINGDOM.

**872**   **Risks And Benefits Of Withholding Beta Blockers During Aspirin Desensitization**

**L. V. Sachs** ^1,2^, S. Zubair^3^, L. Fisher^4^, E. Pratt^4^, J. Gibbs^4^, S. Chegini^4^, J. Larson^4^, T. Craig^4^; ^1^Penn State University Hershey Medical Center, Harrisburg, PA, ^2^Internal Medicine, PinnacleHealth System, Harrisburg, PA, ^3^College of Medicine, Penn State University Hershey Medical Center, Hershey, PA, ^4^Allergy and Immunology, Penn State University Hershey Medical Center, Hershey, PA.

**873**   **Iodixanol May be Agent of Choice in Patients with Prior Anaphylactoid Reactions to Radiocontrast Media**

P. K. Mehra, **J. Y. Lee**, R. A. Simon; Division of Allergy, Asthma, and Immunology, Scripps Clinic, La Jolla, CA.

**874**   **Assessment of Allergic Skin Reactions and their Inhibition by Antihistamines using Photoplethysmography Imaging (PPGI)**

**C. R. Blazek** ^1^, H. F. Merk^1^, H. Schmid-Schoenbein^2^, M. Huelsbusch^3^, V. Blazek^3^; ^1^Department of Dermatology and Allergology, University Hospital of RWTH Aachen, Aachen, GERMANY, ^2^Department of Physiology, University Hospital of RWTH Aachen, Aachen, GERMANY, ^3^Institute of High Frequency Technology, RWTH Aachen University, Aachen, GERMANY.

**875**   **Anaphylaxis to Multiple HIV-1 Protease Inhibitors (PIs) with Successful Desensitization to Ritonavir**

**P. Saengaram**, H. Chantaphakul, K. Ruxrungtham; Division of Allergy and Clinical Immunology, Department of Medicine, Chulalongkorn University, Bangkok, THAILAND.

**876**   **A Case Of Carbamazepine Induced Onychomadesis**

K. You^1^, **J. Jeong** ^2^, S. Nahm^2^, E. Kim^3^; ^1^Internal Medicine, Kun-Kuk University Hospital, Seoul, REPUBLIC OF KOREA, ^2^Internal Medicine, ILSAN PAIK HOSPITAL, Kyungki-do, REPUBLIC OF KOREA, ^3^Internal Medicine, Dong-Kuk University Hospital, Kyungki-do, REPUBLIC OF KOREA.

**877**   **Anaphylaxis After Epidermal Contact with Cefotiam Hydrochloride**

**J. Jeong** ^1^, K. You^2^, S. Nahm^1^, E. Kim^3^; ^1^Internal Medicine, ILSAN PAIK HOSPITAL, Kyungki-do, REPUBLIC OF KOREA, ^2^Internal Medicine, Kun-Kuk University, Seoul, REPUBLIC OF KOREA, ^3^Internal Medicine, Dong-Kuk University, Kyungki-do, REPUBLIC OF KOREA.

**878**   **Drug-Induced Petechial Eruption during Aspirin Therapy in a Patient with Positive Aspirin Allergy History but Negative Oral Challenge**

**A. P. Hope**, R. A. Simon, K. M. Woessner; Allergy and Immunology, Scripps Clinic/Green Hospital, La Jolla, CA.

**879**   **Enhanced Immediate Allergic Skin Test Responses to *Blomia tropicalis* in Urticaria/Angioedema NSAID-Sensitive Subjects**

**M. Sanchez-Borges**, A. Capriles-Hulett, F. Caballero-Fonseca; Allergy and Clinical Immunology, Centro Medico-Docente La Trinidad, Caracas, VENEZUELA.

**880**   **Potential Adverse Reaction from Complementary and Alternative Medicines (CAM) Brought in from Overseas**

**G. Wong**; Vancouver General Hospital, University of British Columbia, Vancouver, BC, CANADA.

**881**   **Efficacy of Percutaneous and Intradermal Skin Tests, and Patch Test to Predict Hypersensitivity to Trimetropin-Sulfametoxazol (TMP-SMX) in Hiv-infected Patients**

**P. Mantilla Guevara**, D. D. Delgado, G. R. Hernandez. Vivas, V. Quintero Parada; Instituto de Oncología y Hematología, Universidad Central de Venezuela, Ministerio de Salud y Desarrollo Social, Caracas, VENEZUELA.

**882**   **Severity of Allergic Reactions to Drugs**

**L. Bousquet-Rouanet**, P. Bousquet, B. Arnoux, J. Bousquet, P. Demoly; Exploration des Allergies, CHU Montpellier, Montpellier Cedex 5, FRANCE.

**883**   **Allergic Reaction During Challenge Test for Local Anaesthetics**

**S. Isola**, G. Santoro, P. L. Minciullo, P. Galati, B. Ferlazzo, S. Gangemi; Department of Human Pathology, School and Operative Unit of Allergy and Clinical Immunology, Messina, ITALY.

**884**   **Serum-Sickness-Like Reactions Following Placement of Sirolimus-Eluting Stents**

**J. S. Rana** ^1^, J. Sheikh^2^; ^1^Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, ^2^Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

**885**   **Contact Allergy to Inhaled Budesonida**

**D. V. Tovar Flores**; Alergia, Hospital Gregorio Marañon, Madrid, SPAIN.

**886**   **Lichenoid Drug Eruption Associated with TNF Inhibitors**

**T. M. Wilson** ^1^, G. H. Louie^2^, A. V. Rapkiewicz^3^, B. Foster^4^, M. L. Turner^3^, R. Goldbach-Mansky^2^, R. L. Rabin^5^, C. Prussin^4^; ^1^Laboratory of Allergic Diseases, National Institutes of Health, Bethesda, MD, ^2^NIAMS, National Institutes of Health, Bethesda, MD, ^3^NCI, National Institutes of Health, Bethesda, MD, ^4^Laboratory of Allergic Disease, National Institutes of Health, Bethesda, MD, ^5^CBER, FDA, Bethesda, MD.

**887**   **A Three Year Old Girl with Recurrent Urticaria Triggered by Multiple Inhaled Beta-Agonist Class Medications**

**B. A. Becker** ^1^, B. J. Mark^2^, M. S. Dykewicz^2^; ^1^Pediatrics, Saint Louis University School of Medicine, Saint Louis, MO, ^2^Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

**888**   **Modified Desensitization Protocol Using Two Formulations of L-Asparaginase in a Pediatric Patient with Recurrent Acute Lymphoblastic Leukemia (ALL)**

**M. H. LeBras**, S. L. Saccente, R. L. Saylors, T. T. Perry, S. M. Jones, A. M. Scurlock; UAMS/AR Children\'s Hospital, Little Rock, AR.

**889**   **A Case Report of Anticonvulsant Hypersensitivity Syndrome (AHS): Importance of Early Recognition and Future Avoidance**

**V. Patel** ^1^, S. Kearney^2^; ^1^Medicine, Lehigh Valley Hospital, Allentown, PA, ^2^Allergy & Immunology, Lehigh Valley Hospital, Allentown, PA.

**890**   **All-*Trans* Retinoic Acid (ATRA) Desensitization**

**D. M. Kearney**, D. K. Ledford, R. F. Lockey; University of South Florida and James A. Haley Veterans Hospital, Tampa, FL.

**891**   **Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a Retrospective Study in Chulalongkorn Hospital**

**A. Sukkul**, H. Chantapakul, K. Ruxrungtham; Allergy and Clinical Immunology Division, Chulalongkorn Hospital, BKK, THAILAND.

**892**   **Intravenous Immunoglobulin Therapy-Induced Pompholyx**

**C. H. Larramendi** ^1^, J. L. Garcia-Abujeta^1^, M. Llombart^2^, R. Sanchez^3^; ^1^Unidad de Alergia, Hospital Marina Baixa, La Vila Joiosa (Alacant), SPAIN, ^2^Sección de Neumología, Hospital Sant Joan, Sant Joan (Alacant), SPAIN, ^3^Sección de Neurologia, Hospital Marina Baixa, La Vila Joiosa (Alacant), SPAIN.

**893**   **First Case Report of Dapsone-Induced Neuromuscular Respiratory Impairment**

**W. S. Micka**, P. Korenblat; Barnes Hospital/Washington University School of Medicine, Saint Louis, MO.

**894**   **Trimethoprim-Sulfamethoxazole Desensitization in a VIH-Infected Child**

**J. M. Del Rio-Chivardi**, M. A. Rosas-Vargas, J. A. Luna-Pech, J. J. L. Sienra-Monge, B. E. Del Rio-Navarro; Departamento de Alergia e Inmunología Clínica, Hospital Infantil de Mexico 'Federico Gomez', Mexico City, MEXICO.

**895**   **Mesalamine Administration in Allergic Patients with Inflammatory Bowel Disease**

**J. Yoo**, K. Gundling; Allergy/Immunology, UCSF, San Francisco, CA.

**896**   **Contribution of the Basophil Activation Test in the Diagnosis of Wasp Venom Allergy and Follow-Up of Venom Immunotherapy**

**D. G. EBO**, M. M. Hagendorens, A. J. Schuerwegh, L. M. Beirens, C. H. Bridts, L. S. De Clerck, W. J. Stevens; Immunology - Allergology - Rheumatology, University of Antwerp, Antwerp, BELGIUM.

**897**   **High Frequency and Long-Lasting Reactivity of Drug-Specific T-cells after Systemic Drug Hypersensitivity Reactions**

**A. Beeler**; Clinic of Rheumatology and Clinical of Immunology/Allergology, Bern, SWITZERLAND.
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**898**   **Effects of DA-9102 on Atopic Dermatitis in Animal Models**

**M. Jung**, I. Lee, J. Son, S. Choi, C. Cho, M. Son, J. Rhee, M. Yoo; DONG-A PHARM. CO., LTD, Yongin, REPUBLIC OF KOREA.

**899**   **Anti-Viral Effects of C-C Chemokine Macrophage Inflammatory Peptide 3 Alpha (MIP-3a)**

**B. Kim** ^1,2^, J. Streib^1^, M. Boguniewicz^1^, D. Y. M. Leung^1^, M. D. Howell^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Inje University, Seoul, REPUBLIC OF KOREA.

**900**   **House Dust Mite Sublingual Immunotherapy (SLIT) for Atopic Dermatitis (AD) a Randomized Controlled Trial**

**G. B. Pajno**, D. Vita, L. Caminiti, T. Arrigo, F. Lombardo, G. Barberio; Department of Pediatrics - Allergy Unit, University of Messina, Messina, ITALY.

**901**   **Circulating CD4+T Cells with Skin-homing Properties in Atopic Dermatitis**

**G. N. Drannik** ^1^, A. I. Kurchenko^1^, L. M. DuBuske^2^; ^1^Dept. Clinical Immunology and Allergology, National Medical University, Kiev, UKRAINE, ^2^Immunology Research Institute of New England, Gardner, MA.

**902**   **Functional Status Following Treatment of Children with Atopic Dermatitis**

**K. Kelsay**, K. Carel, D. L. Bratton, E. W. Gelfand, M. D. Klinnert; National Jewish Medical and Research Center, Denver, CO.

**903**   **Polymorphisms of the Bcl-2 Family Member *bfl-1* and the Genetic Predisposition to Atopic Dermatitis**

**P. D. Arkwright** ^1^, A. Gray^2^, H. Stewart^2^, V. Pravica^2^, A. A. Fryer^3^, W. Lenney^3^, I. V. Hutchinson^2^; ^1^Child Health, University of Manchester, Manchester, UNITED KINGDOM, ^2^Biological Sciences, University of Manchester, Manchester, UNITED KINGDOM, ^3^Keele University, Stoke on Trent, UNITED KINGDOM.

**904**   **Role of Natural Killer T-Cells in a Murine Model of Atopic Dermatitis (AD)**

**A. Elkhal**, M. Pichavant, R. Geha, D. Umetsu; immunology, Childrens Hospital Boston, Boston, MA.

**905**   **Alcohol during Pregnancy and Atopic Dermatitis in the Offspring**

**A. Linneberg** ^1^, J. Petersen^1^, M. Grønbæk^2^, C. Benn^3^; ^1^Research Centre for Prevention and Health, Copenhagen, DENMARK, ^2^Centre for Alcohol Research, National Institute of Public Health, Copenhagen, DENMARK, ^3^Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, DENMARK.

**906**   **Bacterial DNA and Endotoxin are Higher in the Bedding Dust of People with Atopic Dermatitis**

**A. D. Leung** ^1^, A. M. Schiltz^1^, A. H. Liu^1,2^; ^1^Pediatric Allergy and Immunology, National Jewish Medical and Research Center, Denver, CO, ^2^Pediatrics, University of Colorado School of Medicine, Denver, CO.

**907**   **The Sensitization of House Dust Mite(HDM) and Food Allergen of Atopic Dermatitis in Korean Infants and Young Children**

**W. SEO**; Dept. of Pediatrics, Samsung Medical Center, SEOUL, REPUBLIC OF KOREA.

**908**   **Body Self Concept in Children with Atopic Dermatitis (AD)**

**B. Novotna** ^1^, N. Novotna^2^; ^1^Allergology Unit, Dept.Int.Med, University Hospital, Brno, CZECH REPUBLIC, ^2^Psychology, Charles University, Prague, CZECH REPUBLIC.

**909**   **Role of Eosinophil Cationic Protein as a Predictor for Atopic Dermatitis Flare-ups**

**E. Yousef**; Division of Allergy and Clinical Immunology, DuPont Hospital for Children, Wilmington, DE.

**910**   **Hypoproteinemia, Including Hypogammaglobulinemia, in Infants with Severe Atopic Dermatitis**

**J. H. Lin**, R. L. Roberts, E. R. Stiehm; Dept of Allergy, Immunology, Rheumatology, UCLA, Los Angeles, CA.

**911**   **Geographical and Socio-Economical Factors Enhance Regional Variation of the Prevalence of Atopic Dermatitis in Japan**

**Y. Ohya**, M. Akashi, M. Futamura, N. Kojima, A. Saitoh, A. Aota, A. Akasawa; Division of Allergy, Department of Medical Specialties, National Center for Child Health and Development, Tokyo, JAPAN.

**912**   **Evaluation of Predictors for Persistence of Atopic Dermatitis**

**N. Ehsan** ^1^, S. Kung^2^, E. Yousef^2^; ^1^Cecil Community College, North East, MD, ^2^DuPont Hospital for Children, Wilmington, DE.

**913**   **Expression of Neutrophil Chemoattractants and their Receptors in Subjects with Atopic Dermatitis and Psoriasis**

**L. G. Bankova**, M. Brummet, M. Paltiel, L. Y. McGirt, L. A. Beck; Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, MD.

**914**   **Turnip Rape and Oilseed Rape Allergy in Children with Atopic Dermatitis: a Case Control Study**

**T. Reunala** ^1^, S. Poikonen^1^, H. Kautiainen^1^, T. Puumalainen^2^, T. Palosuo^2^, K. Turjanmaa^1^; ^1^Tampere University Hospital, Tampere, FINLAND, ^2^National Public Health Institute, Helsinki, FINLAND.

**915**   **Cytology of Skin Exudates in Severe Childhood Atopic Dermatitis**

**I. Nomura** ^1^, M. Yoshida^1^, N. Inoue^1^, A. Aota^1^, A. Saito^1^, M. Futamura^1^, M. Akashi^1^, M. Narita^1^, T. Suda^1^, A. Akasawa^2^, Y. Ohya^1^; ^1^Division of Allergy and Immunology, National Center for Child Health and Development, Tokyo, JAPAN, ^2^Department of Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, JAPAN.

**916**   **Increased Expression and a Potential Anti-Inflammatory Role of Trail in Atopic Dermatitis**

**D. Simon** ^1^, E. Vassina^2^, M. Leverkus^3^, L. R. Braathen^1^, H. Simon^2^; ^1^Dept. of Dermatology, University of Bern, Inselspital, Bern, SWITZERLAND, ^2^Dept. of Pharmacology, University of Bern, Bern, SWITZERLAND, ^3^Dept. of Dermatology, University of Magdeburg, Magdeburg, GERMANY.

**917**   **Diagnostic Role of the Atopy Patch Test in Children with Atopic Dermatitis and Food Allergy**

**L. M. Brunetti**, R. Tesse, M. Lore, M. Leone, R. Procacci, O. Sillecchia, M. Mastronardi, D. Locantore, L. Armenio; Department of Pediatrics-U.O. Maggiore, University of Bari, Bari, ITALY.

**918**   **Development of a Classification System for Atopic Dermatitis (AD)**

**A. DiDario** ^1^, E. Yousef^2^; ^1^Allergy/Immunology, Thomas Jefferson University, Philadelphia, PA, ^2^Allergy/Immunology, AI duPont Hospital for Children, Wilmington, DE.

**919**   **The Classification between IgE and Non-IgE Mediated Atopic Dermatitis in Korean Children**

**J. Lee** ^1^, J. Jung^2^, J. Kim^3^, C. Kim^4^, Y. Park^5^; ^1^Pediatric allergy, Masan samsung hospital, Masan si, REPUBLIC OF KOREA, ^2^Pediatric allergy, Dong-A university hospital, Pusan, REPUBLIC OF KOREA, ^3^Pediatric allergy, Ulsan University hospital, Ulsan, REPUBLIC OF KOREA, ^4^Pediatric allergy, Kwan-Dong University hospital, Seoul, REPUBLIC OF KOREA, ^5^Pediatric allergy, Kyun-kuk university hospital, Seoul, REPUBLIC OF KOREA.

**920**   **The Differences and the Correlation with the Clinical Severity between Food (Milk, Egg, and Soybean) Specific and House Dust Mite Specific Atopic Dermatitis**

**J. Oh** ^1^, S. Shin^2^, H. Lee^2^; ^1^Pediatrics, Hanyang University Guri Hospital, Kyunggi-do, REPUBLIC OF KOREA, ^2^Pediatrics, Hanyang University Guri Hospital, Seoul, REPUBLIC OF KOREA.

**921**   **Factors Involved Between Ige Mediatied and Non-ige Mediated Atopic Dermatitis in Child and there Use of Complementary Alternative Medicine**

**W. Kim** ^1^, H. Yoon^2^; ^1^pediatrics, Inje University, Seoul, REPUBLIC OF KOREA, ^2^pediatrics, Hallym University, Seoul, REPUBLIC OF KOREA.

**922**   **A Muckle-Wells Syndrome Kindred Confirmed by *Cias1* Dna Sequencing**

**M. R. Gupta** ^1^, G. Alvarez Del Real^1^, F. H. Hsieh^1^, K. A. Knauer^2^; ^1^Allergy and Immunology, Cleveland Clinic, Cleveland, OH, ^2^Internal Medicine-Division of Allergy and Immunology, Case Western Reserve University School of Medicine, Cleveland, OH.

**923**   **An Autoimmune Blistering Skin Disorder: Paraneoplastic Pemphigus (PNP) In Association With A Breast Neoplasm**

**P. Buddiga**; Baz Allergy, Asthma & Sinus Center, Fresno, CA.

**924**   **Induction of a Pathergy-Like Reaction Following Prick Skin Testing**

**T. L. Johnson, II** ^1^, P. McCleskey^2^, M. Rathkopf^1^, J. Meffert^2^, L. L. Hagan^1^; ^1^Allergy/Immunology, Wilford Hall Medical Center, Lackland AFB, TX, ^2^Dermatology, Wilford Hall Medical Center, Lackland AFB, TX.

**925**   **Profiles and Prognosis of Severe Infantile Atopic Dermatitis with Food Allergy**

**M. Iguchi** ^1^, M. Ebisawa^2^, H. Tachimoto^2^; ^1^Jikei University school of Medicine, Tokyo, JAPAN, ^2^18-1 Sakuradai, Department of pediatrics, National Organization Sagamihra National Hospital, Sagamihara city, Kanagawa, JAPAN.

**926**   **Randomized, Placebo-Controlled Trial of *Lactobacillus rhamnosus GG* as Treatment of Mild to Moderate Atopic Dermatitis in Infancy**

**C. Grüber** ^1^, M. Wendt^2^, S. Lau^1^, M. Kulig^1^, U. Wahn^1^, T. Werfel^3^, B. Niggemann^1^; ^1^Dept. of Pediatric Pneumology/Immunology, Charité Universitätsmedizin Berlin, Berlin, GERMANY, ^2^Department of Dermatology and Allergology, Hanover Medical University, Hanover, GERMANY, ^3^(2) Department of Dermatology and Allergology, Hanover Medical University, Hanover, GERMANY.

**927**   **Contact Dermatitis to Lanolin Masquerading as Chronic Dyshydrotic Eczema**

**R. Harris**, M. S. Johnson; Allergy and Asthma Associates, Beverly Hills, CA.
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**928**   **Evaluating the Internet as a Source of Information about Steroids for Asthma Patients**

**V. U. Rao**, A. J. Apter; Pulmonary, Allergy, and Critical Care, University of Pennsylvania, Philadelphia, PA.

**929**   **Accurate and Effortless Retrieval and Interpretation of Evidence Based Medical Literature**

D. Dinakarpandian^1^, Y. Lee^1^, K. Vishwanath^1^, **C. Dinakar** ^2^; ^1^Computer Science and Electrical Engineering, University of Missouri at Kansas City, Kansas city, MO, ^2^Section of Allergy, Asthma and Immunology, Children\'s Mercy Hospital, Kansas city, MO.

**930**   **Utilizing International Resources to Conduct Clinical Trials More Effectively and Efficiently**

**P. Muniyappa**, S. Swami; ExcelTrials, Los Angeles, CA.

**931**   **Young Adult Asthmatics Dissatisfied with Small Hospital Care**

**J. L. Langager**, J. M. Dammann, L. M. Weaver Swartz; Press Ganey Associates, Inc, South Bend, IN.
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**932**   **Foxp3 Tr1 Regulatory T cells as a Therapeutic Antidote in Reversing Cockroach-Induced Asthma**

**H. S. McGee**; Biomedical Science, Creighton University, Omaha, NE.

**933**   **Major Basic Protein Homolog (MBP2): A Specific Human Eosinophil Marker**

**D. A. Plager** ^1^, D. A. Loegering^1^, J. L. Checkel^1^, J. Tang^1^, G. M. Kephart^1^, P. L. Caffes^1^, C. R. Adolphson^1^, L. E. Ohnuki^2^, G. J. Gleich^2^; ^1^Mayo Clinic, Rochester, MN, ^2^University of Utah, Salt Lake City, UT.

**934**   **Plasmacytoid Dendritic Cell Recruitment to Murine Lung During Paramyxoviral Infection is Type I Ifn Receptor Dependent**

**S. S. Joo**, M. M. Rohlfing, M. H. Grayson; Allergy Immunology, Washington University School of Medicine, Saint Louis, MO.

**935**   **Number and Phenotypes of Dendritic Cells in the Bronchial Mucosa of Asthmatics and Controls**

**A. V. H. Jayaratnam**, S. Ying, Q. Meng, C. Corrigan; Department of Asthma, Allergy and Respiratory Sciences, King\'s College London School of Medicine at Guy\'s, King\'s College and St. Thomas\'s Hospitals, London, UNITED KINGDOM.

**936**   **Toll-like Receptor Agonists and PGE2 Differentially Regulate CysLT1 Receptor Expression and Function in Human Dendritic Cells**

**M. Rola-Pleszczynski**, M. Thivierge, J. Stankova; Immunology Division, UniversitÃ© de Sherbrooke, Sherbrooke, PQ, CANADA.

**937**   **CD8+/BLT1+/IL-13+ T Cells in (Human) Asthma: Is There a Link to Steroid-Resistance**

**E. W. Gelfand**; Department of Pediatrics, National Jewish Medical and Research Centr, Denver, CO.

**938**   **Regulatory Role of CD4^+^CD25^+^ T Cells in the Antigen Specific Induction of Tolerance in a Murine Model of Asthma**

**C. Boudousquié**, C. Longaretti, N. Barbier, F. Spertini; Centre Hospitalier Universitaire Vaudois, LAUSANNE, SWITZERLAND.

**939**   **Cross-Linking FceRIa on a Dendritic Cell Line Induces Increased IFNγ Production from CD8^+^ T Cells**

**D. S. Cheung**, K. M. Shaw, M. M. Rohlfing, M. H. Grayson; Division of Allergy and Immunology, Washington University School of Medicine, Saint Louis, MO.

**940**   **IL-10 Is Essential For Naturally Occurring Lung CD4+CD25+ T Cell Regulation of Allergen-induced Airway Hyperresponsiveness**

**A. A. Joetham**, K. Takeda, M. Shigeki, C. Taube, N. Miyahara, T. Koya, A. Dakhama, E. Gelfand; PEDS, NJC, Denver, CO.

**941**   **Critical Role Of Antigen-Specific Lymphocytes In The Induction Of Asthma Associated Eosinophilic Esophagitis (EE)**

**A. Mishra**, E. Brandt, J. Schlotman, M. E. Rothenberg; Allergy and Immunology, Childrens Hospital Medical Center, Cincinnati, OH 45229, Cincinnati, OH.

**942**   **Regulatory T Cells Protect Against Experimentally-Induced Asthma by Altering the Dendritic Cell Phenotype and Activation State**

**I. P. Lewkowich**, N. S. Herman, K. W. Schleifer, A. A. Sproles, M. Wills-Karp; Immunobiology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**943**   **The Leukotriene B4 Receptor (BLT1) is Required for Effector CD8+ T-Cell-Mediated, Mast Cell-Dependent Airway Hyperresponsiveness**

**N. Miyahara** ^1^, C. Taube^1^, V. Ott^2^, B. Swanson^2^, K. Takeda^1^, S. Miyahara^1^, S. Matsubara^1^, T. Koya^1^, J. Loader^1^, L. D. Shultz^3^, A. M. Tager^4^, A. D. Luster^4^, A. Dakhama^1^, E. W. Gelfand^1^; ^1^Pediatrics, National Jewish Medical and Research Center, denver, CO, ^2^Immunology, National Jewish Medical and Research Center, denver, CO, ^3^The Jackson Laboratory, Bar Harbor, MN, ^4^Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Charlestown, MA.

**944**   **Th2 and Th1 Cytokines and Chemokines in Allergen-Challenged Skin Blisters in Atopic Subjects**

**Y. Ong**, A. B. Kay; NHLI Division, Imperial College, London, UNITED KINGDOM.

**945**   **Effect of Nasal Steroid Treatment on Mucosal FOXP3+ Cells in Allergic Rhinitis Patients**

**C. Malmhäll**, A. Bossios, T. Pullerits, J. Lötvall; Lung Pharmacology group, Respiratory Medicine and Allergology, Göteborg University, Gothenburg, SWEDEN.

**946**   **Demethylation of IL-13 and IL-4 Promoter Regions is Associated with Allergen Sensitization and Atopic Asthma**

**A. M. Schiltz** ^1^, L. Yan^2^, A. H. Liu^1,3^; ^1^Pediatric Allergy and Immunology, National Jewish Medical and Research Center, Denver, CO, ^2^Biosystem Group, Biotage, Inc, Foxboro, MA, ^3^Pediatrics, University of Colorado School of Medicine, Denver, CO.

**947**   **Novel Ribbon-Type NF-AT Decoy Oligodeoxynucleotides Preclude Th2 Cytokines Expression and Airways Hyperreactivity in Experimental Asthma**

**Y. Nakamura**, K. Yamauchi, H. Inoue; Third Department of Internal Medicine, Iwate Medical University, Morioka, JAPAN.

**948**   **Hydrocortisone Upregulates Th2-type Cytokine and Chemokine Receptor mRNA on Human B-lymphocytes.**

S. Al-Tamemi^1,2^, H. Zuzan^3^, A. Norris^3^, A. Saenz^3^, A. Ponton^3^, J. Guay^2^, O. Hajoui^2^, T. Hudson^3^, **B. Mazer** ^1,2^; ^1^Pediatrics, McGill University/Montreal Children\'s Hosp., Montreal, PQ, CANADA, ^2^Meakins Christie Laboratories, Montreal, PQ, CANADA, ^3^McGill University/Genome Quebec Innovation Center, Montreal, PQ, CANADA.

**949**   **Flt3L Treatment Increases Tolerogenic Semimature Dendritic Cells in the Lungs of Asthmatic Mice**

**A. S. Bharadwaj** ^1^, D. K. Agrawal^2^; ^1^Medical Microbiology and Immunuology, Creighton University School of Medicine, Omaha, NE, ^2^Biomedical Sciences, Medicine, Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE.

**950**   **The Role of T Cells in a Murine Model of Contact Hypersensitivity**

**N. Fyhrquist-Vanni** ^1^, A. Lauerma^2^, H. Alenius^1^; ^1^Unit of Excellence in Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, FINLAND, ^2^Section of Dermatology, Finnish Institute of Occupational Health, Helsinki, FINLAND.

**951**   **Gr-1+ Cells Induce the Expression of Matrix Metalloproteinases (MMPs) that Are Crucial for Antigen-Stimulated Recruitment of Th Cells into Murine Airways**

**Y. W. Jung** ^1^, C. L. Zindl^1^, C. T. Weaver^2^, D. D. Chaplin^1^; ^1^Microbiology, University of Alabama at Birmingham, Birmingham, AL, ^2^Pathology, University of Alabama at Birmingham, Birmingham, AL.

**952**   **Functional and Phenotypic Characterization of CD8+CD28- T Cells in Atopic and Non-Atopic Individuals**

**O. M. M. Lourenco**, A. R. S. Rafael, A. M. L. Fonseca, L. M. P. Taborda-Barata; Department of Medical Sciences, University of Beira Interior, Health Sciences Research Centre, Covilha, PORTUGAL.

**953**   **Inverse Correlation between Circulating CD4^+^CD25^high^ Cells and CD4^+^IL4^+^ Cells *In Vivo***

**K. Orihara** ^1,2^, T. Tobe^2^, A. Akasawa^3^, H. Saito^1^, K. Matsumoto^1^; ^1^Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN, ^2^Graduate School of Pharmaceutical Sciences, Showa University, Tokyo, JAPAN, ^3^Department of Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, JAPAN.

**954**   **CD4+CD25++ T Cells in Peripheral Blood Correlate with Total and Pollen-Specific IgE in Young Children**

**K. A. Burmeister** ^1^, C. Seroogy^2^, C. Tisler^1^, M. Evans^3^, L. Franco^1^, L. Pleiss^1^, R. Gangnon^3^, R. F. Lemanske, Jr.^2^, J. E. Gern^2^; ^1^Dept of Pediatrics, University of Wisconsin-Madison, Madison, WI, ^2^Dept of Medicine, University of Wisconsin-Madison, Madison, WI, ^3^Dept of Biostatistics and Medical Informatics and Population Health Sciences, University of Wisconsin-Madison, Madison, WI.

**955**   **Expression of Polarized T-Cell Surface Markers in Respiratory Allergy**

U. De Fanis, F. Mori, S. L. Limb, R. G. Hamilton, N. F. Adkinson, Jr., **V. Casolaro**; Johns Hopkins University, Baltimore, MD.

**956**   **Monitoring the T Cell Response in a Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) to Phenytoin in both Peripheral Blood and Skin**

J. A. Cornejo-Garcia^1^, E. Martin^2^, T. D. Fernandez^1^, C. Mayorga^1^, S. Lopez^1^, R. R-Pena^1^, I. Doña^2^, J. L. Rodriguez-Bada^1^, **M. Blanca** ^2^; ^1^Research Laboratory, Carlos Haya Hospital, Malaga, SPAIN, ^2^Allergy Service, Carlos Haya Hospital, Malaga, SPAIN.

**957**   **Non-Immediate Reaction to Iodine Contrast Media**

**E. Martin** ^1^, J. A. Cornejo-Garcia^2^, R. R-Pena^2^, T. D. Fernandez^2^, S. Lopez^2^, C. Mayorga^2^, M. J. Torres^1^, C. Antunez^2^, M. Valenzuela^1^, M. Blanca^1^; ^1^Allergy Service, Carlos Haya Hospital, Malaga, SPAIN, ^2^Research Laboratory, Carlos Haya Hospital, Malaga, SPAIN.

**958**   **Tolerance Induction Via the Nasal Route is Associated with Downregulation of Lung Cytokine Production, Including Il-10, in a Mouse Model of Asthma**

**C. Longaretti**, C. Boudousquié, F. Spertini; Laboratoire d\'Immunologie et Allergie, CHUV, Lausanne, SWITZERLAND.
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**959**   **In Vitro and in Vivo Effects of IL-10-Treated Dendritic Cells on Airway Allergic Inflammation**

**T. Koya**, K. Takeda, S. Matsubara, N. Miyahara, S. Miyahara, C. Swasey, A. Barhorn, A. Joetham, A. Dakhama, E. W. Gelfand; Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO.

**960**   **Prenatal Exposure with Aerosolized Allergen Prevents Subsequent Allergen-Induced Sensitization and Airway Inflammation in Young Mice**

**K. Gerhold**, A. Avagyan, C. Seib, B. Ahrens, J. Jaworska, A. Dittrich, U. Wahn, E. Hamelmann; Department of Pediatric Pulmology and Immunology, Charité, Campus Virchow-Clinic, Berlin, GERMANY.

**961**   **IL-13 Receptors in the Skin**

**M. R. Warrier**, Y. Tabata, M. O. Daines, W. Chen, G. K. Khurana Hershey; Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**962**   **Gene-gene Interaction Between IL-13 and IL-13Ra1 Polymorphisms is Associated with Total IgE in Korean Children with Atopic Asthma**

**H. Kim** ^1^, S. Lee^2^, J. Kim^1^, B. Kim^1^, M. Kang^3^, S. Jang^3^, S. Hong^1^; ^1^Pediatrics, Asan Medical Center, Seoul, REPUBLIC OF KOREA, ^2^Pediatrics, Hallym Medical Center, Seoul, REPUBLIC OF KOREA, ^3^Pediatrics, Asan Institute for Life Science, Seoul, REPUBLIC OF KOREA.

**963**   **Combination of Interleukin (IL)-2 and IL-18 Attenuates Allergen-Induced Airway Hyperresponsiveness (AHR) and Inflammation through An IL-12-STAT4-Interferon (IFN)-gamma Pathway**

**S. Matsubara**, K. Takeda, T. Kodama, T. Koya, N. Miyahara, A. Joetham, C. H. Swasey, A. Dakhama, E. W. Gelfand; Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO.

**964**   **Activating Signals from the IL-5 Receptor Simultaneously Initiate a Termination Pathway**

**M. M. Gorska** ^1^, O. Cen^2^, S. J. Stafford^2^, Q. Liang^1^, R. Alam^1^; ^1^Medicine, National Jewish Medical and Research Center, Denver, CO, ^2^Medicine, University of Texas Medical Branch, Galveston, TX.

**965**   **Hepatitis B Core Antigen (HBcAg) Particles Carrying Interleukin (IL)-4 Epitopes Break Immune Tolerance and Down-regulate Murine Allergic Airway Responses**

**S. Ying** ^1^, Y. Ma^1^, K. T. HayGlass^2,1^, G. Srinivasan^1^, Y. Fan^3^, X. Yang^3,2^, A. B. Becker^1,2^, F. E. R. Simons^1,2^, Z. Peng^1,2^; ^1^Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, CANADA, ^2^Immunology, University of Manitoba, Winnipeg, MB, CANADA, ^3^Medical Microbiology, University of Manitoba, Winnipeg, MB, CANADA.

**966**   **Nerve Growth Factor Regulates the Production of Lung Mucins in a Transgenic Mice Model of Asthma**

**A. Micera** ^1^, C. Hahn^2^, A. Lambiase^1^, A. Nockher^2^, G. Rasi^3^, S. Bonini^1^, H. Renz^2^, S. Bonini^3^; ^1^Dept Ophthalmology, Campus Biomedico and G.B. Bietti Eye Foundation, IRCCS, Rome, ITALY, ^2^Dept of Clinical Chemistry and Molecular Diagnostics, Faculty of Medicine, Philippe University, Marburg, GERMANY, ^3^INMM-CNR and IRCCS San Raffaele, Rome, ITALY.

**967**   **NNY-CCL14 Acts on Diverse CC Chemokine Receptors and Prevents Airway Hyperresponsiveness**

**S. Gupta** ^1^, U. Forssmann^2^, S. Schulz-Maronde^1^, B. Fuchs^3^, A. Braun^3^, W. G. Forssmann^1^, J. Elsner^4^; ^1^Dept. of Pharmacology & Toxicology, Hannover Medical School, Hannover, GERMANY, ^2^IPF PharmaCeuticals GmbH, Affiliated Institute of Hannover Medical School, Hannover, GERMANY, ^3^Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, GERMANY, ^4^Department of Dermatology and Allergology, Fachklinik Bad Bentheim, Bad Bentheim, GERMANY.

**968**   **The Relationship between Childhood Wheezing and Overweight Status as a Function of the Proinflammatory Mediators IL-6 and Leptin in a High-Risk Birth Cohort**

**S. L. Friedlander** ^1^, D. J. Mueller^2^, Z. Zhang^3^, K. A. Roberg^2^, E. L. Anderson^2^, M. D. Evans^4^, R. E. Gangnon^5^, H. J. Lai^3^, J. E. Gern^6^, R. F. Lemanske, Jr.^6^; ^1^Medicine, University of Wisconsin at Madison, Madison, WI, ^2^Pediatrics, University of Wisconsin at Madison, Madison, WI, ^3^Nutritional Sciences, University of Wisconsin at Madison, Madison, WI, ^4^Biostatistics and Medical Informatics, University of Wisconsin at Madison, Madison, WI, ^5^Biostatistics and Medical Informatics; Population Health Sciences, University of Wisconsin at Madison, Madison, WI, ^6^Pediatrics and Medicine, University of Wisconsin at Madison, Madison, WI.

**969**   **Novel Interleukin-13 Peptide-based Vaccine Downregulates Murine Allergic Airway Responses**

**Z. Peng** ^1^, Y. Ma^1^, Y. Fan^2^, G. Srinivasan^1^, X. Yang^2^, A. Becker^1^, F. E. R. Simons^1^, K. T. HayGlass^3^; ^1^Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, MB, CANADA, ^2^Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, MB, CANADA, ^3^Immunology, University of Manitoba, Winnipeg, Manitoba, MB, CANADA.

**970**   **Transforming Growth Factor-Beta 2 (TGF-b2) is Expressed in the Remodeled Airways of Mice with Allergic Asthma**

**A. V. Le** ^1^, J. Y. Cho^2^, M. Miller^2^, D. H. Broide^2^; ^1^Allergy & Immunology, Scripps Clinic, La Jolla, CA, ^2^Allergy & Immunology, UCSD, La Jolla, CA.

**971**   **DA-9601 Reduces Inflammatory Respopnses in OVA-Specific Allergic Asthma in Mice**

**J. Ro** ^1,2^, J. Kim^1,2^, S. Ryu^1,2^, B. Lee^3^; ^1^Department of Pharmacology, Sungkyunkwan University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Center for Molecular Medicine, Samsung Biomedical Research Institute, Suwon, REPUBLIC OF KOREA, ^3^Department of Microbiology, College of Medicine Yonsei University, Seoul, REPUBLIC OF KOREA.

**972**   **Pro-Angiogenic Activity is Increased in Bronchoalveolar Lavage Fluid (BALf) from Asthmatics**

**D. E. Simcock**, G. W. Clarke, V. Kanabar, S. D. Greenaway, S. J. Hirst, B. J. O\'Connor; Asthma, Allergy and Respiratory Science, King\'s College School of Medicine, London, UNITED KINGDOM.

**973**   **Th1 and Th2 Cytokine-mediated CXC Chemokine Production in Human Lung Microvascular Endothelial Cells in Vitro**

**A. Matsuda**, H. Saito, K. Matsumoto; Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**974**   **Differential IL-2-Induced Accumulation of IL-13^+^ and IFN-Gamma^+^ Peripheral Blood T Cells (PBL) between Asthmatic and Non-Asthmatic Subjects**

**M. J. Loza**, S. Foster, S. P. Peters, R. B. Penn; Internal Medicine/Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC.

**975**   **Regulation Of IL-5Ra On Bone Marrow Eosinophils and CD34^+^ Progenitors**

**L. D. Saleh**, G. M. Gauvreau, M. Duong, K. Howie, A. Cordova, R. Sung, T. Rerecich, P. M. O\'Byrne; McMaster University, Hamilton, ON, CANADA.

**976**   **Brain Derived Neurotrophic Factor (BDNF), B-Lymphocyte Chemoattractant (CXCL13), and Macrophage Inhibitory Protein 3α (MIP-3α) are Increased in Sputum of Severe and Nonsevere Asthmatics with Elevated Neutrophil Percentages**

**A. T. Hastie**, W. C. Moore, J. Krings, R. Smith, P. Vestal, M. Wu, D. A. Meyers, S. P. Peters, E. Bleecker; Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC.

**977**   **Nasal Fibroblasts Derived from Allergic Patients Retain Their Typical Gene Expression Profile in Culture**

**M. Yoshikawa** ^1^, K. Wada^1^, N. Otori^1^, S. Haruna^1^, N. Okada^2^, H. Saito^2^, H. Moriyama^1^; ^1^Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, JAPAN, ^2^Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**978**   **Epigenetic Maintenance of Immunological Responses in Asthma**

**R. Su** ^1^, A. Becker^1,2^, A. L. Kozyrskyj^2,3^, K. T. HayGlass^1,2^; ^1^CIHR National Training Program in Allergy and Asthma Research, Immunology, University of Manitoba, Winnipeg, MB, CANADA, ^2^Community Health Sciences, Winnipeg, MB, CANADA, ^3^Pediatrics/Child Health, Winnipeg, MB, CANADA.

**979**   **Diesel Exposure Favors Th2 Cell Recruitment by Mononuclear Cells from Nonatopic Subjects by Differentially Regulating CCL18/PARC and CXCL10/IP-10 Production**

**Y. CHANG** ^1,2^, S. SENECHAL^1^, P. de NADAI^1^, C. CHENIVESSE^1,3^, J. GILET^1^, H. VORNG^1^, A. TONNEL^1,3^, B. WALLAERT^1,3^, A. TSICOPOULOS^1,3^; ^1^INSERM U-416, Institut Pasteur de Lille, Lille, FRANCE, ^2^Department of Central Research, The Third Clinical College, Jilin University, Chang Chun, CHINA, ^3^Clinique des Maladies Respiratoires et Centre Hospitalier Régional et Universitaire de Lille, Lille, FRANCE.

**980**   **Transgenic Mice Overexpressing Human IL-17E Exhibit an Asthma-Like Phenotype that is Exacerbated in an Ovalbumin-Induced Model of Asthma**

**A. L. Budelsky**, L. A. Steffen; Inflammation Research, Amgen, Seattle, WA.

**981**   **Allergic Cytokines Regulate Expression of Glucocorticoid Receptor \[GR\] Alpha and Beta Isoforms**

J. L. Rabbitt, **W. J. Calhoun**; Allergy, Pulmonary, Immunology, CCM, and Sleep, University of Texas Medical Branch, Galveston, TX.

**982**   **The Role of Cytokines in Allergic Inflammation in Human Lung Tissue**

**L. R. C. Barnicott**, T. Hackett, J. A. Warner; School of Biological Sciences, University of Southampton, Southampton, UNITED KINGDOM.

**983**   **Involvement of TRAIL in Transforming Growth Factor-Beta-Induced Apoptosis of Human Airway Epithelial Cells**

**B. Chaudhari**, G. Cheng, D. Agrawal; Biomedical Science, Creighton University School of Medicine, Omaha, NE.

**984**   **Mold Allergen, Pen C 13, Induce Inflammatory Cytokines in Human Bronchial Epithelial Cells via Activation of Protease-Activated Receptor**

**L. Chow** ^1^, L. Chiu^1^, C. Yu^1^, S. Su^2^; ^1^Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan Univ., Taipei, TAIWAN REPUBLIC OF CHINA, ^2^Department of Medical Research and Education, Veterans General Hospital-Taipei, Taipei, TAIWAN REPUBLIC OF CHINA.

**985**   **Inflammatory Cytokines in Lung Lavage Fluid Determined by Bead-Based and ELISA Cytokine Assays**

**K. Kulhankova**, S. Hadina, P. S. Thorne; Occupational & Environmental Health, University of Iowa, College of Public Health, Iowa City, IA.

**986**   **Expression of IL-13 Receptors in Human Airway and Skin Cells**

**Y. Tabata**, M. R. Warrier, M. O. Daines, W. Chen, G. K. Khurana Hershey; Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**987**   **Newly Produced CD4+ Cells in Bone Marrow after Airway Allergen Exposure**

**A. Bossios**, C. Malmhäll, M. Rådinger, L. Mannerås, L. Petersson, M. Sjöstrand, J. Lötvall; The Lung Pharmacology Group, Department of Respiratory & Allergology, Göteborg University, Gothenburg, SWEDEN.

**988**   **Effect of Prolonged Budesonide Therapy on IL-4, IL-5, and IL-10 in a Murine Model of Asthma**

**K. S. Konduri** ^1^, S. D. Nandedkar^1^, S. Deenamsetty^1^, D. A. Rickaby^2^, N. Duzgunes^3^; ^1^Pediatrics, Medical College of Wisconsin, Milwaukee, WI, ^2^Physiology, Zablocki VA Medical Center, Milwaukee, WI, ^3^Microbiology, University of Pacific School of Dentistry, San Franscisco, CA.

**989**   **Signal Pathway of Eotaxin Production by Human Nasal Fibroblast**

**S. Fujieda**, N. Takahashi, T. Yamada; Otorhinolaryngology, University of Fukui, Fukui, JAPAN.

**990**   **Anti-inflammatory Mechanism of Simvastatin in OVA-specific Mouse Allergic Asthma**

**J. Ro** ^1,2^, J. Kim^1,2^, S. Ryu^1,2^; ^1^Department of Pharmacology, Sungkyunkwan University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Center for Molecular Medicine, Samsung Biomedical Research Institute, Suwon, REPUBLIC OF KOREA.

**991**   **Cytokine Responses to Allergens during the First Two Years of Life in Estonian and Swedish Children**

**M. C. Jenmalm** ^1^, M. F. Böttcher^1^, T. Voor^2^, K. Julge^2^, P. G. Holt^3^, B. Björkstén^4^; ^1^Department of Molecular and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, SWEDEN, ^2^Children\'s Clinic, Tartu University Clinic, Tartu, ESTONIA, ^3^Telethon Institute for Child Health Research, University of Western Australia, Perth, AUSTRALIA, ^4^Institute of Environmental Medicine, Karolinska Institute, Stockholm, SWEDEN.

**992**   **Regulation of osteopontin by IL-10 and Th2 cytokines in human monocytes and monocyte-derived dendritic cells**

**S. Konno** ^1^, N. Hizawa^1^, J. A. Eckman^2^, B. Plunkett^2^, D. B. K. Golden^2^, J. Schroeder^2^, M. Nishimura^1^, S. Huang^2^; ^1^1st department of Medicine, Hokkaido University, Sapporo, JAPAN, ^2^Johns Hopkins Asthma Allergy Center, Baltimore, MD.

**993**   **SERUM INTERLEUKIN-7 LEVELS IN PATIENTS WITH ALLERGIC ASTHMA Keskin GOKSAL\*, Inal ALI, Musabak UGUR, Sengul ALI \*Ankara Etlik Ihtisas Hospital, Immunology Department GATA Immunology Department**

**A. I^.^nal**; Gülhane Military Medicine Academy, Ankara, TURKEY.

**994**   **Correlation of IL-18, TARC, LTB4 and LTC4D4E4 and Lung Function in Childhood Asthma**

**R. Y. T. Sung** ^1^, Y. O. Wong^1^, C. K. Wong^1^, T. F. Leung^1^, A. M. Li^1^, K. L. Cheung^1^, K. P. Fung^2^, P. C. Leung^2^, T. F. Fok^1^, P. C. Ng^1^; ^1^Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, HONG KONG SPECIAL ADMINISTRATIVE REGION OF CHINA, ^2^Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, HONG KONG SPECIAL ADMINISTRATIVE REGION OF CHINA.

**995**   **Association Between Secondhand Smoke Exposure (SSE) and Increased IL-13 Production from CD4+ Cells During Early Childhood**

**D. Gentile**, J. Koehrsen, A. Patel, D. P. Skoner; Department of Pediatrics, Allegheny General Hospital, Pittsburgh, PA.

**996**   **sICAM-1 and IL-8 Levels of Bronchoalveolar Lavage Fluid from Patients undergoing Open-Heart Surgery**

**Z. Chen**, J. Li; Children\'s Hospital, Medical School of Zhejiang University, Hangzhou, Zhejiang Province, CHINA.

**997**   **Skin Test Reactivity of Asthmatic Patients Associated with Exhaled Breath Condensate IFN-gamma Levels**

**D. M. Laber**, W. C. Moore, A. MacDowell, J. Krings, R. Smith, A. T. Hastie, S. P. Peters, D. Meyers, E. Bleecker; Internal Medicine, Wake Forest University, Winston-Salem, NC.

**998**   **Leukotriene D~4~-Induced Transforming Growth Factor β1 in Bronchial Smooth Muscle Cell Proliferation**

**Y. Bossé**, C. Thompson, S. McMahon, C. Dubois, J. Stankova, M. Rola-Pleszczynski; Pediatrics, Université de Sherbrooke, Sherbrooke, PQ, CANADA.

**999**   **ICAM-1 and TNF-a in Patients with Persistent Asthma - Relationship with the Disease Severity**

**M. Gorska-Ciebiada** ^1^, M. Ciebiada^1^, P. Gorski^1^, I. Grzelewska-Rzymowska^2^; ^1^Dept.Pneumology & Allergy, Medical University, Lodz, POLAND, ^2^Dept.Cancer and Chest Diseases, Medical University, Lodz, POLAND.

**1000**   **Comparative Effects of Organic and Inorganic Mercury Compounds on Human Cytokines Production**

**E. Jerschow**, G. de Vos, S. Abotaga, D. Rosenstreich; Allergy/Immunology Division, Albert Einstein College of Medicine, Bronx, NY.

**1001**   **Responses to Methacholine, Histamine and Osmotic Stimuli after Treatment with Interleukin-13 or Propranolol in Balb/c Versus CFW Mice**

**N. Qutna**, R. Townley; Dept of Medicine - Allergy Division, Creighton University Allergy, Omaha, NE.

**1002**   **The Effect of Smoking on the Expression of Various Cytokines in the Peripheral Blood Mononuclear Cells from Patients with Asthma and COPD**

**Y. Cho** ^1^, E. Chun^1^, C. Park^1^, J. Lee^1^, S. Woo^2^; ^1^Internal Medicine, Ewha Womans University, Seoul, REPUBLIC OF KOREA, ^2^Micobiology, Ewha Womans University, Seoul, REPUBLIC OF KOREA.
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**1003**   **Effects of Coadministration of Intranasal Ciclesonide (CIC) and Inhaled Beclomethasone Dipropionate (BDP) on Cortisol Suppression**

**P. H. Ratner** ^1^, M. A. Wingertzahn^2^, N. Hall^2^, P. Darken^2^, T. Shah^2^; ^1^Sylvana Research Associates, San Antonio, TX, ^2^Altana Pharma, Florham Park, NJ.

**1004**   **Efficacy and Safety of Ciclesonide (CIC) for the Treatment of Perennial Allergic Rhinitis (PAR)**

**E. O. Meltzer** ^1^, S. Kunjibettu^2^, N. Hall^2^, W. Berger^3^, C. LaForce^4^; ^1^Allergy & Asthma Medical Group & Research Center, San Diego, CA, ^2^Altana Pharma, Florham Park, NJ, ^3^Allergy and Asthma Associates, Mission Viejo, CA, ^4^Clinical Professor of Pediatrics, University of North Carolina School of Medicine, Raleigh, NC.

**1005**   **Nighttime Symptoms Score Provides Clinically Relevant Measure of Allergic Rhinitis Burden**

**N. C. Santanello**; Merck Research Labs, Merck & Co. Inc, Blue Bell, PA.

**1006**   **Intranasal Phototherapy is an Effective Treatment in Allergic Rhinitis**

**A. I. Koreck**, A. S. Kenderessy, L. Kemeny; Department of Dermatology and Allergology, University of Szeged, Szeged, HUNGARY.

**1007**   **Effect of Levalbuterol on Nasal Mucociliary Transport (MCT) in Healthy Adult Subjects**

J. Koehrsen, **D. A. Gentile**, D. P. Skoner; Department of Pediatrics, Allegheny General Hospital, Pittsburgh, PA.

**1008**   **Persistence and Effusion Clearance to Esophagus of Ciclesonide in Hypotonic and Isotonic Suspensions**

M. A. Wingertzahn^1^, **K. Takanashi** ^2,3^, A. Nagano^2,3^, Y. Namiki^2,3^, K. Sakon^2,3^, Y. Makino^2^; ^1^Altana Pharma, Florham Park, NJ, ^2^Teijin Institute for Bio-Medical Research, Tokyo, JAPAN, ^3^Teijin Pharma Limited, Tokyo, JAPAN.

**1009**   **Benzalkonium Chloride Containing Saline Impairs Nasal Mucociliary Clearance. A Double Blind, Cross-over, Randomized Study**

**J. Â. Rizzo**, A. R. Silva, D. Medeiros, M. Mota, E. S. C. Sarinho; Pediatrics Dept., Universidade Federal de Pernambuco, Recife-PE, BRAZIL.

**1010**   **Intranasal, Non-Inhaled CO2 Provides Rapid Relief of Seasonal Allergic Rhinitis (SAR) Nasal Symptoms**

**T. B. Casale**, F. A. Romero, L. Mahon, A. Bewtra, J. Stokes, R. Hopp; Department of Medicine: Division of Allgery and Immunology, Creighton University, Omaha, NE.

**1011**   **Changes in Urinary Leukotriene E4 Concentration after Sinus Treatment (Surgery or Corticosteroid Therapy) in Patients with Aspirin-Intolerant Asthma**

**E. Ono**, M. Taniguchi, N. Higashi, H. Yamamoto, A. Higashi, C. Oshikata, T. Tsuburai, Y. Maeda, A. Mori, T. Ishii, H. Mita, K. Akiyama; Asthma reseach devision, National Sagamihara Hospital, Sagamihara, JAPAN.

**1012**   **Response to a Standardised Management Strategy for Refractory Chronic Rhinosinusitis: Implications for Studies of Genetics**

H. Al-Shemari, M. Cabaluna, M. Duval, S. Sidani, S. Frenkiel, **M. Y. Desrosiers**; Otorhinolaryngology, McGill University MUHC, Montreal, PQ, CANADA.

**1013**   **Montelukast Augments Bacterial Sinusitis in Allergic Mice**

**R. M. Naclerio** ^1^, P. Khoury^1^, F. M. Baroody^1^, J. J. Klemens^1^, K. Thompson^2^; ^1^Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, IL, ^2^Pathology, University of Chicago, Chicago, IL.

**1014**   **Drowsiness and Sedation: A Comparison Between Levocetirizine and Desloratadine Using Post-Marketing Observational Data**

**D. Layton** ^1,2^, L. W. Wilton^1,2^, A. Boshier^1,2^, V. Cornelius^1^, S. Harris^3^, S. A. W. Shakir^1,2^; ^1^Drug Safety Research Unit, Southampton, UNITED KINGDOM, ^2^Faculty of Science, University of Portsmouth, Portsmouth, UNITED KINGDOM, ^3^Public Health Sciences & Medical Statistics, Southampton University Hospital Trust, Southampton, UNITED KINGDOM.

**1015**   **Sinus and Mastoid Involvement in Cystic Fibrosis and the Efficacy of Surgical Intervention**

**A. A. Horwitz** ^1^, G. Graff^1^, R. Vender^1^, L. Sachs^2^, T. Craig^1^; ^1^Hershey Medical Center, Hershey, PA, ^2^Harrisburg Hospital, Harrisburg, PA.

**1016**   **Radiofrequency for the Treatment of Allergic Rhinitis Refractory to Medical Therapy**

**D. Matesic** ^1^, J. B. Bitner^2^, R. O. Gustafson^2^, J. F. Pallanch^2^; ^1^Allergic Diseases, Mayo Clinic and Foundation, Rochester, MN, ^2^Otolaryngology, Mayo Clinic and Foundation, Rochester, MN.

**1017**   **Azelastine Nasal Spray and Fluticasone Nasal Spray in the Treatment of Geriatric Patients with Rhinitis**

V. B. Behncke^1^, G. Alemar^2^, D. A. Kaufman^1^, **F. J. Eidelman** ^1^; ^1^Allergy and Immunology, Cleveland Clinic Florida, Weston, FL, ^2^Otorhinolaryngology, Cleveland Clinic Florida, Weston, FL.
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**1018**   **Change In Plasma C5a Levels After Routine Allergen Immunotherapy Correlates With Dust Mite Dosage, Changes in Wheal Size, And Rhinoconjunctivitis Symptoms**

**C. Charlot**, C. Bowser, H. Drew, R. Feliz, M. Nowakowski, R. Joks; Center for Allergy and Asthma Research, SUNY-HSC, Brooklyn, NY.

**1019**   **Screening for Cellular Changes During Grass-Specific Subcutaneous Immunotherapy**

**A. H. Millner** ^1^, G. Lund^1^, J. Francis^2^, S. Durham^2^, K. Lund^1^, P. A. Würtzen^1^; ^1^Research, ALK-Abelló, Hørsholm, DENMARK, ^2^Upper Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, UNITED KINGDOM.

**1020**   **Cytokine and Chemokine Gene Expression Monitoring in a Ragweed Allergy Clinical Trial with Omalizumab Pre-Treatment**

**V. Seyfert-Margolis** ^1^, T. B. Casale^2^, A. Asare^1^, R. S. Wang^1^; ^1^Tolerance Assay and Data Analysis, UCSF - Immune Tolerance Network, Bethesda, MD, ^2^Medicine, Creighton University, Omaha, NE.

**1021**   **Induction of a Competitive Non-IgE Antibody Response by Specific Immunotherapy is Related to Clinical Efficacy**

**C. Ljørring** ^1^, A. J. Frew^2^, S. R. Durham^3^, L. Jacobsen^1^, N. Johansen^1^, J. N. Larsen^1^, H. Ipsen^1^; ^1^ALK-Abelló, Hørsholm, DENMARK, ^2^Infection, Inflammation and Repair Division, Southampton General Hospital, Southampton, UNITED KINGDOM, ^3^Upper Respiratory Medicine, National Heart and Lung Institute, London, UNITED KINGDOM.

**1022**   **Induction of Regulatory T Cells with Sublingual Allergy Vaccines**

**P. E. MOINGEON**, L. VAN OVERTVELT, A. RAZAFINDRATSITA, L. MASCARELL, E. WAMBRE, V. LOMBARDI, N. SAINT-LU; R&D, Stallergenes SA, Antony, FRANCE.

**1023**   **The Comparison of Influence of Two Different Application Forms of Grass Pollen Immunotherapy- the Changes on the Level of Cytokines Il-4 and Ifn Gamma After 24 Months of Immunotherapy**

**I. Krcmova**, C. Andrys; of Clinical Immunology and Allergy, Faculty Hospital Charles University, Hradec Kralove, CZECH REPUBLIC.

**1024**   **Safety of Allergenic Immunotherapy in Systemic Lupus Erythematosus**

**A. Fiorillo**, L. Fonacier, C. Diola; Allergy and Immunology, Winthrop University Hospital, Mineola, NY.
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**1025**   **Prescription Fill Patterns in Underserved Children with Asthma**

**M. E. Bollinger** ^1^, A. Boldt^1^, K. E. Mudd^1^, A. Manning^2^, V. D. Hsu^3^, M. G. Tsoukleris^3^, A. M. Butz^2^; ^1^Pediatrics, University of Maryland School of Medicine, Baltimore, MD, ^2^Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, ^3^University of Maryland School of Pharmacy, Baltimore, MD.

**1026**   **Objective Measurement of Adherence with Asthma Medications**

**B. Bender** ^1^, S. Bartlett^2^, C. Rand^2^, C. Turner^3^, F. Wamboldt^1^, L. Zhang^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Johns Hopkins University, Baltimore, MD, ^3^Research Triangle Institute, Research Triangle Park, NC.

**1027**   **Adherence with Treatment Guidelines in Mild Asthma Patients: Clinical Outcomes Associated with Fluticasone Propionate/salmeterol Vs. Inhaled Corticosteroid Therapy**

C. Carter^1^, S. Sison^1^, B. Yawn^2^, **H. M. Harris** ^1^, D. Ollendorf^1^; ^1^PharMetrics, Inc., Watertown, MA, ^2^Olmsted Medical Center, Rochester, MN.

**1028**   **Asthma Control: Associations with Patient Characteristics, Severity, Exacerbations, Quality of Life and Feno at an Specialized Outpatient Clinic**

**J. A. Fonseca** ^1,2^, L. Fernandes^3^, A. Costa-pereira^1^, L. Delgado^4,2^, S. Martins^2^, A. Moreira^4,2^, M. Vaz^2^, M. Castel-Branco^2^; ^1^Bioestatistica e Informatica Medica, Faculdade Medicina Universidade do Porto, Porto, PORTUGAL, ^2^Imunoalergologia, Hospital S. Joao, Porto, PORTUGAL, ^3^Psiquiatria, Faculdade Medicina Universidade do Porto, Porto, PORTUGAL, ^4^Imunologia, Faculdade Medicina Universidade do Porto, Porto, PORTUGAL.
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**1029**   **Both α4 And β2 Integrins Regulate Acute Allergic Asthma but by Different Pathways**

**E. Ray Banerjee** ^1^, W. R. Henderson, Jr.^1^, T. Papayannopoulou^2^; ^1^Medicine, Allergy and Inflammation, University of Washington, Seattle, WA, ^2^Medicine, Hematology, University of Washington, Seattle, WA.

**1030**   **Critical Evaluation of Adhesion Molecule Targeting Therapy in Murine Models of Multiple Sclerosis**

**S. M. Kerfoot** ^1,2^, M. U. Norman^2^, P. Kubes^2^; ^1^Yale University School of Medicine, New Haven, CT, ^2^University of Calgary, Calgary, AB, CANADA.

**1031**   **CX~3~CR1 Deficiency Results in Diminished Vascular Inflammation**

**P. Liu** ^1^, S. Patil^1^, M. Rojas^2^, A. M. Fong^1^, S. S. Smyth^2^, D. D. Patel^1^; ^1^Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ^2^Carolina Cardiovascular Biology Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.

**1032**   **CCR5 Usage by CCL5 Induces a Selective Leukocyte Recruitment in Human Skin Xenografts in Vivo**

**A. Tsicopoulos** ^1^, P. de Nadai^1^, C. Chenivesse^1^, H. Porte^2^, H. Vorng^1^, A. F. Walls^3^, B. Wallaert^1^, A. Tonnel^1^, H. Zerwes^4^; ^1^Institut Pasteur de Lille, U416 INSERM, Lille cedex, FRANCE, ^2^Service de Chirurgie, CHRU de Lille, Lille cedex, FRANCE, ^3^Immunopharmacology group, Southampton general hospital, Southampton, UNITED KINGDOM, ^4^Novartis, basel, SWITZERLAND.
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**1033**   **Immunologic Changes in Human Albumin Exposed to Toluene Diisocyanate (TDI) Vapor: Differences Compared with Liquid TDI Exposure and Association with IgE/IgG Binding and TDI Asthma**

**Y. Ye** ^1^, S. Kim^2^, S. Lee, III^3^, H. Park^1^, C. A. Redlich^4^, A. V. Wisnewski^4^; ^1^Dept. of Allergy & Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Dept. of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, REPUBLIC OF KOREA, ^3^Donga University School of Medicine, Busan, REPUBLIC OF KOREA, ^4^Yale University School of Medicine, New Haven, CT.

**1034**   **Prediction of Specific Airway Responsiveness from Skin Sensitivity to Allergen and Airway Hyperresponsiveness to Methacholine in Baker\'s Asthma**

**S. Quirce**, M. Fernández-Nieto, C. Escudero, J. Cuesta, M. de las Heras, J. Sastre; Allergy Department, Fundación Jiménez Díaz, Madrid, SPAIN.

**1035**   **Evaluation of Eosinophilic Inflammation in Patients with Suspected Occupational Asthma or Rhinitis**

**G. Moscato**, M. Yacoub, D. Moretto, L. Perfetti, M. Pozzoni, P. Pignatti; Allergy and Immunology Unit, Fondazione Salvatore Maugeri, IRCCS, Pavia, ITALY.

**1036**   **Hexamethylene Diisocyanate Exposed Workers Are Less Likely to Have Confirmed Occupational Asthma than Workers Exposed to Other Isocyanates**

**A. M. Smith** ^1^, P. Campo^1^, Z. L. Lummus^1^, A. Cartier^2^, J. Malo^2^, L. Boulet^3^, D. I. Bernstein^1^; ^1^Division of Immunology, University of Cincinnati, Cincinnati, OH, ^2^Hôpital du Sacré Coeur de Montréal, Montreal, PQ, CANADA, ^3^Hôpital Laval, Laval, PQ, CANADA.
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**1037**   **Glucocorticoid-Induced TNF-Receptor Related Ligand (GITR-L) is Increased in Atopic Dermatitis (AD) Skin**

**I. D. Cardona** ^1^, E. Goleva^1^, M. D. Howell^1^, L. S. Ou^2^, M. Boguniewicz^1^, D. Y. Leung^1^; ^1^Pediatrics, National Jewish Med. and Research Center, Denver, CO, ^2^Pediatrics, Chang Gung Children\'s Hospital, Taoyuan, TAIWAN REPUBLIC OF CHINA.

**1038**   **Delineation of IL-13 Functions in Allergic Eczematous Skin Diseases**

**R. Purwar**, T. Werfel, M. Wittmann; Dermatology & Allergology, Hannover Medical School, Hannover, GERMANY.

**1039**   **Co-Signalling Molecules (B7 homologs) are Expressed by Human Keratinocytes**

**A. De Benedetto** ^1^, A. C. Myers^2^, L. McGirt^1^, L. Chen^3^, M. Brummet^1^, R. P. Schleimer^4^, L. A. Beck^1^; ^1^Division of Allergy and Clinical Immunology, Johns Hopkins, Baltimore, MD, ^2^Clinical Immunology, Johns Hopkins, Baltimore, MD, ^3^Department of dermatology, Johns Hopkins, Baltimore, MD, ^4^Allergy-Immunology Division, Northwestern University Feinberg, Chicago, IL.

**1040**   **Eosinophils Produce an Innate Immune Response to Staphylococcus Aureus through Recognition of Peptidoglycan**

**A. Terada** ^1^, H. Kita^2^; ^1^Pediatric Allergy, Daido Hospital, Nagoya, JAPAN, ^2^Medicine and Immunology, Mayo Clinic, Rochester, MN.
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**1041**   **A Study to Assess the Quality of Life in Children with Peanut Allergy, their Parents and Siblings**

**R. M. King** ^1^, R. C. Knibb^2^, J. O. Hourihane^3^; ^1^Wellcome Trust Clinical Research Facility, Southampton University Hospitals NHS Trust, UNITED KINGDOM, ^2^School of Social Sciences, University of Derby, UNITED KINGDOM, ^3^Dept Child Health, University College Cork, IRELAND.

**1042**   **Development of a Disease Specific Health-related Quality of Life (HRQOL) Questionnaire in Adults with Hereditary Angioedema due to C1 inhibitor Deficiency (HAE) in Spain (First Phase)**

**N. Prior** ^1^, E. Remor^2^, C. López Serrano^3^, T. González^4^, S. Cimbollek^4^, M. Guilarte^5^, D. Hernandez^6^, M. Tejedor^7^, M. Rubio^8^, T. Caballero^3^; ^1^Allergy Department, Hospital Universitario, Madrid, SPAIN, ^2^Faculty of Psychology, Autonoma University, Madrid, SPAIN, ^3^Allergy Department, Hospital Universitario "La Paz", Madrid, SPAIN, ^4^Allergy Department, Hospital Universitario "Virgen del Rocío", Seville, SPAIN, ^5^Allergy Department, Hospital Universitario "Vall D´Hebrón", Barcelona, SPAIN, ^6^Allergy Department, Hospital Universitario "La Fe", Valencia, SPAIN, ^7^Allergy Department, Fundación Hospital Alcorcón, Madrid, SPAIN, ^8^Allergy Department, Hospital Universitario "Gregorio Marañón", Madrid, SPAIN.

**1043**   **The Impact of Asthma on Quality-of-Life (QoL) and Other Patient-Reported Outcomes: The Patient\'s Perspective**

**S. P. McKenna** ^1^, D. M. Meads^1^, K. M. Beusterien^2^, R. Flood^2^, H. Lau^3^, A. Glendenning^4^; ^1^Galen Research, Manchester, UNITED KINGDOM, ^2^MEDTAP International, Bethesda, MD, ^3^Novartis Pharmaceuticals, East Hanover, NJ, ^4^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.

**1044**   **Factors that Influence Quality of Life (QOL) in Rural Families with Asthma**

**J. M. Walker** ^1^, L. Lewis-Boyer^2^, K. Hill^2^, C. Lewis^1^, L. Pham^3^, A. Butz^1^; ^1^Pediatrics, Johns Hopkins University, school of medicine, Baltimore, MD, ^2^Johns Hopkins University, School of Nursing, Baltimore, MD, ^3^Biostatistics, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD.
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**1045**   **Transduction of PTEN into Eosinophils Attenuates Survival and Chemotaxis**

**T. Adachi**, S. Hanaka, S. Ueki, H. Nagase, K. Ohta; Internal Medicine, Teikyo University School of Medicine, Tokyo, JAPAN.

**1046**   **FIP1L1-PDGFRα Induces Stem Cell Factor Dependent Eosinophil and Mast Cell Development from Murine Hematopoietic Stem Cell/Progenitors in Vitro**

**Y. Yamada** ^1^, J. A. Cancelas^2,3^, A. W. Lee^2^, D. A. Williams^2^, M. E. Rothenberg^1^; ^1^Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Experimental Hematology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^3^Hoxworth Blood Center, University of Cincinnati Medical Center, Cincinnati, OH.

**1047**   **Expression and Inhibitory Function of Siglecs on Culture-Derived Human Mast Cells (MC)**

**H. Yokoi** ^1^, K. Matsumoto^2^, P. R. Crocker^3^, H. Saito^4^, C. A. Bickel^1^, W. Hubbard^1^, S. A. Hudson^1^, B. S. Bochner^1^; ^1^Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, ^2^Division of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN, ^3^Division of Cell Biology and Immunology, The Wellcome Trust Biocentre, University of Dundee, Dundee, UNITED KINGDOM, ^4^Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**1048**   **Intestinal Peristaltic Reflex (IPR) is Regulated by Mast Cells and IL-9**

**K. R. Groschwitz** ^1^, E. Forbes^2^, E. B. Brandt^1^, K. I. Matthaei^2^, S. P. Hogan^1^; ^1^Division of Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Allergy and Inflammation Research Group, The John Curtin School of Medical Research, Canberra, AUSTRALIA.
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**1049**   **Mechanism of Tissue Remodeling in a Murine Model of Chronic Allergic Conjunctivitis**

**C. K. Oh** ^1^, J. Davidson^1^, S. Baik^1^, Z. Yao^2^, R. Martin^2^; ^1^Pediatrics, Harbor-UCLA Medical Center, Torrance, CA, ^2^Tanox Inc., Houston, TX.

**1050**   **Ocular Olopatadine Treatment of Seasonal Allergic Conjunctivitis Decreases the Ability of Tears to Promote *In Vitro* Eosinophil Adhesion to Tear-Stimulated Conjunctival Epithelial Cells**

**E. B. Cook** ^1^, J. L. Stahl^1^, J. B. Sedgwick^1^, A. M. Brooks^1^, F. M. Graziano^1^, N. P. Barney^2^; ^1^Medicine, University of Wisconsin, Madison, WI, ^2^Ophthalmology & Visual Science, University of Wisconsin, Madison, WI.

**1051**   **The Role of IL-13 in the Development of Allergic Rhinitis in Mice**

**S. Miyahara**, N. Miyahara, S. Matsubara, T. Koya, K. Takeda, E. W. Gelfand; pediatrics, National Jewish Medical and Research Center, Denver, CO.

**1052**   **Value of Measuring Nasal IgE in Subjects with Seasonal Rhinitis**

**N. FUIANO** ^1,2^, D. Procaccini^3^, C. Incorvaia^4^; ^1^Pediatric allergy service, A.USL FG 1, San Severo, ITALY, ^2^Pediatrics, National Health, San Severo, ITALY, ^3^Nephrology Dpt., OO.RR., Foggia, ITALY, ^4^Reumatology/Allergology Unit, I.C.P., Milano, ITALY.
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**1053**   **Update on the Effect of a Multidisciplinary Team (MDT) Clinic on Asthma Outcome for Medicaid-Eligible Inner City Children with Moderate to High-Risk Asthma**

**P. P. PATEL**, G. DHILLON, J. MELLESMOEN, P. SEIGEL, P. MUNZENBERGER, R. RICH, E. SECORD; Allergy and Immunology, CARMAN AND ANN ADAMS DEPARTMENT OF PEDIATRICS, CHILDREN\'S HOSPITAL OF MICHIGAN - WAYNE STATE UNIVERSITY, DETROIT, MI.

**1054**   **Non-Classical Symptoms used by Inner-City Hispanics to Describe Asthma Attacks**

**R. A. Vicens**; University of Puerto Rico School of Medicine, San Juan, PR.

**1055**   **Asthma Severity Predicts Future Asthma Morbidity in Inner-City Preschool Children but Controller Medication Use is Not an Important Additional Predictor**

**H. P. Sharma** ^1^, E. C. Matsui^1^, P. A. Eggleston^1^, S. L. Swords^1^, G. B. Diette^2^; ^1^Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, ^2^Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

**1056**   **Factors Predictive of Future Clinically Significant Exacerbations in Severe Asthma**

**R. Slavin** ^1^, H. Fox^2^, K. Surrey^2^, C. Reisner^3^; ^1^Saint Louis University School of Medicine, Saint Louis, MO, ^2^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, ^3^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**1057**   **Improving Influenza Vaccination Rates in a Pediatric Asthma Management Program by Utilization of an Electronic Medical Record**

**E. Martin**; Health Point Family Care, Covington, KY.

**1058**   **Which Patients are More Likely to Receive an Asthma Action Plan?**

**D. C. Chaffin**, Jr., K. K. Slish, M. D. Cabana, N. M. Clark; Division of Allergy/Immunology, University of Michigan, Ann Arbor, MI.

**1059**   **Asthma Education Camp : Immediate and Long term Impacts on Thai Asthmatic Children and Their Families**

**S. Numkiatwongsa** ^1^, T. Tongkaew^1^, S. Tongkum^2^, P. Chatchatee^1^, J. Ngamphaiboon^1^; ^1^Pediatric, Chulalongkorn University School Medicine, Bangkok, THAILAND, ^2^Rehabilitation and physiotherapy, Chulalongkorn University School Medicine, Bangkok, THAILAND.

**1060**   **A School Based Asthma Intervention Program For Asthma And Allergic Emergencies**

**M. D. Moncino** ^1^, C. Hammen^2^, N. Rithmire^3^, K. A. Sheerin^1^; ^1^Breathe Georgia, Atlanta, GA, ^2^Mt Vernon Presbyterian School, Atlanta, GA, ^3^Forsyth County Schools, Forsyth, GA.

**1061**   **Assessment of Asthma Exacerbations in a Real-World Setting over 4 Years**

**R. O\'Connor** ^1^, D. Tashkin^2^, S. Peters^3^, A. Long^4^, E. Bleecker^3^, B. Parasuraman^5^, R. Boggs^5^; ^1^Sharp Rees-Stealy Medical Group, San Diego, CA, ^2^University of California at Los Angeles, Los Angeles, CA, ^3^Wake Forest University, Winston-Salem, NC, ^4^Massachusetts General Hospital, Boston, MA, ^5^AstraZeneca, Wilmington, DE.

**1062**   **Children with Asthma Post Adenotonsillectomy: A Prospective Analysis**

**D. E. Karas**, K. Farmer, W. Mackey; Yale University, New Haven, CT.

**1063**   **Results of a Two Week Intensive Educational Intervention for Asthma in Children**

**G. Schauerte**; CJD Asthmazentrum Berchtesgaden, Berchtesgaden, GERMANY.

**1064**   **Therapy of Established Chronic Experimental Asthma with a Low Molecular Weight Ccr-3 Antagonist**

**M. Wegmann** ^1^, R. Goeggel^2^, S. Sel^1^, K. J. Erb^2^, F. Kalkbrenner^2^, H. Renz^1^, H. Garn^1^; ^1^Department of Clinical Chemistry and Molecular Diagnostics, Hospital of the Philipps-University Marburg, Marburg, GERMANY, ^2^Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH, Biberach, GERMANY.

**1065**   **Effect of Anti-Reflux Medical Treatment on Respiratory Symptoms of Asthma Patients Less than 24 Months Old**

**M. Oh**, J. Becker; Allergy, St. Christopher\'s Hospital for Children, Philadelphia, PA.

**1066**   **Potent and Persistent Effects of an Anti-Asthma Herbal Formula (ASHMI) on Severe Allergic Airway Responses in Chronic Asthma Model**

**S. M. Termanini**; Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.

**1067**   **Patients with Intermittent Asthma Account for a Substantial Portion of Asthma-Related Hospital Emergency Department Visits**

**R. T. Hsu** ^1^, W. W. Crawford^2^, W. B. Klaustermeyer^1^; ^1^Allergy and Immunology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, ^2^Allergy and Immunology, Kaiser Permanente, Harbor City, CA.

**1068**   **The Use of Macrolide Antibiotics in the Management of Asthma**

**F. Abrahamian**, J. Vintch; Internal Medicine, Harbor-UCLA Medical Center, Torrance, CA.

**1069**   **Asthma Care Practices of Pediatricians in Incheon, Korea and Adherence to Asthma Guidelines**

**Y. Sun**, D. In, J. Kim; Pediatrics, Gachon Medical School, Icheon, REPUBLIC OF KOREA.
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**1070**   **The Chinese Herbal Formula CUF2 Modulates Th1/Th2 Responses in a Rat Model of Allergic Asthma**

**Y. O. Wong** ^1^, R. Y. T. Sung^1^, K. Li^1^, Y. Zhao^2^, A. M. Li^1^, Y. X. Bao^3^, T. F. Fok^1^, K. P. Fung^2^; ^1^Dept of Paediatrics, The Chinese University of Hong Kong, Hong Kong, CHINA, ^2^Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, CHINA, ^3^Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, CHINA.

**1071**   **Characterization of The Protective and Therapeutic Efficiency of a DNA Vaccine Encoding The Cockroach Allergen Bla g 1**

**B. Zhou**, M. Ensell, J. Glickstein, C. Cai, M. Kermany, Q. Cai, T. J. Yoo; Department of Medicine, University of Tennessee, Memphis, TN.

**1072**   **Immunoregulatory Effects of Saccharomyces (S.) cerevisiae Mannan via Th2/Th3 Polarization in Mice**

**J. M. Lehman**, M. R. Streck, A. S. Tyagi, D. B. Lew; Pediatrics, University of Tennessee Health Science Center, Memphis, TN.

**1073**   **Immunologic Changes after Long-Term Immunotherapy with Hop Japanese Pollen Extracts**

**S. Lee** ^1^, S. Kim^2^, Y. Ye^2^, S. Kim^3^, S. Kim^2^, D. Nahm^2^, H. Park^2^; ^1^Internal Medicine, Dong-A University, Busan, REPUBLIC OF KOREA, ^2^Allergy and Rheumatology, Ajou University, Suwon, REPUBLIC OF KOREA, ^3^Internal Medicine, Seoul National University, Seoul, REPUBLIC OF KOREA.

**1074**   **Induction of Rabbit Specific IgG against Der p 1 and Der p 2 after Immunization with an Allergoid of Dermatophagoides Pteronyssinus**

**E. Fernández-Caldas**, M. Gallego, J. Carnés, M. Casanovas, V. Iraola; Laboratorios LETI S.L., Tres Cantos, SPAIN.

**1075**   **Reproducibility of Missing doses as a Predictor of Poor Medication Adherence in Patients Receiving Specific Immunotherapy**

**P. A. Mahesh** ^1^, V. pudupakkam^2^, A. D. Holla^3^, V. Rajesh^3^; ^1^JSS Medical College, Mysore, INDIA, ^2^University of Colorado Health Sciences, Colorado, CO, ^3^Allergy Asthma and Chest Center, Mysore, INDIA.

**1076**   **Protollin Adjuvanted Birch Pollen Extract Induces Long-Term Prevention of Airway Inflammation in a Mouse Model of Allergic Asthma**

**C. R. Rioux** ^1^, N. Karp^2^, H. Koohsari^1^, A. Migneault^1^, D. S. Burt^1^, J. G. Martin^2^, Q. A. Hamid^2^; ^1^ID Biomedical, Laval, PQ, CANADA, ^2^McGill University, Montreal, PQ, CANADA.

**1077**   **Effects of Tacrolimus on Neutrophil Superoxide Production in Asthmatics Compared to Controls**

**S. M. Bonilla**, N. Bobba, E. Park, B. Goldberg; Allergy and Immunology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.

**1078**   **The Effect of BCG Treatment on the Allergic Responses in a Murine Model of Chronic Asthma**

**S. S. Kwon**, C. H. Kim, J. H. Ahn, S. Y. Lee, S. J. Kim, Y. K. Kim, K. H. Kim, H. S. Moon, J. S. Song, S. H. Park; Dept. of Internal Medicine, Catholic University of Korea, Medical College, Seoul, REPUBLIC OF KOREA.

**1079**   **IgE Immunotherapy Efficiently Induces Neutralizing Anti-Human IgE Antibodies in Primates**

**Å. Jansson**, A. Fuentes, E. Landström, S. Persson, B. Xu; Resistentia Pharmaceuticals AB, Uppsala, SWEDEN.

**1080**   **Omalizumab Reduced Need for Steroid Bursts in Asthmatics Concomitantly Using Leukotriene Receptor Antagonists (LTRAs)**

**R. Zeldin** ^1^, M. Massanari^1^, R. Maykut^1^, F. Kianifard^1^, Y. Deniz^2^, C. Reisner^1^, G. Geba^1^; ^1^Novartis, East Hanover, NJ, ^2^Genentech, So San Francisco, CA.

**1081**   **Comparison of Multi-Test II and Skintestor Omni Allergy Skin Test Devices**

**M. S. Dykewicz**, J. K. Lemmon, D. L. Keaney; Allergy/Immunology, Internal Medicine, St. Louis University Medical School, Saint Louis, MO.

**1082**   **Measuring Airway Hyperresponsiveness: Does it Add to Routine Measures of Clinical Efficacy in Guiding Asthma Therapy?**

J. Stauffer, S. Yancey, L. Baitinger, B. Prillaman, **P. Dorinsky**; GlaxoSmithKline, Research Triangle Park, NC.

**1083**   **Seroatopy in Childhood-Onset and Adult-Onset Asthma**

**C. M. Abraham** ^1^, E. L. Peterson^2^, G. Wegienka^2^, M. Maliarik^2^, E. M. Zorratti^2^, C. C. Johnson^2^, D. R. Ownby^1^; ^1^Medical College of Georgia, Augusta, GA, ^2^Henry Ford Health System, Detroit, MI.

**1084**   **Impulse Oscillometry System (IOS) as a Method of Early Detection of Lower Airway Obstruction in Patients with Allergic Rhinitis (AR)**

**G. K. Deogun** ^1^, M. Cooper^2^, S. Hauptman^2^, G. D. Sharma^2^; ^1^Allergy and Immunology, Rush University Medical Center and Stroger Hospital of Cook County, Chicago, IL, ^2^Section of Pediatric Pulmonology, Rush University Medical Center, Chicago, IL.

**1085**   **Association of MS4A2 Gene Polymorphisms with a Susceptibility to Aspirin-Intolerant Asthma**

**S. H. Kim**, J. S. Bae, Y. M. Ye, C. H. Suh, D. H. Nahm, H. S. Park; Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA.

**1086**   **Effects of Inhaled Corticosteroids on Exhaled Breath Condensate (EBC) pH and Cytokines Levels in Children with Asthma and Atopic Dermatitis (AD)**

R. Tesse, F. Fiore, O. Sillecchia, M. Mastronardi, R. Procacci, D. Locantore, L. Armenio, **L. M. Brunetti**; Department of Pediatrics-U.O. Maggiore, University of Bari, Bari, ITALY.

**1087**   **Myasthenia Gravis Presenting as Restrictive Lung Disease**

**M. M. Montalbano** ^1^, M. Bowman^1^, D. Stickler^2^; ^1^Pediatric Pulmonary, Asthma, Allergy & Immunology, Medical University of South Carolina, Charleston, SC, ^2^Pediatric Neurology, Medical University of South Carolina, Charleston, SC.

**1088**   **Allergen-Induced Late Cutaneous Responses Are Associated with Elevated CD3^+^CCR4^+^ Cells and no Change in CD3^+^CCR3^+^ or CD3^+^CCR8^+^ Cells**

**S. C. Martins** ^1^, K. T. Nouri-Aria^1^, G. K. Banfield^1^, M. R. Jacobson^1^, H. Watanabe^1^, S. Radulovic^1^, D. S. Robinson^1^, C. M. Lloyd^2^, S. R. Durham^1^; ^1^Upper Respiratory Medicine, National Heart and Lung Institute at Imperial College London, London, UNITED KINGDOM, ^2^Leukocyte Biology, Imperial College London, London, UNITED KINGDOM.
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**1089**   **Penicillosis in Patients with X-linked Hyperimmunoglobulin M Syndrome (XHIGM), Case Reports from Thailand**

**W. Kamchaisatian** ^1^, P. Kosalaraksa^2^, S. Benjaponpitak^1^, S. Hongeng^1^, C. Direkwattanachai^1^, P. Lumbiganon^2^, S. Wiangnon^2^; ^1^Division of Allergy/Immunology, Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, ^2^Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, THAILAND.

**1090**   **Coronary Artery Aneurysms in a Patient with Hyperimmunoglobulinemia E Syndrome**

**T. Young** ^1^, D. Jerome^2^, S. Gupta^1^; ^1^U.C. Irvine, Irvine, CA, ^2^Long Beach VA Hospital, Long Beach, CA.

**1091**   **Treatment of Pyoderma Gangrenosum (PG) with Infliximab in Leukocyte Adhesion Deficiency (LAD) Type 1**

**K. P. Shanks** ^1^, E. J. Popek^2^, S. L. Abramson^1^; ^1^Department of Pediatrics, Section of Allergy and Immunology, Baylor College of Medicine, Houston, TX, ^2^Department of Pathology, Baylor College of Medicine, Houston, TX.

**1092**   **A Case of Hyper IgM Syndrome with an Intronic Point Mutation at Intervening Sequence 2, Position 16 in Activation-Induced Cytidine Deaminase *(AID)* Gene**

**R. J. Marchlewski**, D. W. Rosenthal, V. R. Bonagura; Allergy & Immunology, North Shore Long Island Jewish Health System, New Hyde Park, NY.

**1093**   **Hypogammaglobulinemia Associated with Rituximab Therapy after Bone Marrow Transplantation**

**N. D. Hare**, A. M. Dowden, Z. K. Ballas; University of Iowa, Iowa City, IA.

**1094**   **The Use of Low Dose Intramuscular Immunoglobulin for Prophylaxis against Recurrent Respiratory Tract Infections and Varicella Infections in Children with Mitochondrial Disorders**

**S. S. Wallace**, R. W. Hostoffer, Jr.; Pediatrics, Case Western Reserve University, Cleveland, OH.

**1095**   **Neutropenia, With a Cyclical Pattern, In Antibody Deficiency**

**A. Azar**, Z. Ballas; Allergy/Immunology, University of Iowa Health Care and the Iowa City VA Medical Center, Iowa City, IA.

**1096**   **Oral Immunoglobulin Therapy in a Child with Severe Clostridium Difficile Diarrhea**

**E. J. Saturno** ^1,2^, H. Costa^3^, R. Sorensen^2^; ^1^Pediatrics, Pediatric Specialty Center, West Jefferson Medical Center, Marrero, LA, ^2^Pediatric, division of A/I, LSU Health Sciences Center, New Orleans, LA, ^3^Clinica de Alergia, Asma e Inmunologia, Panama, PANAMA.

**1097**   **Immunoglobulin Deficiency in Stickler Syndrome**

**Z. Mikhak**, P. Kelly, T. S. Cohen, J. E. Cox; Healthy Link Asthma Education Program, Children\'s Hospital Boston, Boston, MA.

**1098**   **Case Series of Juvenile Arthritis in Two Females With Autosomal Recessive Agammaglobulinemia**

**R. F. Lavi**, N. Tangsinmankong, N. K. Day, J. W. Sleasman; Division of Allergy/Immunology/Rheumatology, University of South Florida/All Children\'s Hospital, Saint Petersburg, FL.

**1099**   **A Clinical Study of Primary Immunodeficiency Disease in a Single Center in Seoul from 1996 to 2004**

**S. Park**; Samsung Seoul hospital, Seoul, REPUBLIC OF KOREA.

**1100**   **Pro- and Anti-Sleep Cytokines Regulate Attention and Sleep Disorders in Older Children and Adolescents with Advanced HIV Disease**

**S. B. Foster** ^1^, M. E. Paul^1^, D. G. Glaze^1^, J. M. Reuben^2^, L. L. Harris^1^, E. N. Cohen^2^, B. Lee^2^, C. A. Kozinetz^1^, S. G. Cron^1^, H. L. Schwarzwald^1^, M. W. Kline^1^, C. D. Jackson^1^, A. J. Loeb^1^, P. R. Frerking, Jr.^1^, P. Y. Brouwers^1^, W. T. Shearer^1^; ^1^Pediatrics, Baylor College of Medicine, Houston, TX, ^2^Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX.

**1101**   **Distinct Anti-HIV-1 Specificities Among Different Immunoglobulin Isotypes Before and After HAART**

A. Kuver, **M. H. Bluth**, J. Moallem, H. G. Durkin, M. Nowakowski; Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY.

**1102**   **Il-21 Upregulates CD8 T Cell Immune Function in HIV-Infected Individuals**

**S. Krishnan**, S. Pahwa, N. Strbo, M. Kolber; University of Miami-Miller School of Medicine, Miami, FL.

**1103**   **Virologic Outcome of Gastrostomy Tube Insertion in Treatment-Experienced Pediatric HIV-Infected Patients**

**S. M. Fung** ^1^, J. Shliozberg^2^; ^1^Division of Allergy and Immunology, Albert Einstein College of Medicine, Bronx, NY, ^2^Department of Pediatrics, Children\'s Hospital at Montefiore Medical Center, Bronx, NY.

**1104**   **Investigation of Pediatric and Adolescent HIV Practitioner Prescribing Practices as Compared to National Guidelines**

**C. Cotronei-Cascardo** ^1^, C. Rongkavilit^2^, E. Secord^1^; ^1^Allergy-Immunology, Wayne State University, Children\'s Hospital of Michigan, Detroit, MI, ^2^Infectious Disease, Wayne State University, Children\'s Hospital of Michigan, Detroit, MI.

**1105**   **Different Patterns of Delayed-Type Hypersensitivity Skin Tests Reactivity in HIV-1-Infected and Non-Infected Children and Adolescentes Immunized with BCG in Central-West Brazil**

**N. M. X. Costa** ^1^, M. Albuquerque^2^, J. B. A. Lins^1^, A. M. R. Visconde^1^, M. M. A. Stefani^1^; ^1^Immunology, Universidade Federal de Goias, Goiania - Goias, BRAZIL, ^2^Pediatrics, Hospital Anuar Auad, Goiania - Goias, BRAZIL.

**1106**   **Suppressed Exhaled Nitric Oxide in HIV-1 Infected Children**

O. Asimolowo, H. Muzumdar, N. Desai, M. Rao, H. G. Durkin, **M. Nowakowski**; Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY.

**1107**   **IgE and Atopy in Perinatally HIV-Infected Children**

**C. S. Bowser** ^1^, J. Kaye^1^, C. Charlot^2^, R. Joks^2^, J. Moallem^1^; ^1^Pediatrics, Division of Allergy and Immunology, Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY, ^2^Medicine, Division of Allergy and Immunology, Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY.

**1108**   **Intracellular IL-17 Expression in Peripheral Blood CD4+ and CD4- T Cells of HIV-Infected Individuals**

**W. Maek-A-Nantawat** ^1^, S. Buranapraditkun^2^, K. Ruxrungthum^2^; ^1^Mahidol University, Bangkok, THAILAND, ^2^Medicine, Chulalongkorn University, Bangkok, THAILAND.
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**1109**   **Severe Combined Immunodeficiency in Twins Presenting with Different T, B, and NK Cell Phenotypes**

**H. Tcheurekdjian** ^1^, M. Cowan^2^, M. Muskat^2^, D. Wara^2^; ^1^Medicine and Pediatrics, University of California, San Francisco, San Francisco, CA, ^2^Pediatrics, University of California, San Francisco, San Francisco, CA.

**1110**   **Clinical Features of Pediatric Immunology Patients Referred to a Tertiary Care Clinic**

**I. Warrier**, E. Secord; Allergy and Immunology, Children\'s Hospital of Michigan/WSU, Detroit, MI.

**1111**   **Suspected Atypical Common Gamma Chain Severe Combined Immunodeficiency**

**A. Chandra** ^1^, D. Webster^2^, K. C. Gilmour^3^, D. S. Kumararatne^1^, A. Thrasher^3^; ^1^Clinical Immunology, Addenbrooke\'s Hospital, Cambridge, UNITED KINGDOM, ^2^Clinical Immunology, Royal Free Hospital, London, UNITED KINGDOM, ^3^Clinical Immunology, Great Ormand St Hospital, London, UNITED KINGDOM.

**1112**   **Rapid *In Vitro* T-Cell Functional Assays May Fail to Detect Immunodeficiencies**

**R. K. Merchant**, J. R. Perez, N. Y. Olson; Department of Pediatrics Division of Allergy and Immunology, University of Kansas Medical Center, Kansas City, KS.

**1113**   **Characterization of Immune Function in a Patient with Ectopic Thymus**

**V. S. Kancherla** ^1^, S. B. Foster^1^, C. Holsinger^2^, M. Luna^2^, J. Jones^1^, C. Hanson^1^; ^1^Texas Childrens Hospital, Houston, TX, ^2^University of Texas at Houston Medical School, Houston, TX.

**1114**   **Mycobacterium Avium Complex (MAC) Infection In 2 Siblings with Autosomal Recessive Interferon Gamma (INFγ) Receptor Deficiency (I87T)**

**C. Cotronei-Cascardo** ^1^, E. Secord^1^, S. Ebbinghaus^1^, S. Patel^2^, S. Holland^3^; ^1^Allergy-Immunology, Wayne State University, Children\'s Hospital of Michigan, Detroit, MI, ^2^Laboratory of Clinical Infectious Diseases, NIAID/NIH, Bethesda, MD, ^3^Laboratory of Clinical Infectoius Diseases, NIAID/NIH, Bethesda, MD.

**1115**   **Prostacyclin-Induced Antibody Deficiency in the Treatment of Pulmonary Hypertension**

**A. M. Dowden** ^1^, Z. K. Ballas^1,2^; ^1^Department of Internal Medicine, University IA Hospitals and Clinics, Iowa City, IA, ^2^Iowa City VA Medical Center, Iowa City, IA.

**1116**   **A Case of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) Without Serological Evidence of Autoimmunity**

**P. Ponda** ^1^, D. W. Rosenthal^1^, B. Kaplan^1^, P. LoGalbo^1^, S. J. Schuval^1^, T. R. Torgerson^2^, H. D. Ochs^2^, V. R. Bonagura^1^; ^1^Department of Allergy and Immunology, North Shore Long Island Jewish Medical Center - Schneider Children\'s Hospital, Great Neck, NY, ^2^Pediatric Immunology, University of Washington and Children\'s Hospital Regional Medical Center, Seattle, WA.

**1117**   **PET Imaging and Needle Biopsy in Granulomatous Variant-Common Variable Immunodeficiency (GD-CVID) with Peripheral Adenopathy**

**J. W. Blume**, M. F. Sands; Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Buffalo, NY.

**1118**   **Absence of Pre B Lymphocytes in a 16 Year Old Girl with Agammaglobulinemia and Cytopenias**

**C. S. Koenig** ^1^, M. Conley^2^, K. A. DeMuth^3^, A. Irani^1^; ^1^Allergy-Immunology, Virginia Commonwealth University, Richmond, VA, ^2^Immunology, University of Tennessee College of Medicine, Memphis, TN, ^3^Allergy-Immunology, Washington University, St. Louis, MO.

**1119**   **Gastrointestinal (GI) Involvement in Iranian Patients with Chronic Granulomatous Disease (CGD)**

**N. Shahnavaz**, A. Aghamohammadi, A. Babaei Jandaghi, K. Abolmaali, N. Rezaei, M. Ezzati, A. Aghaei Lasboo, M. Movahedi, M. Moin; Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, IRAN (ISLAMIC REPUBLIC OF).

**1120**   **T Cell Repertoire in 22q11.2 Deletion Syndrome**

**J. Yu** ^1^, G. Uzel^2^; ^1^Pediatrics, Division of Allergy and Immunology, Mount Sinai School of Medicine, New York, NY, ^2^NIAID, National Institutes of Health, Bethesda, MD.

**1121**   **IPEX with Normal FOXP3 Gene and Diminished Expression**

**M. Solomon** ^1^, H. Ochs^2^, R. Hostoffer, Jr.^3^; ^1^Kirksville College of Osteopathic Medicine, Kirksville, MO, ^2^University of Washington, Seattle, WA, ^3^Pediatrics, Case Western Reserve University, Cleveland, OH.

**1122**   **Mutation of NEMO Associated with Neutrophil Chemotaxis Abnormality**

**D. Alle** ^1^, J. Venglarcik^2^, D. Williams^3^, J. Casanova^4^, R. Hostoffer, Jr.^5^; ^1^Internal Medicine, Case Western Reserve University, Cleveland, OH, ^2^Pediatrics, Northeastern Ohio Universities College of Medicine, Rootstown, OH, ^3^Hematology, University of Cincinnati, Cincinnati, OH, ^4^Immunology, Necker Hospital, Paris, FRANCE, ^5^Pediatrics, Case Western Reserve University, Cleveland, OH.

**1123**   **Autosomal Dominant Common Variable Immunodeficiency in a Large Pedigree**

**A. Marks** ^1^, B. Grimbacher^2^, R. Hostoffer, Jr.^1^; ^1^Pediatrics, Case Western Reserve University, Cleveland, OH, ^2^Internal Medicine, University Hospital Freiburg, Frieburg, GERMANY.

**1124**   **Impaired Immunity in May Hegglin Anomaly due to MYH9 Mutation**

**M. L. Heltzer**, J. S. Orange; Allergy and Immunology, Children\'s Hospital of Philadelphia, Philadelphia, PA.

**1125**   ***Disseminated Mycobacterium* tuberculosis Infection Due to IFN-γ Deficiency. Response to Replacement Therapy**

**S. L. Seneviratne** ^1^, J. Macfarlane^2^, R. Doffinger^3^, L. Ceron-Gutierrez^3^, M. Amel Kashipaz^1^, A. Robbins^1^, T. Patel^1^, P. T. Powell^1^, D. S. Kumararatne^3^, R. J. Powell^1^; ^1^Clinical Immunology Unit, Queens Medical Centre, Nottingham, UNITED KINGDOM, ^2^Respiratory Medicine Department, Nottingham City Hospital, Nottingham, UNITED KINGDOM, ^3^Department of Clinical Immunology, Addenbrookes Hospital, Cambridge, UNITED KINGDOM.

**1126**   **Novel Mutation of BTK Gene in an XLA Patient with Late Manifestation of Chronic Arthritis, Encephalopathy and *Pseudomonas* Sepsis**

**W. Manuyakorn** ^1^, W. Kamchaisatian^1^, S. Benjaponpitak^1^, D. Wattanasirichaigoon^2^, C. Direkwattanachai^1^; ^1^Pediatrics, Division of Allergy/Immunology, Ramathibodi Hospital,Mahidol University, Bangkok, THAILAND, ^2^Pediatrics, Division of genetic, Ramathibodi Hospital,Mahidol University, Bangkok, THAILAND.

**1127**   **Cartilage-Hair Hypoplasia Syndrome: A Pediatric Case Report of Nonalcoholic Steatohepatitis and Liver Failure**

**I. S. Randhawa**, G. Yanni; Allergy & Immunology, Loma Linda University Medical Center- UCLA West Los Angeles VA, Los Angeles, CA.

**1128**   **Ectodermal Dysplasia (ED) and Recurrent Pneumonia in a Ten Year Old Girl**

**M. Bathija** ^1^, D. McDonald^2^, M. Adams^1^, E. V. Bawle^3^, R. S. Geha^2^, E. A. Secord^1^; ^1^Division of Allergy, Immunology & Rheumatology, Wayne State University/Children\'s Hospital of Michigan, Detroit, MI, ^2^Division of Immunology, Children\'s Hospital Boston, Boston, MA, ^3^Division of Genetics and Metabolic Disorders, Wayne State University/Children\'s Hospital of Michigan, Detroit, MI.

**1129**   **Atopic Patient with Cyclic Neutropenia Associated**

R. Cordoba Cordoba, **M. E. Gonzalez Serrano**, A. T. Staines Boone, G. López; Alergia e Inmunologia Pediatrica, Instituto Nacional de Pediatria, Mexico City, MEXICO.
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**1130**   **The First Nation-Wide Survey on the Prevalence of Asthma for School Children by Using ISAAC Questionnaire in Japan**

**M. Akashi** ^1,2^, Y. Ohya^1,2^, M. Futamura^1,2^, N. Kojima^1,2^, M. Narita^1,2^, K. Akiyama^2^, K. Takahashi^2^, T. Nakagawa^2^, F. Kobayashi^2^, A. Eboshida^2^, H. Nakamura^2^, H. Odajima^2^, Y. Adachi^2^, A. Akasawa^1,2^; ^1^National Center for Child Health and Development, Tokyo, JAPAN, ^2^Japanese Asthma Survey Group, Tokyo, JAPAN.

**1131**   **Comparison of the Prevalence of Wheeze, Persistent Rash and Doctor-Diagnosed Eczema in the Three South East Asian Cities of Jarkarta, Bandung and Singapore**

**K. Baratawidjaja** ^1^, B. Setabudiawan^2^, Z. Munasir^3^, N. Kurniati^3^, T. N. Tan^4^, D. L. Lim^4^, B. W. Lee^4^, H. Van Bever^4^; ^1^Medicine, University of Indonesia, Jarkarta, INDONESIA, ^2^Division of Allergy Immunology/Child Health Dept., Hasan Sadikin General Hospital, Bandung, INDONESIA, ^3^Pediatric, Cipto Mangunkusumo General Hospital, Jarkarta, INDONESIA, ^4^Paediatrics, National University of Singapore, Singapore, SINGAPORE.

**1132**   **Prevalence of Asthma and Rhinitis Among Adolescents Living in Urban or Rural Areas of Different Cities of Brazil**

**D. Sole** ^1^, V. E. Cassol^2^, A. R. Silva^3^, L. C. Bandim^4^, T. Rizatto^2^, S. P. Teche^2^, E. C. S. Sarinho^3^; ^1^Pediatric Allergy, Federal University of São Paulo-Escola Paulista de Medicina, São Paulo, BRAZIL, ^2^Pediatric Pulmonology, Federal University of Santa Maria, Santa Maria, BRAZIL, ^3^Pediatrics, Federal University of Pernambuco, Recife, BRAZIL, ^4^Pediatrics, Federal University of Pernambuco, São Paulo, BRAZIL.

**1133**   **Sensitization to Aeroallergens in Brazilian Adolescents Living at Large Urban Centers**

**A. C. Pastorino** ^1^, F. C. Kuschnir^2^, L. C. P. Arruda^3^, R. R. D. Casagrande^1^, R. G. L. Souza^1^, G. A. C. Dias^4^, H. H. N. Silveira^4^, A. J. L. A. Cunha^5^, C. M. A. Jacob^1^, D. Solé^6^; ^1^Pediatric Department, Instituto da Criança, University of São Paulo, São Paulo, BRAZIL, ^2^Federal University of Rio de Janeiro, School of Medicine , Rio de Janeiro, Rio de Janeiro, BRAZIL, ^3^Department of Internal Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, BRAZIL, ^4^Secretariat of Civil Defense, School Health Program, Rio de Janeiro, BRAZIL, ^5^Pediatric Department, Federal University of Rio de Janeiro, Rio de Janeiro, BRAZIL, ^6^Pediatric Department, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, BRAZIL.

**1134**   **Lifestyle, Sports Activities and Allergic Diseases**

**M. Bresciani** ^1^, C. Parisi^1^, V. Porcaro^2^, M. A. Schirru^3^, A. Torre^4^, M. Bonini^1^, A. Biffi^5^, F. Fernando^5^, G. Rasi^4^, C. D\'Ambrosio^1^, S. Bonini^1^; ^1^IRCCS San Raffaele, Rome, ITALY, ^2^Istituto Malattie dell\'Apparato Respiratorio, Università di Modena e Reggio Emilia, Modena, ITALY, ^3^USL Roma H, Rome, ITALY, ^4^INMM-CNR, Rome, ITALY, ^5^Istituto di Scienze dello Sport, Rome, ITALY.

**1135**   **Influenza Vaccine Compliance among Pediatric Asthmatic Patients: What is the Better Method of Notification?**

**A. L. Parker** ^1^, M. L. Moore^2^; ^1^Allergy/Immunology (Wilford Hall Medical Center), San Antonio Uniformed Services Health Education Consortiuim, Lackland AFB, TX, ^2^Department of Pediatrics, Shaw Air Force Base, 20th Medical Group, Shaw AFB, SC.

**1136**   **The Relationship Between Allergen Sensitization and Bronchial Hyperresponsiveness in Children Aged 6-8 Years**

**J. Yu** ^1^, Y. Yoo^2^, H. Kang^3^, D. Kim^4^, S. Choi^4^, Y. Koh^4^; ^1^Pediatrics, Dongguk University International Hospital, Goyang, REPUBLIC OF KOREA, ^2^Pediatrics, Korea University Anam Hospital, Seoul, REPUBLIC OF KOREA, ^3^Pediatrics, Korea University Guro Hospital, Seoul, REPUBLIC OF KOREA, ^4^Pediatrics, Seoul National University Hospital, Seoul, REPUBLIC OF KOREA.

**1137**   **Does Breast Feeding Protect Against Atopic Diseases?**

**M. Herrag**; Paediatric Respiratory Diseases, Ibn Sina University Hospital, Rabat, MOROCCO.

**1138**   **Topical Diclofenac Induced Asthma And Contact Dermatitis**

**H. Langer**; Allergy And Immunology, Hospital For Sick Children, Toronto, ON, CANADA.

**1139**   **Prevalence of Asthma and Rhinitis Symptoms Among 13 to 14-Year-Old Schoolchildren from Criciúma-SC, Brazil**

**J. BETTIOL** ^1^, C. C. RAASCH^2^, M. B. SANTOS^2^, J. C. SALVADOR^2^, M. O. PRESADO^2^, J. A. SCHMIDT^2^; ^1^Medicine Department and Health Science Post-graduation Course, Universida de do Extremo Sul Catarinense - UNESC, Criciúma - Santa Catarina, BRAZIL, ^2^Medecine Department, Universidade do Extremo Sul Catarinense - UNESC, Criciúma - Santa Catarina, BRAZIL.

**1140**   **Prevalence of Asthma Like Symptoms and Other Allergic Diseases in Scholars from Pamplona, Colombia**

**M. Sarrazola-Sanjuan**, L. Gomez-Cabeza, E. Herrera; Universidad de Pamplona, Pamplona, COLOMBIA.

**1141**   **Association between IgA and IgG1 Serum Level and Atopy in Children**

**P. Majak**, J. Jerzynska, I. Stelmach; Dep. Allergy and Pediatrics, M Curie Hospital, Zgierz, POLAND.

**1142**   **Asthma Prevalence in Public Housing Communities**

**J. Poyser**, T. Richards, D. Collins, T. Green, R. Morgan, E. Horowitz, A. Togias; Johns Hopkins University, Baltimore, MD.

**1143**   ***Association of Mycoplasma Pneumoniae* with Initial Wheezer for 3 Years Follow-Up**

**H. Yoon** ^1^, W. Kim^2^; ^1^Hallym University, Seoul, REPUBLIC OF KOREA, ^2^Pediatrics, Inje University, Seoul, REPUBLIC OF KOREA.

**1144**   **Anthropometric Measures and Lung Function Test in Asthmatic Pacients, Asthmatic Obese, Obese without Asthma and Healthy Pacients**

**J. E. Guillen Escalon**, J. J. L. Sienra, G. Toussaint, M. A. Rosas, B. E. Del Rio; Pediatric Allergy and Immunology, Hospital Infantil de Mexico, Mexico DF, MEXICO.
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**1145**   **Wheezing in a High Risk Cohort Predicts an Increased Prevalence of Positive Skin Test Results Relative to a General Population Sample**

**K. T. Sullivan Dillie** ^1^, E. L. Anderson^1^, D. F. DaSilva^1^, M. Evans^2^, R. Gangnon^2^, T. E. Pappas^1^, L. E. Pleiss^1^, K. A. Roberg^1^, C. J. Tisler^1^, J. E. Gern^1^, R. F. Lemanske, Jr.^1^; ^1^Department of Pediatrics, University of Wisconsin - Madison, Madison, WI, ^2^Department of Biostatistics, University of Wisconsin - Madison, Madison, WI.

**1146**   **Rhinitis and Asthma Caused by Sport Fishing**

**M. F. Madero** ^1^, M. Fernandez-Nieto^1^, S. Quirce^1^, C. Seoane^2^, B. Sastre^2^, V. del Pozo^2^, C. Lahoz^2^, J. Sastre^1^; ^1^Servicio de Alergia, Fundacion Jimenez Diaz, Madrid, SPAIN, ^2^Servicio de Inmunologia, Fundacion Jimenez Diaz, Madrid, SPAIN.

**1147**   **Association between Obstructive Sleep Apnea Syndrome and Atopy in Children**

**P. L. Ramirez** ^1^, U. Emre^1^, A. Schneider^2^; ^1^Pediatrics, Long Island College Hospital, Brooklyn, NY, ^2^Allergy and Immunology, Long Island College Hospital, Brooklyn, NY.

**1148**   **Importance of Polysensitization in Allergic Rhinitis and Asthma**

**G. Moscato** ^1^, L. Perfetti^1^, R. Cantone^2^, L. La Rosa^2^, C. Cosentino^3^, L. Berardi^4^, P. Puccinelli^5^, C. Incorvaia^6^, F. Frati^5^; ^1^Allergy Center, Istituto Maugeri, Pavia, ITALY, ^2^Allergy Service, General Hospital, Borgomanero, ITALY, ^3^Allergy Service, General Hospital, Tortona, ITALY, ^4^Dermatology, Policlinico S. Matteo, Pavia, ITALY, ^5^Scientific Department, Stallergenes Italy, Milan, ITALY, ^6^Allergy/Rheumatology, ICP Hospital, Milan, ITALY.

**1149**   **An Unusual Case of Red Tide Poisoning**

**M. Sanka**; Allergy and Immunology, Uinversity of South Florida, Tampa, FL.

**1150**   **Allergies: Our Reality**

**J. L. Rodríguez Barata**; Centro Médico Familiar, San Marcos, Tarrazú. San José., COSTA RICA.

**1151**   **House Dust Mites Survive Travel in the Baggage Compartment of Commercial Jet Airliners**

**J. D. Miller**; Allergy & Asthma Associates, PC, Danbury, CT.

**1152**   **Onset of Nasal Symptoms Induced by the Pollen of *Cryptomeria fortunei* in a Japanese Patient with Cedar Pollinosis: A Clinical Pilot Study**

**L. Cheng** ^1^, H. B. Shi^2^, M. Yin^1^, A. Miyoshi^2^; ^1^International Research Centre for Nasal Allergy, Nanjing Medical University, The First Affiliated Hospital, Nanjing, CHINA, ^2^International Research Centre for Nasal Allergy, Nanjing Medical University, Miyoshi ENT Clinic, Sendai, JAPAN.

**1153**   **The Efficacy of Medic-Air™ in Patients with Dust Mite Allergy**

**Z. M. Sthoeger** ^1^, D. Elbirt^1^, S. Kivity^2^; ^1^Kaplan Medical Center, Rehovot, ISRAEL, ^2^Sourasky Medical Center, for the Israeli Medic-Air™ study group, Tel-Aviv, ISRAEL.

**1154**   **Identifying Domestic Aeroallergen Exposure in a Cystic Fibrosis Patient: A Case Study**

**J. K. Sercombe** ^1^, D. Liu-Brennan^1^, B. J. Green^2^, E. R. Tovey^1^; ^1^Woolcock Institute of Medical Research, Sydney NSW, AUSTRALIA, ^2^Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV.
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**1155**   **Faecal Eosinophilic Protein X (f-EPX), Atopic Dermatitis, Sensitisation and Gastrointestinal Permeability in Infants Aged 3-6 Months**

**C. Peterson** ^1^, T. Hansson^1^, E. Hadley^2^, C. Chaloner^3^, A. Woodcock^2^, A. Custovic^2^, C. Gore^2^; ^1^Gastrointestinal Research, Pharmacia Diagnostics, Uppsala, SWEDEN, ^2^North West Lung Research Centre, Manchester, UNITED KINGDOM, ^3^Department of Biochemistry, Booth Hall Children\'s Hospital, Manchester, UNITED KINGDOM.

**1156**   **Gastrointestinal Permeability is Abnormal in Young Infants with Atopic Dermatitis but Not Associated with Disease Severity or Sensitisation**

**C. Gore** ^1^, E. Hadley^1^, C. Chaloner^2^, G. Kerry^1^, K. Johnson^1^, A. Woodcock^1^, A. Custovic^1^; ^1^Wythenshawe Hospital, North West Lung Research Centre, Manchester, UNITED KINGDOM, ^2^Booth Hall Children\'s Hospital, Manchester, UNITED KINGDOM.

**1157**   **Diagnosing Egg and Milk Hypersensitivity in Children with Atopic Dermatitis using Atopy Patch and Skin Prick Tests**

**M. Yazicioglu** ^1^, U. Ozdagli^1^, D. Kircuval^2^, A. Gorgulu^2^, O. Pala^1^; ^1^Department of Pediatrics, Trakya University, Edirne, TURKEY, ^2^Department of Dermatology, Trakya University, Edirne, TURKEY.

**1158**   **Distinguishing Features of Eosinophilic Esophagitis in Children**

**S. S. Aceves** ^1^, R. O. Newbury^2^, R. Dohil^3^, J. Schwimmer^3^, J. F. Bastian^1^; ^1^Allergy, Immunology, Children\'s Hospital, San Diego, University of California, San Diego, San Diego, CA, ^2^Pathology, Children\'s Hospital, San Diego, San Diego, CA, ^3^Pediatric Gastroenterology, University of California, San Diego, Children\'s Hospital, San Diego, San Diego, CA.

**1159**   **Increased Intestinal Permeability in Asymptomatic Children with Food Allergy**

**K. M. Jarvinen** ^1^, J. Meddings^2^, S. Noone^1^, H. A. Sampson^1^, M. C. Arrieta^2^, A. Nowak-Wegrzyn^1^; ^1^Allergy and Immunology, Mt. Sinai Medical Center, New York, NY, ^2^University of Alberta, Edmonton, AB, CANADA.

**1160**   **The Expression Frequency of Th1/Th2-Positive Cells and the Antiallergic Effect of Oligosaccharide in a Food Allergy Mouse Model**

**S. Fujitani**, K. Ueno, T. Kamiya, T. Kitabayashi, K. Itabashi; Department of Pediatrics, Showa University, TOKYO, JAPAN.

**1161**   **Descriptive Study of Food and Aeroallergen Sensitizations in Eosinophilic Esophagitis**

**A. Letran Camacho** ^1^, T. Caballero Molina^1^, A. Lucendo Villamarin^2^, B. Cid Sánchez^1^, M. Martín Esteban^1^, C. López Serrano^1^; ^1^Allergy Department, Hospital Universitario La Paz, Madrid, SPAIN, ^2^Gastroenterology Department, Hospital Universitario La Paz, Madrid, SPAIN.

**1162**   **Severe Reactions to Grape, As Part of a Lipid Transfer Protein-Associated Clinical Syndrome**

**E. Vassilopoulou** ^1^, J. Akkerdaas^2^, I. Tassios^1^, N. Rigby^3^, L. Zuidmeer^2^, R. van Ree^2^, C. Mills^3^, P. Saxoni-Papageorgiou^1^, N. G. Papadopoulos^1^; ^1^Research Laboratories of 2nd Paediatric Clinic, University of Athens, Athens, GREECE, ^2^Academic Medical Centre, University of Amsterdam, Amsterdam, THE NETHERLANDS, ^3^Institute of Food Research, Norwich, UNITED KINGDOM.

**1163**   **Allergic Reactions to Fresh Fruits: Beyond Oral Symptoms**

**J. Rodriguez**, R. Mielgo, A. Gonzalez, J. F. Crespo; Servicio de Alergia, Hospital Universitario 12 de Octubre, Madrid, SPAIN.

**1164**   **Prevalence of Skin Test Reactivity to Tomato Peel and Pulp Extracts in the Mediterranean Coast of Spain**

A. Ferrer^1^, C. Larramendi^2^, J. Huertas^3^, J. García-Abujeta^2^, C. Andreu^1^, R. Tella^4^, M. Cerdà^4^, J. Lavin^3^, J. Pagán^5^, J. Bartra^6^, J. Carnés^7^, **E. Fernández-Caldas** ^7^; ^1^Hospital Vega Baja, Alicante, SPAIN, ^2^Hospital Marina Baixa, Alicante, SPAIN, ^3^Hospital General Básico de la Defensa, Cartagena, SPAIN, ^4^Hospital Universitari de Girona, Gerona, SPAIN, ^5^Hospital Virgen de la Arrixaca, Murcia, SPAIN, ^6^Hospital Clínic de Barcelona, Barcelona, SPAIN, ^7^Laboratorios LETI S.L., Tres Cantos, SPAIN.

**1165**   **Immunochemical Characterization of Tomato Peel and Pulp Extracts**

**J. Carnés** ^1^, M. López-Matas^1^, A. Ferrer^2^, C. Larramendi^3^, J. Huertas^4^, M. Casanovas^1^, E. Fernández-Caldas^1^; ^1^Laboratorios LETI S.L., Tres Cantos, SPAIN, ^2^Hospital de la Vega Baja, Alicante, SPAIN, ^3^Hospital Marina Baixa, Alicante, SPAIN, ^4^Hospital General Básico de la Defensa, Cartagena, SPAIN.

**1166**   **Gene Silencing is an Efficient Tool to Reduce the Allergenic Potential of Tomato Fruits**

**Y. Lorenz**; Allergology, Paul-Ehrlich-Institut, Langen, GERMANY.

**1167**   **Cabbage Lipid Transfer Protein Bra o 3 is a Major Allergen Responsible for Cross-Reactivity between Plant Foods and Pollens**

J. Cumplido^1^, A. Palacín^2^, J. Figueroa^1^, O. Ahrazem^2^, R. Sánchez-Monge^2^, T. Carrillo^1^, G. Salcedo^2^, **C. Blanco** ^1^; ^1^Hospital Universitario Dr. Negrín, Las Palmas de GC, SPAIN, ^2^E.T.S. Ingenieros Agrónomos, Madrid, SPAIN.

**1168**   **IgE-Binding Capacity and Cross-Reactivity of Lipid-Transfer-Proteins (LTP) from Peach (Pru p 3) and Hazelnut (Cor a 8)**

**C. Hartz** ^1^, I. Lauer^1^, J. Lidholm^2^, K. Fötisch^1^, M. San Miguel-Moncin^3^, A. Cistero-Bahima^3^, S. Vieths^1^, S. Scheurer^1^; ^1^Paul-Ehrlich-Institut, Langen, GERMANY, ^2^Pharmacia Diagnostics, Uppsala, SWEDEN, ^3^Institut Universitari Dexeus, Barcelona, SPAIN.

**1169**   **Quantification and Regional Distribution of Eosinophils in the Gastrointestinal Tract of Children**

**C. W. DeBrosse** ^1^, J. W. Case^2^, M. Collins^3^, M. E. Rothenberg^1^; ^1^Division of Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Division of Allergy and Immunology, Cincinnati Children\'s Hospitla Medical Center, Cincinnati, OH, ^3^Pathology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**1170**   **Treatment of Eosinophilic Esophagitis with Low to Moderate Dose Swallowed Inhaled Corticosteroids**

**K. M. Maples** ^1^, S. Pustilnik^1^, W. Zhao^1^, T. Williams^2^, M. Graham^2^, A. Irani^1^; ^1^Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, VA, ^2^Pediatric Gastroenterology, Virginia Commonwealth University, Richmond, VA.

**1171**   **Resolution of Eosinophilic Esophagitis Following Dietary Restriction of Corn**

**R. M. Casper** ^1^, M. B. Levy^1^, M. C. Stephens^2^; ^1^Allergy and Immunology, Medical College of Wisconsin, Milwaukee, WI, ^2^Gastroenterology, Medical College of Wisconsin, Milwaukee, WI.

**1172**   **Esophageal Fibrosis in Children with Allergic Eosinophilic Esophagitis (AEE)**

**M. Chehade** ^1^, H. A. Sampson^1^, M. S. Magid^2^; ^1^Pediatrics, Mt. Sinai School Medicine, New York, NY, ^2^Pathology, Mt. Sinai School Medicine, New York, NY.

**1173**   **Food Protein-Induced Enterocolitis Syndrome Caused by Fish**

**G. Davila**, L. Zapatero, E. Alonso, P. Rojas, E. Martin, I. Martinez-Molero; Pediatric Allergy Section, Hospital Gregorio Marañon, Madrid, SPAIN.

**1174**   **Pilot Study of Omalizumab (anti-IgE) in Eosinophilic Gastroenteritis**

**S. Foroughi** ^1^, P. J. Mannon^2^, L. B. Bernardino^1^, B. Foster^1^, L. M. Scott^1^, D. D. Metcalfe^1^, C. Prussin^1^; ^1^Laboratory of Allergic Diseases, NIAID, National Institutes of Health, Bethesda, MD, ^2^Mucosal Immunity Section, Laboratory of Host Defense, NIAID, National Institutes of Health, Bethesda, MD.

**1175**   **Digestibility and Availability of Nitrogen for Whey Protein Hydrolysate Products Assessed Using a Dynamic In Vitro Gastrointestinal Model**

**K. Venema** ^1^, M. H. Dohnalek^2^; ^1^Physiological Sciences, TNO Quality of Life, Zeist, THE NETHERLANDS, ^2^Abbott Nutrition International, Abbott Laboratories, Abbott Park, IL.
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**1176**   **Anaphylaxis, A Review of Emergency Department Management and Discharge Planning**

**F. Rezaee**, J. Mendelson; Pediatrics, Newark Beth Israel Medical Center, Newark, NJ.

**1177**   **Doctor - How Do I Use my Epipen?**

**S. S. Mehr**, M. Robinson, M. Tang; Immunology Department, Royal Children\'s Hospital, Melbourne, Victoria, Melbourne, Victoria, AUSTRALIA.

**1178**   **Factors Affecting the Use of Automatic Epinephrine Injectors (AEI)**

**M. Varghese**, P. Lieberman; Medicine, University of Tennessee College of Medicine, Memphis, TN.

**1179**   **Differences in Cytokine Production Between Idiopathic Anaphylaxis (IA) Subjects and Controls**

**J. Reed** ^1^, M. Yedulapuram^1^, P. Lieberman^1^, E. Fitzpatrick^2^; ^1^Medicine, University of Tennessee College of Medicine, Memphis, TN, ^2^Microbiology, University of Tennessee College of Medicine, Memphis, TN.

**1180**   **Recognition, Evaluation, and Treatment of Anaphylaxis in the Child Care Setting: Six Months and One Year Later**

**B. M. Patel** ^1,2^, P. J. Bansal^1,3^, M. C. Tobin^1^; ^1^Department of Immunology and Microbiology, Department of Pediatrics, Rush University Medical Center, Chicago, IL, ^2^Department of Medicine, McGaw Medical Center, Northwestern University Evanston Hospital, Evanston, IL, ^3^Asthma & Allergy Center, Bloomingdale, IL.

**1181**   **Exercise Induced Anaphylaxis: A Series from Guipúzcoa, Spain**

**J. A. Navarro** ^1^, O. Villarreal^2^, A. Aranzabal^3^, A. Joral^1^, J. F. Garmendia^1^, S. Lizarza^1^, E. Lasa^1^; ^1^Allergy Section, Hospital Donostia, San Sebastian, SPAIN, ^2^Allergy Section, Hospital Mendaro, Mendaro, SPAIN, ^3^Allergy Section, Hospital Zumarraga, Zumarraga, SPAIN.

**1182**   **Clinical Evidence of a Priming Mechanism for Insect Sting Anaphylaxis**

**D. B. K. Golden** ^1^, R. G. Hamilton^1^, S. Saini^1^, D. Kelly^1^, K. Chichester^1^, N. Breisch^2^, T. Craig^3^, J. Schroeder^1^; ^1^Johns Hopkins University, Baltimore, MD, ^2^University of Maryland, College Park, MD, ^3^Penn State Hershey Medical Center, Hershey, PA.

**1183**   **Prescribing of EpiPen to Patients Presenting to an Inner-City Hospital Emergency Room (ER) with Acute Allergic Reactions**

**S. Amara**, T. Tavartkiladze, Y. Persaud, B. Silverman, P. Hemmers, N. Gupta, A. T. Schneider; Alergy and Immunology, Long Island College Hospital, Brooklyn, NY.

**1184**   **Usefulness of Serum Tryptase in the Diagnosis of Anaphylaxis by Food Allergy in Childhood**

**M. Narita** ^1^, I. Nomura^1^, A. Aota^1^, A. Saitoh^1^, M. Akashi^1^, M. Futamura^1^, H. Watanabe^1^, T. Suda^1^, Y. Ohya^1^, M. Ebisawa^2^, A. Akasawa^3^; ^1^Division of Allergy, National Center for Child Health and Development, Tokyo, JAPAN, ^2^Department of Allergy, National Sagamihara Hospital, Clinical Research Center, Sagamihara, JAPAN, ^3^Department of Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, JAPAN.

**1185**   **Management of Acute Allergic Reactions and Anaphylaxis in the Emergency Department Between 1993-2003**

**S. Clark** ^1^, A. J. Pelletier^1^, T. J. Gaeta^2^, C. A. Camargo, Jr.^1^; ^1^Massachusetts General Hospital, Boston, MA, ^2^New York Methodist Hospital, Brooklyn, NY.

**1186**   **Anaphylaxis in Patients with Mastocytosis - a Prospective Study on Prevalence, Severity and Trigger Factors in 121 Patients**

**K. Brockow**, C. Jofer, J. Ring; Dpt. of Dermatology and Allergology Biederstein, Technical University Munich, Munich, GERMANY.

**1187**   **Epidemiology of Hymenoptera Stings and Allergic Reactions in 10,000 Midschoolchildren- Results From a National Study**

**Y. Graif** ^1^, O. Romano-Zelekha^2^, M. S. Green^2^, T. shohat^3^; ^1^allergy and immunology clinic,Pulmonary institute, Rabin Medical Center, Petach-Tiqva, ISRAEL, ^2^Israel center of disease control, Israel Ministry of Health, Tel-hashomer, ISRAEL, ^3^Tel-Aviv health district, Israel Ministry of Health, Tel-aviv, ISRAEL.

**1188**   **Long-Term Effectiveness of Venom Immunotherapy (VIT)**

T. Hafner, **M. Kosnik**; University Clinic of Respiratory and Allergic Diseases, Golnik, SLOVENIA.

**1189**   **Identification of the Major Allergens of the Venom from the South American Social Wasp Agelaia Pallipes**

**C. E. S. Galvao** ^1^, L. K. Iwai^2^, L. D. Santos^3^, M. A. Mendes^3^, M. S. Palma^3^, F. F. M. Castro^1^, E. Cunha Neto^2^, J. Kalil^1,2^; ^1^Clinical Immunology and Allergy, University of Sao Paulo Medical School, Sao Paulo, BRAZIL, ^2^Laboratory of Immunology - Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, BRAZIL, ^3^Biology Department, Institute of Biosciences, Center of Study of Social Insects, Sao Paulo State University - UNESP, Rio Claro, BRAZIL.

**1190**   **Predictive Value of Sting Challenge**

**D. Kelly** ^1^, T. Grace^1^, D. B. K. Golden^1^, T. Craig^2^, N. Breisch^3^, R. G. Hamilton^1^; ^1^Johns Hopkins University, Baltimore, MD, ^2^Penn State Hershey Medical Center, Hershey, PA, ^3^University of Maryland, College Park, MD.

**1191**   **Comparison of North American and European Polistes Venom Allergens**

C. D. Fitch^1^, P. R. Morris^1^, T. I. S. Moawad^1^, M. Schmidt^2^, **D. R. Hoffman** ^1^; ^1^Pathology and Laboratory Medicine, Brody School of Medicine, Greenville, NC, ^2^Biology, East Carolina University, Greenville, NC.

**1192**   **A Cost-Effectiveness Analysis of Venom Desensitization in Children Treated for Cure and Risk-Reduction**

K. F. Brown, **M. S. Shaker**, P. C. Jenkins, M. S. Verdi; Allergy and Clinical Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

**1193**   **Expression of the Recombinant Honeybee Venom CUB Protease Allergen**

M. Schmidt^1^, N. M. Trulli^2^, **D. R. Hoffman** ^2^; ^1^Biology, East Carolina University, Greenville, NC, ^2^Pathology and Laboratory Medicine, Brody School of Medicine, Greenville, NC.

**1194**   **Delayed and Recurrent Anaphylactic Reaction to Yellow Jacket Sting**

**G. Ghaffari** ^1^, T. Craig^1^, D. Golden^2^, S. Chegini^1^; ^1^Penn State Milton S Hershey Medical Center, Hershey, PA, ^2^Johns Hopkins University, Baltimore, MD.

**1195**   **Production of a cDNA library to *Harmonia Axyridis* Multicolor Lady Beetle**

**C. Bermant**, A. Pratt, M. Opsahl, H. Sanchez, R. K. Bush; Research, William S. Middleton VA Hospital, Madison, WI.

**1196**   **Cimex Lectularius (Bedbug) Bites Presenting as Chronic Urticaria**

**M. R. Borts**; Division of Allergy and Clinical Immunology, St. Louis University, St. Louis, MO.
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**1197**   **The Significance of Clonality and Affinity of Individual Allergen-Specific IgE Antibodies for the Activation of Human Basophils**

**L. H. Christensen**, J. Holm, J. Skovsgaard, K. Lund; Research Department, ALK-Abelló A/S, Hørsholm, DENMARK.

**1198**   **Expression Pattern and Function of Fc Epsilon RI-beta in Human Mast Cells**

**Y. Okayama** ^1^, A. Matsuda^2^, K. Yuki^1^, H. Katayama^1^, H. Saito^1^; ^1^Research Unit for Allergy Transcriptome, RIKEN Yokohama Institute, Research Center for Allergy and Immunology, Yokohama, JAPAN, ^2^Laboratory for Genetics of Allergy Diseases, RIKEN Yokohama Institute, SNP Research Center, Yokohama, JAPAN.

**1199**   **Essential Role for RasGRP1 in the IgE-dependent Allergic Response**

**Y. Liu**; Department of Immunology, Duke University Medical Center, Durham, NC.

**1200**   **Exposure to Repeated Early Childhood Infections in Relation to Atopy in Children Living in Orphanage**

**I. Stelmach**, K. Smejda, J. Jerzynska; Department of Pediatrics and Allergy, Medical University of Lodz, M Curie Hospital, Zgierz, POLAND.

**1201**   **Requirement of Fc Epsilon RI Gamma-subunit for IgE-mediated Up-regulation of Surface Fc Epsilon RI**

**H. Katayama** ^1^, S. Kagaya^1^, K. Yuki^1^, T. Arai^2^, H. Saito^1,3^, Y. Okayama^1^; ^1^Reserch Unit for Allergy Transcriptome, RIKEN Yokohama Institute, Yokohama, JAPAN, ^2^Laboratory of Seeds Finding Technology, Eisai Co., Ltd., Tsukuba, JAPAN, ^3^Department of Allergy & Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**1202**   **An IgE Antibody Reduce the Release of IL-5 from Mouse OVA treated CD34+ Hematopoietic Progenitor Cells In *V*itro**

**M. Sjöstrand**, A. Alm, A. Bossios, M. Rådinger, J. Lötvall; Respiratory Medicine and Allergology, Göteborg University, Gothenburg, SWEDEN.

**1203**   **Increased Prevalence of Blomia Tropicalis Mite Allergens in Cord Blood of Patients with a Maternal History of Asthma**

**W. Chiang** ^1^, M. Iancovici Kidon^1^, W. Liew^1^, V. Rajadurai^2^, F. Chew^3^; ^1^Department of Paediatrics, KK Children\'s Hospital, Singapore, SINGAPORE, ^2^Department of Neonatology, KK Children\'s Hospital, Singapore, SINGAPORE, ^3^Institute of Biological Sciences, National University, Singapore, SINGAPORE.

**1204**   **High Heritability of Total and Specific IgE levels in a Brazilian Population Endemic for Schistosomiasis**

**A. V. Grant** ^1,2^, M. I. Araujo^3^, K. Held^2^, E. V. Ponte^4^, Á. A. Cruz^4^, T. H. Beaty^1^, K. C. Barnes^2^; ^1^Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ^2^Division of Allergy and Clinical Immunology, Department of Medicine, The Johns Hopkins University, Baltimore, MD, ^3^Servico de Imunologia, Hospital Universitario Professor Edgard Santos, Salvador, Bahia, BRAZIL, ^4^Brazil Center for Respiratory Diseases, Federal University of Bahia, Salvador, Bahia, BRAZIL.

**1205**   **Is Human IgE+ Equivalent to Mouse Highly Cytokinergic (HC) IgE?**

**L. Xie**, J. Langdon, R. Sora, S. M. MacDonald; Medicine/Division of Allergy and Clinical Immunology, JHUSM, Baltimore, MD.

**1206**   **H3/H4 Histamine Receptor Antagonists Modulate IgE-Regulatory Cytokine Production**

**R. A. Khanferyan** ^1^, D. V. Lesik^1^, L. M. DuBuske^2^; ^1^Kuban State Medical Academy, Krasnodar, RUSSIAN FEDERATION, ^2^Immunology Research Institute of New England, Gardner, MA.

**1207**   **IgE during Pregnancy is Not Associated with Number of Prior Live Births**

**G. Wegienka** ^1^, S. Havstad^1^, D. R. Ownby^2^, C. C. Johnson^1^; ^1^Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, MI, ^2^Department of Allergy and Immunology, Medical College of Georgia, Augusta, GA.

**1208**   **Agreement Between Results of an In Vitro Assay for Plasma Allergen-Specific IgE and Skin Testing in a High-Risk Birth Cohort**

**C. J. Tisler** ^1^, M. Evans^2^, K. Roberg^1^, E. Anderson^1^, L. Pleiss^1^, D. DaSilva^1^, T. Pappas^1^, R. Gangnon^2^, J. Gern^1^, R. Lemanske, Jr.^1^; ^1^Medical School, University of Wisconsin - Madison, Madison, WI, ^2^Biostatistics and Medical Informantics, University of Wisconsin - Madison, Madison, WI.

**1209**   **Decrease in Skin Test Wheal and Flare Response after Omalizumab Therapy**

**A. Banerji**, A. A. Long; Department of Rheumatology, Allergy & Immunology, MGH, Boston, MA.

**1210**   **CD8+CD60+ T Cells, Cells Expressing Epsilon Specific mRNA, Soluble CD23 (sCD23), and Th1/Th2 Cytokines In Cord Blood**

**T. A. Smith-Norowitz**, K. B. Norowitz, S. Chice, V. Shah, M. Hagler, D. Walker, J. P. Brennan, H. G. Durkin, M. H. Bluth; Center for Allergy and Asthma Research at SUNY Downstate Medical Center, Brooklyn, NY.

**1211**   **Rhinovirus Infection in Lower Airways of Asthmatic Patients**

M. Woś^1^, M. Sanak^1^, L. Burchell^2^, A. G. Mosser^2^, J. Soja^1^, H. Olechnowicz^3^, **A. T. Szczeklik** ^1^, W. W. Busse^2^; ^1^Department of Medicine, Jagiellonian University School of Medicine, Krakow, POLAND, ^2^Division of Allergy and Immunology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, ^3^Cracow\'s Thoracosurgery Hospital, Krakow, POLAND.

**1212**   **The Role of Innate Immunity in Suppression of Allergic Inflammation by Ascaris Suum Antigens**

**A. Boesen** ^1^, B. Wetzel^1^, H. Norris^1^, V. Bundoc^1^, J. Urban^1^, J. Urban^2^, A. Keane-Myers^1^; ^1^Niaid/lad/ais, National Institutes of Health, Rockville, MD, ^2^United States Department of Agriculture, Beltsville, MD.

**1213**   **Mycobacterial Products Augment Ragweed Induced Allergic Airway Inflammation**

**N. G. Dharajiya**, S. Sur; Internal Medicine, University TX Medical Branch, Galveston, TX.

**1214**   **Th2 Cytokine and Chemokine are Elevated In Nasopharyngeal Secretions of Pediatric Patients with RSV Infection**

**H. Murai** ^1^, A. Terada^2^, H. Togari^1^; ^1^Pediatrics, Nagoya City University School Of Medicine, Nagoya, Aichi, JAPAN, ^2^Pediatric allergy, Daido Hospital, Nagoya, Aichi, JAPAN.

**1215**   **Virus Detection, Cytokine Response Profiles, and Eosinophil Activation in Acute Exacerbation of Childhood Asthma**

**M. Kato** ^1^, M. Saitoh^2^, H. Tsukagoshi^2^, K. Maruyama^3^, Y. Hayashi^4^, K. Kozawa^2^, H. Kimura^2^; ^1^Allergy and Immunology, Gunma Children\'s Medical Center, Hokkitsu, Gunma, JAPAN, ^2^Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi, Gunma, JAPAN, ^3^Internal Medicine, Gunma Children\'s Medical Center, Hokkitsu, Gunma, JAPAN, ^4^Hematology and Oncology, Gunma Children\'s Medical Center, Hokkitsu, Gunma, JAPAN.

**1216**   **Toll-like Receptor 3 and Chemokine Synthesis in Human Bronchial Smooth Muscle Cells**

**K. Niimi**, K. Asano, Y. Shiraishi, T. Takihara, J. Kagyo, M. Wakaki, T. Nakajima, Y. Suzuki, T. Shiomi, T. Oguma, A. Ishizaka; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JAPAN.
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**1217**   **Oral Treatment with Live Lactobacillus Reuteri Attenuates the Allergic Airway Response in Mice**

**P. Forsythe** ^1^, J. Wattie^2^, M. Inman^2^, J. Bienenstock^1^; ^1^Brain Body Institute and Department of Pathology and Molecular Medicine, McMaster University and St Joseph\'s Healthcare, Hamilton, ON, CANADA, ^2^Firestone Institute for Respiratory Health, McMaster University and St Joseph\'s Healthcare, Hamilton, ON, CANADA.

**1218**   **Wheezing with Rhinovirus but not Respiratory Syncytial Virus Infections in the First Three Years of Life Predicts Decreased Lung Function at Age Five**

**T. E. Pappas** ^1^, M. D. Evans^2^, K. T. Sullivan Dillie^1^, K. A. Roberg^1^, D. F. DaSilva^1^, C. J. Tisler^1^, E. L. Anderson^1^, L. E. Pleiss^1^, R. Gangnon^2^, J. E. Gern^3^, R. F. Lemanske, Jr.^3^; ^1^Department of Pediatrics, University of Wisconsin - Madison, Madison, WI, ^2^Department of Biostatistics and Medical Informatics, University of Wisconsin - Madison, Madison, WI, ^3^Department of Medicine, University of Wisconsin - Madison, Madison, WI.

**1219**   **The Influence of Eosinophilic Airway Inflammation in Response to Double-Stranded RNA Instillation**

**Y. Shiraishi** ^1,2^, K. Asano^1,2^, K. Niimi^1,2^, M. Wakaki^1,2^, J. Kagyo^1,2^, T. Takihara^1,2^, K. Sayama^1^, T. Nakajima^1^, T. Oguma^1^, Y. Suzuki^1^, T. Shiomi^1^, E. Ikeda^3^, A. Ishizaka^1,2^; ^1^Division of Pulmonary Medicine, Department of Medicine, Keio University, Tokyo, JAPAN, ^2^Pfizer-Keio Research Laboratories, Tokyo, JAPAN, ^3^Department of Pathology, Keio University, Tokyo, JAPAN.

**1220**   **Increased Tumor Necrosis Factor-a and Endothelin-1 in Nasal Secretion of Infants with Respiratory Syncytial Virus Bronchiolitis**

**H. Chung**, S. Kim; Pediatrics, School of Medicine, Catholic University of Taegu, Taegu, REPUBLIC OF KOREA.

**1221**   **Human Bronchoalveolar (BAL) Cells Secrete Increased Amounts of Monocyte Chemoattractant Protein 1 (MCP-1) During an Experimental Rhinovirus (RV) Infection**

**M. Bates** ^1^, N. L. Korpi^1^, D. J. Hall^2^, R. L. Heuser^1^, M. Aga^1^, W. W. Busse^3^, P. J. Bertics^1^; ^1^Biomolecular Chemistry, University of Wisconsin, Madison, WI, ^2^Chemistry, Lawrence University, Appleton, WI, ^3^Medicine, University of Wisconsin, Madison, WI.

**1222**   **Rhinovirus (RV)-Stimulated Release of Interferon γ-Inducible Protein 10 (IP-10) by Human Monocytes and Alveolar Macrophages**

**N. L. Korpi** ^1^, M. Bates^1^, D. J. Hall^2^, P. J. Bertics^1^; ^1^Biomolecular Chemistry, University of Wisconsin Madison, Madison, WI, ^2^Chemistry, Lawrence University, Appleton, WI.

**1223**   **C57BL6 not Balb/c Mice Develop Enhanced Ova-Specific IgE after Paramyxomal Viral Infection**

**U. Kaza**, M. M. Rohlfing, M. H. Grayson; Division of Allergy and Immunology, Washington University School of Medicine, St. Louis, MO.

**1224**   **Increased BAL Levels of Surfactant Protein (SP)-D in a Transgenic Mouse Model of Allergic Bronchopulmonary Aspergillosis**

**S. L. Koehm** ^1^, P. S. Hutcheson^2^, S. Kierstein^3^, C. J. Bellone^1^, A. Haczku^3^, R. G. Slavin^2^; ^1^Molecular Microbiology & Immunology, Saint Louis University School of Medicine, Saint Louis, MO, ^2^Internal Medicine/Allergy & Immunology, Saint Louis University School of Medicine, Saint Louis, MO, ^3^University of Pennsylvania School of Medicine, Philadelphia, PA.

**1225**   **FcεR1 and Toll-Like Receptors Mediate Synergistic Signals to Markedly Augment Production of Inflammatory Cytokines in Murine Mast Cells**

**H. Qiao** ^1^, M. A. Beaven^2^; ^1^Lab of Molecular Immunology, National Heart, Lung and Blood Institute, Bethesda, MD, ^2^Lab. of Molecular Immunology, National Heart, Lung and Blood Institute, Bethesda, MD.

**1226**   **Pulmonary and Systemic Responses to Inhaled Allergens are Aggravated by Inhaled Endotoxin**

**K. Kulhankova** ^1^, C. S. George^2^, J. N. Kline^3,1^, P. S. Thorne^1^; ^1^Occupational & Environmental Health, College of Public Health, University of Iowa, Iowa City, IA, ^2^Pediatrics, College of Medicine, University of Iowa, Iowa City, IA, ^3^Internal Medicine, College of Medicine, University of Iowa, Iowa City, IA.

**1227**   **(R)-, But Not (S)-, Enantiomers of Beta2 Agonists Inhibit IL-8 Secretion by RSV Antigen-Stimulated Confluent HumanAlveolar Epithelial Cells (cA549)**

**M. Frieri**, A. Capetandes; Division of Allergy Immunology, Nassau University Medical Center, East Meadow, NY.

**1228**   **Association Between TGF-B1 Genotype and the Development of Otitis Media (OM) in Young Children during Respiratory Virus Season**

**A. Patel**, D. A. Gentile, J. Koehrsen, D. P. Skoner; Department of Pediatrics, Allegheny General Hospital, Pittsburgh, PA.

**1229**   **The Influence of Daycare, Older Siblings and Wheezing Respiratory Illnesses During Infancy on the Development of Allergic Sensitization**

**D. F. G. DaSilva** ^1^, M. D. Evans^2^, J. D. Bufford^3^, C. J. Tisler^1^, K. A. Roberg^1^, T. E. Pappas^1^, E. L. Anderson^1^, L. E. Pleiss^1^, K. T. Sullivan Dillie^1^, R. E. Gangnon^2^, J. E. Gern^3^, R. F. Lemanske, Jr.^3^; ^1^Department of Pediatrics, University of Wisconsin - Madison, Madison, WI, ^2^Biostatistics and Medical Informatics, University of Wisconsin - Madison, Madison, WI, ^3^Department of Medicine, University of Wisconsin - Madison, Madison, WI.

**1230**   **Comparisons of Cytokine Expression and Nuclear Factor-kB Activation between Respiratory Syncytial Virus Infected and Adenovirus Infected Human Bronchial Epithelial Cells**

**J. Yoon**, M. Lee, H. Kim, J. Kim, J. Lee; Department of pediatrics, the Catholic University of Korea, Seoul, REPUBLIC OF KOREA.
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**1231**   **Azelastine Nasal Spray Compared to Cetirizine in the Treatment of Patients with Seasonal Allergic Rhinitis: a Pooled Analysis of Two Double-Blind, Multicenter Studies**

**E. Sher** ^1^, H. Sacks^2^; ^1^Atlantic Allergy Asthma and Immunology Associates, Ocean, NJ, ^2^MedPointe Pharmaceuticals, Somerset, NJ.

**1232**   **Effects of the Novel Intranasal Glucocorticosteroid Gw685698 (200μG Once-daily) on Seasonal Allergic Rhinitis (sar) Symptoms Induced in the Vienna Challenge Chamber Model (vcc)**

**P. Stuebner**; ENT University Clinic, Vienna, AUSTRIA.

**1233**   **Effects of Levocetirizine on Symptoms and Quality of Life in Persistent Allergic Rhinitis and Comorbid Asthma**

**G. Passalacqua**, M. Pasquali, A. Rogkakou, I. Baiardini, A. Riccio, C. Gamalero, G. Canonica; Allergy & Respiratory Diseases Dept of Internal Medicine, Genoa University, Genova, ITALY.

**1234**   **High Affinity Histamine Binding Protein Attenuates Nasal Allergen Challenge Induced Allergic Rhinitis**

**W. H. Weston-Davies** ^1^, P. H. Ratner^2^, C. P. Andrews^3^, G. C. Paesen^4^, P. A. Nuttall^4^; ^1^Evolutec Group plc, Reading, UNITED KINGDOM, ^2^Sylvana Research Associates, San Antonio, TX, ^3^Diagnostics Research Group, San Antonio, TX, ^4^Centre for Ecology and Hydrology, Natural Environment Research Council, Oxford, UNITED KINGDOM.

**1235**   **Evaluation of Nasal Patency and Nasal Nitric Oxide Levels in Subjects with Allergic Rhinitis After Pharmacologic or Physiologic Stimuli: a Two Parallel Groups Study**

**C. D. Serrano** ^1^, A. L. Valero^2^, J. Bartra^2^, A. Torrego^2^, J. Mullol^3^, C. Picado^2^; ^1^Allergy Unit, Fundación Clínica Valle del Lili, Cali, COLOMBIA, ^2^Pneumology and Respiratory Allergy Departament, Hospital Clínic, Barcelona, SPAIN, ^3^Rhinology Unit, ENT Departament, Hospital Clínic, Barcelona, SPAIN.

**1236**   **Desloratadine is Safe and Effective in the Treatment of the Nasal Symptoms of Perennial Allergic Rhinitis (PAR): Results of Two Observational Studies**

**M. Montagne** ^1^, C. Gennaro^2^, M. Bouchard^3^, D. Flores^4^, G. Hernández^5^, E. Urdaneta^6^; ^1^Centro Policlínico Valencia, Valencia, VENEZUELA, ^2^Centro Médico Maracay, Maracay, VENEZUELA, ^3^Instituto de Inmunología de la Universidad de los Andes, Mérida, VENEZUELA, ^4^Instituto Clínico Unare, Bolívar, VENEZUELA, ^5^Hospital Universitario de Caracas, Caracas, VENEZUELA, ^6^Schering-Plough, Caracas, VENEZUELA.

**1237**   **Desloratadine for the Relief of Nasal and Non-Nasal Allergic Symptoms: an Observational Study**

**W. Aberer**; Dermatologic University Clinic Graz, Austria, Graz, AUSTRIA.

**1238**   **Desloratadine is Effective in Relieving the Nasal and Non-Nasal Symptoms of Perennial Allergic Rhinitis (PAR) in Patients With or Without Concurrent Respiratory Tract Conditions**

**C. Loureiro** ^1^, C. Chieira^1^, M. A. P. Guilherme^2^, A. Arrobas^3^, G. Castelo Branco^4^, F. Inácio^5^, P. L. Pinto^6^, A. Afonso^7^, M. Branco^8^, F. D. Borges^9^, M. Trindade^10^; ^1^Hospitais da Universidade de Coimbra, Coimbra, PORTUGAL, ^2^Centro Hospitalar de Vila Nova de Gaia., Gaia, PORTUGAL, ^3^Centro Hospitalar de Coimbra, Coimbra, PORTUGAL, ^4^Hospital de S.João, Porto, PORTUGAL, ^5^Hospital de S. Bernardo, Setúbal, PORTUGAL, ^6^Hospital D.Estefânia, Lisboa, PORTUGAL, ^7^Hospital de S.Pedro, Vila Real, PORTUGAL, ^8^Hospital de Santa Maria, Lisboa, PORTUGAL, ^9^Centro Hospitalar do Funchal, Funchal, PORTUGAL, ^10^Hospital Pulido Valente, Lisboa, PORTUGAL.

**1239**   **Azelastine Nasal Spray is Safe and Effective at a Dosage of 1 Spray per Nostril Twice Daily in Patients with Seasonal Allergic Rhinitis (SAR)**

**W. Lumry** ^1^, W. Wheeler^2^; ^1^Allergy and Asthma Research, Dallas, TX, ^2^MedPointe Pharmaceuticals, Somerset, NJ.
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**1240**   **Rhinitis Symptom Sufferers Report a Significant Symptom Burden During an Allergy Season**

**R. Stanford** ^1^, E. Meltzer^2^, J. Derebery^3^, R. Nathan^4^, U. Campbell^5^, P. Stang^5^; ^1^GlaxoSmithKline, Research Triangle Park, NC, ^2^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^3^House Ear Clinic, Los Angeles, CA, ^4^Asthma & Allergy Associates and Research Center, Colorado Springs, CA, ^5^Galt Associates, Blue Bell, PA.

**1241**   **Infrequent Treatment of Symptoms Among Rhinitis Symptom Sufferers During an Allergy Season**

**P. Stang** ^1^, E. Meltzer^2^, J. Derebery^3^, R. Nathan^4^, U. Campbell^1^, R. H. Stanford^5^; ^1^Galt Associates, Blue Bell, PA, ^2^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^3^House Ear Clinic, Los Angeles, CA, ^4^Asthma & Allergy Associates and Research Center, Colorado Springs, CO, ^5^GlaxoSmithKline, Research Triangle Park, NC.

**1242**   **Measurement of Nitric Oxide (no) as a Tool in the Diagnosis of a Child with Recurrent Pneumonias**

**M. J. Lanz** ^1^, C. M. Ferrer^2^, M. Laufer^3^; ^1^Allergy and Immunology, AAADRS Research Center and Miami Childrens Hospital, Coral Gables, FL, ^2^Allergy and Asthma, AAADRS Research Center, Coral Gables, FL, ^3^Pediatric Infectious Disease, Miami Childrens Hospital, Miami, FL.

**1243**   **Allergic Rhinitis (AR) and its Impact on Cost, Productivity and Healthcare Resource Use of Patients**

**Y. S. Punekar** ^1^, R. D. O\'Connor^2^; ^1^GlaxoSmithKline, Greenford, UNITED KINGDOM, ^2^Sharp Rees-Stealy Medical Group, San Diego, CA.

**1244**   **Assessing Symptomatic Burden of Patients Suffering from Allergic Rhinitis (AR)**

**R. D. O**\'Connor^1^, Y. S. Punekar^2^; ^1^Department of Quality Management, Sharp Rees-Stealy Medical Group, San Diego, CA, ^2^Global Health Outcomes, GlaxoSmithKline, London, UNITED KINGDOM.

**1245**   **Heterogeneity of Effects in the Appearance of Rhinitis or/and Asthma According to Age and Atopy**

**A. Rosado**, M. Tejedor, M. Moro, C. Vila, M. Fernández-Rivas, M. Mugica, M. D. Alonso, T. Verdura; Unidad de alergia, FUNDACION HOSPITAL ALCORCON, ALCORCON, SPAIN.

**1246**   **Great Comorbidity Burden Related to Rhinitis Symptom Sufferers**

**R. A. Nathan** ^1^, J. Derebery^2^, E. Meltzer^3^, P. Stang^4^, U. Campbell^4^, R. H. Stanford^5^; ^1^Asthma & Allergy Associates and Research Center, Colorado Springs, CO, ^2^House Ear Clinic, Los Angeles, CA, ^3^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^4^Galt Associates, Blue Bell, PA, ^5^GlaxoSmithKline, Research Triangle Park, NC.

**1247**   **Seasonal Rhinoconjnctivitis in a Farner. A Case Report**

**A. Moreno** ^1^, J. Ruiz^2^, J. Mira^1^; ^1^allergy, Hospital Virgen de la Luz, Cuenca, SPAIN, ^2^allergy, Hospital Gregorio Marañon, Madrid, SPAIN.

**1248**   **Another Good Reason to Live in Cleveland, Ohio**

**A. E. Varner**; Allergy Diagnostic, Beachwood, OH.

**1249**   **Azelastine Nasal Spray Significantly Improves Health-Related Quality of Life Compared to Cetirizine Tablets in Patients with Seasonal Allergic Rhinitis (SAR)**

**E. O. Meltzer** ^1^, H. Sacks^2^; ^1^Allergy & Asthma Medical Group & Research Center, A.P.C, San Diego, CA, ^2^MedPointe Pharmaceuticals, Somerset, NJ.
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**1250**   **Further Evidence for Asthma Susceptibility Gene on Chromosome 11 in African Americans**

**P. S. Gao** ^1^, R. A. Mathias^2^, J. Goldstein, Sr.^3^, W. Alexander F^2^, E. W. Pugh^3^, A. Togias^1^, K. C. Barnes^1^, T. Beaty^4^, S. K. Huang^1^; ^1^Johns Hopkins School of Medicine, Baltimore, MD, ^2^Inherited Disease Research Branch, NIH, Baltimore, MD, ^3^Center for Inherited Disease Research, Baltimore, MD, ^4^Johns Hopkins University Bloomberg School of Medicine, Baltimore, MD.

**1251**   **Genetic Association Study Between Asthma and Plasma IgE and Human Beta-Defensin-1 Gene in Chinese Children**

**T. F. Leung** ^1^, C. Y. Li^1^, C. W. K. Lam^2^, N. L. S. Tang^2^, G. W. K. Wong^1^; ^1^Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, HONG KONG SPECIAL ADMINISTRATIVE REGION OF CHINA, ^2^Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, HONG KONG SPECIAL ADMINISTRATIVE REGION OF CHINA.

**1252**   **CTLA-4 Exon 1 and Promoter Gene Polymorphisms in Childhood Asthma**

**H. Yang** ^1^, J. Shin^1^, K. Kim^1^, C. Kim^2^, M. Sohn^1^, K. Kim^1^; ^1^Pediatrics, Sinchon Severance, Seoul, REPUBLIC OF KOREA, ^2^Pediatrics, Kwandong university, Seoul, REPUBLIC OF KOREA.

**1253**   **Involvement of Il-10 Gene Promoter Polymorphisms in the Susceptibility for Childhood Asthma**

**M. Sohn**, H. Yang, K. Kim; Department of Pediatrics, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.
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**1254**   **Natural Killer T (NKT) Cell Development in Severe Combined Immunodeficiency (SCID) After T Cell Depleted Haploidentical Bone Marrow Transplantation (BMT)**

**E. O. Sajaroff**, R. H. Buckley; Pediatric, Allergy and Immunology, Duke University Medical Center, Durham, NC.

**1255**   **Microfluidic Device Allows Low-Cost Newborn Screening for Severe Combined Immune Deficiency (SCID)**

**M. J. Butte** ^1,2^, A. P. Wong^3,4^, A. Sridhar^5^, A. H. Sharpe^2^, G. M. Whitesides^4^; ^1^Division of Immunology, Children\'s Hospital Boston, Boston, MA, ^2^Pathology, Harvard Medical School, Boston, MA, ^3^Biophysics Graduate Group, Harvard University, Boston, MA, ^4^Chemistry and Chemical Biology, Harvard University, Boston, MA, ^5^Summer Research Internship, Boston University, Boston, MA.

**1256**   **Epigallocatechin Gallate, Green Tea Catechin, Binds to the T Cell Receptor, CD4**

**C. L. Nance** ^1,2^, M. P. Williamson^3^, T. G. McCormick^1^, S. M. Paulson^1^, W. T. Shearer^1,2^; ^1^Baylor College of Medicine, Houston, TX, ^2^Texas Children\'s Hospital, Houston, TX, ^3^University of Sheffield, Sheffield, UNITED KINGDOM.

**1257**   **Cell-Cell Interactions and Cell Fate Determination: Involvement of Dlk in B Cell Developmentand Function**

r\. raghunandan, E. Rudikoff, S. Bauer; Laboratory of Stem cell biology, CBER, FDA, Bethesda, MD.
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**1258**   **Positive Phase IIa Data of CYT005-AllQbG10, a Novel Vaccine for Treatment of Allergic Rhinitis and Asthma**

**T. M. Kuendig** ^1^, P. Mueller^2^, G. Senti^1^; ^1^University of Zurich, Zurich, SWITZERLAND, ^2^Cytos Biotechnology, Zurich, SWITZERLAND.

**1259**   **Chemical Modification of Birch Allergen Extract Leads to a Reduction in Allergenicity as well as Immunogenicity**

**P. A. W**ürtzen, G. Lund, L. Lund, K. Lund, H. Henmar; Experimental Immunology, ALK-Abello, Hørsholm, DENMARK.

**1260**   **Quality of Life in Specific Immunotherapy with Alutard Sq^®^ Grass Pollen in Allergic Rhinoconjuntivitis - The Ukis-Study Results**

**T. Krishna** ^1^, A. Frew^2^, S. Durham^3^; ^1^Birmingham Heartlands Hospital, W. Midlands, Birmingham, UNITED KINGDOM, ^2^Southamton General Hospital, Southampton, UNITED KINGDOM, ^3^Imperial College National Heart & Lung Institute, London, UNITED KINGDOM.

**1261**   **Peptide Immunotherapy in Fel d 1-Sensitized HLA-DR1 Transgenic Mice is Associated with Increased IL-10 but Independent of TGFbeta and Foxp3 Expression**

**D. Campbell** ^1^, H. Gronlund^2^, M. van Hage-Hamsten^2^, D. M. Altmann^3^, C. M. Lloyd^1^, M. Larché^4^; ^1^Leukocyte Biology Section, Imperial College London, London, UNITED KINGDOM, ^2^Department of Medicine, Karolinska Institutet, Stockholm, SWEDEN, ^3^Infectious Diseases Department, Imperial College London, London, UNITED KINGDOM, ^4^Allergy & Clinical Immunology, Imperial College London, London, UNITED KINGDOM.
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**1262**   **Oral Desensitization and Induction of Tolerance in Peanut-Allergic Children**

**A. Buchanan** ^1^, A. M. Scurlock^2,3^, S. M. Jones^2,3^, L. Christie^2,3^, K. M. Althage^2,3^, L. Pons^1^, P. H. Steele^1^, A. W. Burks^1^; ^1^Duke University Medical Center, Durham, NC, ^2^Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, ^3^Arkansas Children\'s Hospital, Little Rock, AR.

**1263**   **Comparison of Efficacy of a Novel Probiotic from Koji Fermentation(ImmuSoy) with LGG on Peanut Allergy**

**W. PAN** ^1^, T. ZHANG^2^, M. TAKEBE^3^, H. A. SAMPSON^2^, X. LI^2^; ^1^Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, ^2^Pediatrics, Allergy & Immunology, Mount Sinai School of Medicine, New York, NY, ^3^Biotics R&D Division, NICHIMO CO., LTD, Tokyo, JAPAN.

**1264**   **Silencing Peanut Allergy: A Chinese Herbal Formula, Fahf-2, Completely Blocks Peanut-induced Anaphylaxis for up to 6 Months Following Therapy in a Murine Model Of Peanut Allergy**

**K. D. Srivastava**, T. Zhang, C. Qu, H. A. Sampson, X. M. Li; Graduate School of Biological Sciences, Mount Sinai School of Medicine, New York, NY.

**1265**   **Breeding a Hypoallergenic Peanut**

**T. Perkins** ^1^, D. A. Schmitt^1^, T. G. Isleib^2^, H. Cheng^1^, S. J. Maleki^1^; ^1^Food Allergy Unit, USDA-Agricultural Research Service, New Orleans, LA, ^2^Department of Crop Science, NCSU, Raleigh, NC.
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**1266**   **A Novel CCR3-CD300a Bispecific Antibody Fragment Reverses Airway Inflammation and Tissue Remodeling in a Model of Established-Chronic Experimental Asthma**

**A. Munitz**, I. Bachelet, F. Levi-Schaffer; Hebrew University Of Jerusalem, Jerusalem, ISRAEL.

**1267**   **Cysteinyl Leukotrienes in a Murine Model of Allergic Pulmonary Inflammation**

**F. I. Hsu**, D. C. Kim, N. A. Barrett, D. S. Friend, K. F. Austen, Y. Kanaoka; Division of Rheumatology, Immunology, and Allergy, Brigham and Women\'s Hospital, Boston, MA.

**1268**   **In Vivo Depletion of Murine Eosinophils by Antibodies to Siglec-F**

**N. Zimmermann** ^1^, M. McBride^1^, Y. Yamada^1^, A. Raper^2^, P. R. Crocker^2^, M. E. Rothenberg^1^, B. S. Bochner^3^; ^1^Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Division of Cell Biology and Immunology, The Wellcome Trust Biocentre at Dundee, Dundee, UNITED KINGDOM, ^3^Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.

**1269**   **A Central Regulatory Role for Eosinophils and the Eotaxin/CCR3 Axis in Chronic Experimental Asthma**

**P. C. Fulkerson** ^1,2^, C. A. Fischetti^1^, S. P. Hogan^1^, M. E. Rothenberg^1,2^; ^1^Division of Allergy & Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^University of Cincinnati College of Medicine, Cincinnati, OH.
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**1270**   **Immunological Response to Administration of Standardized Dog Allergen Extract at Differing Doses**

**A. M. Lent**, R. Harbeck, M. Sills, K. Schmidt, B. Efaw, T. Lebo, H. S. Nelson; Allergy and Immunology, National Jewish Medical and Research Center, Denver, CO.

**1271**   **T-cells Apoptosis induced by Allergens**

**J. Fernandez** ^1^, J. M. García^1^, J. Carreton^1^, A. Esteban^2^; ^1^Allergy Sect. Clinical Medicine., Elche U. Hospital. Miguel Hernández University, Elche Alicante, SPAIN, ^2^Biochemical laboratory, Alicante U. Hospital., Alicante, SPAIN.

**1272**   **Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immunotherapy**

**L. K. Wilcock** ^1^, J. N. Francis^2^, G. Paraskavopoulos^2^, S. J. Till^2^, S. R. Durham^2^; ^1^National Heart and Lung Institute, Imperial College, London, UNITED KINGDOM, ^2^Allergy and Clinical Immunology, Imperial College, London, London, UNITED KINGDOM.

**1273**   **Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Efficacy of Immunotherapy**

**M. H. Shamji** ^1^, L. K. Wilcock^2^, M. Larche^2^, J. N. Francis^2^, S. R. Durham^2^; ^1^National Heart and Lung Institute, Imperial College, London, UNITED KINGDOM, ^2^Allergy and Clinical Immunology, Imperial College, London, London, UNITED KINGDOM.
